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Abstract 
A series of co-crystallizations between four biimidazole based compounds with nine 
symmetric aliphatic di-acids and fifteen perfluorinated halogen-bond donors were carried out to 
determine if a MEPS based ranking can be used to effectively assign selectivity in hydrogen- and 
halogen-bond interactions. The results suggested that a simple electrostatic view provides a 
reliable tool for successfully implementing the practical co-crystal synthesis with desired 
connectivity. 
MEPS based selectivity guidelines for halogen-bond interactions were explored in co-
crystallizations between twelve asymmetric ditopic acceptors and nine halogen-bond donors. If 
the difference between the two acceptor sites is below 35 kJ/mol, no selectivity was observed; 
above 65 kJ/mol halogen bond selectivity dominates and mid ΔE range was recognized as the grey 
area where predictions cannot be made.  
To examine competition between hydrogen and halogen bonds, five heteroaryl-2-
imidazoles were co-crystallized with fifteen halogen-bond donors. It was found that halogen bonds 
prefer best the acceptor site, demonstrating that a suitably activated halogen-bond donor can 
compete with a strong hydrogen-bond donor.  
The benefits of ‘double activation’ for promoting halogen bond effectiveness was explored 
with nine haloethynylnitrobenzenes. The positive potential on halogen atoms was enhanced 
through a combination of an sp-hybridized carbon and electron-withdrawing nitro group(s). 
Iodoethynylnitrobenzenes were identified as the most effective halogen-bond donors reported to 
date and the compounds were exploited for the interaction preferences of nitro group and nitro⋯X-
Csp interactions were identified as synthetic tools for energetic co-crystal assembly. 
  
A synthetic strategy for the deliberate assembly of molecular polygons was developed 
utilizing bifurcated halogen bonds constructed from N-oxides and complementary halogen-bond 
donors via co-crystallization. 
A convenient, effective, and scalable protocol for stabilizing volatile liquid chemicals with 
co-crystallization was achieved. Through the use of halogen-bonding, liquid iodoperfluoroalkanes 
were transformed into crystalline materials with low-vapor pressure, considerable thermal stability 
and moisture resistance.  
To stabilize the energetic compound ethylenedinitramine, a co-crystallization approach 
targeting the acidic protons was employed. Eight co-crystals were obtained and the acceptors were 
identified as supramolecular protecting groups leading to diminished reactivity and enhanced 
stability while retaining the desirable energetic properties. 
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determine if a MEPS based ranking can be used to effectively assign selectivity in hydrogen- and 
halogen-bond interactions. The results suggested that a simple electrostatic view provides a 
reliable tool for successfully implementing the practical co-crystal synthesis with desired 
connectivity. 
MEPS based selectivity guidelines for halogen-bond interactions were explored in co-
crystallizations between twelve asymmetric ditopic acceptors and nine halogen-bond donors. If 
the difference between the two acceptor sites is below 35 kJ/mol, no selectivity was observed; 
above 65 kJ/mol halogen bond selectivity dominates and mid ΔE range was recognized as the grey 
area where predictions cannot be made.  
To examine competition between hydrogen and halogen bonds, five heteroaryl-2-
imidazoles were co-crystallized with fifteen halogen-bond donors. It was found that halogen bonds 
prefer best the acceptor site, demonstrating that a suitably activated halogen-bond donor can 
compete with a strong hydrogen-bond donor.  
The benefits of ‘double activation’ for promoting halogen bond effectiveness was explored 
with nine haloethynylnitrobenzenes. The positive potential on halogen atoms was enhanced 
through a combination of an sp-hybridized carbon and electron-withdrawing nitro group(s). 
Iodoethynylnitrobenzenes were identified as the most effective halogen-bond donors reported to 
date and the compounds were exploited for the interaction preferences of nitro group and nitro⋯X-
Csp interactions were identified as synthetic tools for energetic co-crystal assembly. 
  
A synthetic strategy for the deliberate assembly of molecular polygons was developed 
utilizing bifurcated halogen bonds constructed from N-oxides and complementary halogen-bond 
donors via co-crystallization. 
A convenient, effective, and scalable protocol for stabilizing volatile liquid chemicals with 
co-crystallization was achieved. Through the use of halogen-bonding, liquid iodoperfluoroalkanes 
were transformed into crystalline materials with low-vapor pressure, considerable thermal stability 
and moisture resistance.  
To stabilize the energetic compound ethylenedinitramine, a co-crystallization approach 
targeting the acidic protons was employed. Eight co-crystals were obtained and the acceptors were 
identified as supramolecular protecting groups leading to diminished reactivity and enhanced 
stability while retaining the desirable energetic properties. 
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1 
Chapter 1 - Introduction 
 1.1 Structure-property relationship in chemistry 
The axiom that “function follows form” is of fundamental importance in chemistry and the 
design and preparation of materials with desired properties are principal goals of chemists.1 The 
very essence of chemistry, the periodic table, provides a systematic classification of all known 
elements into different periods and groups to help chemists in rationalizing the properties of these 
elements based on their structure at an atomic level. Moving from the atomic to the molecular 
level, a pioneering investigation conducted in 1947 on saturated hydrocarbons recognized that the 
properties of these compounds varied with molecular bulk and branching.2 
One of the many examples of structure-property relationship in molecules comes from the 
enantiomers of thalidomide, Figure 1.1.3 It turns out that one enantiomer has effective 
antidepressant properties while the other is teratogenic.4 The property difference is directly 
connected to the chirality of the molecular structure.  
 
 
 
Figure 1.1 Chemical structure of thalidomide 
 1.1.1 Structure-property relationship in bulk materials 
For bulk materials, structure-property relations fall into two broad categories,5 Figure 1.2. 
In the first, the property alterations are due to variations in molecular structure and molecular 
conformation. In the second category property alterations arise from differences in the spatial 
relationships between molecules in the crystal, such as intermolecular arrangement, interactions 
and packing of individual building blocks with respect to each other in a crystal lattice. Thus, in 
2 
order to manipulate the properties of bulk materials, either alterations of molecular structure and 
conformations or refinements in packing arrangements are required.  
Figure 1.2 Categorization of structure-property relationships in bulk materials 
The best examples which show property alterations under both above categories are 
polymorphs. A polymorph is defined as “Different crystalline forms of the same substance”.6 
Polymorphs of a substance can be attained in two ways (Figure 1.3), if the molecule can have 
different conformations and if the molecule is flexible, polymorphs can be attained by 
conformational changes (conformational polymorphism) and if the molecule is rigid, polymorphs 
can be attained by changing the packing arrangements (packing polymorphism).7 Conformational 
polymorphs give rise to property alterations under category 1 and packing polymorphs under 
category 2, Figure 1.2.  
 
 
 
Structure- property 
relationship of bulk materials
Category 1
Molecular structure and 
conformations
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Intermolecular 
arrangement, interactions 
and packing
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Figure 1.3 Schematic representation of a) conformational polymorphism and b) packing 
polymorphism 
Ritonavir provides an example of conformational polymorphism where form 1 is 
comprised of beta like stacks of ritonavir molecules held together via hydrogen bonding while in 
form II, OH groups are participating in hydrogen bonding due to the change in conformation of 
ritonavir molecule. As a result, solubility of the two forms are distinct from each other. Form 1 has 
90 mg/mL of solubility in a 99:1 ethanol water mixture at 5 °C and form II has only 19 mg/mL of 
solubility under same conditions,8 Figure 1.4.  
 
Figure 1.4 Conformational polymorphs of ritonavir and their solubilities8 
 
4 
Polymorphic forms of aspirin provide an example of packing polymorphism. Both form I 
and II consist of layers of aspirin molecules with same conformation and similar interactions, and 
the subtle difference between the two forms is the position of the molecules in one layer relative 
to the molecules of the adjacent layer, Figure 1.5. When considering the properties, form II is 
unstable under mechanical stress such as milling and tableting, and readily converted to stable 
form I.9  
 
 
 
 
 
 
 
 
 
Figure 1.5 Packing of aspirin polymorphs shown along the a axis9 
One of the well-known example for how the changes in molecular structure correlate with 
the materials properties comes from even numbered aliphatic dicarboxylic acids. It has been 
observed that melting points of dicarboxylic acids decrease monotonically with increasing number 
of methylene groups in the chain, Figure 1.6.10 Thus alteration of molecular structure by adding 
methylene groups, leads to a predictable alteration of melting properties in the bulk. 
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Figure 1.6 Correlation between the carbon chain length and the melting temperature of aliphatic 
dicarboxylic acids10 
 1.2 Supramolecular chemistry: A way to modify spatial relationships of a 
molecule 
Supramolecular chemistry has been defined as“…the chemistry of the intermolecular bond, 
covering the structures and functions of the entities formed by association of two or more chemical 
species…” by Jean-Marie Lehn.11 In simple terms, supramolecular chemistry refers to 
chemistry beyond molecules and focuses on chemical systems composed of molecular subunits 
brought together via intermolecular interactions.12 One of the underlying goals of supramolecular 
chemistry is to control assembly and arrangement of individual components in a predictable way 
and thus to control macroscopic properties of materials.  
Because supramolecular chemistry can lead to modifications in the spatial relationships of 
a molecule of interest, it directly affects macroscopic properties. As an example, trans-stilbene 
molecule is known to give only weak fluorescence in solution and inside loosely-fitting synthetic 
capsules. But it has been shown that by encapsulating trans-stilbene in an elongated 
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supramolecular capsule made up of cavitand molecules, where the molecule is allowed to adapt a 
fully coplanar arrangement, fluorescence of the molecule is enhanced, Figure 1.7.13 
 
 
 
 
Figure 1.7 Encapsulated trans-stilbene inside a cavitand derived capsule13 
 1.3 Crystal engineering: Design of ultimate supramolecules 
Organic crystals can be recognized as the best examples of supramolecules. Indeed Jack 
Dunitz has referred to organic crystals as “supermolecule(s) par excellence”14 where millions of 
molecules are held together in a periodic arrangement by non-covalent interactions. The subsection 
of supramolecular chemistry which focuses on crystals, their packing and property alterations has 
been identified as crystal engineering. Thus, crystal engineering has defined as “The understanding 
of intermolecular interactions in the context of crystal packing and the utilization of such 
understanding in the design of new solids with desired physical and chemical properties”.15  
 1.3.1 Supramolecular synthons 
If crystals can be recognized as supramolecular equivalents of molecules, then crystal 
engineering can be recognized as the supramolecular equivalent of organic synthesis.16 Organic 
synthesis mainly depends on traditional synthons, likewise definite spatial arrangements of 
intermolecular interactions are required to establish reliable connections between individual 
building blocks in crystal engineering. Supramolecular synthons are such recognition units and 
have been defined as “structural units within a supermolecule which can be formed andlor 
assembled by known or conceivable synthetic operations involving intermolecular interactions”.17 
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Supramolecular synthons can be categorized as homosynthons (occur between same 
complementary functional groups) and heterosynthons (occur between different functional 
groups),18 Figure 1.8. 
 
Figure 1.8 Supramolecular synthons 
 1.4 Co-crystal: A supramolecular entity 
The definition of what a co-crystal is, remains under debate.19 Thus, for the scope of this 
dissertation, a co-crystal will be defined as, solids that are crystalline single phase materials 
composed of two or more different molecular compounds generally in a stoichiometric ratio. In 
simple terms, a co-crystal is comprised of two or more distinctly different molecular entities known 
as co-formers that are brought together via non-covalent interactions within the same crystal 
lattice. This is done without making or breaking any covalent bonds, thus the chemical integrity 
of each individual molecule is preserved. The end result is the formation of a heteromeric species 
via co-crystallization over the natural tendency to form homomeric species via re-crystallization, 
Figure 1.9. Thus, a co-crystal can be recognized as a supramolecular entity which enables the 
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modification of physical properties of a material by changing the spatial relationships between 
molecules in the crystal. 
Figure 1.9 Schematic representation of re-crystallization and co-crystallization 
 1.5 Intermolecular interactions: Glue to design co-crystals 
Co-crystals contain periodic assemblies of molecules connected via intermolecular 
interactions such as π-π stacking interactions,20 dipole-dipole interactions,21 halogen bonds,22 and 
hydrogen bonds,23 Figure 1.10. Knowledge of the intermolecular interactions and their effects on 
crystal packing allows for the engineering of co-crystals with desired properties. 
Figure 1.10 a) CH⋯π interactions in the co-crystal of bis(trimethylsilyl)acetylene with 
benzene24 and b) π-π interactions in the co-crystal between trinitrotoluene (TNT) and 9-
bromoanthracene25 
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 1.5.1 Hydrogen bond based co-crystals  
A hydrogen bond (HB) is defined as “an attractive interaction between a hydrogen atom 
from a molecule or a molecular fragment, X−H⋯A in which X is more electronegative than H, 
and an atom or a group of atoms in the same or different molecule, in which there is evidence of 
bond formation”,26 Figure 1.11. 
 
 
Figure 1.11 Schematic diagram showing the formation of a hydrogen bond (X-more 
electronegative atom than hydrogen; H-hydrogen; A-acceptor) 
Hydrogen bonds are useful tools for assembling supramolecular structures because they 
are both strong and directional and arguably the most widely used interaction for constructing co-
crystals,27 Figure 1.12. In order to recognize the preferred connectivity patterns, the hydrogen-
bond rules proposed by Margaret C. Etter are very useful.28  
The general rules are, 
1. All acidic hydrogens available in a molecule will be used in hydrogen bonding in the 
crystal structure of that compound.29 
2. All good acceptors will be used in hydrogen bonding when there are available 
hydrogen-bond donors.30 
3. The best hydrogen-bond donor and the best hydrogen-bond acceptor will preferentially 
form hydrogen bonds to one another.31 
These guidelines have provided the stage for important advances in co-crystallizations.  
  
 
 
  A H X A + X H 
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Figure 1.12 A binary co-crystal between pyridine and terephthalic acid formed via 
acid⋯pyridine heterosynthon32 
 1.5.2 Halogen bond based co-crystals 
The definition of halogen bond (XB) states that, “A halogen bond R−X⋯Y−Z occurs when 
there is evidence of a net attractive interaction between an electrophilic region on a halogen atom 
X belonging to a molecule or a molecular fragment R–X (where R can be another atom, including 
X, or a group of atoms) and a nucleophilic region of a molecule, or molecular fragment, Y−Z”,33 
Figure 1.13 
 
 
Figure 1.13 Schematic diagram showing the formation of a halogen bond (R and Z-molecular 
fragments or atoms; X-halogen atom; Y-nucleophilic atom) 
As a new addition to the toolbox of supramolecular chemistry, the halogen bond has gained 
widespread attraction due to its strong, specific and directional nature.34 Key to this interaction is 
the electron-poor nature of the tip of the halogen atom known as the σ hole,35 whose electron-
density is depleted by virtue of the presence of an electron withdrawing group, Figure 1.14.  The 
R–X⋯Y angle is typically close to 180°.36 The strength of the interaction increases in going from 
chlorine to bromine to iodine depending on the polarizability of the halogen atom.37 Electrostatic 
attractive nature of halogen bonds result in a shorter distance between the donor and acceptor to 
the sum of their van der Waals radii.38 Figure 1.15 shows a conventional halogen bond formed 
between iodine and nitrogen.  
R X + Y Z R X Y Z 
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Figure 1.14 Formation of the σ hole in halogen atoms 
 
 
 
Figure 1.15 A halogen bond formed between the iodine of 1,4-diiodotetrafluorobenzene and 
pyridine nitrogen of 4-dimethylaminopyridine39 
 1.5.2.1 Techniques to detect halogen bonds 
The best method to detect halogen bond formation in solid state is single crystal X-ray 
diffraction (SCXRD). This is the most common experimental method of obtaining a detailed 3D 
structure of a molecule that allows resolution of individual atoms, and provides detailed 
information about the internal lattice of crystalline substances, including unit cell dimensions, 
bond-lengths, bond-angles, and intermolecular interactions.40 SCXRD is performed by analyzing 
the pattern of X-rays diffracted by an ordered array of many identical molecules (single crystal) 
and requires diffractable crystals in good quality and reasonable size, which is not easily accessible 
always. Thus, other characterization techniques like NMR, IR, Raman, UV-Vis, EPR and 
calorimetry based techniques are utilized for the purpose of detecting halogen bond formation in 
solid, solution and gas phases.  
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NMR spectroscopy is the method of choice in detecting halogen bonds in solution. For 
example, 19F NMR spectroscopy has been utilized to detect chemical shift alterations of 
polyfluorinated XB donors upon interaction with solvents of varying electron donating properties. 
It has observed that a stronger Lewis basic solvent causes a larger 19F shift alteration reflecting the 
strength of the formed XB interactions, Figure 1.16.41  
Figure 1.16 19F NMR chemical shift differences (Δδ) of 1,2-diiodoperfluoroethane in 
cyclohexane and the given solvent41  
IR spectroscopy is a simple and effective method in detecting halogen bond formation both 
in solid and solution phases. For example, when a halogen bond is formed with an ethynyl iodine 
atom, the weakening of triple bond occurs, which is accompanied by a red shift of the triple bond 
stretch in IR spectra,42 Figure 1.17.  
 
 
 
13 
 
 
 
 
 
 
 
 
Figure 1.17 Comparison of IR spectra between 1-iodoethynyl-4-iodobenzene (IEIB) and the co-
crystal of IEIB formed with 4,4’-bipyridine (IEIB:12); red circles highlights the shifts in triple 
bond stretch42 
 1.6 Application of co-crystals 
Co-crystal technology has been used for altering the physical properties of 
pharmaceuticals,43 energetic materials,44 agrochemicals,45 nutraceuticals,46 organic 
semiconductors,47 optoelectronic materials,48 ferroelectric materials,49 charge transfer 
complexes,50 non-linear optics51 and liquid crystals.52 Furthermore, co-crystallization approaches 
have been applied in solid state solvent free synthesis,53 separation and purification processes,54 
chiral resolution,55 and crystallization of non-solid compounds to facilitate manufacturing 
processes.56 
 1.6.1 Pharmaceutical co-crystals 
The most widely applied field of co-crystallization is development of pharmaceutical co-
crystals. In this area co-crystallization has shown prominent results in the formation, design and 
implementation of active pharmaceutical ingredients (API).57 Changing the solid form of an API 
can greatly influence its bioavailability, thermal stability and solubility.58 Pharmaceutical co-
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crystals focus on developing superior physico-chemical properties of the API while holding the 
properties of the drug molecule itself constant.59  
For instance, one study showed how to systematically modulate the aqueous solubility and 
melting behavior of an anticancer drug hexamethylene-4-pyridineacetamide with the assistance of 
hydrogen-bond based co-crystallization, Figure 1.18.60 
Figure 1.18 Aqueous equilibrium solubilities of the API of interest and the five co-crystals 
obtained with even chain dicarboxylic acids60 
Another example provides evidence for the halogen-bond based co-crystals of the 
antimicrobial drug 3-iodo-2-propynyl-N-butylcarbamate (IPBC). Angle of repose tests were 
conducted to study the powder flow properties of the drug and the co-crystals obtained. Free IPBC 
has poor flow properties (no angle of repose is detectable), while  the co-crystal involving the 
excipient CaCl2 has shown superior powder flow characteristics (20° angle of repose form 
funnel/flat surface distance of 25 mm), representing a promising solution to the handling issues 
related to the manufacturing of products containing IPBC.61 
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 1.6.2 Energetic co-crystals 
Energetic materials are a class of compounds that rapidly release energy through a chemical 
reaction or change of state, often accompanied by the expansion of gas.62 The term energetic 
materials encompasses three basic materials classes: explosives, propellants, and pyrotechnics.63 
Explosives contain destructive power, while propellants supply thrust for rockets and engines. 
Pyrotechnics include both explosives and propellants and are used to produce various effects, 
including light, color, smoke and sound.  
When designing safe and effective energetic compounds, a large number of critical 
properties need to be addressed. The main property to consider is the explosive power, and this 
property is affected by the other factors such as density, detonation enthalpy, oxygen balance and 
gas formation upon detonation.64 Another factor to consider is safety, which is based on the 
sensitivity of the material to shock, impact and spark65 and also the toxicity of the compound and 
detonation products.66 Furthermore, cost, processability, water solubility and chemical stability are 
critical factors to consider when designing novel energetics.67 
Traditional methods for improving these properties focus on modifying the chemical 
structure.68 Co-crystallization is an alternative route to modify the properties of available energetic 
materials to design superior materials.69  
One of the most famous examples in the field of energetic co-crystals is the 1:2 hybrid co-
crystal of HMX and CL-20. The co-crystal is a combination of the low sensitivity of HMX and 
high power of CL-20, thus provided a solution to overcome the drawbacks associated with both 
starting energetic compounds, Figure 1.19.64  
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Figure 1.19 a) Detonation velocity comparison and b) impact sensitivity comparison for HMX 
and CL-20 co-crystal and starting compounds64 
 1.6.3 Agrochemical co-crystals 
Agrochemicals refers to chemicals used for agricultural purposes such as pesticides, 
insecticides, herbicides and fungicides and are used to protect crops from pests and thus help to 
improve the quality and quantity of crop production.70 Co-crystallizations provides means for 
altering the physical properties such as solubility, hygroscopicity, thermal stability, filterability 
and flowability of agrochemicals and thereby affecting the overall usability and efficacy of a given 
agrochemical. For example, flupyradifurone is an active ingredient (AI) with insecticidal 
properties. Co-crystal of the AI with salicylic acid (1:1) has been synthesized which displays a 
higher melting point, 85 °C when compared to that of the active by itself (72-74 °C).71  
Another study highlights the ability of fine-tuning the solubility of an agrochemical active, 
cyprodinil, via co-crystallization. Co-crystals of cyprodinil have been obtained with even chain 
aliphatic dicarboxylic acids (C4-C12) and for the co-crystal with succinic acid (C4), more than 
threefold increase in the solubility has observed, Figure 1.20.72  
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Figure 1.20 Solubility profile of cyprodinil co-crystals72 
 1.6.4 Nutraceutical co-crystals 
Nutraceuticals are defined as “a food (or part of a food) that provides medical or health 
benefits, including the prevention and/or treatment of a disease and possesses a physiological 
benefit or reduces the risk of chronic disease”.73 Nutraceuticals have become attractive targets for 
co-crystallizations as many of them have major problems with solubility and bioavailability. For 
an instance co-crystals of curcumin with resorcinol and pyrogallol have obtained and the melting 
point analysis has shown the co-crystals (with resorcinol - 166 °C; with pyrogallol - 158 °C) to 
have lower melting points than curcumin (177 °C).74  
In another study, co-crystals of pterostilbene have obtained with carbamazepine, piperazine 
and caffeine. The solubility studies have shown that co-crystal obtained with piperazine to show 
six fold higher aqueous solubility and co-crystal with caffeine to have 27 fold solubility compared 
to single-component pterostilbene. On the other hand, co-crystal with carbamazepine has 
decreased the overall solubility of pterostilbene nearly by threefold, Figure 1.21.75 
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Figure 1.21 Aqueous solubility of pterostilbene and co-crystals75 
 1.6.5 Organic semiconductor co-crystals 
Organic semiconductors are extended conjugated π-systems that have the ability to 
transport charge when an electrical bias is applied. Enforced face-to-face stacking of aromatics in 
the solid state is important to achieve efficient charge transport properties of these materials. Co-
crystallization provides effective means in stacking the semiconductor building blocks. One such 
study has shown how the co-former, resorcinol could enforce face-to-face π-stacking of the 
semiconductor building block 9,10-bis(4-pyridylethynyl)anthracene, Figure 1.22.76 
Figure 1.22 Effective face to-face π-stacking achieved via co-crystallization76 
 1.7 Goals of the dissertation 
Designing co-crystals with practical applications in materials science requires a thorough 
understanding of solid state behavior of non-covalent interactions and a good rationale to control 
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the supramolecular architectures in a predictable manner. Such controlled supramolecular 
assemblies can lead to a better understanding of structure-property relationships. The basic 
concepts can then be focused on spatial modifications of functional materials leading to fine-tuning 
of macroscopic properties.  
Thus, this dissertation will focus on the following goals, 
1. Chapter 2 focuses on understanding the molecular electrostatic potential dependent 
selectivity behaviors of hydrogen bond interactions in the solid state and on 
implementing a simple electrostatic view for co-crystal synthesis.77 
2. Chapter 3 focuses on the solid state behavior of halogen bonding, specifically how a 
simple molecular electrostatic potential surface (MEPS) based view can be used in 
predicting selectivity in halogen bonding.78   
3. Chapter 4 explores if MEPS based selectivity of halogen bonding can lead to guidelines 
that can be used for predicting preferable halogen bonds. 
4. Chapter 5 focuses on the competitive nature of hydrogen bonding and halogen bonding 
when probed with multiple acceptor sites.79 
5. Chapter 6 focuses on design and synthesis of more effective halogen-bond donors, 
haloethynylnitrobenzenes, using double activation phenomena.80  
6. Chapter 7 combines complementary geometric factors of selected halogen-bond donors 
in designing well-defined and discrete supramolecular architectures.81  
7. The capability of halogen-bond based co-crystallization to stabilize volatile liquid 
chemicals and the effectiveness, scalability, isolation capabilities and property 
alterations of this technology is explored in Chapter 8.82  
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8. Chapter 9 focuses on establishing the effectiveness of co-crystal technology to modify 
the properties of an energetic compound, ethylenedinitarmine (EDNA). The main goal 
is to eliminate the high chemical reactivity of EDNA by introducing a supramolecular 
protecting group.83  
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Chapter 2 - Molecular electrostatic potential dependent selectivity in 
hydrogen bonding1  
 2.1 Introduction 
The hydrogen bond2 is undoubtedly the most extensively studied intermolecular 
interaction3 and even after a century of investigations it is still of utmost interest, which is reflected 
by the IUPAC proposed change in 2011 of its very definition.4 The new definition, “The hydrogen 
bond is an attractive interaction between a hydrogen atom from a molecule or a molecular fragment 
X–H in which X is more electronegative than H, and an atom or a group of atoms in the same or a 
different molecule, in which there is evidence of bond formation”,5 clearly recognizes 
electrostatics at being at the core of this interaction. Long lasting interest in hydrogen bonding is 
related to its importance in the fields of chemistry, physics, biochemistry, biology, materials 
science, organic synthesis, medicine, pharmacy, mineralogy, crystal engineering, supramolecular 
chemistry, surface science and many more.6 It is indeed the basis of life due to its structural role 
in DNA,7 enzymes,8 and proteins.9 
From a fundamental supramolecular10 and crystal engineering11 viewpoint, the hydrogen 
bond is a key synthetic tool in assembly of molecules into well-defined architectures.12 An 
established set of guidelines in directing hydrogen bonds in a supramolecular context is required 
to design supramolecular architectures in a rational and predictable manner,13 to recognize robust 
synthons,14 to obtain reproducibility in experimental designing and to avoid “synthon crossover”15 
and “synthon polymorphism”.16  
In this context, Etter proposed that, in a system with multiple potential structural outcomes, 
the best hydrogen-bond donor and the best hydrogen-bond acceptor will preferentially interact 
25 
with each other,17 Figure 2.1. This simple set of guidelines offers powerful and practical protocols 
for the directed assembly of solid-state architectures.   
 
 
 
 
 
Figure 2.1 Schematic representation of Etter’s rules in hydrogen bonding (A1-best acceptor, A2-
2nd best acceptor, D1-best donor, D2-2nd best donor) 
In order to take advantage of this approach, it is necessary to find a convenient method for 
recognizing and ranking the best donors and best acceptors in a given system. Several solutions to 
the challenge have been reported.18 One such method utilizes pKa/pKb values of the participating 
molecules to rank the relative strength.19 There are many examples in literature where the 
supramolecular outcome has been successfully predicted based on pKa values.
20 This approach has 
been utilized in designing ternary co-crystal system where the strong acid binds to the best acceptor 
site while the weak acid binds to the second best acceptor site, Figure 2.2.21  
 
 
 
 
 
 
 
Figure 2.2 Designing ternary co-crystals utilizing the pKa ranking method
21 
A1 
A2 D2 
D1 A1 
A2 D2 
D1 
D2 A2 
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This method is effective as long as the molecules carry the same chemical functionality. 
For example, thiophenol has a pKa of 6.61, which is considerably lower than that of phenol 
(pKa=9.86), which indicates that thiophenol should be a better hydrogen bond donor. But phenols 
have significant hydrogen bond donor ability and are commonly used as hydrogen bond donors22 
whereas thiophenols hardly exhibit any hydrogen bond donor ability.23 
A more general approach proposed by Hunter and co-workers utilizes calculated molecular 
electrostatic potential surface (MEPS) values,24 where the best acceptor represents the highest 
negative value on the surface and the best donor carries the highest positive value. This approach 
has been used extensively in designing hydrogen bonded co-crystals. One such study focuses on 
the calculated molecular electrostatic potential values to rank the relative hydrogen bond strengths 
of hydroxybenzoic acids.25 The structural results agree with the predicted outcome by MEPS and 
follow best-donor best-acceptor hierarchy, Figure 2.3.  
Figure 2.3 a) Ranking of hydrogen bonding sites of 4-hydroxybenzoic acid based on calculated 
MEPS and b) structural outcome: best donor binds to the best acceptor and 2nd best donor binds 
to the 2nd best acceptor25 
In order to gather information on such studies where a ranking of acceptor sites have been 
done, a comprehensive Cambridge Structural Database (CSD)26 search was conducted targeting 
interaction between any nitrogen and acid functionality. Results yielded 1141 hits and among them 
180 structures contained an acceptor with multitopic of acceptor sites. Further analysis of these 
180 hits revealed that, even though the underlying concepts of MEPS based ranking is applied in 
a)                                            b)  
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few of the studies,27 none of these studies directly utilize a ranking of acceptor sites based on 
calculated MEPS in hydrogen bonding.  
Thus, designing of a system that can be used to study MEPS dependent ranking of 
hydrogen bond acceptor sites is of utmost interest. Because of this reason, a series of co-
crystallizations between four biimidazole based compounds, (1,1'-bis(pyridin-4-ylmethyl)-2,2'-
biimidazole A1, 1,1'-bis(pyridin-3-ylmethyl)-2,2'-biimidazole A2, 1,1'-bis(pyridin-2-ylmethyl)-
2,2'-biimidazole A3 and 1,1'-dibenzyl-2,2'-biimidazole A4) Figure 2.4 and nine symmetric 
aliphatic di-acids (Figure 2.5) were carried out in order to determine if a ranking based on 
calculated MEPS can be used to effectively assign selectivity in hydrogen-bond based 
intermolecular interactions. A1-A3 have two identical pyridine nitrogen atoms (blue), and two 
identical imidazole nitrogen atoms (red) to give four acceptors per molecule. Acceptor A4 (Figure 
2.4) was synthesized as a control molecule, in order to study the impact of sterics when forming 
hydrogen bonds with imidazole nitrogen sites. Thus A4 contain only imidazole nitrogen sites while 
retaining the structure similarities to other molecules of this family.  
 
 
 
 
 
 
 
 
Figure 2.4 Acceptors employed in the study  
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Figure 2.5 Donors (aliphatic di-acids) employed in the study 
The different acceptor sites were ranked (best and second-best) with the utilization of 
calculated MEPS for A1-A3. Systematic co-crystallizations with nine aliphatic diacids28 (Figure 
2.5) in 1:2 stoichiometry were performed with these three molecules. With A4, 1:1 stoichiometric 
studies were performed. In addition, experiments using 1:1 and 1:4 stoichiometries (of acceptor to 
donor) were performed with A1 and A3. 
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The study is undertaken in response to two hypotheses, 
1. If a hydrogen-bond donor has a choice of two different acceptor sites, it will 
preferentially select the best-acceptor as determined by molecular electrostatic 
potentials surfaces (MEPS). 
2. The selectivity in hydrogen bonding will not be affected by the relative amount of 
reactants present in the system. 
 2.2 Experimental 
 2.2.1 General 
All precursors, solvents and dicarboxylic acids were purchased from commercial sources 
and used without further purification. 2,2’-Biimidazole was synthesized following a reported 
procedure.29 1H NMR spectra were recorded on a Varian Unity plus 400 MHz spectrometer in 
CDCl3 or DMSO-d6. Infrared spectra were recorded with a Nicolet 380 FT-IR with a digital 
resolution of 0.9 cm-1 and data processed using Omnic30 software. Melting points were determined 
using Fischer-Johns Mel-Temp melting point apparatus and are uncorrected.   
 2.2.2 Electrostatic potential calculations  
Molecular electrostatic potential surfaces of A1-A4 were generated with density functional 
B3LYP level of theory using 6-311++G** basis set in vacuum. All calculations were carried out 
using Spartan’08 software.31 All molecules were geometry optimized and the maxima and minima 
on the electrostatic potential surface (0.002 e/au isosurface) determined using a positive point 
charge in the vacuum as a probe. The numbers indicate the interaction energy (kJ/mol) between 
the positive point probe and surface of the molecule at that particular point. These numbers are 
related to the electrostatic potentials on the atoms with the negative number corresponding to a 
negative potential and positive number corresponding to a positive potential. 
30 
 2.2.3 Synthesis of acceptors  
 2.2.3.1 Synthesis of 1,1'-bis(pyridin-4-ylmethyl)-2,2'-biimidazole, A1 
 
2,2’-Biimidazole (0.27 g, 2.0 mmol) and NaOH (0.32 g, 8.0 mmol) were placed in a 100 
mL round bottomed flask with 20 mL of acetonitrile.  The mixture was stirred at room temperature 
for two hours. 4-Picolyl chloride hydrochloride (0.65 g, 4.0 mmol) in acetonitrile (20 mL) was 
added to the mixture and refluxed for 24 hours at 50 °C - 60 °C.  The reaction was monitored with 
TLC and after completion, the solvent was removed by rotary evaporation. The residue was 
dissolved in water (50 mL) and extracted with methylene chloride (30 mL x 3).  Organic layers 
were combined, dried over anhydrous MgSO4 and rotary evaporated to obtain the dark brown 
powder as the product. Yield: 0.35 g (56%); m.p. 157-160 °C; 1H NMR (400 MHz, CDCl3):8.49 
(d, 4H), 7.11 (d, 2H), 6.94 (d, 2H), 6.91 (d, 4H), 5.84 (s, 4H). 
 2.2.3.2 Synthesis of 1,1'-bis(pyridin-3-ylmethyl)-2,2'-biimidazole, A2 
 
2,2’-Biimidazole (0.27 g, 2.0 mmol) and NaOH (0.32 g, 8.0 mmol) were placed in a 100 
mL round bottomed flask with 20 mL of acetonitrile.  The mixture was stirred at room temperature 
for two hours. 3-Picolyl chloride hydrochloride (0.65 g, 4.0 mmol) in acetonitrile (20 mL) was 
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added to the mixture and refluxed for 24 hours at 50 °C - 60 °C.  The reaction was monitored with 
TLC and upon completion the solvent was removed by rotary evaporation. The residue was 
dissolved in water (50 mL) and extracted with methylene chloride (30 mL x 3).  Organic layers 
were combined, dried over anhydrous MgSO4 and rotary evaporated to obtain the brown powder 
as the product. Yield: 0.45 g (71%); m.p. 112-115 °C; 1H NMR (400 MHz, CDCl3):8.46 (d, 2H), 
8.45 (s, 2H), 7.39 (d, 2H), 7.17 (m, 2H), 7.11 (d, 2H), 6.95 (d, 2H), 5.78 (s, 4H). 
 2.2.3.3 Synthesis of 1,1'-bis(pyridin-2-ylmethyl)-2,2'-biimidazole, A3 
 
2,2’-Biimidazole (0.27 g, 2.0 mmol) and NaOH (0.32 g, 8.0 mmol) were placed in a 100 
mL round bottomed flask with 20 mL of acetonitrile.  The mixture was stirred at room temperature 
for two hours. 2-Picolyl chloride hydrochloride (0.65 g, 4.0 mmol) in acetonitrile (20 mL) was 
added to the mixture and refluxed for 24 hours at 50 °C - 60 °C.  The reaction was monitored with 
TLC and upon completion the solvent was removed by rotary evaporation. The residue was 
dissolved in water (50 mL) and extracted with methylene chloride (30 mL x 3).  Organic layers 
were combined, dried over anhydrous MgSO4 and rotary evaporated to obtain the pale brown 
powder as the product. Yield: 0.25 g (40%); m.p. 180-183 °C; 1H NMR (400 MHz, CDCl3): 8.53 
(d, 2H), 7.53 (t, 2H), 7.15 (t, 2H), 7.12 (s, 2H), 7.07 (s, 2H), 7.05 (d, 2H), 5.87 (s, 4H). 
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 2.2.3.4 Synthesis of 1,1'-dibenzyl-2,2'-biimidazole, A4 
 
2,2’-Biimidazole (0.33 g, 2.5 mmol) and NaOH (0.39 g, 9.9 mmol) were placed in a 100 
mL round bottomed flask with 20 mL of acetonitrile.  The mixture was stirred at room temperature 
for two hours. Benzyl bromide (0.63 g, 5.0 mmol) in acetonitrile (20 mL) was added to the mixture 
and refluxed for 24 hours at 50 °C - 60 °C. The reaction was monitored with TLC and after 
completion the solvent was removed by rotary evaporation. The residue was dissolved in water 
(50 mL) and extracted with methylene chloride (30 mL x 3).  Organic layers were combined, dried 
over anhydrous MgSO4 and rotary evaporated to obtain the yellow powder as the product. Yield: 
0.69 g (89%); m.p. 144-146 °C; 1H NMR (400 MHz, CDCl3):5.71 (s, 4H), 6.94 (d, 2H), 7.03 (m, 
4H), 7.14 (d, 2H), 7.25 (m, 6H). 
 2.2.4 Grinding experiments and IR spectroscopy 
A1-A4 were initially put through a co-crystal screen using solvent-assisted grinding (a few 
drops of methanol) with nine aliphatic dicarboxylic acids. In all 36 reactions the acceptors and 
donors were mixed in 1:2 stoichiometric ratio (A1-A3) or 1:1 stoichiometric ratio (A4) and the 
solid resulting from each reaction was characterized using IR spectroscopy to determine if a co-
crystal had formed. In each reaction, 10 mg of the acceptor was used with the respective 
stoichiometric amount of the acid. In 28 out of 36 experiments the vibrational spectra displayed 
broad stretches near 1,850 and 2,450 cm−1 (Figure 2.6) indicative of intermolecular O−H⋯N 
hydrogen bond formation.32  
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 2.2.5 Synthesis of co-crystals  
The mixtures obtained in the grinding experiments were dissolved in a minimum amount 
of methanol (2 ml) and placed in a 2 dram borosilicate vial for slow evaporation in order to obtain 
crystals suitable for single crystal X-ray diffraction. In the instances where the single crystals were 
not produced with the above approach, a range of methods such as slow evaporation with ethyl 
acetate, vapor diffusion with methanol and hexane as the solvent and anti-solvent, and 
crystallization under freezing conditions were used. All in all, thirteen crystals were obtained and 
analyzed with single crystal X-ray diffraction. Table 2.1 summarizes the experimental details. 
Appendix B.1 contains the relevant X-ray experimental data.  
Table 2.1 Experimental details of the thirteen co-crystals obtained 
Code 
Mixed 
Mole 
ratio 
Amounts used 
Solvent and 
method 
Crystal 
stoichiometry 
Melting 
point 
(°C) 
Crystal 
color & 
habit 
A1:Suc 1:2 
A1 -10 mg, 0.032 mmol 
Suc - 7.5 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 161-165 
Colorless 
prism 
A1:Adi 1:2 
A1 - 10 mg, 0.032 mmol 
Adi - 9.2 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 167-170 
Bronze 
plate 
A1:Sub 1:2 
A1 - 10 mg, 0.032 mmol 
Sub - 11 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 148-151 
Orange 
plate 
A1:Seb 1:2 
A1 - 10 mg, 0.032 mmol 
Seb - 13 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 140-144 
Orange 
plate 
A1:Dod 1:2 
A1 - 10 mg, 0.032 mmol 
Dod - 15 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 138-143 
Bronze 
prism 
A1:Mal 1:2 
A1 - 10 mg, 0.032 mmol 
Mal - 6.6 mg, 0.063 mmol 
Methanol 
Slow evaporation 
Freezing conditions 
1:1 95-98 
Colorless 
needle 
A1:Glu 1:2 
A1 - 10 mg, 0.032 mmol 
Glu - 9.2 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 153-155 
Bronze 
prism 
A3:Adi 1:2 
A3 - 10 mg, 0.032 mmol 
Adi - 9.2 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 159-162 
Colorless 
plate 
A3:Sub 1:2 
A3 - 10 mg, 0.032 mmol 
Sub - 11 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 131-135 
Colorless 
prism 
A3:Seb 1:2 
A3 - 10 mg, 0.032 mmol 
Seb - 13 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 130-133 
Colorless 
prism 
A3:Dod 1:2 
A3 - 10 mg, 0.032 mmol 
Dod - 15 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 120-123 
Colorless 
prism 
A3:Pim 1:2 
A3 - 10 mg, 0.032 mmol 
Pim - 10 mg, 0.063 mmol 
Methanol 
Slow evaporation 
Freezing conditions 
1:2 90-93 
Colorless 
plate 
A4:Mal 1:1 
A4 - 10 mg, 0.033 mmol 
Mal - 3.3 mg, 0.032 mmol 
Methanol 
Slow evaporation 
1:1 90-94 
Yellow 
prism 
Freezing conditions were achieved by keeping the vials inside a freezer at 0 ºC 
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 2.2.6 Variable stoichiometric studies  
 To explore the possible influence of reaction stoichiometry in hydrogen bond selectivity, 
A1 and A3 were combined with adipic acid, suberic acid, sebacic acid and dodecandioic acid, 
respectively in 1:1 and 1:4 stoichiometries. The reactants were dissolved in a minimum amount of 
methanol and slow evaporated in pursuance of crystals and were analysed using IR spectroscopy 
in order to determine the co-crystal formation and 1H NMR spectroscopy in order to determine the 
stoichiometry. 
 2.3 Results 
 2.3.1 Electrostatic potentials 
The ditopic acceptorss used in this study (A1-A3) contain two different acceptor sites, 
pyridine nitrogen (N(py)) and imidazole nitrogen (N(im)). The control molecule A4 contain only 
N(im) sites. The ranking of the acceptor sites is established using molecular electrostatic potential 
surfaces and the results from the density functional theory (DFT) calculations are shown in Table 
2.2. Higher negative potential on the acceptor suggests better hydrogen-bond accepting ability. 
Table 2.2 Calculated electrostatic potential values of the acceptors 
 
 2.3.2 Grinding experiments and characterization by IR spectroscopy 
The solvent-assisted grinding experiments were analyzed through IR spectroscopy and 28 
of the 36 experiments resulted a successful co-crystal formation, equivalent to a supramolecular 
yield of 78%. All co-crystals displayed broad bands near the 1,850 and 2,500 cm−1 region (as a 
Molecule Atom Electrostatic potential (kJ/mol-1) 
1,1'-bis(pyridin-4-ylmethyl)-2,2'-biimidazole A1 
Pyridine N -188 
Imidazole N -124 
1,1'-bis(pyridin-3-ylmethyl)-2,2'-biimidazole A2 
Pyridine N -180 
Imidazole N -125 
1,1'-bis(pyridin-2-ylmethyl)-2,2'-biimidazole A3 
Pyridine N -150 
Imidazole N -120 
1,1'-dibenzyl-2,2'-biimidazole A4 Imidazole N -149 
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result of O-H⋯N hydrogen bonds)33 and significant changes in the C=O stretch of the carboxylic 
acid indicating co-crystal formation Table 2.3. Figure 2.6 compare the IR spectrum of the co-
crystal A3:Dod with the starting compounds (A3: blue; A3:Dod co-crystal: red; Dod: purple);  
green circles highlights the formation of broad stretches near 2495 and 1865 cm−1 and black circles 
highlights the shift of carbonyl stretch (1686 to 1698 cm−1). The supramolecular yields from IR 
analysis are summarized in Table 2.4. 
Table 2.3 IR data for the grinding experiments 
Mixture 
Carbonyl stretch (cm-1) O-H⋯N stretches 
(cm-1) 
Co-crystal? 
Di-acid Ground mixture 
A1:Suc 1685 1692 2532,1870 Y 
A1:Adi 1685 1687 2600,1900 Y 
A1:Sub 1685 1688 2500,1906 Y 
A1:Seb 1686 1689 2497,1896 Y 
A1:Dod 1686 1689 2541,1914 Y 
A1:Mal 1696 1692 2586,1900 Y 
A1:Glu 1683 1694 2590,1900 Y 
A1:Pim 1685 1688 2450,1900 Y 
A1:Aze 1689 1688 2500,1940 Y 
A2:Suc 1685 1686 2532,1900 Y 
A2:Adi 1685 1688 2488,1915 Y 
A2:Sub 1685 1689 2495,1900 Y 
A2:Seb 1686 1686 2499,1924 Y 
A2:Dod 1686 1686 2495,1922 Y 
A2:Mal 1696 1716 2561,1964 Y 
A2:Glu 1683 1701 2588,1941 Y 
A2:Pim 1685 1690 2530,1941 Y 
A2:Aze 1689 1690 2528,1924 Y 
A3:Suc 1685 1695 2503,1943 Y 
A3:Adi 1685 1691 2528,1895 Y 
A3:Sub 1685 1690 2495,1850 Y 
A3:Seb 1686 1701 2520,1888 Y 
A3:Dod 1686 1698 2495,1865 Y 
A3:Mal 1696 1708 2582,1980 Y 
A3:Glu 1683 1689 2550,1957 Y 
A3:Pim 1685 1689 2511,1942 Y 
A3:Aze 1689 n/a n/a N 
A4:Suc 1685 1681 n/a N 
A4:Adi 1685 1686 n/a N 
A4:Sub 1685 1686 n/a N 
A4:Seb 1686 1689 n/a N 
A4:Dod 1686 1686 n/a N 
A4:Mal 1696 1701 2586,1970 Y 
A4:Glu 1683 1685 2600,1900 Y 
A4:Pim 1685 1687 n/a N 
A4:Aze 1689 1686 n/a N 
36 
Figure 2.6 Comparison of hydrogen bond formation in A3:Dod (green circles highlight the 
formation of broad stretches and black circles highlight the shifts in the carbonyl stretch)  
 Table 2.4 Summary of supramolecular yields 
 
 2.3.3 Crystal growth and structure analysis  
Although vibrational spectroscopy provides unambiguous information about whether a co-
crystal has formed or not, it does not reveal the actual interactions between the donor and acceptor 
sites. Thus, in order to examine any hydrogen-bond preferences, single crystal data are required.  
The initial approach for crystal growth was slow evaporation with methanol, but many of these 
experiments produced gels or powders, thus a variety of other methods were employed. Ultimately 
thirteen crystals suitable for single crystal analysis was obtained and structurally characterized. 
Acceptor 
Grinding experiments 
Success rate Supramolecular yield 
1,1'-bis(pyridin-4-ylmethyl)-2,2'-biimidazole A1 9/9 100% 
1,1'-bis(pyridin-3-ylmethyl)-2,2'-biimidazole A2 9/9 100% 
1,1'-bis(pyridin-2-ylmethyl)-2,2'-biimidazole A3 8/9 89% 
1,1'-dibenzyl-2,2'-biimidazole A4 2/9 22% 
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Seven structures were obtained for A1-based co-crystals, five for A3-based co-crystals, 
and one co-crystal of A4 was structurally characterized. Despite the fact that IR spectroscopy 
indicates that A2 is also capable of forming co-crystals, suitable crystals of A2 were not available 
even after repeated attempts. 
Thirteen crystal structures were solved (A1:Suc, A1:Adi, A1:Sub, A1:Seb, A1:Dod, 
A1:Mal, A1:Glu, A3:Adi, A3:Sub, A3:Seb, A3:Dod, A3:Pim and A4:Mal) and the relevant 
crystallographic data and  hydrogen bond geometries are provided in Appendix B.1.  
 2.3.4 Crystal structures 
 2.3.4.1 Structures of A1:Suc A1:Adi, A1:Sub, A1:Seb and A1:Dod 
In A1:Suc, both acid groups form hydrogen bonds with the pyridine nitrogen atoms of the 
acceptor resulting in a 1:1 stoichiometric co-crystal. These interactions produce infinite 1-D 
chains, and imidazole nitrogen atoms are not participating in any noticeable short contacts, Figure 
2.7.  
 
 
 
Figure 2.7 Primary hydrogen bond interactions in A1:Suc 
The remaining four structures of A1 with even-chain acids, A1:Adi, A1:Sub, A1:Seb and 
A1:Dod, all display the same primary hydrogen-bond interactions between the carboxylic acid 
functionality and the pyridine nitrogen atoms of the acceptor resulting in 1:1 stoichiometric co-
crystals in each instance, Figure 2.8.  The 1-D chains persist and no notable short contacts to the 
N(im) sites can be seen.  
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Figure 2.8 Primary hydrogen bond interactions in a) A1: Adi, b) A1: Sub, c) A1: Seb and d) 
A1: Dod 
 2.3.4.2 Structure of A1:Mal 
The existence of an odd-chain diacid as the hydrogen-bond donor in A1:Mal does not 
affect the principle interaction trend. Each acid binds to two pyridine nitrogen atoms generating 1-
D chains with a 1:1 stoichiometric co-crystal, Figure 2.9. 
Figure 2.9 Primary hydrogen bond interactions in A1:Mal 
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 2.3.4.3 Structure of A1:Glu 
However, in the last crystal structure of A1, with glutaric acid as the donor, the expected 
O-H⋯N(py) hydrogen bonds are present, but at the same time a head-to-head acid⋯acid dimer 
formation can also be seen. Thus, the stoichiometry is changed to 1:2 (acceptor:donor) although 
the 1-D chains prevail, Figure 2.10.    
Figure 2.10 Primary hydrogen-bond interactions in A1:Glu 
 2.3.4.4 Structures of A3:Adi A3:Sub, A3:Seb and A3:Dod 
In the crystal structure of A3:Adi, the primary hydrogen bonds occur between the acid 
functionality and the best acceptor site, the N(py) leading to a 1-D chain architecture, Figure 2.11. 
 
 
 
 
Figure 2.11 Primary hydrogen bond interactions in A3:Adi 
All four even-acid co-crystals of A3 essentially display the same structural features leading 
to  1:1 stoichiometric co-crystal formation via O-H⋯N(py) bonds resulting infinite 1-D chains, 
Figure 2.12.  
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Figure 2.12 Primary hydrogen bond interactions in a) A3:Sub b) A3:Seb and c) A3:Dod 
2.3.4.5 Structure of A3:Pim 
A3:Pim is the only co-crystal of A3 obtained with an odd-chain diacid and this structure 
is similar to that of A1:Glu with primary O-H⋯N(py) hydrogen bonds and an acid⋯acid dimer 
leading to 1:2 stochiometric 1-D chains, Figure 2.13. 
 
Figure 2.13 Primary hydrogen bond interactions in A3:Pim 
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 2.3.4.6 Structure of A4:Mal  
The only crystal structure obtained with A4 shows primary O-H⋯N(im) hydrogen bond 
formation, Figure 2.14. 
 
 
 
 
Figure 2.14 Primary hydrogen bond interactions in A4:Mal 
 2.4 Discussion  
 2.4.1 Characterization by IR spectroscopy 
All co-crystallization experiments were first screened using IR spectroscopy. Co-crystal 
formation was confirmed by two broad stretches in the 1800-2500 cm-1 region as a result of O-
H⋯N hydrogen bond formation. The other indication was the shifts of C=O stretch. According to 
these observations a 78% of supramolecular yield was obtained. In all cases, the C=O stretch 
appeared above 1670 cm-1 (Table 2.3) confirming the neutral co-crystal formation. If a salt 
formation occurs, the proton is transferred to the acceptor site and an asymmetric carboxylate 
(COO-) band appears around 1650-1590 cm-1, combined with a weaker symmetric carboxylate 
stretch in the 1400 cm-1 region.34 
On the other hand, when a co-crystal is formed, the acid⋯acid dimer in the free carboxylic 
acid is breaking and the acid⋯acceptor interaction is forming, Figure 2.15. These changes can be 
picked up from the IR spectra. The carboxylic acid dimer has a center of symmetry, thus only 
asymmetric C=O stretching vibrations absorb in the infrared. When the co-crystal is formed, the 
dimer is converted to monomer and the C=O stretching frequency shifts to a higher wave number. 
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The lower absorption frequency of the carboxylic acid dimer is due to hydrogen bonding and 
resonance which lengthens the C=O bond, but when a co-crystal is formed the C=O is free of 
interactions and strengthens the bond leading to the higher wave number shifts of infrared.35 
Furthermore the O-H out-of-plane bending of an acid⋯acid dimer produces a broad, medium-
weak band around 930 cm-1 and the co-crystal formation via acid⋯acceptor interactions leads to 
the disappearance of this band.   
Figure 2.15 Conversion from acid⋯acid dimer to acid⋯pyridine heterosynthon 
 2.4.2 Relationship between molecular electrostatic potentials and interaction selectivity 
The MEPS calculations indicate that the pyridine nitrogen atoms in A1-A3 represent the 
best acceptor sites leaving the imidazole nitrogen atoms as the second-best acceptors. Thus if the 
molecular electrostatic potentials can be used to rank the acceptor sites, then the hydrogen bond 
formation should prefer the best acceptor site.  
In fact, in all twelve crystal structures of A1 and A3, the primary hydrogen bond involves 
the pyridine nitrogen atoms which were considered the best acceptors based on the calculated 
MEPS.  In none of these cases, imidazole nitrogen site compete successfully for an acid-based O-
H donor. These results underscores that a relatively simplified, electrostatic-based, view of 
hydrogen bonding can provide a powerful tool for predicting selectivity in competitive molecular 
recognition events. Furthermore, analysis of the relationship between the molecular electrostatic 
potential value on the pyridine nitrogen in A1-A3 and their success rate in forming co-crystals 
determined by grinding results shows a good correlation, Figure 2.16. 
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Figure 2.16 Relationship between the molecular electrostatic potential value on the pyridine 
nitrogen in A1-A3 and their success rates in forming co-crystals 
 2.4.3 Selectivity or steric effects?  
An alternative argument why the N(py) site was selected in all these structures, could point 
to unfavorable steric hindrance at the N(im) site. To discard such an idea, A4 was utilized as a 
control molecule as it only contains N(im) acceptor sites, but otherwise displays the same shape 
and size as A1-A3. Two of nine attempted co-crystallization reactions yielded co-crystals and the 
crystal structure obtained for A4:Mal confirmed that the imidazole nitrogen sites of these 
molecules are in fact accessible for interactions. Thus, there is no inherent steric reason for why 
all co-crystals of A1-A3 are constructed via O-H⋯N(py) instead of O-H⋯N(im) bonds.  
 2.4.4 Melting point analysis and structure relations  
Melting points of all the co-crystals were plotted against the melting points of respective 
co-formers. For co-crystals of A1, the melting points does not show much of a trend, Figure 2.17. 
Other than the co-crystals of A1:Mal and A1:Adi, all co-crystals have a melting point between 
the two co-formers.  
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Figure 2.17 Melting points of A1-based co-crystals 
Furthermore, the melting point of A1:Glu is considerably higher than the melting point of 
glutaric acid, almost close to the value of A1. This irregularity can be correlated to the structure of 
A1:Glu, where the 1:2 stoichiometry is observed compared to the other co-crystals of A1 with 1:1 
stoichiometry.  
 Melting points of A3 co-crystals show a linear relationship with the melting points of the 
respective acid, Figure 2.18. Other than the A3:Adi, all melting points are lower than both the co-
formers in each instance. As in the A1:Adi co-crystal the melting point of A3:Adi is also different, 
but a simple structural explanation for this anomaly is not apparent.  
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Figure 2.18 Melting points of A3-based co-crystals 
 2.4.5 Variable stoichiometries  
In addition to investigating the viability of molecular electrostatic potential dependent 
selectivity of hydrogen bonding one of the other goals was to explore if the structural outcomes 
could be substantially affected by changes in reaction stoichiometries. Therefore, we focused our 
attention on a group of eight reactions that had produced 1:1 co-crystals with A1 and A3, despite 
a starting reaction stoichiometry of two donors to one acceptor. A1 and A3 were then combined 
with four diacids (adipic acid, suberic acid, sebacic acid and dodecandioic acid) in two different 
stoichiometries, 1:1 and 1:4 respectively. The objective was to determine if different ratios would 
influence the nature or extent of O-H⋯N binding in this family of compounds. Crystalline solids 
were obtained in all sixteen instances and analyzed using IR spectroscopy and 1H NMR on single-
crystal samples. According to the 1H NMR results, all eight crystals produced from 1:1 reaction 
mixtures yielded products with a 1:1 ratio of donor to acceptor. One of the 1H NMR spectrum is 
shown in Figure 2.19 and the remaining spectra are provided in Appendix A.1. At this 
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stoichiometric ratio an excess of acid is not available, thus the hydrogen bond formation 
undoubtedly prefer the best acceptor pyridine site forming 1:1 co-crystals.  
 
 
 
 
 
 
 
 
 
Figure 2.19 1H NMR of 1:1 stoichiometric co-crystal formation in A1:Adi with 1:1 reaction 
stoichiometry 
In six out of eight reactions using 1:4 stoichiometry of reactants, the resulting co-crystals 
displayed a 1:1 ratio indicating the preference towards the best acceptor site. In two cases, A1:Sub2 
and A3:Sub2, the 1H NMR spectra reveal the formation of 1:2 co-crystals, Figure 2.20 and Figure 
2.21. Such 1:2 co-crystals can be envisioned as the result of either all four nitrogen atoms in the 
acceptor being engaged in an O-H⋯N hydrogen bond or, as observed in A1:Glu  and A3:Pim,  
the involvement of two nitrogen atoms and a self-complementary acid⋯acid dimer formation. To 
distinguish between these two options, the fingerprint region in each infrared spectrum was 
examined to find evidence for the presence/absence of a symmetric acid⋯acid dimer, Figure 2.22.  
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Figure 2.20 1H NMR of 1:2 stoichiometric co-crystal of A1:Sub2 with 1:4 reaction 
stoichiometry 
 
Figure 2.21 1H NMR of 1:2 stoichiometric co-crystal of A3:Sub2 with 1:4 reaction 
stoichiometry 
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Figure 2.22 O-H out of plane bend for a) suberic acid b) A1:Sub and c) A1:Sub2 
The mode associated with an out-of-plane O-H bend in the acid⋯acid dimer in suberic acid 
itself shows up as broad stretch of medium intensity at 923 cm-1.  No such mode can be found in 
the IR spectra of either A1:Sub2 or A3:Sub2 which leads to the conclusion that the excess of acid 
has resulted in a 1:2 co-crystal where all available nitrogen atoms (both pyridine and imidazole) 
participate in O-H⋯N heterosynthons. Figure 2.22 compares the O-H out of plane bend stretch in 
the finger print region of Suberic acid, A1:Sub and A1:Sub2. Similar results were observed for 
O-H out of plane bend 
O-H out of plane 
bend - absent 
O-H out of plane 
bend – absent  
a) 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
c) 
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A3:Sub and A3:Sub2 co-crystals providing evidence for the absence of acid⋯acid dimer, thus the 
presence of four O-H⋯N hydrogen bond interactions leading to 1:2 co-crystal formation in 
A1:Sub2 and A3:Sub2. These results suggest that even in variable stoichiometry, electrostatic 
potential dependent selectivity still plays the major role in directing intermolecular hydrogen 
bonds. 
 2.5 Conclusions 
A systematic structural study based on co-crystallizations of four biimidazole based-
acceptors and nine aliphatic di-acids was carried out and the results indicate that the use of 
calculated molecular electrostatic potential surfaces provide a reliable and practical tool for 
predicting the resulting molecular recognition events. The carboxylic acid moieties in each of the 
twelve co-crystals always prefer to bind to the better acceptor predicted by MEPS calculations, 
which, in this case, is a pyridine nitrogen atom rather than an imidazole nitrogen atom, Figure 
2.23. In other words, if a powerful hydrogen-bond donor has a choice of acceptor, the selection 
depends strongly on the molecular electrostatic potential on the acceptor.  
Figure 2.23 Results of the postulated structural outcome 
Additionally, variable stoichiometric studies suggested that even the presence of an 
excessive amount of hydrogen-bond donor does not affect the molecular recognition event. This 
molecular electrostatic potential dependent selectivity of hydrogen bonding is likely to be a general 
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feature of strong hydrogen bonds and, as such, will facilitate the use of more complex synthetic 
strategies for desired supramolecular targets. 
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Chapter 3 - Halogen bond preferences in co-crystal synthesis: A 
hierarchy based on molecular electrostatic potential surfaces1 
 3.1 Introduction 
Intermolecular interactions are important for all molecular recognition events, and 
represent the primary tools in supramolecular chemistry and crystal engineering.2 Thus, it is crucial 
to have a better understanding of the fundamental nature of these interactions in order to 
successfully design complex supramolecules in a predetermined and effective manner.3 Halogen 
bonding is a relatively recent addition to the tool box of supramolecular chemistry.4 According to 
IUPAC, “A halogen bond R−X⋯Y−Z occurs when there is evidence of a net attractive interaction 
between an electrophilic region on a halogen atom X belonging to a molecule or a molecular 
fragment R–X (where R can be another atom, including X, or a group of atoms) and a nucleophilic 
region of a molecule, or molecular fragment, Y−Z”.5 According to this definition, the halogen-
bond donor is the halogen atom with an electropositive tip which accepts the electrons from the 
electronegative acceptor atom, Figure 3.1. The convention is adopted to align it with the generally 
accepted definition of the hydrogen bond.6  
Figure 3.1 Formation of a halogen bond between the electropositive tip of a halogen atom (X) 
and an electronegative acceptor (Y); R and Z are molecular fragments 
Halogen bonds have tunable strength7 and directionality8, thus possess the necessary 
requirements of a suitable supramolecular tool.  Halogen-bond donor ability increases in the order 
of F<Cl<Br<I reflecting the ease of polarizability.9 Presence of electron-withdrawing substituents 
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increase the halogen bond strength by serving to activate the halogen-bond donor atom by 
removing the electron density from the halogen atom.10 Generally, the bond distance between 
acceptor and donor atoms in a halogen bond is significantly shorter than the sum of van der Waals 
radii.11 In addition to conventional halogen bonds, two other halogen⋯halogen contacts, classified 
as type I and type II depending on the geometry of interactions, are frequently reported in crystal 
structures of halogen-substituted molecules, Figure 3.2.12 Between these two halogen⋯halogen 
contacts, type II interactions are now considered true halogen bonds as they are analogous to 
conventional halogen bonds according to the IUPAC definition.13   
Figure 3.2 (a) Conventional halogen bond (b) type I halogen⋯halogen contact (c) type II 
halogen⋯halogen contact; (R & Z- connected molecular fragments, X-halogen atom, Y- 
acceptor atom) 
The interest in halogen bonding started to expand in the last decade or so, rapidly making 
a transition from fundamental to applied chemistry. For example, halogen bonded mesomorphic 
and electronic components have been prepared,14 and catalysis,15 ion sensing,16 macromolecular 
organizations,17 solid state synthesis18 and recycling or resolution processes19 have all been 
performed with halogen bonding.  In addition, halogen bonds have found uses in non-linear optical, 
photoresponsive and phosphorescent materials, liquid crystals, magnetic and conducting materials 
and in nanoparticle self-assembly.20 Halogen bonds are also relevant to life sciences.21 
As discussed in Chapter 2, in a system with multiple hydrogen-bond moieties, the best 
hydrogen-bond donor and the best hydrogen-bond acceptor (as determined by electrostatic 
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potential surfaces) preferentially bind to each other.22 Considering the fundamental similarities 
between the hydrogen bond and halogen bond in strength, directionality and specificity,23 it would 
be possible to rank and utilize the halogen bonds in a similar manner. Different approaches have 
been utilized in order to explore a possible hierarchy of halogen bonds. 
One such approach24 uses a basicity scale towards iodoorganic compounds and has found 
an interesting correlation between the pKb and the I⋯Y normalized intermolecular distances. In 
another study25 19F NMR titrations have been used to determine association constants for the 
interactions of a variety of Lewis bases with fluorinated iodoalkanes and iodoarenes. The results 
suggest linear free energy relationships for the halogen-bond donor ability of substituted 
iodoperfluoroarenes, demonstrating that both substituent constants (σ) and calculated molecular 
electrostatic potential surfaces are useful for constructing such relationships. Numerous theoretical 
studies26 as well as experiments in solution phase27 lead to further revelations about hierarchical 
halogen bonding. Furthermore, a supramolecular hierarchy among halogen-bond donors have been 
established using calculated molecular electrostatic potential values.28 Another study has shown 
that the relative strength and capability of iodo- and bromo-based molecules to act as halogen-
bond donors in a competitive scenario can be related to molecular electrostatic potentials, Figure 
3.3.29  
Figure 3.3 Hierarchical halogen bond formation of iodine and bromine (best donor (I) binds to 
the acceptor while second best donor (Br) forms a type I halogen contact)27 
All these studies have focused on the ranking of halogen-bond donors, but there is a lack 
of systematic studies based on the molecular electrostatic potential surfaces for halogen bond 
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formations. At this point, it is not clear if an electrostatic potential-based ranking of acceptors will 
work in halogen bonding, due to the scarcity of relevant studies. Thus, we decided to carry out a 
systematic co-crystallizations on a series of N-heterocyclic halogen-bond acceptors, in order to 
establish if halogen bonds are also likely to follow best-donor/best-acceptor guidelines. Selected 
acceptors (A1-A3) are shown in Figure 3.4. Each of these molecules contain of two types of 
binding sites, pyridine nitrogen and imidazole nitrogen leading to a total of four acceptor sites per 
molecule. In addition, to ensure that the imidazole nitrogen atom was not inaccessible due to some 
steric hindrance, we also included ligand A4, with essentially the same shape, but with only one 
type of acceptor site.   
 
 
 
 
 
 
Figure 3.4 Acceptors employed in the study 
Ranking of the acceptor sites were performed through calculated molecular electrostatic 
potential surfaces. These four compounds were then co-crystallized with 13 halogen-bond donors, 
including ten iodine-based donors (D1-D10) and three bromine donors (D11-D13), Figure 3.5. D5 
was included as a control molecule where the iodine is not activated.  
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Figure 3.5 Halogen-bond donors employed in this study 
The study is undertaken in response to three hypotheses, 
1. If a halogen-bond donor has a choice of two different halogen-bond acceptors, it will 
preferentially select the best-acceptor as determined by molecular electrostatic 
potentials surfaces (MEPS). 
2. A brominated halogen-bond donor will be less successful at forming co-crystals than 
the corresponding iodoinated analogues. 
3. Activation of the halogen bond donor is crucial to form halogen bond interactions.  
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 3.2 Experimental  
 3.2.1 General 
All reagents, solvents, and donors D1-D9 and D11-D13 were purchased from commercial 
sources and used as received. 2,2’-Biimidazole30 and A1-A4 were synthesized according to 
previously reported methods31 and discussed in Chapter 2. Donor D10 was prepared according to 
the synthetic methods reported.32 1H NMR spectra were recorded on a Varian Unity plus 400 MHz 
spectrometer in CDCl3 or DMSO-d6. Infrared spectra were recorded with a Nicolet 380 FT-IR with 
a digital resolution of 0.9 cm-1 and data processed using Omnic33 software. Melting points were 
determined using Fischer-Johns Mel-Temp melting point apparatus and are uncorrected.    
 3.2.2 Electrostatic potential calculations  
Electrostatic potentials on the acceptors and donors were calculated with density functional 
B3LYP level of theory with 6-311++G** basis set in vacuum. All calculations were carried out 
using Spartan 8 software.34 All molecules were geometry optimized and the maxima and minima 
on the electrostatic potential surface (0.002 e/au isosurface) determined using a positive point 
charge in the vacuum as a probe. The numbers indicate the interaction energy (kJ/mol) between 
the positive point probe and the surface of the molecule at that particular point. These numbers are 
related to the electrostatic potentials on the atoms with the negative number corresponding to a 
negative potential and positive number corresponding to a positive potential. 
 3.2.3 Grinding experiments and IR spectroscopy 
The initial screening was carried out with solvent-assisted grinding using methanol as the 
solvent. Acceptors and donors were mixed in respective stoichiometric quantities and the solid 
resulting from each reaction was characterized by IR spectroscopy. Successful interactions 
between the acceptor and donor were identified using specific shifts of the peaks of the mixture 
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compared to starting compounds, Figure 3.6. In each reaction, 10 mg of the acceptor was used 
with stoichiometric amount of the respective halogen-bond donor. In 25 of 52 experiments the 
vibrational spectra displayed shifts of peaks in the fingerprint region compared to their initial 
positions (Figure 3.6) indicative of halogen bond formation. 
 3.2.4 Synthesis of co-crystals  
The resulting mixtures from grinding experiments were dissolved in a minimum amount 
of methanol and placed in a 2 dram borosilicate vial for slow evaporation in order to obtain crystals 
suitable for single crystal X-ray diffraction. Once the crystals were formed they were again 
analyzed using IR spectroscopy, melting point analysis and subjected to single crystal X-ray 
diffraction. 16 crystals were obtained and their structures subsequently solved with single crystal 
X-ray diffraction. Table 3.1 summarizes the experimental details. Appendix B.2 contains the 
relevant X-ray experimental data.  
Table 3.1 Experimental details of the sixteen co-crystals obtained 
Code 
Mixed 
Mole 
ratio 
Amounts used 
Solvent and 
method 
Crystal 
stoichiometry 
Melting 
point 
(°C) 
Crystal 
color & 
habit 
A1:D1 1:2 
A1 -10 mg, 0.032 mmol 
D1 - 22 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 57-60 
Colorless 
prism 
A1:D2 1:2 
A1 - 10 mg, 0.032 mmol 
D2 - 29 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 118-120 
Colorless 
plate 
A1:D3 1:2 
A1 - 10 mg, 0.032 mmol 
D3 - 35 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 94-97 
Bronze 
prism 
A1:D4 1:2 
A1 - 10 mg, 0.032 mmol 
D4 - 41 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 99-103 
Colorless 
plate 
A1:D7 1:2 
A1 - 10 mg, 0.032 mmol 
D7 - 25 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 152-154 
Colorless 
prism 
A1:D8 1:2 
A1 - 10 mg, 0.032 mmol 
D8 - 25 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 139-143 
Colorless 
plate 
A1:D10 1:2 
A1 - 10 mg, 0.032 mmol 
D10 - 35 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 140-142 
Colorless 
prism 
A2:D2 1:2 
A2 - 10 mg, 0.032 mmol 
D2 - 29 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 75-78 
Colorless 
plate 
A2:D3 1:2 
A2 - 10 mg, 0.032 mmol 
D3 - 35 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 95-97 
Colorless 
block 
A2:D7 1:2 
A2 - 10 mg, 0.032 mmol 
D7 - 25 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 92-95 
Colorless 
plate 
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A2:D8 1:2 
A2 - 10 mg, 0.032 mmol 
D8 - 25 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 160-163 
Colorless 
prism 
A2:D9 1:2 
A2 - 10 mg, 0.032 mmol 
D9 - 32 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 150-152 
Colorless 
prism 
A2:D10 1:2 
A2 - 10 mg, 0.032 mmol 
D10 - 35 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 143-146 
Colorless 
prism 
A3:D9 1:2 
A3 - 10 mg, 0.032 mmol 
D9 - 32 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:1 149-153 
Colorless 
prism 
A3:D10 1:2 
A3 - 10 mg, 0.032 mmol 
D10 - 35 mg, 0.063 mmol 
Methanol 
Slow evaporation 
1:2 142-145 
Colorless 
plate 
A4:D9 1:1 
A4 - 10 mg, 0.032 mmol 
D9 - 16 mg, 0.032 mmol 
Methanol 
Slow evaporation 
1:1 148-150 
Colorless 
plate 
 
 3.3 Results 
 3.3.1 Electrostatic potentials 
The ditopic acceptor molecules used in this study (A1-A3) contain two different types of 
acceptor sites, pyridine nitrogen (N(py)) and imidazole nitrogen (N(im)). The control molecule A4 
contains only N(im) sites. The ranking of the acceptor sites is established using molecular 
electrostatic potential surfaces and the results from the DFT calculations are provided in Table 3.2. 
Higher negative potential on the acceptor depicts better halogen-bond accepting ability. Table 3.2 
also summaries the electrostatic potentials on halogen-bond donors. The higher the positive value 
on the donor site, the higher the expected halogen-bond donor ability.  
Table 3.2 Calculated surface potential values of the acceptors and donors 
 Molecule Atom Electrostatic potential (kJ/mol-1) 
Acceptors 
1,1'-bis(pyridin-4-ylmethyl)-2,2'-
biimidazole A1 
Pyridine N -188 
Imidazole N -124 
1,1'-bis(pyridin-3-ylmethyl)-2,2'-
biimidazole A2 
Pyridine N -180 
Imidazole N -125 
1,1'-bis(pyridin-2-ylmethyl)-2,2'-
biimidazole A3 
Pyridine N -150 
Imidazole N -120 
1,1'-dibenzyl-2,2'-biimidazole A4 Imidazole N -149 
Donors 
1,2-diiodotetrafluoroethane D1 Iodine +163 
1,4-diiodooctafluorobutane D2 Iodine +168 
1,6-diiodoperfluorohexane D3 Iodine +169 
1,8-diiodoperfluorooctane D4 Iodine +169 
Iodobenzene D5 Iodine +103 
Iodopentafluorobenzene D6 Iodine +166 
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 3.3.2 Grinding experiments and characterization by IR spectroscopy 
Based on IR spectroscopy 25 of the 52 experiments resulted in successful co-crystal 
formation, equivalent to a supramolecular yield of 48%. All co-crystals showed the presence of 
peaks from both starting compounds as well as shifts of C-F vibrations compared to the respective 
halogen-bond donor. Table 3.3 summarizes the selected peak shifts of co-crystals identified by IR 
analysis along with the comparison of IR spectra for co-crystal A2:D3, Figure 3.6.  
Table 3.3 IR analysis of C-F stretches for the ground mixtures 
 
1,2-diiodotetrafluorobenzene D7 Iodine +162 
1,4-diiotetrafluorobenzene D8 Iodine +169 
1,3,5-triiodotrifluorobenzene D9 Iodine +158 
4,4’-diiodoperfluorobiphenyl D10 Iodine +164 
Bromopentafluorobenzene D11 Bromine +143 
1,4-diiodotetrafluorobenzene D12 Bromine +139 
4,4’-dibromopurfluorobiphenyl D13 Bromine +132 
Co-crystal Halogen-bond donor (cm-1) Ground mixture (cm-1) 
A1:D1 1153, 1099 1118, 1083 
A1:D2 1192, 1133 1187, 1115 
A1:D3 1199, 1141 1211, 1134 
A1:D4 1204, 1146 1211, 1139 
A1:D6 1488, 974 1483, 962 
A1:D7 1489, 1438 1500, 1433 
A1:D8 1459, 941 1455, 938 
A1:D9 1403, 1049 1396, 1037 
A1:D10 1459, 954 1456, 948 
A2:D1 1153, 1099 1131, 1083 
A2:D2 1192, 1133 1162, 1137 
A2:D3 1199, 1141 1213, 1138 
A2:D4 1204, 1146 1216, 1142 
A2:D6 1488, 974 1479, 967 
A2:D7 1489, 1438 1487, 1435 
A2:D8 1459, 941 1461, 937 
A2:D9 1563, 1049 1560, 1041 
A2:D10 1459, 954 1453, 945 
A3:D7 1489, 1438 1488, 1434 
A3:D8 1459, 941 1462, 942 
A3:D9 1403, 1049 1397, 1039 
A3:D10 1459, 954 1455, 951 
A4:D7 1489, 1438 1486, 1434 
A4:D8 1459, 941 1461, 938 
A4:D9 1563, 1403 1561, 1400 
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Figure 3.6 Comparison of IR spectra for A2:D3 (red) with the IR spectra of A2 (blue) and D3 
(green); purple circles highlight the shifts in C-F stretches 
 3.3.3 Crystal growth and structure analysis  
All the reaction combinations were used in solvent based crystallization attempts even if 
the IR results did not show successful reaction. The method of crystallization for all attempts was 
slow evaporation from methanolic solutions. 16 crystals were obtained and analyzed using single 
crystal X-ray diffraction in order to examine any halogen-bond preferences.  
Seven structures were obtained for A1-based co-crystals, six for A3-based co-crystals, and 
two co-crystals with A2 and one with A4 was structurally characterized. The supramolecular yields 
from the study are summarized in Table 3.4. Relevant crystallographic data and key halogen bond 
geometries for the 16 crystal structures are provided in Appendix B.2.  
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Table 3.4 Summary of supramolecular yields 
 
 3.3.4 Crystal structures 
 3.3.4.1 Structures of A1-based co-crystals  
Seven co-crystals based on A1 were obtained, A1:D1, A1:D2, A1:D3, A1:D4, A1:D7, 
A1:D8 and A1:D10.  
The crystal structure of A1:D1 shows a 1:1 stoichiometry and primary halogen bonds take 
place with the N(py) atoms of the acceptor, Figure 3.7, leading to infinite 1-D chains. There are 
no obvious structure directing short contacts involving the imidazole nitrogen atoms.  
 
 
 
 
 
 
 
Figure 3.7 Primary halogen bond interactions in A1:D1 
The crystal structure of A1:D2 shows a 1:1 stoichiometry with primary halogen bond 
interactions between iodine and pyridine nitrogen atoms, Figure 3.8. The imidazole nitrogen atoms 
are not involved in any notable short contacts.  
 A1 A2 A3 A4 
Potentials kJ/mol 
Npyridine – (-188) 
Nimidazole – (-124) 
Npyridine – (-180) 
Nimidazole – (-125) 
Npyridine – (-150) 
Nimidazole – (-120) 
Nimidazole – (-149) 
Success rate - grinding 9/13 9/13 4/13 3/13 
Success rate – slow 
evaporation 
7/13 6/13 2/13 1/13 
Total supramolecular 
yield 
69% 69% 31% 23% 
Success rate with iodine 
donors – grinding 
9/10 9/10 4/10 3/10 
Supramolecular yield with 
iodine donors 
90% 90% 40% 30% 
Total supramolecular yield – 48% 
Total supramolecular yield with iodine donors – 63% 
Total supramolecular yield with bromine donors – 0% 
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Figure 3.8 Primary halogen bonds in the crystal structure of A1:D2 
Unlike in previous cases, the crystal structure of A1:D3 shows 1:2 stoichiometry. Thus all 
four nitrogen atoms of A1, Figure 3.9, participate in halogen bonds. The extended architecture is 
composed of 1-D chains of molecular rectangles.  
Figure 3.9 Primary halogen bond interactions in A1:D3 
The crystal structure A1:D4 has a 1:2 stoichiometry. Unlike in previous structures, iodine 
atoms in D4 behave asymmetrically leading to a trimer formation in A1:D4, with only one iodine 
atom participating in a halogen bond with pyridine N, Figure 3.10. The second iodine atom and 
the imidazole nitrogen atoms are not involved in any notable short contacts.  
Figure 3.10 Primary halogen bond interactions in A1:D4 leading to a trimer  
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The crystal structure of A1:D7 displays 1:2 stoichiometry where one acceptor molecule 
interacts with two donor molecules forming a discrete trimer, Figure 3.11. The primary halogen 
bonds take place between one of the two iodine atoms and the N-pyridine moiety (the best 
acceptor) whereas the second iodine atom is involved in an I⋯I type II contact (Figure 3.2) with 
an iodine atom from a neighboring donor molecule, Figure 3.11.   
Figure 3.11 a) Primary halogen bond interactions in the co-crystal A1:D7 and b) secondary 
interactions in co-crystal A1:D7 
The crystal structure of A1:D8 has a 1:1 stoichiometry and contains infinite 1-D chains 
constructed from I⋯N(py) halogen bonds, Figure 3.12. The imidazole nitrogen atoms do not 
participate in halogen bonding and instead form short contacts with C-H moieties of a neighboring 
acceptor molecule, resulting in a stacking of adjacent chains, Figure 3.12.  
 
Figure 3.12 a) Formation of infinite chains via halogen bonds in A1:D8 and b) secondary 
interactions of imidazole nitrogen atoms 
a) 
 
 
 
 
b) 
a)                                                                                              b)  
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The last co-crystal structure obtained with A1, A1:D10 has 1:2 stoichiometry and contains 
discrete trimers as the second iodine atom does not participate in a halogen bond. Again, the best 
acceptor, N(py) is the preferred binding site, Figure 3.13. Neither imidazole nitrogen atom nor the 
second iodine atom of the donor participate in any notable intermolecular interactions.  
 
Figure 3.13 Trimer formation in co-crystal A1:D10 
 3.3.4.2 Structures of A2-based co-crystals  
Six co-crystal structures were obtained with A2, A2:D2, A2:D3 A2:D7, A2:D8, A2:D9 
and A2:D10. Co-crystal A2:D2 has a stoichiometry of 1:1. A2:D2 is constructed via the primary 
halogen bonds between iodine and pyridine nitrogen atoms (the best acceptor) which lead to 1-D 
infinite chains, Figure 3.14. The imidazole nitrogen atoms are not engaged in any short contacts. 
Figure 3.14 Halogen bonds in the crystal structure of A2:D2 
 
The crystal structure of A2:D3 also shows that the co-crystal has a 1:1 stoichiometry with 
I⋯N(py) halogen bonds, Figure 3.15. The structure contains 1-D chains in a zigzag pattern formed 
via I⋯N(py) and imidazole nitrogen atoms are participating in self-complementary hydrogen 
bonds, Figure 3.15.  
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Figure 3.15 a) Primary halogen bond interactions in A2:D3 and b) self-complementary 
hydrogen bonds of imidazole moiety 
In the crystal structure of A2:D7 the best-acceptor, N(py) forms a bifurcated halogen bond, 
Figure 3.16, which leads to the formation of  chains of tetrameric rhombic shape architectures. No 
notable secondary interactions are found with the imidazole nitrogen atoms.    
 
 
 
 
 
 
Figure 3.16 Primary halogen bond interaction in A2:D7 
The crystal structure of A2:D8 has a 1:1 stoichiometry and contains 1-D chains. Imidazole 
nitrogen atoms participate in secondary short contacts as observed in A1:D8, Figure 3.17.  
Figure 3.17 a) Primary and b) secondary interactions in A2:D8 
a)                                                                                                            b)          
a)                                                                                                b)  
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The crystal structure of A2:D9 also displays a 1:1 stoichiometry. Unlike in previous cases, 
this structure contains two distinct halogen-bond motifs. First, a trimer assembled via a I⋯N(py) 
halogen bonds, Figure 3.18. The latter leads to ‘chains of hexamers’ where all four nitrogen atoms 
form halogen bonds, Figure 3.18. The third iodine atom of the donor molecule is inactive, which 
is a documented phenomenon associated with this particular halogen-bond donor.35 
Figure 3.18 a) Trimer formation in A2:D9 and b) a hexagon in the crystal structure of A2:D9 
In crystal structure of A2:D10 all four nitrogen atoms are participating in halogen bonds 
leading to infinite ribbons, Figure 3.19.   
Figure 3.19 An infinite ribbon in A2:D10 
 3.3.4.3 Structures of A3-based co-crystals  
Only two crystal structures were obtained with A3. A3:D9 has a stoichiometry of 1:1 and 
contains 1-D chains assembled using I⋯N(py), Figure 3.20. The imidazole nitrogen atoms and the 
third iodine atom do not have any significant short contacts. 
a)                                                                             b)  
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Figure 3.20 Primary halogen bond interactions in co-crystal A3:D9 
The structure of A3:D10 shows that the acceptor and donor are present in a 1:2 
stoichiometry and, similarly to the structure A2:D10, contains chains of rectangles using all four 
nitrogen atoms on the acceptor, Figure 3.21.  
 
 
 
 
 
 
 
 
Figure 3.21 Rectangle in the structure of A3:D10 
 3.3.4.4 Structures of A4-based co-crystals  
Only one crystal structure was obtained with A4, A4:D9. In the 1:1 co-crystal of A4:D9, 
the ‘arms’ of the acceptor are directed to same side of the molecule. One of the imidazole nitrogen 
atoms form a conventional, near-linear halogen bond, whereas the other imidazole nitrogen atom 
forms a bifurcated halogen bond with two adjacent donor molecules, Figure 3.22. Interestingly, all 
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three iodine atoms of the donor participate in halogen bonds which is unique in this series of crystal 
structures, Figure 3.22.  
Figure 3.22 a) Halogen bond interactions in the structure of A4:D9 and b) all three iodine atoms 
in D9 participating in halogen bonding 
 3.4 Discussion  
The sequence of experiments performed in this study represents an attempt at identifying 
patterns of behavior that can have a general applicability when it comes to understanding halogen-
bond driven molecular recognition events and co-crystal synthesis, as well as to determine if 
halogen-bond interactions follow the same best-donor/best-acceptor rules (where the ranking is 
based on electrostatics) as are hydrogen bonds. 52 co-crystallizations were performed using three 
molecules with two different acceptor sites on each of them and one control molecule with only 
one type of nitrogen atoms. Co-crystallization attempts were conducted between the four acceptors 
and 13 halogen-bond donors.  
 3.4.1 Characterization by IR spectroscopy 
IR spectroscopy is known to be a versatile, convenient and accurate screening method for 
determining if a particular combination of donors and acceptor resulted in the formation of a co-
a)                                                                                           b) 
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crystal.36 When the halogen bonds are formed between acceptors and donors, some of the original 
stretching bands are affected although it is sometimes difficult to find obvious patterns to the way 
in which some of modes are red or blue shifts compared to their original positions. This is 
consistent with previously reported observations of halogen bonds in the solid state.37 
 3.4.2 Relationship between molecular electrostatic potentials and halogen bond 
formation  
The three ditopic acceptors A1-A3 have two acceptor sites that differ primarily by their 
electrostatic potentials. According to the DFT calculated MEPS values, N(py) has more negative 
potential than N(im) making it the best acceptor. The grinding experiments showed a good 
correlation between the potential on the acceptor sites and the supramolecular yield (success of 
reaction) indicating that electrostatic potentials play a major role in ranking the relative strength 
and efficiency of competing halogen-bond sites, Table 3.4. Partial potential on the N(py) atoms of 
A1 and A2 are close, and their success rates are also similar. Upon moving from A1 to A4 the 
electrostatic potential on the nitrogen atoms are decreasing and their success rates are also 
decreasing indicating the strong dependency of electrostatic potential governing halogen bond 
formation in co-crystal synthesis. An examination of all 15 crystal structures with ditopic acceptors 
clearly demonstrate that, given a choice, a strong halogen-bond donor preferentially interacts with 
an acceptor atom with a higher negative electrostatic potential, which proves the initial hypothesis 
that halogen-bond selectivity follows a best-donor/best acceptor guideline. Four of these 15 
structures showed the participation of an imidazole nitrogen atom in a halogen bond, A1:D3, 
A2:D9, A2:D10 and A3:D10. In all four structures I⋯N(im) distances were substantially longer 
than the I⋯N(py) distances. An analysis of van der Waals radii reduction percentages for two types 
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of halogen bonds for these four structures provide an indication that I⋯N(py) interactions are more 
favorable and stronger than I⋯N(im) interactions,38 Figure 3.23.  
 
 
 
 
 
 
 
 
Figure 3.23 Van der Waals radii reduction percentages for A1:D3, A2:D9, A2:D10 and A3:D10 
 3.4.3 Importance of activation and polarizability towards halogen bond formation  
All activated iodine based halogen-bond donors showed comparable electrostatic potential 
values and the experimental data show the increased success in forming halogen bonds with these 
donors. Furthermore, there is a dramatic difference in halogen-bond ability between iodo- and 
bromo-substituted compounds, which reflect the polarizability, MEPS and size/depth of the 
respective σ-hole; the success rate of iodine based donors is 63%, whereas none of the bromo-
substituted donors produced co-crystals. On the other hand, the control experiments with 
iodobenzene showed that the ‘activation’ offered by electron-withdrawing fluorine substituents 
increase the ability of halogen bond formation by boosting the size and strength of σ-hole and by 
influencing the MEPS on the halogen atom.  
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 3.4.4 Electrostatic based selectivity or steric effects?  
In order to ensure that observed binding preferences were not simply the result of steric 
hindrance, A4 was included as a control molecule which only contains imidazole sites in the same 
steric environment as in A1-A3. Co-crystal structure A4:D9 supports that fact that there is no steric 
effect that impacts the interactions with imidazole nitrogen. Furthermore, the structures A1:D3, 
A2:D9, A2:D10 and A3:D10 also supports this fact which show successful halogen bond 
formations with imidazole nitrogen atoms, apart from the major interactions with pyridine nitrogen 
atoms in each co-crystal. The conformational flexibility of the acceptor molecules means that they 
can adjust their shape according to the demand, thus the observed best-donor/best-acceptor 
interactions in each co-crystal is purely based on their molecular electrostatic potential values. 
 3.4.5 Variations in intermolecular interactions 
Apart from the conventional halogen bonds and secondary interactions with pyridine and 
imidazole nitrogen atoms, in A2:D7 and A4:D9 the nitrogen atoms are participating in 
dissymmetric bifurcated halogen bonds, where one of the contacts is shorter than the other. Such 
halogen bonds are rare, as nitrogen atoms, with only one lone pair, tend to be satisfied with a single 
electron-pair acceptor, forming one non-covalent interaction.  
When considering the donor molecules in these 16 co-crystal structures various patterns 
can be recognized. In A1:D7, one of the iodine atoms of halogen-bond donor is participating in 
forming an I⋯I halogen bond where the electropositive tip of the iodine atom is interacting with 
the electronegative region of another iodine atom, Figure 3.11. In A1:D4 and A1:D10, even though 
the two iodine atoms in donors “should” have the same initial strength as they are symmetric 
molecules, the second iodine atom is not participating in any interactions leading to a trimer. It is 
possible that once the first halogen bond is formed, some electron density is donated into the donor 
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molecule and this new charge has to be dispersed through the remaining molecule which may lead 
to a slight reduction of the positively charge -hole on the remaining iodine atom thereby rendering 
it less effective. In A4:D9, all three donor atoms of D9 are participating in halogen bonds, which 
is uncommon with this molecule, Figure 3.22b. On the other hand, this illustrates that all three 
iodine atoms of D9 are capable of simultaneously forming halogen bonds in a single solid state 
structure.    
 3.5 Conclusions 
This study highlights the importance of using molecular electrostatic potentials as a way 
of ranking halogen bond acceptor ability in a system with multiple acceptor sites. In fact, halogen 
bonds reflect the previously established guidelines of hydrogen bonding and follows a best-donor 
best-acceptor interaction hierarchy in the solid state. In all 15 crystal structures obtained with 
ditopic acceptors A1-A3, halogen bonds involving the better acceptor are favored, Figure 3.24. 
The supramolecular yield for each acceptor was a reflection of the maximum value of its 
electrostatic potential. Furthermore, halogen-bond ability of activated iodine donors is 
dramatically greater compared to that of activated bromo-analogues and unactivated iodo-
compounds. These facts realize the importance of polarizability and activation in successful 
halogen bond formations.  
Figure 3.24 Results of the postulated structural outcome 
74 
 3.6 Reference
1. Aakeröy, C.B.; Wijethunga, T.K.; Desper, J. New J. Chem. 2015, 39, 822-828; Aakeröy, C.B.; Wijethunga, T.K.; 
Desper, J.; Moore, C. J. Chem. Crystallogr. 2015, 45, 267-276. 
2. Lehn, J.M. Chem. Soc. Rev. 2007, 36, 151-160.  
3. Benedict, J.B. Recent advances in crystallography, 2012, InTech; Meyer, F.; Dubois, P. CrystEngComm 2013, 15, 
3058-3071; Cinčić, D.; Friščič, T.; Jones, W. Chem. Eur. J. 2008, 14, 747-753. 
4. Metrangolo, P.; Meyer, F.; Pilati, T.; Resnati, G.; Terraneo, G. Angew. Chem. Int. Ed. 2008, 47, 6114-6127. 
5. Desiraju, G.R.; Ho, S.; Kloo, L.; Legon, A.C.; Marquardt, R.; Metrangolo, P.; Politzer, P.A.; Resnati, G.; Rissanen, 
K. Pure Appl. Chem. 2013, 85, 1711-1713. 
6. Priimagi, A.; Cavallo, G.; Metrangolo, P.; Resnati, G. Acc.Chem.Res. 2013, 46, 2686-2695; Tottadi, S.; Desiraju, 
G. R. Chem. Commun. 2013, 49, 7791-7793. 
7. Gavezzotti, A. Mol. Phys. 2008 106, 1473-1485; Walsh, R.B.; Padgett, C.W.; Metrangolo, P.; Resnati, G.; Hanks, 
T.W.; Pennington, W.T.; Cryst.Growth Des 2001, 1, 165-175; Crihfield, A.; Hartwell, J.; Phelps, D.; Walsh, R.B.; 
Harris, J.L.; Payne, J.F.; Pennington, W.T.; Hanks, T.W. Cryst.Growth Des 2003, 3, 313-320. 
8. Valerio, G.; Raos, G.; Meille, S.V.; Metrangolo, P.; Resnati, G. J. Phys. Chem. A 2000, 104, 1617-1620; Bailey, 
R.D.; Drake, G.W.; Grabarczyk, M.; Hanks, T.W.; Hook, L.L.; Pennington, W.T. J. Chem. Soc., Perkin Trans. 2 
1997, 12, 2773-2779; Karpfen, A. Theor. Chem. Acc. 2003,  110, 1-9; Shen, Q.J.; Jin, W.J. Phys. Chem. Chem. 
Phys. 2011, 13, 13721-13729. 
9. Politzer, P.; Lane, P.; Concha, M.C.; Ma, Y.; Murray, J.S. J. Mol. Model. 2007, 13, 305-311. 
10. Metrangolo, P.; Resnati, G. Chem. Eur. J. 2001, 7, 2511-2519; Bauzá, A.; Quiñonero, D.; Frontera, A.; Deyà, P. 
M. Phys. Chem. Chem. Phys. 2011, 13, 20371-20379. 
11. Metrangolo, P.; Neukirch, H.; Pilati, T.; Resnati, G. Acc. Chem. Res. 2005, 38, 386-395. 
12. Aakeröy, C. B.; Sinha, A.S.; Chopade, P. D.; Desper, J. Dalton Trans. 2011, 40, 12160-12168. 
13. Metrangolo, P.; Resnati, G. IUCrJ 2014, 1, 5-7.  
14. Beale, T.M.; Chudzinski, M.G.; Sarwar, M.G.; Taylor, M.S. Chem. Soc. Rev. 2013, 4, 1667-1680. 
15. Bruckmann, A.; Pena, M.A.; Bolm, C. Synlett 2008, 6, 900-902. 
16. Chudzinski, M.G.; McClary, C.A.; Taylor, M.S. J. Am. Chem. Soc. 2011, 133, 10559-10657. 
17. Shirman, T.; Freeman, D.; Posner, Y.D.; Feldman, I.; Facchetti, A.; Van der Boom, M.E. J. Am. Chem. Soc. 2008, 
130, 8162-8163. 
18. Marras, G.; Metrangolo, P.; Meyer, F.; Pilati, T.; Resnati, G.; Vij, A. New J. Chem. 2006, 30, 1397-1402.  
19. Dordonne, S.; Crousse, B.; Delpon, D.B.; Legros, J. Chem. Commun. 2011, 47, 5855-5857. 
20. Meyer, F.; Dubois, P. CrystEngComm 2012, 15, 3058-2071. 
21. Politzer, P.; Murray, J.S.; Clark, T. Phys. Chem. Chem. Phys. 2010, 12, 7748-7757; Vallejos, M.J.; Auffinger, P.; 
Ho, P.S.; International Tables of Crystallography F, 2012, 821-826; Scholfield, M.R.; Zanden, C.M.V.; Carter, 
M.; Ho, P.S. Protein Sci. 2013, 22, 139-152. 
22. Etter, M.C. Acc. Chem. Res. 1990, 23, 120-126; Aakeröy, C.B.; Beatty, A.M.; Helfrich, B.A. J. Am. Chem. Soc. 
2002, 48, 14425-12232; Aakeröy, C.B.; Salmon, D.J. CrystEngComm 2005, 72, 439-448; Bowers, J.R.; Hopkins, 
G.W.; Yap, G.P.A.; Wheeler, K.A. Cryst.Growth Des. 2005, 5, 727-736. 
23. Aakeröy, C.B.; Wijethunga, T.K.; Desper, J. CrystEngComm 2014, 16, 28-31. 
24. Questel, J.Y.L.; Laurence, C.; Graton, J. CrystEngComm 2013, 15, 3212-3221. 
                                                 
75 
                                                                                                                                                             
25. Sarwar, M.G.; Dragisic, B.; Salsberg, L.J.; Gouliaras, C.; Taylor, M.S. J. Am. Chem. Soc. 2010, 132, 1646-1653. 
26. Riley, K.E.; Hobza, P. Phys. Chem. Chem. Phys 2013, 15, 17742-17752. 
27. Lu, Y.; Li, H.; Zhu, X.; Zhu, W.; Liu, H. J. Phys. Chem. A 2011, 115, 4467-4475. 
28. Aakeröy, C.B.; Baldrighi, M.;  Desper, J.;  Metrangolo, P.; Resnati, G. Chem. Eur. J. 2013, 19, 16240-16247. 
29. Aakeröy, C.B.; Chopade, P.D.; Desper, J. Cryst. Growth Des. 2013, 13, 4145-4150. 
30. Xiao, J.; Shreeve, J. M. J. Org. Chem. 2005, 70, 3072-3078. 
31. Aakeröy, C.B.; Wijethunga, T.K.; Desper, J. New J. Chem. 2014, 39, 822-828.  
32. Espallargas, G.M.; Recuenco, A.; Romero, F.M.; Brammer, L.; Libri, S. CrystEngComm 2012, 14, 6381-6383. 
33. Omnic 8.0 © 1992-2008, Thermo Fisher Scientific Inc. 
34. Spartan’08, Wavefunction, Inc. 
35. Lucassen, A. C. B.; Karton, A.; Leitus, G.; Shimon, L. J. W.; Martin, J. M. L.; van der Boom, M. E. Cryst. Growth 
Des. 2007, 7, 386-392. 
36. Nagels, N.; Hauchecorne, D.; Herrebout, W.A. Molecules 2013, 18, 6829-6851; Erdélyi, M. Chem. Soc. Rev. 2012, 
41, 3547-3557. 
37. Dey, A.; Metrangolo, P.; Pilati, T.; Resnati, G.; Terraneo, G.; Wlassics, I. J. Fluorine Chem. 2009, 130, 816-823; 
Priimagi, A.; Cavallo, G.; Forni, A.; Gorynsztejn-Leben, M.; Kaivola, M.; Metrangolo, P.; Milani, R.; Shishido, 
A.; Pilati, T.; Resnati, G.; Terraneo, G. Adv. Funct. Mater. 2012, 22, 2572-2579. 
38. Valerio, G.; Raos, G.; Meille, S.V.; Metrangolo, P.; Resnati, G. J. Phys. Chem. A 2000, 104, 1617-1620; Caronna, 
T.; Liantonio, R.; Logothetis, R.A.; Metrangolo, P.; Pilati, T.; Resnati, G. J. Am. Chem. Soc. 2004, 126, 4500-
4501; Awwadi, F.F.; Willett, R.D.; Peterson, K.A.; Twamley, B. Chem. Eur. J. 2006, 12, 8952-8960. 
76 
Chapter 4 - Dependency of electrostatic potential differences in 
governing halogen bond selectivity  
 4.1 Introduction 
Designing predictable supramolecular architectures requires a clear understanding of 
intermolecular interactions.1 In this context, there is an abundance of studies on hydrogen bonding, 
the most well-known among non-covalent interactions.2 Halogen bonding,3 a recent addition to 
the tool box of supramolecular chemistry, has not yet received the same amount of attraction. 
Halogen bonding can be viewed as a primarily electrostatic interaction between an electron 
deficient halogen atom and an electronegative region of another atom or molecule.4 The 
anisotropic distribution of the electrostatic potential leaves an amphiphilic character to the halogen 
atom, where there is a region of positive potential known as the “σ hole”5 and a region of negative 
potential, Figure 4.1. Therefore, a covalently bound halogen can interact with both electronegative 
and electropositive entities depending on the approaching direction.  
 
 
 
 
Figure 4.1 Anisotropic distribution of positive and negative electrostatic potential on a halogen 
atom (X); R- attached molecular fragment 
Even though the concept of halogen bonding dates back more than a century,6 the ability 
of halogen atoms to function as effective and reliable sites for structure directing molecular 
recognition processes remained underexplored until the 1990s.7 Thus, halogen bonding (XB) and 
its potentials in the field of supramolecular chemistry are still in the infancy stage of realization.8  
R 
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Fundamental studies on halogen bonding span a wide range including examination of the 
electrostatic nature,9 geometric features of halogen bonding,10 activation process for halogen 
atoms,11 design of halogen-bond donors and acceptors,12 hierarchy of halogen bonding13 and the 
nature of halogen bonding in gas phase,14 solution phase15 and in the solid state.16 Furthermore, 
studies on controlling halogen bonding in supramolecular architectures have been at the center of 
some studies.17 Apart from these fundamental studies, halogen bonding has received attraction 
from material chemists due to applications in supramolecular gels,18 nanoparticle self-assembly,19 
liquid crystals,20 optical materials,21 separation processes,22 stabilization processes23 and electric 
and magnetic materials.24 In addition, halogen bonding in biological systems25 is attracting much 
attention, and medicinal chemistry promises a bright future in applying halogen bonding in drug 
discoveries26 and in transmembrane anion transport.27  
Etter’s rules on hydrogen bond selectivity28 provide a clear understanding on the molecular 
recognition behavior of hydrogen bonding,29 but a similar set of guidelines are still to be realized 
in halogen bonding. Chapter 3 describes the study on electrostatic potential dependent selectivity 
of halogen bonding and the results suggested that halogen bonding favors a better acceptor site as 
ranked by MEPS calculations while a second best acceptor site on the molecule did not form any 
noticeable interactions.30 Even though the results were conclusive, in some structures, a best-
donor/best-acceptor preference is missing. Further analysis lead to the realization that when the 
MEPS difference between the two acceptor sites is low, there is no binding preference. This was 
further confirmed by a CSD31 survey conducted on halogen bonded systems of acceptors with two 
different acceptor moieties where even though a MEPS based ranking is possible in predicting the 
best acceptor site, halogen bond interactions did not follow any preference for binding.32  
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Thus in a system with two different types of acceptor sites and a halogen-bond donor probe, 
there are essentially three possible outcomes, Figure 4.2.  
1. If the electrostatic potential difference on the two acceptor sites is sufficiently large; 
halogen bonding will follow best-donor/best-acceptor interaction hierarchy and will 
interact preferentially with best acceptor site.  
2. If the electrostatic potential difference of the two acceptor sites are very small, halogen 
bonding will occur with both acceptor sites.  
3. There might be a region of MEPS difference where binding preference cannot be 
predicted.  
Figure 4.2 Three possible outcome of co-crystallizations between an asymmetric ditopic 
acceptor and halogen-bond donors 
In order to address these possibilities, a library of acceptors with multitude of acceptor sites 
with different values of MEPS values on each acceptor were required. Furthermore, the selected 
library was required to include a wide range of MEPS difference between the two acceptor sites. 
The evaluated library of acceptors are shown in Figure 4.3, along with the MEPS value of each 
acceptor site and the MEPS difference for each molecule (ΔE value) is also provided.  
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Probing of halogen bond selectivity was done through a systematic co-crystallization 
approach. Nine iodine-based perfluorinated halogen-bond donors were selected (including 
aromatic and aliphatic donors), Figure 4.4. Co-crystallization experiments between the twelve 
acceptors and nine donors were conducted (108 reactions) and solid state structures were obtained 
for 36 combinations.  
Figure 4.3 Acceptors under study; MEPS values on each acceptor site and ΔE value for each 
acceptor are shown in kJ/mol 
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Figure 4.4 Halogen-bond donors under study 
The study is undertaken in response to three hypotheses, 
1. There is a cut off value for MEPS difference where halogen bonds lack selectivity. 
2. There is a MEPS range that the halogen bond selectivity cannot be predicted (grey area 
of MEPS difference). 
3. A systematic co-crystallization study would minimize the range of this grey area. 
 4.2 Experimental  
 4.2.1 General 
All precursors, solvents, donors and acceptor A13 were purchased from commercial 
sources and used without further purification. A1 and A2 were synthesized as reported in Chapter 
2.33 A5-A12 were synthesized following a modified procedure of a literature report.34 A1435 and 
D1036 were also synthesized following literature procedures. 1H NMR spectra were recorded on a 
Varian Unity plus 400 MHz spectrometer in DMSO-d6. Infrared spectra were recorded with a 
Nicolet 380 FT-IR with a digital resolution of 0.9 cm-1 and data processed using Omnic37 software. 
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Melting points were determined using Fischer-Johns Mel-Temp melting point apparatus and are 
uncorrected. 
 4.2.2 Electrostatic potential calculations 
Molecular electrostatic potentials surfaces on the acceptor molecules and donor molecules 
were calculated with density functional B3LYP level of theory using 6-311++G** basis set in 
vacuum. All calculations were carried out using Spartan 8 software.38 All molecules were 
geometry optimized and the maxima and minima on the electrostatic potential surface (0.002 e/au 
isosurface) determined using a positive point charge in the vacuum as a probe. The numbers 
indicate the interaction energy (kJ/mol) between the positive point probe and surface of the 
molecule at that particular point. A positive value for the interaction energy indicates a positive 
surface potential while a negative value indicates a negative surface potential. 
 4.2.3 Synthesis of acceptors 
 4.2.3.1 Synthesis of 1-(pyridin-4-ylmethyl)-benzimidazole, A5 
 
 
 
 
 
 
Benzimidazole (0.23 g, 2.0 mmol) and NaOH (0.16 g, 4.0 mmol) were placed in a 100 mL 
round bottomed flask with 20 mL of acetonitrile. The mixture was stirred at room temperature for 
one hour. 4-Picolyl chloride hydrochloride (0.33 g, 2.0 mmol) in acetonitrile (20 mL) was added 
to the mixture and refluxed for 24 hours at 50 °C - 60 °C. The reaction was monitored with TLC 
and after completion, the solvent was removed by rotary evaporation. The residue was dissolved 
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in water (50 mL) and extracted with methylene chloride (30 mL x 3). The organic layers were 
combined, dried over anhydrous MgSO4 and rotary evaporated to obtain an orange colored solid. 
Yield: 0.35 g (85%); m.p. 105-107 °C (reported 105-110 °C);34 1H NMR (400 MHz, DMSO-
d6):8.52 (d, 1H), 8.45 (s, 1H), 7.70 (d, 1H), 7.47 (d, 1H), 7.22 (m, 4H), 5.59 (s, 2H). 
 4.2.3.2 Synthesis of 5,6-dimethyl-1-(pyridin-4-ylmethyl)-benzimidazole, A6 
 
 
 
 
 
 
 
5,6-Dimethylbenzimidazole (0.29 g, 2.0 mmol) and NaOH (0.16 g, 4.0 mmol) were placed 
in a 100 mL round bottomed flask with 20 mL of acetonitrile. The mixture was stirred at room 
temperature for one hour. 4-Picolyl chloride hydrochloride (0.33 g, 2.0 mmol) in acetonitrile (20 
mL) was added to the mixture and refluxed for 24 hours at 50 °C - 60 °C. The reaction was 
monitored with TLC and after completion the solvent was removed by rotary evaporation. The 
residue was dissolved in water (50 mL) and extracted with methylene chloride (30 mL x 3). The 
organic layers were combined, dried over anhydrous MgSO4 and rotary evaporated to obtain the 
pale orange powder as the product. Yield: 0.34 g (72%); m.p. 180-185 °C (reported 185-190 °C);34 
1H NMR (400 MHz, DMSO-d6): 8.51 (d, 2H), 8.26 (s, 1H), 7.45 (s, 1H), 7.22 (s, 1H), 7.14 (d, 
2H), 5.51 (s, 2H), 2.27 (s, 6H). 
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 4.2.3.3 Synthesis of 4-((imidazol-1-yl)methyl)pyridine, A7 
 
 
 
 
 
 
Imidazole (0.14 g, 2.0 mmol) and NaOH (0.16 g, 4.0 mmol) were placed in a 100 mL round 
bottomed flask with 20 mL of acetonitrile. The mixture was stirred at room temperature for one 
hour. 4-Picolyl chloride hydrochloride (0.33 g, 2.0 mmol) in acetonitrile (20 mL) was added to the 
mixture and refluxed for 24 hours at 50 °C - 60 °C. The reaction was monitored with TLC and 
after completion the solvent was removed by rotary evaporation. The residue was dissolved in 
water (50 mL) and extracted with methylene chloride (30 mL x 3). The organic layers were 
combined, dried over anhydrous MgSO4 and rotary evaporated to obtain the dark green powder as 
the product and recrystallized with ethyl acetate to obtain dark green crystals. Yield: 0.32 g (62%); 
m.p. 65-68 °C; 1H NMR (400 MHz, DMSO-d6): 8.54 (d, 2H), 7.81 (s, 1H), 7.23 (s, 1H), 7.14 
(d, 2H), 6.98 (s, 1H), 5.29 (s, 2H). 
 4.2.3.4 Synthesis of 1-(pyridin-3-ylmethyl)-benzimidazole, A8 
 
 
 
 
 
 
Benzimidazole (0.23 g, 2.0 mmol) and NaOH (0.16 g, 4.0 mmol) were placed in a 100 mL 
round bottomed flask with 20 mL of acetonitrile. The mixture was stirred at room temperature for 
one hour. 3-Picolyl chloride hydrochloride (0.33 g, 2.0 mmol) in acetonitrile (20 mL) was added 
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to the mixture and refluxed for 24 hours at 50 °C - 60 °C. The reaction was monitored with TLC 
and after completion the solvent was removed by rotary evaporation. The residue was dissolved in 
water (50 mL) and extracted with methylene chloride (30 mL x 3). The organic layers were 
combined, dried over anhydrous MgSO4 and rotary evaporated to obtain a brown solid and 
recrystallized with ethyl acetate to obtain brown crystals as the product. Yield: 0.33 g (79%); m.p. 
50-52 °C (reported 50-55 °C);34 1H NMR (400 MHz, DMSO-d6): 8.67 (s, 1H), 8.48 (d, 2H), 7.68 
(m, 2H), 7.59 (m, 1H), 7.35 (m, 1H), 7.21 (m, 2H), 5.57 (s, 2H).  
 4.2.3.5 Synthesis of 4-((2-phenyl-imidazol-1-yl)methyl)pyridine, A9 
 
 
 
 
 
 
2-Phenylimidazole (0.29 g, 2.0 mmol) and NaOH (0.16 g, 4.0 mmol) were placed in a 100 
mL round bottomed flask with 20 mL of acetonitrile. The mixture was stirred at room temperature 
for one hour. 4-Picolyl chloride hydrochloride (0.33 g, 2.0 mmol) in acetonitrile (20 mL) was 
added to the mixture and refluxed for 24 hours at 50 °C - 60 °C. The reaction was monitored with 
TLC and after completion the solvent was removed by rotary evaporation. The residue was 
dissolved in water (50 mL) and extracted with methylene chloride (30 mL x 3). The organic layers 
were combined, dried over anhydrous MgSO4 and rotary evaporated to obtain the orange powder 
as the product and recrystallized in ethyl acetate to obtain the product as a dark orange crystals. 
Yield: 0.21 g (45%); m.p. 35-38 °C (reported 33-38 °C);39 1H NMR (400 MHz, DMSO-d6): 8.50 
(d, 2H), 7.51 (m, 2H), 7.39 (m, 4H), 7.12 (s, 1H), 6.97 (s, 1H), 5.40 (s, 2H). 
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 4.2.3.6 Synthesis of 5,6-dimethyl-1-(pyridin-3-ylmethyl)-benzoimidazole, A10 
 
 
 
 
 
 
5,6-Dimethylbenzimidazole (0.29 g, 2.0 mmol) and NaOH (0.16 g, 4.0 mmol) were placed 
in a 100mL round bottomed flask with 20 mL of acetonitrile. The mixture was stirred at room 
temperature for one hour. 3-Picolyl chloride hydrochloride (0.33 g, 2.0 mmol) in acetonitrile (20 
mL) was added to the mixture and refluxed for 24 hours at 50 °C - 60 °C. The reaction was 
monitored with TLC and after completion the solvent was removed by rotary evaporation. The 
residue was dissolved in water (50 mL) and extracted with methylene chloride (30 mL x 3). The 
organic layers were combined, dried over anhydrous MgSO4 and rotary evaporated to obtain pale 
orange powder as the product. Yield: 0.29 g (63%); m.p. 87-90 °C (reported 91-93 °C);40 1H NMR 
(400 MHz, DMSO-d6): 8.62 (s, 1H), 8.48 (d, 1H), 8.30 (s, 1H), 7.65 (d, 1H), 7.43 (s, 1H), 7.33 (m, 
2H), 5.49 (s, 2H), 2.27 (s, 6H). 
 4.2.3.7 Synthesis of 3-((2-phenylimidazol-1-yl)methyl)pyridine, A11 
 
 
 
 
 
 
 
2-Phenylimidazole (0.29 g, 2.0 mmol) and NaOH (0.16 g, 4.0 mmol) were placed in a 100 
mL round bottomed flask with 20 mL of acetonitrile. The mixture was stirred at room temperature 
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for one hour. 3-Picolyl chloride hydrochloride (0.33 g, 2.0 mmol) in acetonitrile (20 mL) was 
added to the mixture and refluxed for 24 hours at 50 °C - 60 °C. The reaction was monitored with 
TLC and after completion the solvent was removed by rotary evaporation. The residue was 
dissolved in water (50 mL) and extracted with methylene chloride (30 mL x 3). Organic layers 
were combined, dried over anhydrous MgSO4 and rotary evaporated to obtain pale orange powder 
as the product. Yield: 0.35 g (69%); m.p. 39-42 °C (reported 33-38 °C);34 1H NMR (400 MHz, 
DMSO-d6): 8.46 (d, 1H), 8.26 (s, 1H), 7.56 (m, 2H), 7.38 (m, 6H), 6.08 (m, 1H), 5.39 (s, 2H). 
 4.2.3.8 Synthesis of 3-((imidazol-1-yl)methyl)pyridine, A12 
 
 
 
 
 
 
Imidazole (0.14 g, 2.0 mmol) and NaOH (0.16 g, 4.0 mmol) were placed in a 100 mL round 
bottomed flask with 20 mL of acetonitrile. The mixture was stirred at room temperature for one 
hour. 3-Picolyl chloride hydrochloride (0.33 g, 2.0 mmol) in acetonitrile (20 mL) was added to the 
mixture and refluxed for 24 hours at 50 °C - 60 °C. The reaction was monitored with TLC and after 
completion the solvent was removed by rotary evaporation. The residue was dissolved in water 
(50 mL) and extracted with methylene chloride (30 mL x 3). The organic layers were combined, 
dried over anhydrous MgSO4 and rotary evaporated to obtain the dark brown color powder as the 
product. Yield: 0.32 g (82%); m.p. 41-45 °C; 1H NMR (400 MHz, DMSO-d6): 8.56 (s, 1H), 8.52 - 
8.52 (d, 1H), 7.82 (s, 1H), 7.67 (d, 1H), 7.38, (d, 1H), 7.24 (d, 1H), 6.93 (d, 1H), 5.26 (s, 2H). 
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 4.2.3.9 Synthesis of 1,1'-bis(pyridin-4-ylmethyl)-2,2'-biimidazole, A14 
 
 
 
 
A round-bottom flask equipped with a magnetic stir bar was charged with 3-aminopyridine 
(1.0 g, 11 mmol), formaldehyde (2.5 mL, 37% in water), and formic acid (3.0 mL). The reaction 
mixture was stirred for 19 hours at reflux, allowed to cool to room temperature, acidified with 6M 
aqueous hydrochloric acid (pH < 2), and evaporated to dryness in vacuo. The dry material was 
mixed with 15 mL of saturated NaHCO3 and extracted with chloroform (4 x 10 mL). The combined 
organic layers were dried (Na2SO4) and concentrated in vacuo to produce a brick red oil. The 
product was further purified via flash column chromatography on silica gel (eluent petroleum 
ether/ethyl acetate 15:1) to produce a light-tan oil as the product. Yield: 0.45 g (35%); 1H 
NMR (400 MHz, DMSO-d6) 8.10 (d, 1H), 7.89 (d, 1H), 7.15 (dd, 1H), 7.05 (m, 1H), 2.89 (s, 6H).  
 4.2.4 Co-crystal screening  
The screening was carried out through solvent-assisted grinding with methanol. Each 
acceptor and donor was mixed together in stoichiometric ratio and ground with the assistance of a 
drop of methanol (a total of 108 experiments). In each experiment, 10 mg of the acceptor was used 
with the corresponding amount of donor. Once the solvent had evaporated, the solid was analyzed 
using IR spectroscopy to determine whether a co-crystal had formed or not. Successful interactions 
between the acceptor and donor were identified using the specific shifts of the peaks of the mixture 
compared to starting compounds.  
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 4.2.5 Synthesis of co-crystals 
Solids from grinding experiments were dissolved in a minimum amount (~2 ml) of 
methanol and left in a vial for slow evaporation in order to obtain crystals suitable for single crystal 
X-ray diffraction; 36 crystal growth experiments were successful. Details on thirteen of these were 
reported in Chapter 3.30 Table 4.1 summarizes the experimental details for the remaining 23 
structures. 
Table 4.1 Experimental details of the 23 co-crystals obtained 
Code 
Mixed 
Mole ratio 
Amounts used Solvent and method 
Crystal 
stoichiometry 
Crystal 
color & 
habit 
A5:D8 1:1 
A5 -10 mg, 0.048 mmol 
D8 - 19 mg, 0.048 mmol 
Methanol, 
Slow evaporation 
2:3 
Colorless 
needle 
A5:D10 1:1 
A5 -10 mg, 0.048 mmol 
D10 - 27 mg, 0.048 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
plate 
A6:D2 1:1 
A6 -10 mg, 0.042 mmol 
D2 - 19 mg, 0.042 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
plate 
A6:D8 1:1 
A6 - 10 mg, 0.042 mmol 
D8 - 17 mg, 0.042 mmol 
Methanol, 
Slow evaporation 
2:3 
Colorless 
needle 
A7:D3 1:1 
A7 - 10 mg, 0.063 mmol 
D3 - 35 mg, 0.063 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
plate 
A7:D8 1:1 
A7 - 10 mg, 0.063 mmol 
D8 - 25 mg, 0.063 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
prism 
A7:D10 1:1 
A7 - 10 mg, 0.063 mmol 
D10 - 35 mg, 0.063 mmol 
Methanol, 
Slow evaporation 
1:1 
Yellow 
plate 
A8:D8 1:1 
A8 - 10 mg, 0.048 mmol 
D8 - 19 mg, 0.048 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
prism 
A8:D9 1:1 
A8 - 10 mg, 0.048 mmol 
D9 - 25 mg, 0.048 mmol 
Methanol, 
Slow evaporation 
1:2 
Colorless 
rod 
A9:D8 1:1 
A9 - 10 mg, 0.043 mmol 
D8 - 17 mg, 0.043 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
plate 
A9:D9 1:1 
A9 - 10 mg, 0.043 mmol 
D9 - 22 mg, 0.043 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
block 
A10:D4 1:1 
A10 - 10 mg, 0.042 mmol 
D4 - 28 mg, 0.042 mmol 
Methanol, 
Slow evaporation 
2:3 
Colorless 
rod 
A10:D7 1:1 
A10 - 10 mg, 0.042 mmol 
D7 - 17 mg, 0.042 mmol 
Methanol, 
Slow evaporation 
1:2 
Bronze 
plate 
A10:D8 1:1 
A10 - 10 mg, 0.042 mmol 
D8 - 17 mg, 0.042 mmol 
Methanol, 
Slow evaporation 
1:1 Gold prism 
A10:D9 1:1 
A10 - 10 mg, 0.042 mmol 
D9 - 22 mg, 0.042 mmol 
Methanol, 
Slow evaporation 
1:2 
Colorless 
prism 
A11:D9 1:1 
A11 - 10 mg, 0.043 mmol 
D9 - 22 mg, 0.043 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
prism 
A11:D10 1:1 
A11 - 10 mg, 0.043 mmol 
D10 - 24 mg, 0.043 mmol 
Methanol, 
Slow evaporation 
1:2 
Colorless 
prism 
A12:D2 1:1 
A12 - 10 mg, 0.063 mmol 
D2 - 29 mg, 0.063 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
plate 
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A12:D8 1:1 
A12 - 10 mg, 0.063 mmol 
D8 - 25 mg, 0.063 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
prism 
A13:D1 1:1 
A13 - 10 mg, 0.082 mmol 
D1 - 29 mg, 0.082 mmol 
Methanol, 
Slow evaporation 
3:2 
Colorless 
plate 
A13:D2 1:1 
A13 - 10 mg, 0.082 mmol 
D2 - 37 mg, 0.082 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
plate 
A13:D3 1:1 
A13 - 10 mg, 0.082 mmol 
D3 - 46 mg, 0.082 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
plate 
A13:D7 1:1 
A13 - 10 mg, 0.082 mmol 
D7 - 33 mg, 0.082 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
prism 
 
 4.3 Results 
 4.3.1 Electrostatic potentials 
MEPS values for the acceptor molecules are provided in Figure 4.3. For each acceptor 
molecule the difference of MEPS values were calculated using equation 4.1 and was defined as 
the ΔE value. Table 4.2 summarizes the calculated MEPS values for the donors under study.  
ΔE value = |MEP value on the best acceptor| – |MEP value on the 2nd best acceptor|           (4.1) 
  
Table 4.2 Calculated electrostatic potentials on halogen-bond donors under study 
 
 4.3.2 Grinding experiments and characterization by IR spectroscopy 
Solvent-assisted grinding experiments were analyzed using IR spectroscopy to identify any 
notable interactions between the two potential co-formers. The analysis was done by comparing 
the IR spectra of the ground mixture with spectra of the respective co-formers. The key IR modes 
Molecule Atom Electrostatic potential (kJ/mol) 
1,2-diiodotetrafluoroethane D1 Iodine +163 
1,4-diiodooctafluorobutane D2 Iodine +168 
1,6-diiodoperfluorohexane D3 Iodine +169 
1,8-diiodoperfluorooctane D4 Iodine +169 
Iodopentafluorobenzene D6 Iodine +166 
1,2-diiodotetrafluorobenzene D7 Iodine +162 
1,4-diiotetrafluorobenzene D8 Iodine +169 
1,3,5-triiodotrifluorobenzene D9 Iodine +158 
4,4’-diiodoperfluorobiphenyl D10 Iodine +164 
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targeted were the C-F stretches of the halogen-bond donor.  A shift of three wave numbers or more 
was considered to be significant and indicative of a positive result. The summary of the IR analysis 
is provided in the Table 4.3 along with the success rate for each acceptor and donor; 89 of 108 
reactions produced co-crystals resulting in an 82% supramolecular yield.  
Table 4.3 IR analysis for grinding experiments 
 
 4.3.3 Crystal growth and structure analysis  
Even though the IR analysis provides unambiguous results for the successful co-crystal 
formation, it does not provide details about specific interaction sites, which is crucial for 
determining the selectivity of interactions in halogen bonding, thus single crystal data were 
required. Suitable crystals were obtained in 36 experiments and details on thirteen crystal 
structures have reported in Chapter 3,30 remaining 23 structures are presented in the order of 
increasing ΔE value on the ditopic acceptor. X-ray experimental data and crystallographic data 
and halogen bond geometries are provided in the Appendix B.3. 
 
Donors 
% 
Success 
Potential 
(kJ/mol) 
D1 D2 D3 D4 D6 D7 D8 D9 D10 
+163 +168 +169 +169 +166 +162 +169 +158 +164 
Best 
acceptor 
2nd best 
acceptor 
A
cc
ep
to
rs
 
A1 -199 -177          6/9 67 
A2 -207 -181          6/9 67 
A3 -209 -178          8/9 89 
A4 -199 -166          7/9 78 
A5 -207 -171          7/9 78 
A6 -217 -180          7/9 78 
A7 -204 -166          7/9 78 
A8 -213 -167          8/9 89 
A9 -180 -125          9/9 100 
A10 -188 -124          9/9 100 
A11 -217 -50          9/9 100 
A12 -210 -35          7/9 78 
% Success 
3/12 11/12 11/12 10/12 10/12 12/12 12/12 12/12 9/12 
 
25 92 92 83 83 100 100 100 75 
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With A5 (ΔE = 22 kJ/mol) two crystal structures were obtained (A5:D8 and A5:D10) and 
in both cases both binding sites N(im) and N(py) form a halogen bond; no XB preference is noted, 
Figure 4.5.  
Figure 4.5 Primary halogen bond interactions in a) A5:D8 and b) A1:D10; both acceptor sites 
engage in halogen bonding 
Two structures (A6:D2 and A6:D8) were obtained with A6 (ΔE = 26 kJ/mol) and again 
both binding sites form halogen bonds, Figure 4.6.   
 
 
  
Figure 4.6 Primary halogen bond interactions in a) A6:D2 and b) A6:D8 
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Similarly, A7 (ΔE = 31 kJ/mol) produced three structures (A7:D3, A7:D8 and A7:D10) 
with all acceptor moieties participating in halogen bonding, Figure 4.7.  
Figure 4.7 Primary halogen bond interactions in a) A7:D3 b) A7:D8 and c) A7:D10 
In the two structures (A8:D8 and A8:D9) of A8 (ΔE = 33 kJ/mol), again all acceptors were 
involved in halogen bonding, Figure 4.8.  
Figure 4.8 Primary halogen bond interactions in a) A8:D8 and b) A8:D9 
However, with A9 (ΔE = 36 kJ/mol), two structures (A9:D8 and A9:D9) were obtained 
and they behave differently. A9:D8 shows a preferential halogen bond formation with the best 
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acceptor, imidazole, while the pyridine nitrogen site is forming a weak hydrogen bond dimer with 
a nearby pyridine ring. A9:D9 shows no preference over binding, Figure 4.9.  
Figure 4.9 Primary halogen bond interactions in a) A9:D8: only the best acceptor, N(im) 
participate in halogen bonding and b) A9:D9: both acceptor sites form halogen bonds 
Four structures (A10:D4, A10:D8, A10:D9 and A10:D9) were obtained with A10 (ΔE = 
37 kJ/mol) again all acceptors were involved in halogen bonding, Figure 4.10.   
Figure 4.10 Primary halogen bond interactions in a) A10:D4 b) A10:D7 c) A10:D8 and d) 
A10:D9 
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Similarly, A11 (ΔE = 38 kJ/mol), produced two structures (A11:D9 and A11:D10) where 
all acceptors are engaged in halogen bonding, Figure 4.11, which is true for the two structures 
(A12:D2 and A12:D8) obtained with A12 (ΔE = 46 kJ/mol) as well, Figure 4.12.  
Figure 4.11 Primary halogen bond interactions in a) A11:D9 and b) A11:D10 
Figure 4.12 Primary halogen bond interactions in a) A12:D2 and b) A12:D8 
Six structures (A2:D2, A2:D3, A2:D7, A2:D8, A2:D9 and A2:D10) with A2 (ΔE = 55 
kJ/mol) and seven structures (A1:D1, A1:D2, A1:D3, A1:D4, A1:D7, A1:D8 and A1:D10) with 
A1 (ΔE = 64 kJ/mol) were obtained. Structural data and crystallographic data for these thirteen 
structures have been reported in Chapter 3.30 Out of these thirteen structures, ten structures 
preferred binding with the best acceptor site; while only three structures (A2:D9, A2:D10 and 
A1:D7) showed halogen bond formation with all acceptor sites.  
Four structures (A13:D1, A13:D2, A13:D3 and A13:D7) were obtained with A13 (ΔE = 
167 kJ/mol) and all of them show binding with the best acceptor site, while in A13:D3, there is an 
additional short contact formed with the 2nd best acceptor site, Figure 4.13. Even though the 
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grinding results showed a 67% success in forming co-crystals with A14 (ΔE = 175 kJ/mol), none 
of the solution based experiments yielded any co-crystals which could lead to the recognition of 
halogen bond interactions.  
Figure 4.13 Primary halogen bond interactions in a) A13:D1 b) A13:D2 c) A113:D3 and d) 
A13:D7 
 4.4 Discussion 
 4.4.1 Structure analysis depending on the ΔE parameter 
A CSD search was carried for any previously reported structures between the acceptors 
and donors of interest in this study. This search yielded three crystal structures,41 A12:D5, A12:D7 
and A12:D8 where all of them show preferential halogen bond formation with best acceptor site. 
These three structures will also be included as a part of the discussion, Figure 4.14.  
In a previous study on hydrogen and halogen bond competition in a supramolecular system, 
the MEPS difference between the two donor sites has defined with a Q parameter.42 Likewise we 
wanted a parameter to define the MEPS difference between the two acceptor sites in each acceptor 
molecule and the parameter we defined is the ΔE value. Depending on the ΔE value and the 
halogen bond selectivity, the structural data from the 39 crystal structures can be divided into three 
categories, Figure 4.15. This discussion will follow focusing on these three categories.  
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Figure 4.14 Structures reported in the CSD relevant to current study a) A13:D6 b) A13:D8 and 
c) A13:D9 
Figure 4.15 Categorization based on ΔE value and halogen bond selectivity 
Group 1 contains nine structures with acceptors A5-A8. None of them show preference in 
binding as both acceptor sites are interacting. The MEPS difference between the two acceptor sites 
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in each molecule is below 35 kJ/mol. The results clearly indicate that this potential difference is 
not enough to induce selectivity and both acceptors are equally competitive.  
Group 2 contains 23 structures with acceptors A9-A12, A2 and A1. Out of these 23 
structures twelve structures show no preference in binding and display conventional halogen bonds 
with both pyridine nitrogen and imidazole nitrogen in each case. The remaining eleven structures 
show preferential binding with the best acceptor site as ranked by the calculated MEPS.  These 
results suggest that this is an intermediate potential difference region (35 kJ/mol to 65 kJ/mol), 
where a donor is unable to distinguish between two acceptors in a predictable way.    
Group 3 contains seven structures all with A13. All of them preferentially form halogen 
bonds with the best acceptor site indicating the higher potential difference between the two 
acceptor sites leads to halogen bond selectivity. Based on the results from group 2, it can be 
assumed that best-donor/best-acceptor selectivity begins somewhere from the potential difference 
of 65 kJ/mol as for A1 the supramolecular yield of selectivity is 86%. Unfortunately we could not 
find other asymmetric ditopic acceptor molecules that would cover the MEPS difference range 
from 65 kJ/mol to 167 kJ/mol to verify this hypothesis. Thus, the following conclusions can be 
made.   
1. If the MEPS difference between the two acceptor sites are in the range of 35-65 kJ/mol, 
a prediction of binding preference cannot be made. Furthermore, if the MEPS 
difference is less than 35 kJ/mol, both sites will be involved in halogen bonding. 
2. The MEPS difference range from 35 to 65 kJ/mol can be identified as the grey area 
where a prediction of halogen bond selectivity cannot be made. 
3. If the MEPS difference is higher than 65 kJ/mol, halogen bond selectivity for the best 
acceptor can be observed.  
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 4.4.2 Effect of the MEPS on the donor atoms 
According to Table 4.2, MEPS values on the activated iodine in all the donors are almost 
the same other than for D9, which is about 8 kJ/mol units less than the average value for other 
donors. This means that all the donors should have similar effects on the final selectivity process. 
A close look at the success rates depending on the donors (Table 4.3) revealed that, apart from D1 
all of them show comparable success in forming co-crystals. The low yields with D1 can be 
attributed to the high vapor pressure of the compound. Even though D9 has a lower MEPS value 
on the donor site it also has a comparable supramolecular yields. Five structures were obtained 
with D9 and all of them show only two of the three iodine atoms participating in halogen bond 
formations, thus it is possible that the potential on the third iodine atom is depleted towards the 
other two iodine atoms, which boost the MEPS value on those iodine atoms leading to comparable 
strength to other donors in the study.  
 4.4.3 Can we use the ΔE parameter to predict the outcome in other systems? 
To find the validity of the results of this study we thought of using this MEPS outcome in 
predicting the structural outcome of the reported crystal structures. A comprehensive CSD search 
was carried out targeting the halogen-bond donors utilized in this study and the outcome was 
seventeen suitable structures where an asymmetric acceptor with two or more acceptor sites are 
present. Lack of structural data based on halogen bond studies with asymmetric acceptor sites 
further enhances the importance of this study. The group of acceptors contained ditopic as well as 
multitopic acceptors and also acceptors based on N, O and S giving exposure to a diverse group.  
MEPS calculations on these selected systems were carried out and results are summarized in the 
Table 4.4.  
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According to this analysis the predicted outcome from the ΔE value based system is in 
agreement with the actual structural outcome for fourteen of seventeen structures leading to the 
prediction success of 82%. This success rate underscores the importance of such a simple method 
based on easily accessible MEPS calculations in designing halogen-bond based molecular 
recognition studies.  
 Table 4.4 Results comparison for CSD reported structures 
 
Donor CSD code 
Electrostatic potentials (kJ/mol) ΔE value 
(kJ/mol) 
Predicted 
outcome 
Structural 
outcome Best acceptor 2nd best acceptor 
D1 
ULOKOV -160 -41 119 
Preferred for 
best acceptor 
Preferred for 
best acceptor 
ULOLAI -164 -152 12 No preference No preference 
D2 BEWXOS -175 -154 21 No preference No preference 
D3 
BEWXIM -175 -154 21 No preference No preference 
COKNOG -171 -58 113 
Preferred for 
best acceptor 
Preferred for 
best acceptor 
D4 
COKNUM -171 -58 113 
Preferred for 
best acceptor 
Preferred for 
best acceptor 
ECASAE -182 -150 32 No preference 
Preferred for 
best acceptor 
D6       
D7       
D8 
COGKAM -164 -30 134 
Preferred for 
best acceptor 
Preferred for 
best acceptor 
DIVCIV -152 -108 44 Grey region No preference 
KABLAC -174 -30 144 
Preferred for 
best acceptor 
Preferred for 
best acceptor 
JAQMEU -191 -145 46 Grey region 
Preferred for 
best acceptor 
LUKMIN -137 -102 53 Grey region 
Preferred for 
best acceptor 
PEFPAT -212 -57 155 
Preferred for 
best acceptor 
Preferred for 
best acceptor 
QOLJIK -142 -106 36 Grey region 
Preferred for 
best acceptor 
TOJBUQ -178 -174 4 No preference 
Preferred for 
best acceptor 
TOJCAX -195 -155 40 Grey region No preference 
VABNUJ -175 -149 26 No preference 
Binds to 2nd best 
acceptor 
D9       
D10       
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 4.5 Conclusions 
A systematic co-crystallization study was carried out between twelve asymmetric ditopic 
acceptors and nine halogen-bond donors (108 experiments) in order to identify halogen bond 
selectivity depending on the MEPS difference between the two acceptor sites. 36 crystal structures 
were obtained and together with three structures from the CSD lead to the identification of three 
categories based on halogen bond selectivity, Figure 4.16. If the ΔE value is less than 35 kJ/mol, 
there is no halogen bond selectivity. In the intermediate region (35 kJ/mol < ΔE < 65 kJ/mol), no 
prediction can be made. This is recognized as the grey area. If the ΔE value is more than 65 kJ/mol, 
then the halogen bond is selective for the best acceptor site as ranked by electrostatics. These 
results provide a set of guidelines which can be utilized in designing more complex supramolecular 
architectures with halogen bonding, but further studies based on different donor acceptor systems 
are required for the compilation of well-defined rules for halogen bond binding preferences. 
Figure 4.16 Outcome of the study 
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Chapter 5 - Structural landscape of heteroaryl-2-imidazoles: 
Competing halogen- and hydrogen-bond interactions1 
 5.1 Introduction 
Non-covalent interactions reside at the center of fundamental and applied supramolecular 
chemistry and are responsible for any molecular recognition event that initiates the formation and 
stabilization of different supramolecules.2 The practical utilizations of these interactions are 
readily found in crystal engineering,3 biochemistry,4 physics5 and materials science.6 
Intermolecular interactions cover a broad range of binding energies, thus are particularly 
interesting as means for intermolecular communication.7 Although hydrogen bonding is arguably 
the most well-understood non-covalent interaction,8 the halogen bond has been recognized as 
displaying many similarities9 and, consequently, it has gained considerable attention focusing on 
its directionality,10 strength,11 and potential applications.12 
A hydrogen bond is often defined as a chemical bond formed between an electropositive 
hydrogen atom and a strongly electronegative atom,13 and the halogen bond has been defined as 
an attractive interaction between an electrophilic region of a halogen atom and an electron-pair 
donor.14 These definitions acknowledge that there are substantive similarities between the two 
types of interactions.15 Energetically, halogen bonds cover a wide range from less than 5 kJ/mol 
in Cl⋯Cl interactions between chlorocarbons to 180 kJ/mol in Iˉ⋯I2 contacts in Iˉ3.16 Likewise, 
hydrogen bonds can vary from very weak (1–2 kJ/mol) in CH4⋯FCH317 to extremely strong (161.5 
kJ/mol) in HFˉ2.18  
Recent experimental19 and theoretical studies20 underscore that it is not straightforward to 
predict what the outcome is likely to be when hydrogen-bond (HB) and halogen-bond (XB) donors 
compete21 for a limited number of binding sites or for multiple binding sites of different strengths.22 
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One experimental study suggested that the hydrogen bond can outperform halogen bond 
interactions in a competitive scenario where the best acceptor benzimidazole moiety of the probe 
acceptor molecule interact with the oxime functionality while the fluoro-activated organoiodine is 
interacting with the second best acceptor pyridine site, Figure 5.1.23 
 
 
 
 
 
Figure 5.1 A competitive scenario between hydrogen and halogen bond (best acceptor 
benzimidazole nitrogen atom interacts with the oxime hydrogen atom; while the 2nd best acceptor 
the pyridine nitrogen atom interacts with iodine)23 
Another study suggested that the halogen bond can outperform the hydrogen bond.24 In 
equimolar mixtures of 1,2-bispyridylethane, 1,4-diiodoperfluorobenzene and 1,4-
dihydroxybenzene co-crystal formation took place between the 1,2-bispyridylethane and 1,4-
diiodoperfluorobenzene while in a non-competitive setting both the XB donor and the HB donor 
were successful in forming co-crystals with the acceptor, Figure 5.2 
Figure 5.2 Outcome of a competitive study between hydrogen bond and halogen bond24 
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Thus, there is a need for further systematic studies to identify possible guidelines for 
combining HB/XB interactions into concise synthetic strategies in such a way that “synthon cross-
over”25 is minimized resulting in reliable synthetic protocols for the directed assembly of desired 
architectures in the solid state.  
In order to examine the balance between XB and HB interactions in a practical crystal 
engineering context, five heteroaryl-2-imidazole molecules A16-A20, Figure 5.3 were utilized as 
probe molecules. 
 
 
 
 
 
Figure 5.3 Heteroaryl-2-imidazoles employed in this study (hydrogen-bond donor sites are 
depicted in blue and acceptor sites are depicted in red) 
The reason for selecting these molecules is due to the fact that they contain a single 
hydrogen-bond donor site and two or three acceptor sites on the same molecule. In addition, many 
heteroaryl-2-imidazoles are recognized as key intermediates in the synthesis of pharmacologically 
active compounds26 and have gained much attention in the field of coordination chemistry27 and 
palladium-catalyzed cross-coupling chemistry.28  
The primary objective of this study is to use co-crystallizations as a way of determining 
binding preferences in the solid state when hydrogen-bond and halogen-bond donors compete for 
two or more different acceptor sites. The combination of a molecule decorated with one hydrogen-
bond donor and two or three different acceptor sites and one halogen-bond donor can, in principle 
lead to three different outcomes, Figure 5.4.  If the halogen-bond donor is unable to bring about 
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the formation of a co-crystal, nothing will happen. Alternatively, a co-crystal will form with the 
XB donor finding one of the acceptors (best acceptor or 2nd best acceptor), leaving the HB donor 
to interact with the remaining acceptor, Figure 5.4. The acceptor sites are differentiated from each 
other by their different electrostatic potentials which make them more or less competitive in the 
context of electrostatically driven intermolecular interactions. 
Figure 5.4 The three most likely outcomes in co-crystallizations between A16-A20 with a 
halogen-bond donor 
Fifteen potential halogen-bond donors were selected, D1-D15, Figure 5.5, that can be 
divided into three subcategories: iodine-based halogen-bond donors (D1-D10), bromine-based 
halogen-bond donors (D11-D13), and mixed donors (D14-D15). A systemic co-crystallization 
study comprising 75 experiments between five acceptors and 15 donors were conducted with the 
intention of providing more details regarding the structural landscape of competing hydrogen and 
halogen bonds in the solid state. 
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Figure 5.5 Halogen-bond donors employed in this study 
This study is undertaken in response to the hypothesis, 
1. As hydrogen bond and halogen bond have comparable bond strengths, if a hydrogen-
bond donor and a halogen-bond donor have the choice of interacting with an acceptor 
with a multitude of acceptor sites, both donors will have an equal chance to compete 
for the best acceptor site ranked by molecular electrostatic potentials surfaces (MEPS). 
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 5.2 Experimental  
 5.2.1 General 
All the precursors, solvents and D1-D9 and D11-D13 were purchased from commercial 
sources and used without further purification. A16-A20 were synthesized according to the reported 
procedures by Zhichkin and co-workers.29 D10,30 D1431 and D1531 were synthesized using 
literature procedures. 1H NMR spectra were recorded on a Varian Unity plus 400 MHz 
spectrometer in CDCl3 or DMSO-d6. Infrared spectra were recorded with a Nicolet 380 FT-IR with 
a digital resolution of 0.9 cm-1 and data processed using Omnic32 software. Melting points were 
determined using a Fischer-Johns Mel-Temp melting point apparatus and are uncorrected.    
 5.2.2 Electrostatic potential calculations  
Molecular electrostatic potentials were obtained with density functional B3LYP level of 
theory using 6-311++G** basis set in vacuum. All calculations were carried out using Spartan 8 
software.33 All molecules were geometry optimized with the maxima and minima on the 
electrostatic potential surface (0.002 e/au isosurface) determined using a positive point charge in 
the vacuum as a probe. The numbers indicate the interaction energy (kJ/mol) between the positive 
probe and surface of the molecule at that particular point. These numbers are related to the 
electrostatic potentials on the atoms with the negative value corresponding to a negative potential 
and positive value corresponding to a positive potential. 
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 5.2.3 Synthesis of acceptors  
 5.2.3.1 Synthesis of 4-(imidazol-2-yl)pyridine, A16 
 
 
 
 
 
To a flask containing 4-cyanopyridine (2.0 g, 0.019 mol) and MeOH (20 mL) a 30% 
solution of NaOMe in MeOH (0.36 mL, 1.9 mmol) was added. The reaction mixture was stirred 
for one hour at room temperature. Aminoacetaldehyde dimethyl acetal (2.2 mL, 0.019 mol) 
followed by AcOH (2.1 mL, 37 mmol) were added dropwise. The reaction mixture was heated 
under reflux for 30 min. After cooling the reaction mixture to room temperature, MeOH (15 mL) 
and 6 M HCl in H2O (10 mL) were added, and the mixture was heated under reflux for three hours. 
Once the cyclization was complete, the solution was evaporated to dryness on a rotary evaporator. 
A freshly prepared warm solution of K2CO3 (50% w/w in water) was added carefully, bringing the 
pH to 10. The resulting suspension was allowed to cool to room temperature and recrystallized 
from boiling water to obtain 4-(imidazol-2-yl)pyridine, A16, as an off-white solid. Yield: 1.9 g 
(72%); m.p. 207-210 °C (reported 210-211 °C)29; 1H NMR (400 MHz, DMSO-d6) 12.90 (br s, 1H), 
8.62 (dd, 2H), 7.86 (dd, 2H), 7.39 (br s, 1H), 7.13 (br s, 1H). 
 5.2.3.2 Synthesis of 3-(imidazol-2-yl)pyridine, A17 
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To a flask containing 3-cyanopyridine (2.0 g, 0.019 mol) and MeOH (20 mL) a 30% 
solution of NaOMe in MeOH (0.36 mL, 1.9 mmol) was added. The reaction mixture was stirred 
for one hour at room temperature. Aminoacetaldehyde dimethyl acetal (2.2 mL, 0.019 mol) 
followed by AcOH (2.1 mL, 37 mmol) were added dropwise. The reaction mixture was heated 
under reflux for 30 min. After cooling the reaction mixture to room temperature, MeOH (15 mL) 
and 6 M HCl in H2O (10 mL) were added, and the mixture was heated under reflux for eight hours. 
Once the cyclization was complete, the solution was evaporated to dryness on a rotary evaporator. 
A freshly prepared warm solution of K2CO3 (50% w/w in water) was added carefully, bringing the 
pH to 10. The resulting suspension was allowed to cool to room temperature and recrystallized 
from boiling water to obtain 3-(imidazol-2-yl)pyridine, A17, as an off-white solid. Yield: 2.3 g 
(85%); m.p. 204-207 °C (reported 208-209 °C)29; 1H NMR (400 MHz, DMSO-d6) 12.71 (br s, 
1H), 9.13 (d, 1H), 8.53 (dd, 1H), 8.26 (dt, 1H), 7.47 (dd, 1H), 7.20 (br s, 2H). 
 5.2.3.3 Synthesis of 2-(imidazol-2-yl)pyridine, A18 
 
 
 
 
 
To a flask containing 2-cyanopyridine (2.0 g, 0.019 mol) and MeOH (20 mL) a 30% 
solution of NaOMe in MeOH (0.36 mL, 1.9 mmol) was added. The reaction mixture was stirred 
for one hour at room temperature. Aminoacetaldehyde dimethyl acetal (2.2 mL, 0.019 mol) 
followed by AcOH (2.1 mL, 37 mmol) were added dropwise. The reaction mixture was heated to 
reflux for 30 min. After cooling the reaction mixture to room temperature, MeOH (15 mL) and 
6 M HCl in H2O (10 mL) were added, and the mixture was heated under reflux for five hours. 
Once the cyclization was complete, the solution was evaporated to dryness on a rotary evaporator. 
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A freshly prepared warm solution of K2CO3 (50% w/w in water) was added carefully, bringing the 
pH to 10. The resulting suspension was allowed to cool to room temperature and recrystallized 
from boiling EtOAc to afford 2-(imidazol-2-yl)pyridine, A18 as an off-white solid. Yield: 2.0 g 
(73%); m.p. 132-135 °C (reported 137-138 °C)29; 1H NMR (400 MHz, DMSO-d6) 12.69 (br s, 
1H), 8.52 (d, 1H), 7.95 (d, 1H), 7.80 (td, 1H), 7.28 (m, 1H), 7.15 (br s, 1H), 7.00 (br s, 1H). 
 5.2.3.4 Synthesis of 2-(imidazol-2-yl)pyrazine, A19 
 
 
 
 
 
A 100 mL flask was charged with pyrazine-2-carbonitrile (1.1 g, 10 mmol), MeOH 
(10 mL), and a 30% solution of NaOMe in MeOH (0.38 mL, 1.0 mmol). The reaction mixture was 
stirred for 40 minutes at room temperature. Aminoacetaldehyde dimethyl acetal (1.1 mL, 10 mmol) 
was added to the reaction mixture followed by AcOH (1.2 mL, 20 mmol). The reaction mixture 
was heated to 50 °C for one hour and then cooled to room temperature. MeOH (20 mL) and 6 M 
HCl in H2O (5.0 mL) were added, and the reaction mixture was heated under reflux for five hours. 
Once the cyclization was complete, the solution was removed on a rotary evaporator, and the 
residue was taken up in a 1:1 mixture of H2O and Et2O. The layers were separated and the pH of 
the aqueous layer was adjusted to pH 9 with 2 M aqueous NaOH. Then the aqueous mixture was 
stirred for 30 min to allow complete precipitation of the product. The solid was collected by 
filtration and dried under vacuum to obtain pure 2-(imidazol-2-yl)pyrazine, A19, as a white solid. 
Yield: 0.83 g (57%); m.p. 196-198 °C (reported 199-201 °C)29; 1H NMR (400 MHz, CDCl3) 10.34 
(br s, 1H), 9.44 (d, 1H), 8.53 (d, 1H), 8.49 (m, 1H), 7.31 (br s, 1H), 7.23 (br s, 1H).  
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 5.2.3.5 Synthesis of 2-(imidazol-2-yl)pyrimidine, A20 
 
 
 
 
 
To a flask containing pyrimidine-2-carbonitrile (2.0 g, 0.019 mol) and MeOH (20 mL) a 
30% solution of NaOMe in MeOH (0.36 mL, 1.9 mmol) was added. The reaction mixture was 
stirred for two hours at room temperature. Aminoacetaldehyde dimethyl acetal (2.1 mL, 0.019 
mol) followed by AcOH (2.1 mL, 37 mmol) were added dropwise. The reaction mixture was 
heated under reflux for 30 min. After cooling the reaction mixture to room temperature, MeOH 
(15 mL) and 6 M HCl in H2O (10 mL) were added, and the mixture was heated under reflux for 
five hours. Once the cyclization was complete, the solution was evaporated to dryness on a rotary 
evaporator. A freshly prepared warm solution of K2CO3 (50% w/w in water) was added carefully, 
bringing the pH to 10. The resulting suspension was allowed to cool to room temperature and 
washed with ice-cold water to obtain pure 2-(imidazol-2-yl)pyrimidine, A20, as a white solid. 
Yield: 2.61 g (36%); m.p. 193-195 °C (reported 196-197 °C)29; 1H NMR (400 MHz, DMSO-d6) 
12.90 (br s, 1H), 8.83 (d, 2H), 8.28 (s, 1H), 7.39 (d, 1H), 7.18 (d, 2H). 
 5.2.4 Grinding experiments and IR spectroscopy 
A16-A20 were initially combined with all fifteen donors in a screening using solvent-
assisted (a few drops of methanol) grinding. In all 75 combinations the acceptors and donors were 
mixed in respective stoichiometries and the solid resulting from each reaction was characterized 
using IR spectroscopy to determine if a co-crystal had formed. The IR analysis was done by 
comparing the spectra of the initial compounds with the ground mixture. More than three wave 
number shifts of C-F stretches of the halogen-bond donor was considered as a positive 
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interaction.34 In 30 of the 75 experiments the vibrational spectra unambiguously showed that a co-
crystal had been obtained. 
 5.2.5 Synthesis of co-crystals  
Subsequently, the mixtures obtained in the grinding experiments were dissolved in a 
minimum amount of methanol and placed in a 2 dram borosilicate vial for slow evaporation in 
order to obtain crystals suitable for single crystal X-ray diffraction. If this approach did not yield 
appropriate single crystals, a range of solvents were used as well as vapor diffusion with methanol 
and hexane as the solvent and anti-solvent, respectively. Once crystals were formed they were 
again analyzed using IR spectroscopy and subjected to single crystal X-ray diffraction. In the end, 
crystallographic data for fifteen compounds were obtained. Table 5.1 summarizes the experimental 
details. Appendix B.4 contains the relevant X-ray experimental data. 
Table 5.1 Experimental details of the fifteen co-crystals obtained 
Code 
Mixed 
Mole 
ratio 
Amounts used Solvent and method 
Crystal 
stoichiometry 
Crystal 
color & 
habit 
A16:D8 1:1 
A16 -10 mg, 0.069 mmol 
D8 - 28 mg, 0.069 mmol 
Methanol and hexane, 
Vapor diffusion 
2:1 
Colorless 
needle 
A17:D1 1:1 
A17 - 10 mg, 0.069 mmol 
D1 - 24 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
rod 
A17:D2 1:1 
A17 - 10 mg, 0.069 mmol 
D2 - 31 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
prism 
A17:D7 1:1 
A17 - 10 mg, 0.069 mmol 
D7 - 28 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
block 
A17:D8 1:1 
A17 - 10 mg, 0.069 mmol 
D8 - 28 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
plate 
A17:D9 3:2 
A17 - 10 mg, 0.069 mmol 
D9 - 23 mg, 0.046 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
plate 
A17:D10 1:1 
A17 - 10 mg, 0.069 mmol 
D10 - 38 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
prism 
A17:D14 1:1 
A17 - 10 mg, 0.069 mmol 
D14 - 24 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
rod 
A18:D3 1:1 
A18 - 10 mg, 0.069 mmol 
D3 - 38 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
4:1 
Colorless 
prism 
A18:D8 1:1 
A18 - 10 mg, 0.069 mmol 
D8 - 28 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
prism 
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 5.3 Results  
 5.3.1 Electrostatic potentials 
The acceptor molecules in this study have one hydrogen-bond donor and either two (A16-
A18) or three (A19 and A20) acceptor sites. The concept of preferential based best-donor/best-
acceptor interactions in hydrogen-bonded35 and halogen-bonded36 co-crystals were used as a 
guideline for predicting the primary motifs in the solid state, and molecular electrostatic potentials 
(obtained via DFT calculations) were used to rank the relative strength of each donor and acceptor 
site, Figure 5.6 and Table 5.2. 
Figure 5.6 Electrostatic potential values of selected heteroaryl-2-imidazole molecules 
A18:D10 1:1 
A18 - 10 mg, 0.069 mmol 
D10 - 38 mg, 0.069 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
prism 
A19:D2 2:3 
A19 - 10 mg, 0.068 mmol 
D2 - 47 mg, 0.10 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
prism 
A19:D8 2:3 
A19 - 10 mg, 0.068 mmol 
D8 - 41 mg, 0.10 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
plate 
A19:D9 1:1 
A19 - 10 mg, 0.068 mmol 
D9 - 35 mg, 0.068 mmol 
Methanol, 
Slow evaporation 
2:1 
Colorless 
rod 
A19:D10 2:3 
A19 - 10 mg, 0.068 mmol 
D10 - 56 mg, 0.10 mmol 
Methanol, 
Slow evaporation 
2:1 
Yellow 
prism 
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Table 5.2 Calculated surface potential values of selected halogen-bond donors 
 
For the acceptor atoms on A16-A20, the pyridine nitrogen atoms of A16 and A17 represent 
the best acceptors, while the imidazole nitrogen atoms are second best acceptors. In A18 and A19, 
the best acceptor sites are the imidazole nitrogen atoms while the remaining heterocyclic nitrogen 
atoms are second and third, respectively. In the electrostatic potential calculation of A20, the 
imidazole nitrogen and the adjacent pyrimidine nitrogen are too close in space such that it is not 
possible to identify a specific value of the potential associated with either individual nitrogen atom, 
thus the value is reported as a combination for both nitrogen acceptors (-260 kJ/mol).  
 5.3.2 Grinding experiments and characterization by IR spectroscopy 
Initial grinding experiments were analyzed using the IR spectroscopy which gave insight 
into the success rate of co-crystal formation in each case. 30 experiments out of 75 experiments 
showed interactions between the acceptors and donors, Table 5.3. All co-crystals showed the 
presence of peaks from starting compounds and significant shifts of C-F vibrations of co-crystals 
compared to the pure halogen-bond donor. Summary of IR analysis is provided in Table 5.3 and 
detailed IR analysis is provided in Appendix C.1.  
Molecule Donor atom(s) Electrostatic potential(kJ/mol) 
1,2-Diiodotetrafluoroethane D1 Iodine +163 
1,4-Diiodooctafluorobutane D2 Iodine +168 
1,6-Diiodoperfluorohexane D3 Iodine +169 
1,8-Diiodoperfluorooctane D4 Iodine +169 
Iodobenzene D5 Iodine +103 
Iodopentafluorobenzene D6 Iodine +166 
1,2-Diiodotetrafluorobenzene D7 Iodine +162 
1,4-Diiotetrafluorobenzene D8 Iodine +169 
1,3,5-Triiodotrifluorobenzene D9 Iodine +158 
4,4’-Diiodoperfluorobiphenyl D10 Iodine +164 
Bromopentafluorobenzene D11 Bromine +143 
1,4-Diiodotetrafluorobenzene D12 Bromine +139 
4,4’-Dibromopurfluorobiphenyl D13 Bromine +132 
1-Bromo-4-iodotetrafluorobenzene D14 Iodine/Bromine +165/+132 
4-Bromo-4'-iodperfluorobiphenyl D15 Iodine/Bromine +168/+140 
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Table 5.3 Summary of grinding IR results 
  5.3.3 Crystal growth and structure analysis  
Although vibrational spectroscopy provides unambiguous information about whether a co-
crystal has formed or not, it does not show which acceptor site is engaged by the XB- and HB-
donor respectively, thus there is a need for single crystal data. The initial approach for crystal 
growth was slow evaporation, but due to the differences in solubility between the donors and 
acceptors used in this study, the less soluble component (in this case the acceptor) often 
precipitated as a homogenous solid. Even though A16 showed formation of co-crystals on 5/15 
occasions, slow evaporation studies did not yield crystals with A16, due to its poor solubility. 
However, single crystals of A16:D8 was obtained using vapor diffusion. Unfortunately, no single 
crystals were obtained with A20 for the same reasons. Supramolecular yields for the co-
crystallizations are provided in Table 5.4. 
 
 
 
 
Acceptors 
% Success 
A16 A17 A18 A19 A20 
D
o
n
o
rs
 
D1      2/5 40 
D2      2/5 40 
D3      3/5 60 
D4      1/5 20 
D5      0/5 0 
D6      3/5 60 
D7      4/5 80 
D8      5/5 100 
D9      2/5 40 
D10      4/5 80 
D11      0/5 0 
D12      0/5 0 
D13      0/5 0 
D14      2/5 40 
D15      1/5 20 
% Success 
5/15 10/15 5/15 8/15 2/15 
 
33 67 33 53 13 
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Table 5.4 Summary of grinding and solvent based experiments 
 
In total, fifteen compounds yielded suitable quality crystals to be analyzed with X-ray 
diffraction. Crystallographic data and halogen-bond and hydrogen-bond geometry data for all 
fifteen structures are provided in Appendix B.4.  
 5.3.4 Crystal structures 
 5.3.4.1 Structures of A16-based co-crystals  
With acceptor A16 only one crystal structure (A16:D8) could be obtained, where the 
imidazole molecules are held together by N-H⋯N hydrogen bonds formed between the two 
adjacent rings. The pyridine nitrogen atom of A16 forms a halogen bond with D8. The halogen 
bond formation takes place at both ends of D8, resulting in a supramolecular ribbon architecture 
Figure 5.7. 
 
 
 
 
 
 
Figure 5.7 Primary intermolecular interactions in the crystal structure of A16:D8 
 
Acceptor 
Overall 
A16 A17 A18 A19 A20 
Grinding 5/15 10/15 5/15 8/15 2/15 30/75 
Slow evaporation 1/15 7/15 3/15 4/15 0/15 15/75 
Supramolecular 
arrangement 
1/1 
Ribbons 
7/7 
Sheets 
3/3 
Chains 
3/4 sheets 
1/4 chains 
- 
1 ribbon 
10 sheets 
4 chains 
Supramolecular yield 33% 67% 33% 53% 13% 40% 
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 5.3.4.2 Structures of A17-based co-crystals  
With A17, seven crystal structures were obtained (A17:D1, A17:D2, A17:D7, A17:D8, 
A17:D9, A17:D10 and A17:D14). In A17:D1 a hydrogen-bonded chain is constructed by adjacent 
imidazole moieties via N-H⋯N interactions. The best acceptor site, N(py), again interacts with the 
halogen-bond donor, Figure 5.8. Adjacent acceptors are twisted about 700 with respect to each 
other leading to a corrugated 2-D assembly, Figure 5.8.  The crystal structure of A17:D2 displays 
similar features, Figure 5.8.  
Figure 5.8 HB and XB interactions in structures A17:D1 and A17:D2; a) primary interactions in 
A17:D1 b) corrugated sheet in A17:D1 c) primary interactions in A17:D2 d) side view of the 
corrugated layer in the structure of A17:D2 
In A17:D7, a hydrogen-bonded chain is again formed between adjacent imidazole moieties 
via N-H⋯N interactions. The D7 ditopic donors provide a crosslink between chains through two 
symmetry related I⋯N halogen bonds with the N(py) atom, Figure 5.9. The same primary synthons 
and assemblies are present in the crystal structures of A17:D8, A17:D9, A17:D10 and A17:D14, 
Figure 5.9. 
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Figure 5.9 Primary synthons and layers in the crystal structures of a) A17:D7 b) A17:D8 c) 
A17:D9 d) A17:D10 and e) A17:D14 
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In all seven structures the hydrogen-bonded ladders create cores which are interlinked 
through halogen bonds, leading to infinite 2-D assemblies. The A17:D1 and A17:D2 contain layers 
that are more highly corrugated, and the only difference is that they contain aliphatic halogen-bond 
donors.  
 5.3.4.3 Structures of A18-based co-crystals  
With acceptor A18, three structures were obtained, A18:D3, A18:D8 and A18:D10, all of 
which contain a hydrogen-bonded dimer comprising two molecules connected via two symmetry-
related N-H(im)⋯N(py) hydrogen bonds. The remaining acceptor, the imidazole nitrogen atom, 
participates in halogen bonding. These interactions lead to the formation of chain architectures. 
A18:D3 also shows the same interaction as in A18:D8 and A18:D10, but contains an additional 
disordered imidazole molecule in between that does not seem to participate in any significant 
structure directing short contacts.  Figure 5.10 shows the interactions and the formation of chains 
in A18:D8 and A18:D10. Structure of A18:D3 is disordered and not shown.  
Figure 5.10 Primary interactions and the formation of chains in structures a) A18:D8 and b) 
A18:D10 
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 5.3.4.4 Structures of A19-based co-crystals  
With A19, four crystal structures were obtained, A19:D2, A19:D8, A19:D9 and A19:D10. 
In A19:D2 and A19:D9, A19 is essentially replicating the behavior of A17 and only one of the 
nitrogen atoms on the pyrazine ring is participating in significant intermolecular interactions. The 
imidazole nitrogen atom acts as a HB acceptor, forming N-H⋯N interactions, while I⋯N halogen 
bond involves a pyrazine nitrogen atom resulting in a 2-D layer, Figure 5.11.  
Figure 5.11 Primary synthons and the 2-D layers in the crystal structures of a) A19:D2 and b) 
A19:D9 
The interactions in A19:D8 are similar to those in A19:D2 and A19:D9 but the sheets are 
more corrugated compared to what was found in the structures of A17:D1 and A17:D2, Figure 
5.12.  
Figure 5.12 Primary synthons in the crystal structure of A19:D8; a) top view of the layer b) side 
view of the corrugated layer 
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The crystal structure of A19:D10 contains a very different set of interactions compared to 
the other three structures with A19. In this case, the acceptor essentially behaves as A18 where the 
pyrazine nitrogen at the third position is inactive. As in the structures with A18, a hydrogen-bond 
dimer is formed between two acceptor molecules via N-H(im)⋯N(py) interactions and the 
imidazole nitrogen is participating in the formation of halogen bonds leading to a chain 
architecture, Figure 5.13. 
Figure 5.13 Primary synthons producing a 1-D chain in the structure of A19:D10 
 5.4 Discussion  
 5.4.1 Relationship between molecular electrostatic potentials and hydrogen- and 
halogen-bond competition  
For A16, based on the DFT calculations, the pyridine nitrogen atom is recognized as the 
best acceptor site and in A16:D8 it is engaged in a halogen bond whereas the second best acceptor, 
the imidazole nitrogen atom, forms N-H⋯N hydrogen bonds. In all seven structures with A17, the 
imidazole nitrogen atom, which is ranked as the second-best acceptor according to the MEPS 
calculations, engage in hydrogen bonds, whereas the best acceptor atom, N(py), participates in 
halogen bond formation. As was the case in the structures of A16 and A17, with A18 the halogen-
bond involves the best acceptor (as ranked by the relative MEPS). In three of the four structures 
obtained with A19, the best acceptor imidazole nitrogen atom is participating in a hydrogen bond 
while the second-best acceptor is forming halogen bonds. In the fourth structure with A19, the best 
acceptor is participating in the formation of halogen bonds while the third best acceptor is 
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participating in the formation of hydrogen bonds. Surprisingly in this case the second best acceptor 
is not participating in any short contacts. As with A16, A17 and A18, in this structure the halogen 
bond interaction “wins” over the hydrogen bond by engaging with the best acceptor site.  
No crystal structures of co-crystals with acceptor A20 were obtained, possibly due to its 
low solubility relative to that of each co-former. Another reason may be due to the fact that the 
acceptor site on this molecule displays relatively low values for the MEPS (-72 kJ/mol) on the 
heteroaryl ring compared to those values on the other acceptor molecules.  
All in all, in twelve of the fifteen structures obtained, the XB donor interacted with the 
“best acceptor”, which indicates that in a competitive co-crystallization event, it is possible for the 
XB donor to outperform an HB donor for the electrostatically most attractive acceptor site. Despite 
extensive theoretical studies of the HB and XB strength it is still difficult to predict the outcome 
of a supramolecular assembly process that contains multiple viable XB and HB bonds.  
 5.4.2 Effect of MEPS on halogen bond donors 
Supramolecular yields based on halogen-bond donors are summarized in Table 5.5. Based 
on these results, it is clear that iodine-based donors are far superior to their bromine analogues 
when it comes to driving co-crystal formation. Despite the fact that Br⋯N/O/S interactions have 
been shown to display considerable thermodynamic strength, they seem unlikely to become 
prominent primary synthetic tools in supramolcular synthesis, even though they are capable of 
exercising some structure-directing influence in both solution and solid state.37  Similarly, iodine 
atoms that have not been sufficiently polarized by the presence of electron-withdrawing 
substituents are also not effective at driving co-crystal formation by themselves.  This is illustrated 
by the fact that the only non-activated XB donor, iodobenzene, D5, did not produce any co-crystals 
in this study.  
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Table 5.5 Supramolecular yields as a function of halogen-bond donor type 
 
 5.4.3 Different supramolecular outcomes 
Depending on the intermolecular interactions and the relative orientations of the heteroaryl-
2-imidazole molecules in each structure, the supramolecular architectures can be organized in three 
outcomes, chains, ribbons and sheets, Table 5.4. The only structure obtained with A16, contains a 
ribbon architecture where the ladder of A16 molecules are oriented in the same direction. For A17, 
all the structures are comprised of a sheet architecture, due to the twisted nature and the alternate 
orientation of the A17 molecules. With A18 all structures form chains, starting with the A18 dimer 
formation and extend via halogen bond formations. The possible reason behind this is that the 
pyridine nitrogen atom at the 2nd position of the heteroaryl ring leads to N-H⋯N dimer formation 
via chelate effect which is not possible in A16 and A17. As mentioned earlier, A19 behaves both 
as A17 and A18, thus three of the four structures are forming sheet architectures, while the fourth 
one forming a chain architecture.  
 5.5 Conclusions  
Based on the results of our systematic co-crystallizations intended to probe competition 
between XB and HB donors for acceptor sites with different electrostatic potentials, it is clear that 
halogen bonds can readily outperform hydrogen bonds, Figure 5.14. 
 Halogen-bond donor category 
 Iodine-based donors Bromine-based donors Mixed donors 
No of donors 10 3 2 
No of experiments 50 15 10 
Success rate grinding 
experiments 
27/50 0/15 3/10 
Success rate solvent 
experiments 
14/50 0/15 1/10 
Supramolecular yield 54% 0% 30% 
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Figure 5.14 Total outcome of fifteen experiments 
The better acceptor site ranked by calculated MEPS values provided the interaction site for 
a XB donor in twelve of fifteen cases where a crystal structure was obtained. Overall, 30 of 75 
attempts produced co-crystals (40%) and the success rate, the supramolecular yield, rose to 60% 
(27/45) when only activated iodine-based donors were considered.  
At this point it is unclear how the balance between different XB and HB donors will 
manifest itself when they are competing for acceptors sites of different electrostatic characteristics. 
Fundamentally, both interaction types have a large electrostatic component, but it is probably 
necessary to carefully examine additional factors such as geometry and symmetry, before reliable 
predictions can be made. However, it is clear that no one interaction is dominating and their 
thermodynamically comparable strengths mean that the simultaneous use of these interactions in 
supramolecular synthesis offers both tough challenges and interesting opportunities. 
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Chapter 6 - Synthesis, structure, intermolecular interactions and 
crystal engineering with iodoethynylnitrobenzenes: A group of 
highly effective halogen-bond donors1 
 6.1 Introduction 
The halogen bond2 is becoming increasingly important in many aspects of crystal 
engineering and materials design3 because of the possibilities of fine-tuning the strength and 
effectiveness of this non-covalent interaction.4 A halogen bond is, according to a recent IUPAC 
definition, the result of “a net attractive interaction between an electrophilic region associated with 
a halogen atom in a molecular entity and a nucleophilic region in another, or the same, molecular 
entity”,5 which emphasizes the electrostatic component of this interaction. The electrophilic region 
on a halogen atom is referred to as the “σ-hole”, Figure 6.1.6  
 
 
 
 
Figure 6.1 Formation of the σ-hole on iodine of CF3I due to the electron withdrawing nature of 
fluorine atoms 
If the σ-hole of a potential halogen-bond donor can be boosted in some manner, the 
resulting halogen bond (XB) is likely to display increased strength. This process is known as 
‘activation”7 which includes adding one or more electron-withdrawing groups8 to the molecular 
scaffold of the intended XB donor in order to promote depletion of negative charge from the σ-
hole, Figure 6.2.9  In this way, perfluorinated halogen-bond donors,10 nitro activated halogen-bond 
donors,11 and cationic aromatic systems12 have been employed successfully in XB-driven crystal 
σ-hole 
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engineering. It has also been shown that the number of fluorine substituents on the backbone of 
iodobenzene has an additive effect on the molecular electrostatic potential13 that characterizes the 
σ-hole.14 Alternatively, the intended XB donor can be connected to an sp-hybridized carbon atom 
which facilitates polarization and leads to an enhanced positive charge.15 Furthermore, studies 
have confirmed that an sp2-hybridized carbon atom is enough to polarize an iodine to make it a 
better halogen-bond donor.16 Only in very rare cases has a combination of approaches been 
deliberately utilized in order to create an activated XB donor.17 
Figure 6.2 Methods currently used to activate halogen-bond donors 
In order to develop a new series of potent XB donors for effective co-crystal synthesis, we 
decided to combine the electron-withdrawing capabilities of -NO2 moieties with the polarizing 
effects of an sp-carbon atom thereby providing a path to highly electrophilic halogen atoms 
through a ‘double-activation’ process, Figure 6.3.  
 
 
 
 
 
 
Figure 6.3 “Double activation” of a halogen-bond donor (X represents any halogen atom) 
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Since the polarizability of the halogen atom plays an important part in determining the 
magnitude of the σ-hole,18 the study was primarily focused on iodoethynylnitrobenzene 
compounds as potential halogen-bond donors, since halogen atom polarizability decreases in the 
order I>Br>Cl.19 Three molecules based on the design criteria described above were prepared; 1-
(iodoethynyl)-4-nitrobenzene (4N-I), 1-(iodoethynyl)-3-nitrobenzene (3N-I) and 1-(iodoethynyl)-
3,5-dinitrobenzene (3,5DN-I), Figure 6.4.20  
 
 
 
 
 
Figure 6.4 Iodoethynylnitrobenzene compounds under study 
Even though the primary focus on this study was to evaluate the halogen bonding potential 
of iodoethynylnitrobenzenes, it seemed important to examine if the double activation would be 
sufficient to the make the corresponding bromo- and chloro- analogues capable XB donors as well. 
C-Br based halogen-bond donors are known,21 but no crystallographic data exist to indicate that 
C-Cl based moieties are strong enough to drive co-crystal formation through halogen bonds. Thus, 
three bromo- and three chloroethynylnitrobenzenes, 1-(bromoethynyl)-4-nitrobenzene (4N-Br), 1-
(bromoethynyl)-3-nitrobenzene (3N-Br), 1-(bromoethynyl)-3,5-dinitrobenzene (3,5DN-Br), 1-
(chloroethynyl)-4-nitrobenzene (4N-Cl), 1-(chloroethynyl)-3-nitrobenzene (3N-Cl) and 1-
(chloroethynyl)-3,5-dinitrobenzene (3,5DN-Cl), Figure 6.5, were also synthesized. 
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Figure 6.5 Bromo- and chloroethynylnitrobenzene compounds in this study 
Having one or two nitro groups and an activated halogen domain, these nine molecules 
were also used to study the interaction preferences of nitro groups. The nitro group has not been 
employed extensively as a recognition group in supramolecular chemistry due to poor accepting 
nature of nitro group in a supramolecular context.22 But in the recent literature, with the emergence 
of energetic co-crystallizations,23 nitro group has become of central importance. When 
synthesizing energetic co-crystals, the design strategy needs to use functional groups available on 
the energetic compound of interest, and the most common functional group in energetic materials 
is the nitro group.24 The reported literature on energetic co-crystals relies on different non-covalent 
interactions such as hydrogen bonding and π stacking between electron rich and electron poor 
moieties.25 Apart from these, weak interactions between nitro-amino, nitro-nitro or nitro-aromatic 
functional groups have been used as secondary interactions.26 It seems that most of these design 
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strategies try to avoid the use of nitro group in directing intermolecular interactions. Thus there is 
a quest for reliable synthons containing nitro group as one of the recognition groups.  
With this in mind, an extensive search on the interactions containing nitro group as the 
central group was performed. For this, initial mapping of interactions between nitro groups and 
other functional groups were performed using IsoStar,27 a web-based application using an 
extensive knowledge-based library of intermolecular interactions. According to the data presented 
in IsoStar maps, it was surprising that the number of crystal structures reported between the nitro 
group and halogen atoms were less compared to other reported interactions with nitro group, even 
though the nitro⋯halogen interaction is documented as a reliable synthon. The search for the 
interaction between nitro group and any C-I contact group was not reported in the IsoStar 
knowledge base. Thus, a CSD search was performed on reported nitro⋯iodo non covalent 
interactions. The number of hits came out to be 124 without applying any filters, which was quite 
small for a known synthon. One of the other thing that we noted is short contacts between nitro 
groups and an activated halogen atom are particularly rare.28 Thus the library of 
haloethynylnitrobenzenes in this study were optimal candidates to learn more.  
Six of the nine compounds (4N-I,29 4N-Br,30 4N-Cl,31 3N-I,32 3N-Br33 and 3N-Cl34) were 
previously reported as reaction intermediates, substrates for reaction mechanism studies or in the 
development of new organic synthetic methods, but none of them were studied in the context of 
recognition properties of nitro groups or as potential halogen-bond donors.  
After successful synthesis and characterization of the library of compounds, interaction 
modes for iodinated compounds were predicted using IR spectroscopy. For all nine compounds 
we tried to obtain structures in order to map their interactions and to compare the actual 
experimental results with the IR postulated results.  
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In order to examine the propensity of these three XB donors to form co-crystals, each of 
them was allowed to react with fifteen potential acceptors through solvent-assisted grinding. This 
library includes N-based acceptors (A21-A27, A31 and A32) O-based acceptors (A28-A30) and 
N-and O-based mixed acceptors (A33-A35), and the co-formers can be further categorized as 
symmetric ditopic (A21-A30), monotopic, (A31 and A32) and dissymmetric ditopic (A33-A35), 
Figure 6.6. The bromo- and chloroethynylnitrobenzene compounds were also subjected to solvent-
assisted grinding and solution based crystallizations with five acceptors A23, A24, A27, A31 and 
A33. A total of 75 attempted co-crystallizations were carried out in order to determine relative 
success rates (as indicated by IR spectroscopy) for these compounds. The relative propensity for 
co-crystal formation was rationalized in the context of calculated molecular electrostatic potential 
surfaces, and complemented by single-crystal structure determinations of ten new co-crystals.  
 
Figure 6.6 Acceptors utilized in this study 
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The study is undertaken in response to three hypotheses, 
1. Double activation of an iodine atom increases the size and strength of the σ hole and 
leads to the formation of effective halogen-bond donors. 
2. Double activation of a bromine atom or a chlorine atom leads to effective bromine- and 
chlorine-based halogen-bond donors. 
3. Haloethynylnitrobenzene compounds show a diversity of intermolecular interactions 
between the nitro group and the activated halogen atom thus can be utilized as potential 
synthons in co-crystallizations with nitro containing energetics. 
 6.2 Experimental 
 6.2.1 General 
All precursors, solvents and acceptors A21-A26 and A31 were purchased from commercial 
sources and used without further purification. A28-A30 and A33-A35 were synthesized following 
previously reported procedures,35 as were A2736 and A32.37 1H NMR spectra and 13C NMR spectra 
were recorded on Varian Unity plus 400 MHz spectrometer. Differential scanning calorimetry 
(DSC) measurements were carried out on haloethynylnitrobenzene compounds with a TA 
Instruments Q20, using Tzero aluminum pans under nitrogen (50.0 mL/min) purge at a heating 
rate of 10 °C/min over a range from 20 °C to 200 °C. For iodinated compounds DSC measurements 
were carried out until the melting occurs. Melting points of co-crystals were determined using a 
Fischer–Johns Mel-Temp melting point apparatus and uncorrected.  
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 6.2.2 Synthesis of haloethynylnitrobenzene compounds 
 6.2.2.1 Synthesis of trimethyl((4-nitrophenyl)ethynyl)silane 
 
4-Iodonitrobenzene (1.7 g, 7.0 mmol), trimethylsilylacetylene (1.0 mL, 7.7 mmol), CuI 
(0.060 g, 0.35 mmol), and bis(triphenylphosphine)palladium(II) dichloride (0.15 g, 0.21 mmol) 
were dissolved in 50 mL of degassed trimethylamine. The mixture was stirred overnight at room 
temperature under a dinitrogen atmosphere. Completion of reaction was confirmed with TLC. The 
reaction mixture was concentrated in vacuo and the residue was dissolved in diethyl ether (50 mL). 
The ethereal solution was washed with 1 M HCl (10 mL), water (2 x 20 mL) and saturated NaCl 
solution (20 mL). The organic layer was dried with anhydrous MgSO4 and concentrated in vacuo. 
The crude product was purified by flash chromatography in 50:1 hexane: ethyl acetate yielding the 
final product. Yield: 1.3 g (88%); 1H NMR (400 MHz, CDCl3): 0.28 (s, 9H), 7.59 (d, 2H), 8.17 (d, 
2H). 
 6.2.2.2 Synthesis of 1-(iodoethynyl)-4-nitrobenzene, 4N-I 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. Trimethyl((4-
nitrophenyl)ethynyl)silane (1.0 g, 4.6 mmol), and AgF (0.58 g, 4.6 mmol) were added to 
acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
iodosuccinimide (1.0 g, 4.6 mmol). The mixture was connected to a nitrogen inlet and stirred 
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overnight. Completion of the reaction was monitored with TLC and the resulting suspension was 
passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent was concentrated 
in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 mL). The 
organic layer was dried with anhydrous MgSO4 and concentrated in vacuo to obtain 1-
(iodoethynyl)-4-nitrobenzene (4N-I) as a yellow powder. Yield: 1.1 g (85%); m.p. 195-198 °C; 1H 
NMR (400 MHz, CDCl3): 7.59 (d, 2H), 8.20 (d, 2H);
 13C NMR (400 MHz, CDCl3): 15.52, 93.29, 
124.46, 130.91, 134.08, 173.24. 
 6.2.2.3 Synthesis of 1-(bromoethynyl)-4-nitrobenzene, 4N-Br 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. Trimethyl((4-
nitrophenyl)ethynyl)silane (1.0 g, 4.6 mmol), and AgF (0.58 g, 4.6 mmol) were added to 
acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
bromosuccinimide (0.81 g, 4.6 mmol). The mixture was connected to a nitrogen inlet and stirred 
overnight. Completion of the reaction was monitored with TLC and the resulting suspension was 
passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent and was 
concentrated in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 
mL). The organic layer was dried with anhydrous MgSO4 and concentrated in vacuo to obtain 1-
(bromoethynyl)-4-nitrobenzene (4N-Br) as a pale yellow powder. Yield: 0.83 g (81%); m.p. 
174.66 °C (decompose); 1H NMR (400 MHz, CDCl3): 7.61 (d, 2H), 8.18 (d, 2H);
 13C NMR (400 
MHz, CDCl3):56.37, 78.36, 123.59, 129.43, 132.79, 147.30. 
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 6.2.2.4 Synthesis of 1-(chloroethynyl)-4-nitrobenzene, 4N-Cl 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. Trimethyl((4-
nitrophenyl)ethynyl)silane (1.0 g, 4.6 mmol), and AgF (0.58 g, 4.6 mmol) were added to 
acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
chlorosuccinimide (0.60 g, 4.6 mmol). The mixture was connected to a nitrogen inlet and stirred 
for two days. Completion of the reaction was monitored with TLC and the resulting suspension 
was passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent was 
concentrated in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 
mL). The organic layer was dried with anhydrous MgSO4 and concentrated in vacuo to obtain 1-
(chloroethynyl)-4-nitrobenzene (4N-Cl) as a white powder. Yield: 0.29 g (35%); m.p. 148-150 °C; 
1H NMR (400 MHz, CDCl3): 7.61 (d, 2H), 8.21 (d, 2H);
 13C NMR (400 MHz, CDCl3): 67.70, 
73.86, 123.56, 128.93, 132.74, 177.90. 
 6.2.2.5 Synthesis of trimethyl((3-nitrophenyl)ethynyl)silane 
 
 
3-Iodonitrobenzene (1.7 g, 7.0 mmol), trimethylsilylacetylene (1.0 mL, 7.7 mmol), CuI 
(0.060 g, 0.35 mmol), and bis(triphenylphosphine)palladium(II) dichloride (0.15g, 0.21 mmol) 
were dissolved in 50 mL of degassed trimethylamine. The mixture was stirred overnight at room 
temperature under a dinitrogen atmosphere. Completion of reaction was confirmed with TLC. The 
reaction mixture was concentrated in vacuo and the residue was dissolved in diethyl ether (50 mL). 
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The ethereal solution was washed with 1 M HCl (10 mL), water (2 x 20 mL) and a saturated NaCl 
solution (20 mL). The organic layer was dried with anhydrous MgSO4 and concentrated in vacuo. 
The crude product was purified by flash chromatography in 50:1 hexane: ethyl acetate yielding the 
final product. Yield: 1.4 g (91%); 1H NMR (400 MHz, CDCl3): 0.27 (s, 9H), 7.48 (t, 1H), 7.74 (d, 
1H) 8.15 (d, 1H) 8.31 (s, 1H). 
 6.2.2.6 Synthesis of 1-(iodoethynyl)-3-nitrobenzene, 3N-I 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. Trimethyl((3-
nitrophenyl)ethynyl)silane (1.0 g, 4.6 mmol), and AgF (0.58 g, 4.6 mmol) were added to 
acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
iodosuccinimide (1.0 g, 4.6 mmol). The mixture was connected to a nitrogen inlet and stirred 
overnight. Completion of the reaction was monitored with TLC and the resulting suspension was 
passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent and was 
concentrated in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 
mL). The organic layer was dried with anhydrous MgSO4 and concentrated vacuo to obtain 1-
(iodoethynyl)-3-nitrobenzene (3N-I) as a brown solid. Yield: 1.1 g (90%); m.p. 41-47 °C; 1H NMR 
(400 MHz, CDCl3): 7.51 (t, 1H), 7.75 (d, 1H) 8.20 (d, 1H) 8.29 (s, 1H);
 13C NMR (400 MHz, 
CDCl3):11.14, 91.61, 123.45, 124.98, 127.18, 129.29, 137.92, 155.26. 
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 6.2.2.7 Synthesis of 1-(bromoethynyl)-3-nitrobenzene, 3N-Br 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. Trimethyl((3-
nitrophenyl)ethynyl)silane (1.0 g, 4.6 mmol), and AgF (0.58 g, 4.6 mmol) were added to 
acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
bromosuccinimide (0.81 g, 4.6 mmol). The mixture was connected to a nitrogen inlet and stirred 
overnight. Completion of the reaction was monitored with TLC and the resulting suspension was 
passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent and was 
concentrated in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 
mL). The organic layer was dried with anhydrous MgSO4 and concentrated in vacuo to obtain 1-
(bromoethynyl)-3-nitrobenzene (3N-Br) as an off white powder. Yield: 0.90 g (87%); m.p. 55-60 
°C; 1H NMR (400 MHz, CDCl3): 7.51 (t, 1H), 7.73 (d, 1H) 8.18 (d, 1H) 8.29 (s, 1H);
 13C NMR 
(400 MHz, CDCl3):53.58, 77.72, 123.37, 124.38, 126.82, 129.38, 137.61, 147.96. 
 6.2.2.8 Synthesis of 1-(chloroethynyl)-3-nitrobenzene, 3N-Cl 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. Trimethyl((4-
nitrophenyl)ethynyl)silane (1.0 g, 4.6 mmol), and AgF (0.58 g, 4.6 mmol) were added to 
acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
chlorosuccinimide (0.60 g, 4.6 mmol). The mixture was connected to a nitrogen inlet and stirred 
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for two days. Completion of the reaction was monitored with TLC and the resulting suspension 
was passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent was 
concentrated in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 
mL). The organic layer was dried with anhydrous MgSO4 and concentrated in vacuo to obtain 1-
(chloroethynyl)-3-nitrobenzene (3N-Cl) as a brown solid. Yield: 0.34 g (42%); m.p. 50-54 °C; 1H 
NMR (400 MHz, CDCl3): 7.52 (t, 1H), 7.74 (d, 1H) 8.21 (d, 1H) 8.29 (s, 1H);
 13C NMR (400 MHz, 
CDCl3): 67.11, 71.22, 123.31, 123.85, 126.79, 129.41, 137.61, 149.44. 
 6.2.2.9 Synthesis of ((3,5-dinitrophenyl)ethynyl)trimethylsilane 
 
 
 
 
1-Iodo-3,5-dinitrobenzene (2.0 g, 6.8 mmol), trimethylsilylacetylene (1.1 mL, 7.5 mmol), 
CuI (0.065 g, 0.34 mmol), and bis(triphenylphosphine)palladium(II) dichloride (0.14 g, 0.20 
mmol) were dissolved in 50 mL of degassed trimethylamine. The mixture was stirred overnight at 
room temperature under a dinitrogen atmosphere. Completion of the reaction was confirmed with 
TLC. The reaction mixture was concentrated in vacuo and the residue was dissolved in diethyl 
ether (50 mL). The ethereal solution was washed with 1 M HCl (10 mL), water (2 x 20 mL) and 
saturated NaCl solution (20 mL). The organic layer was dried with anhydrous MgSO4 and 
concentrated in vacuo. The crude product was purified by flash chromatography in 50:1 hexane: 
ethyl acetate yielding the final product. Yield: 1.7 g (94%); 1H NMR (400 MHz, CDCl3): 0.31 (s, 
9H), 8.59 (s, 2H), 8.97 (s, 1H). 
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 6.2.2.10 Synthesis of 1-(iodoethynyl)-3,5-dinitrobenzene, 3,5DN-I 
 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. ((3,5-
dinitrophenyl)ethynyl)trimethylsilane (1.0 g, 3.9 mmol), and AgF (0.48 g, 3.9 mmol) were added 
to acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
iodosuccinimide (0.85 g, 3.9 mmol). The mixture was connected to a nitrogen inlet and stirred 
overnight. Completion of the reaction was monitored with TLC and the resulting suspension was 
passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent was concentrated 
in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 mL). The 
organic layer was dried with anhydrous MgSO4 and concentrated in vacuo to obtain 1-
(iodoethynyl)-3,5-dinitrobenzene (3,5DN-I) as a pale brown solid. Yield: 0.98 g (81%); m.p. 111-
113 °C; 1H NMR (400 MHz, CDCl3): 8.57 (s, 2H), 8.98 (s, 1H);
 13C NMR (400 MHz, CDCl3): 
16.59, 89.78, 118.50, 126.85, 132.10, 148.30. 
 6.2.2.11 Synthesis of 1-(bromoethynyl)-3,5-dinitrobenzene, 3,5DN-Br 
 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. ((3,5-
dinitrophenyl)ethynyl)trimethylsilane (1.0 g, 3.8 mmol), and AgF (0.48 g, 3.8 mmol) were added 
to acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
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bromosuccinimide (0.67 g, 3.8 mmol). The mixture was connected to a nitrogen inlet and stirred 
overnight. Completion of the reaction was monitored with TLC and the resulting suspension was 
passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent was concentrated 
in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 mL). The 
organic layer was dried with anhydrous MgSO4 and concentrated in vacuo to obtain 1-
(bromoethynyl)-3,5-dinitrobenzene (3,5DN-Br) as a brown solid. Yield: 0.85 g (83%); m.p. 103-
107 °C; 1H NMR (400 MHz, CDCl3): 8.58 (s, 2H), 9.00 (s, 1H);
 13C NMR (400 MHz, CDCl3): 
57.97, 76.01, 118.45, 126.27, 131.75, 148.34. 
 6.2.2.12 Synthesis of 1-(chloroethynyl)-3,5-dinitrobenzene, 3,5DN-Cl 
 
 
 
 
Acetonitrile (20 mL) was degassed with dinitrogen. ((3,5-
dinitrophenyl)ethynyl)trimethylsilane (1.0 g, 3.8 mmol), and AgF (0.48 g, 3.8 mmol) were added 
to acetonitrile and the mixture was covered with aluminum foil before the introduction of N-
chlorosuccinimide (0.50 g, 3.8 mmol). The mixture was connected to a nitrogen inlet and stirred 
for two days. Completion of the reaction was monitored with TLC and the resulting suspension 
was passed through a 2 cm silica plug and the filtrate with acetonitrile as the solvent was 
concentrated in vacuo. The residue was dissolved in diethyl ether and washed with water (2 x 20 
mL). The organic layer was dried with anhydrous MgSO4 and concentrated in vacuo to obtain 1-
(chloroethynyl)-3,5-dinitrobenzene (3,5DN-Cl) as a brown solid. Yield: 0.51 g (60%); m.p. 93-
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102 °C; 1H NMR (400 MHz, CDCl3): 8.59 (s, 2H), 9.00 (s, 1H);
 13C NMR (400 MHz, CDCl3): 
65.45, 75.07, 118.46, 125.84, 131.77, 148.10. 
 6.2.3 FTIR spectroscopy 
IR spectra of the solid haloethynylnitrobenzene compounds were recorded on a Nicolet 
380 FTIR spectrometer from 500 to 3500 cm-1. Solution spectra for iodinated compounds were 
collected using solutions of 0.1 M in THF. Complete solid state IR spectra and solution IR spectra 
are provided in Appendix C.2. Collected spectra were analyzed for specific IR markers as in 
literature38 in order to identify the interaction modes.  
 6.2.4 IsoStar and CSD searches 
All the interaction maps reported in the IsoStar knowledge base were analyzed and three 
main trends were identified, Figure 6.7. 3D scatter plots and contour surfaces for the interactions 
between nitro group and the halogen moieties were generated using IsoStar. When generating the 
plots only the interactions less or equal to van der Waals radii sum was used. Figure 6.8 shows the 
respective contour surfaces and 3D scatter plots generated. CSD searches for nitro⋯I contact was 
done using Conquest39 without applying any filters.  
 6.2.5 Growing crystals of haloethynylnitrobenzenes 
Crystals suitable for single crystal X-ray analysis (4N-Br, 3,5DN-I, 3,5DN-Br and 3,5-
DN-Cl) were grown by slow evaporation of respective haloethynylnitrobenzene compound in a 
mixture of dichloromethane and methanol. Crystals of 4N-I were obtained by slow evaporation 
from ethyl acetate. Crystals of 4N-Cl and 3N-I were too small to analyze using single crystal X-
ray diffraction thus analyzed using powder structure determination along with 4N-I where both 
single crystal strutures and structure from powder data were obtained. Even though 3N-Br and 
3N-Cl were crystalline in nature, it was not possible to obtain large enough crystals to analyze 
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using single crystal X-ray diffraction. The attempts to solve these two structures using powder X-
ray analysis were also not possible. Even though good quality crystals of 3,5DN-Cl were obtained, 
due to the presence of unknown impurities in the crystal lattice, it was not possible to obtain the 
structure solution. All the X-ray experimental data and halogen bond geometries are provided in 
the Appendix B.5.  
 6.2.6 Electrostatic potential calculations 
Molecular electrostatic potential surfaces for iodoethynylnitrobenzenes were calculated 
with density functional B3LYP level of theory with 6-311++G** basis set in vacuum. The same 
level of theory was used to calculate the electrostatic potentials for iodobenzene, 
pentafluoroiodobenzene, iodoethynylbenzene and 3,5-dinitroiodobenzene, Figure 6.15. 
Electrostatic potential surfaces for bromoethynylnitrobenzenes and chloroethynylnitrobenzenes 
were also calculated using the same level of theory and conditions, Figure 6.16. All calculations 
were carried out using the Spartan 8 software.40 All molecules were geometry optimized with the 
maxima and minima in the electrostatic potential surface (0.002 e/au isosurface) determined using 
a positive point charge in the vacuum as a probe. The numbers indicate the interaction energy 
(kJ/mol) between the probe and the surface of the molecule. A positive value for the interaction 
energy indicates a positive surface potential while a negative value indicate a negative surface 
potential. 
 6.2.7 Co-crystal screening and crystallography 
Initial screening was carried out through solvent-assisted grinding using methanol.  
Iodoethynylnitrobenzenes were combined with each acceptor in stoichiometric ratios (45 
experiments). All bromoethynylnitrobenzenes and chloroethynylnitrobenzenes were combined 
with five acceptors (A23, A24, A27, A31 and A33) in stoichiometric amounts and ground with the 
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assistance of a drop of methanol (a total of 30 experiments). In each experiment 10 mg of the 
haloethynylnitrobenzene was used with the respective stoichiometric amount of the acceptor.  
Once the solvent had evaporated the ground mixtures were analyzed using IR spectroscopy 
to determine whether a co-crystal had formed or not. Successful interactions between the acceptor 
and donor were identified using the specific shifts of the peaks of the mixture compared to starting 
compounds.  
For each successful reaction, the resulting solid was dissolved in a minimum amount (2 
mL) of either ethyl acetate or methylene chloride and methanol (1:1) mixture and then left in a vial 
for slow evaporation in order to obtain crystals suitable for single crystal X-ray diffraction. 
Good quality crystals were obtained from the majority of co-crystals of 
iodoethynylnitrobenzenes and nine of these were crystallographically characterized. For the 
remaining two groups of XB donors, only one reaction yielded suitable single crystals. Table 6.1 
summarizes the experimental details. X-ray crystallographic data and all halogen-bond geometries 
are provided in the Appendix B.5.  
Table 6.1 Experimental details for the ten co-crystals obtained 
Code 
Mixed 
Mole 
ratio 
Amounts used 
Solvent and 
method 
Crystal 
stoichiometry 
Melting 
point (°C) 
Crystal 
color & 
habit 
4N-I:A23 2:1 
4N-I -10 , 0.037 mmol 
A23 – 3.0 mg, 0.019 mmol 
ethyl acetate, 
Slow evaporation 
2:1 61-64 
Yellow 
plate 
4N-I:A24 2:1 
4N-I - 10 mg, 0.037 mmol 
A24 - 3.5 mg, 0.019 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
2:1 72-76 
Bronze 
plate 
4N-I:A32 1:1 
4N-I - 10 mg, 0.037 mmol 
A32 - 6.8 mg, 0.037 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
1:1 107-109 
Orange 
plate 
3N-I:A25 2:1 
3N-I - 10 mg, 0.037 mmol 
A25 - 3.5 mg, 0.019 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
2:1 102-105 
Orange 
plate 
3N-I:A31 1:1 
3N-I - 10 mg, 0.037 mmol 
A31 - 5.7 mg, 0.037 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
1:1 122-126 
Bronze 
prism 
3N-I:A33 2:1 
3N-I - 10 mg, 0.037 mmol 
A33 - 1.8 mg, 0.019 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
1:1 110-112 
Bronze 
rod 
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3,5DN-I:A22 2:1 
3,5DN-I - 10 mg, 0.031 mmol 
A22 - 2.2 mg, 0.016 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
2:1 140-144 
Bronze 
prism 
3,5DN-I:A29 2:1 
3,5DN-I - 10 mg, 0.031 mmol 
A29 - 2.7 mg, 0.016 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
2:1 140-142 
Bronze 
plate 
3,5DN-I:A34 2:1 
3,5DN-I - 10 mg, 0.031 mmol 
A34 - 2.4 mg, 0.016 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
1:1 132-135 Red block 
3N-Br:A27 2:1 
3N-Br - 10 mg, 0.044 mmol 
A27 - 4.1 mg, 0.022 mmol 
DCM & methanol 
(1:1) mixture, 
Slow evaporation 
2:1 98-101 
Bronze 
prism 
 
 6.3 Results  
 6.3.1 IsoStar and CSD analysis 
An extensive IsoStar search on nitro group interactions were done and three different 
interaction patterns were identified, Figure 6.7. It is clear that polar groups prefer interacting with 
the nitro group in three different modes, mode I: symmetric bifurcated type, mode II: asymmetric 
bifurcated type and mode III: single interaction with oxygen.  
 
 
 
 
 
 
 
 
 
Figure 6.7 Most common interactions of nitro groups with a) polar groups (three modes can be 
identified as I: symmetric bifurcated type, II: asymmetric bifurcated type and III: single 
interaction with oxygen b) cationic groups and c) anionic groups; red zone are the most probable 
interaction zones 
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Furthermore, the interactions of nitro groups with cationic groups mainly prefer the 
interactions with the oxygen atoms. Anionic groups prefer interacting with positively charged 
nitrogen atom. Apart from these trends non polar neutral groups interact with nitro group without 
showing any special patterns, thus the contour maps of these interactions were equally distributed 
around the central nitro group.  
When analyzing interactions of nitro groups with different halogen moieties in IsoStar, 
only three maps were reported, interactions with C-F contact group, C-Cl contact group and C-Br 
contact group. The contour surfaces and scatter plots of these interactions are shown in Figure 6.8.  
Even though the most common nitro⋯halogen interaction is reported with iodine, the interaction 
map was not reported in IsoStar, due to the small number of data points reported in the CSD for 
generating the IsoStar interaction map. Thus, we performed a CSD search on structures with 
nitro⋯iodo contacts equal or less than the sum of van der Waals radii and 124 hits were obtained. 
 
 
 
 
 
 
 
 
 
Figure 6.8 Contour surfaces and 3D scatter plots for the interactions between nitro group and C-
X group (X-any halogen); a) contour surface for C-F group, b) contour surface for C-Cl group c) 
contour surface for C-Br group  d) 3D scatter plot for C-F group e) 3D scatter plot for C-Cl 
group and f) 3D scatter plot for C-Br group 
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 6.3.2 Interaction mode predictions using FTIR 
For 4N-I, 3N-I and 3,5DN-I the intermolecular interaction mode was analyzed using IR 
spectroscopy,38 Table 6.2. 
Table 6.2 Interaction modes predicted using FTIR for iodoethynylnitrobenzenes 
 
 6.3.3 Experimental structures of haloethynylnitrobenzenes  
Once the compounds were successfully synthesized the next step was to analyze them with 
single crystal X-ray diffraction to determine the nature of their intermolecular interactions. Even 
though a few of these compounds were reported in the previous literature, none of their structures 
were known. Of the nine compounds that were synthesized suitable crystals were obtained for four 
(4N-I, 4N-Br, 3,5DN-I and 3,5DN-Br). For the purpose of comparison, the crystal structure from 
powder data was also obtained for 4N-I.41 For 4N-Cl and 3N-I structures were obtained from 
powder data.41 Other compounds were not structurally characterized. Single crystal X-ray 
experimental data and the halogen bond geometries for the solved structures are provided in the 
Appendix B.5. Powder experimental data are provided elsewhere.41  
 The crystal structure of 4N-I is shown in Figure 6.9. The iodine atom participates in a 
symmetric bifurcated type (mode I) interaction with the oxygen atoms of nitro group in the 
neighboring molecule. The structure results are similar for the structure obtained with powder data 
as well.41 
 4N-I 3N-I 3,5DN-I 
(νas)solid [cm-1] 1498 1514 1525 
(νas)solution [cm-1] 1521 1531 1542 
Δνas [cm-1] – ( νas solution - νas solid) 23 17 17 
(νs)solid [cm-1] 1335 1343 1336 
[Ias/Is]solid Ias>Is Ias~Is Ias<Is 
Splitting in νs No No Yes 
δ(NO2) [cm-1] 848 841 838 
7a ring vibration mode [cm-1] - 771 780 
Synthon predicted Mode I Mode II Mode III 
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Figure 6.9 Main intermolecular interactions in the crystal structure 4N-I 
The crystal structure of 4N-Br is consistent with the interactions in 4N-I where symmetric 
bifurcated type (mode I) of halogen bonding between the nitro group and the adjacent bromine 
atom can be seen, Figure 6.10. 
Figure 6.10 Primary intermolecular interactions in the crystal structure of 4N-Br 
The structural consistency is persistent in the structure of 4N-Cl as well,41 which shows 
symmetric bifurcated halogen bond formation, similar to 4N-I and 4N-Br, Figure 6.11. 
Figure 6.11 Primary intermolecular interactions in the structure of 4N-Cl41 
The structure of 3N-I obtained with powder data41 is shown in Figure 6.12. Not like in the 
1,4-substituted isomers, this molecule has an asymmetric bifurcated type interaction (mode II) 
between the nitro oxygen atoms and iodine atoms. The shape of the molecule and the asymmetric 
nature of the intermolecular interaction leads to the zig-zag motifs.  
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Figure 6.12 Primary intermolecular interactions in the structure of 3N-I41 
The crystal structure of 3,5DN-I  shows a single interaction between the iodine atom and 
one of the oxygen atoms of the nitro group, Figure 6.13. This interaction and the molecular 
orientation leads to the formation of zig-zag type tapes in this structure.  
 
 
 
 
 
 
 
Figure 6.13 Primary intermolecular interactions in the crystal structure of 3,5DN-I 
The crystal structure of 3,5DN-Br shows interactions similar to that of 3,5-DN-I, Figure 
6.14. This single point interaction leads to the formation of zig-zag motifs.  
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Figure 6.14 Primary intermolecular interactions in the crystal structure of 3,5DN-Br 
 6.3.4 Electrostatic potentials 
Electrostatic potential values for the activated iodine atoms of the three 
iodoethynylnitrobenzenes (4N-I, 3N-I and 3,5DN-I) are shown in Figure 6.15, along with the 
corresponding values for iodobenzene, pentafluoroiodobenzene, iodoethynylbenzene and 3,5-
dinitriodobenzene. 
Figure 6.15 Electrostatic potentials values on the XB donor atom (in kJ/mol); a) iodobenzene b) 
iodoethynylbenzene c) 3,5-dinitroiodobenzene d) pentafluoroiodobenzene e) 3N-I f) 4N-I and   
g) 3,5DN-I 
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Figure 6.16 shows the molecular electrostatic potential values on the bromo- (4N-Br, 3N-
Br and 3,5DN-Br) and chloroethynylnitrobenzene (4N-Cl, 3N-Cl and 3,5DN-Cl) compounds. 
Figure 6.16 Electrostatic potential surfaces for bromo- and chloro- compounds (in kJ/mol); a) 
4N-Br b) 3N-Br c) 3,5DN-Br d) 4N-Cl e) 3N-Cl and f) 3,5-DN-Cl 
 6.3.5 Grinding experiments and characterization by IR spectroscopy 
Solvent-assisted grinding experiments between each of the three iodoethynylnitrobenzenes 
and 15 acceptors were analyzed using IR spectroscopy to identify notable interactions between the 
two potential co-formers. The key IR modes targeted were CC triple bond stretch of the halogen-
bond donor and the symmetric and asymmetric stretches of the nitro group in each halogen-bond 
donor. The IR analysis was done by looking at the shifts of these three IR modes with respect to 
their initial positions of the haloethynylnitrobenzene compound. If any one of those three key IR 
modes were shifted by three or more wave numbers that combination was considered to be a 
successful co-crystal formation. Table 6.3 summarizes the outcomes from grinding experiments. 
Detailed IR analysis for grinding and solvent based experiments is provided in Appendix C.2.  
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For bromo- and chloro- compounds each potential donor was allowed to react with five 
acceptors (A23, A24, A27, A31 and A33), and nine of fifteen bromoethynylnitrobenzenes resulted 
in a co-crystal whereas none of the fifteen attempts with a chloroethynylnitrobenzene produced a 
co-crystal, Table 6.3.  
Table 6.3 Summary of grinding results 
 
Donors 
iodoethynylnitrobenzenes bromoethynylnitrobenzenes chloroethynylnitrobenzenes 
4N-I 3N-I 3,5DN-I 4N-Br 3N-Br 3,5DN-Br 4N-Cl 3N-Cl 3,5DN-Cl 
A
cc
ep
to
rs
 
A21          
A22          
A23          
A24          
A25          
A26          
A27          
A28          
A29          
A30          
A31          
A32          
A33          
A34          
A35          
% Success 
15/15 15/15 15/15 3/5 4/5 2/5 0/5 0/5 0/5 
100 100 100 60 80 40 0 0 0 
 
 6.3.6 Crystal growth, IR analysis and crystallography 
To gather more detail about the exact nature of the binding of XB donor and acceptor, 
crystallographic data were required. Crystals of 4N-I:A23 were grown in ethyl acetate, and all the 
other crystals were grown in a 1:1 mixture of methanol and methylene chloride. The selection of 
the solvent systems for crystal growth are based on the solubility. The first choice of solvents to 
grow crystals was pure methanol but iodoethynylnitrobenzenes were less soluble in pure methanol 
compared to the acceptors of choice. Then the second choice was to use pure ethyl acetate; even 
though the crystal growth was successful in ethyl acetate one of the crystal structure (4N-I:A23) 
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showed solvent incorporation into the lattice. Finally, a mixture of methylene chloride and 
methanol was selected as the donors are highly soluble in methylene chloride, while the acceptors 
are highly soluble in methanol. Thus, a mixture of the two solvents provided a suitable medium 
for both acceptors and donors. The majority of the combinations with iodoethynylnitrobenzenes 
produced suitable crystals, Appendix C.2. The structures for 4N-I:A23, 4N-I:A24, 4N-I:A32, 3N-
I:A25, 3N-I:A31, 3N-I:A33, 3,5DN-I:A22, 3,5DN-I:A29 and 3,5DN-I:A34 were solved. Only 
one of the nine co-crystals from a bromoethynylynitrobenzene, 3N-Br:A27, produced crystals of 
sufficient quality and the remaining compounds yielded either flimsy crystals, gels or fine 
powders, Appendix C.2. For all ten combinations with the structures an extensive IR analysis was 
done to predict the interaction preferences of the nitro group in the co-crystals,42 Table 6.4. 
Crystallographic data and halogen bond geometries are provided in the Appendix B.5.  
Table 6.4 IR analysis for the nitro stretches of co-crystals 
 
Co-crystal 
IR prediction 
Actual interaction present 
in the crystal structure 
Splitting in 
Symmetric stretch 
Intensity of 
stretches 
Type of interaction 
predicted 
4N-I:A23 No I sym < I asym 
Linear NO2⋯H-C 
interaction 
Linear NO2⋯H-C interaction 
4N-I:A24 No I sym ~ I asym Inconclusive Linear NO2⋯H-C interaction 
4N-I:A32 No I sym < I asym 
Linear NO2⋯H-C 
interaction 
Linear NO2⋯H-C interaction 
3N-I:A25 No I sym > I asym Inconclusive No considerable interactions 
3N-I:A31 No I sym > I asym Inconclusive NO2⋯H-C dimer 
3N-I:A33 Yes I sym > I asym NO2⋯H-C dimer NO2⋯H-C dimer 
3,5DN-I:A22 Peak broadened I sym > I asym 
Most probably 
NO2⋯H-C dimer 
NO2⋯H-C dimer 
3,5DN-I:A29 No I sym ~ I asym Inconclusive 
Linear NO2⋯H-C interaction 
and NO2⋯NO2 dimer 
3,5DN-I:A34 No I sym < I asym 
Linear NO2⋯H-C 
interaction 
Linear NO2⋯H-C interaction 
and NO2⋯NO2 dimer 
3N-Br:A27 Yes (Shoulder) I sym > I asym NO2⋯H-C dimer NO2⋯H-C dimer 
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 6.3.7 Crystal structures for the co-crystals  
 6.3.7.1 Structures with iodoethynylnitrobenzenes  
The structure determination of 4N-I:A23 shows the expected trimer constructed from two 
symmetry related C-I⋯N(py) halogen bonds, resulting in a trimer with a 1:2 stoichiometry. Short 
contacts between nitro oxygen atoms and nearby acidic hydrogen atoms from a bipyridine 
molecule leads to the extension of the structure, Figure 6.17.  There is also a disordered solvent 
molecule in the lattice (ethyl acetate) but it does not form any noteworthy intermolecular 
interactions. 
Figure 6.17 (a) C-I⋯N(py) halogen bonds and (b) C-H⋯O2N hydrogen bonds in the crystal 
structure of 4N-I:A23 
The crystal structure of 4N-I:A24 is similar to that of 4N-I:A23 as it also contains a central 
trimer held together by symmetry related halogen bonds, Figure 6.18. This time, however, there is 
only one hydrogen bond between the nitro group and one of the acidic protons of the heterocycle.   
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Figure 6.18 (a) Halogen bonds and (b) hydrogen bonds in the crystal structure of 4N-I:A24 
As expected with a monotopic acceptor the crystal structure of 4N-I:A32 contains 1:1 
dimers connected via C-I⋯N halogen bonds, Figure 6.19. Both oxygen atoms of the nitro group 
act as hydrogen-bond acceptors for C-H donors. 
Figure 6.19 (a) Halogen bonds and (b) hydrogen bonds in the crystal structure of 4N-I:A32 
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Switching the nitro group from the four to the three position does not affect the way that 
the XB donor interacts with a ditopic acceptor; the expected trimer is present in the crystal structure 
of 3N-I:A25, Figure 6.20.     
 
 
 
Figure 6.20 Trimer in the crystal structure of 3N-I:A25 
The monotopic acceptor A31 ensures the formation of a halogen-bonded dimer in the 
crystal structure of 3N-I:A31, Figure 6.21. Adjacent XB donors are connected through a C-
H⋯O/O⋯H-C homosynthon.  
 
 
 
Figure 6.21 Halogen bonded dimer and supramolecular tetramer in the crystal structure of 3N-
I:A31 
The crystal structure of 3N-I:A33 is somewhat different compared to the other members 
in the series; even though A33 is an asymmetric ditopic acceptor the outcome is not a trimeric 
motif; instead, we observe a C-I⋯N halogen bond and a homosynthon between adjacent XB 
donors which gives rise to a linear tetramer, Figure 6.22.   
 
 
 
Figure 6.22 Tetrameric motif in the crystal structure of 3N-I:A33 
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3,5DN-I:A22 shows the expected halogen bonded trimer with a 1:2 ratio of ditopic 
acceptor to XB donor, Figure 6.23. Again, there is a self-complementary C-H⋯O/O⋯H-C 
homosynthon between adjacent XB donors.   
Figure 6.23 (a) Halogen-bonded trimer and (b) C-H⋯O/O⋯H-C homosynthons in the crystal 
structure of 3,5DN-I:A22 
The main motif in the structure of 3,5DN-I:A29, a 1:2 halogen-bonded trimer, is consistent 
with what was found in all structures in this series involving symmetric ditopic acceptors, Figure 
6.24. However, the two nitro groups behave differently when it comes to secondary interactions, 
where one nitro group shows a nitro⋯nitro interaction, while the other nitro group participates in 
a short contact with a hydrogen atom from an adjacent XB donor.  
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Figure 6.24 (a) Halogen-bonded trimer and (b) short contacts involving the nitro groups in the 
crystal structure of 3,5DN-I:A29 
In 3,5DN-I:A34 the acceptor A34 is disordered, but the outcome is another halogen-
bonded 1:2 trimer, Figure 6.25.  The nitro groups are participating in two different types of short 
contacts: one group is forming a short contact with another nitro group while the other is forming 
a short contact with a hydrogen atom of the adjacent 3,5DN-I molecule.  
 
 
 
 
 
 
 
 
Figure 6.25 (a) A halogen-bonded trimer and (b) short contacts involving the nitro groups in the 
crystal structure of 3,5DN-I:A34 
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 6.3.7.2 Structures with bromoethynylnitrobenzenes  
The only crystal structure that could be obtained with bromoethynylnitrobenzenes was 3N-
Br:A27. This structure contains a halogen-bonded trimer in a 1:2 ditopic acceptor:XB donor ratio, 
Figure 6.26. The nitro groups participate in a homosynthon, the same as was found on three 
occasions with co-crystals of iodoethynylnitrobenzenes. 
Figure 6.26 (a) Halogen-bonded trimer and (b) nitro-based homosynthons in the crystal structure 
of 3N-Br:A27 
 6.4 Discussion  
 6.4.1 Synthesis of haloethynylnitrobenzene 
The synthesis of these compounds start with the respective iodonitrobenzenes and as the 
first step the starting compound is coupled with trimethylsilylacetylene via a Sonogashira 
coupling.43 In most of the Sonogashira couplings the reaction conditions require high temperatures 
for the reaction to be complete. But in these family of compounds the reactions happen at room 
temperature indicating the activated nature of the leaving iodine atom due to the presence of highly 
electron withdrawing nitro groups. On the other hand, halogenation of these reactions were 
straightforward directly from the TMS protected compounds. In most cases, the halogenation 
reaction needs to go through the TMS deprotected compound.44 The straightforward nature of this 
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reaction again emphasize the effect of having nitro groups in the moiety. The yields of the reactions 
were in the range of 80% to 90% other than for the chlorinated compounds. In chlorination 
reactions more time was required for the reactions to complete and the yields were in the 35-60% 
range. This indicates the weak leaving group nature of chlorine, even though it is activated by the 
presence of nitro groups.  
 6.4.2 IsoStar and CSD analysis 
When looking at the contour surface of nitro⋯F-C interactions (Figure 6.27a) it seems the 
interactions are mostly occurring “sideways” to the nitrogen atom. This is expected if we consider 
the C-F moiety as a negatively charged species due to the high electronegativity of fluorine. There 
are few structures that show interactions between C-F group and nitro oxygen atoms directly from 
top and bottom; these structures should have an induced positive charge on the fluorine atom in 
order to interact with the oxygen. Due to the electronegativity of chlorine, nitro⋯Cl-C interaction 
map (Figure 6.27b), is also similar to the behavior with C-F. But in this case there are some 
interactions occurring from the middle of the nitro group directly with oxygen atoms. These 
interactions should happen due to the activated chlorines with a positive charged tip. When moving 
on to the interactions between nitro⋯Br-C groups the “hot zone” of interactions are concentrated 
around the middle of the nitro group, Figure 6.27c. This can be directly related to the activated 
nature of bromine in these structures.  
 
 
 
 
162 
 
Figure 6.27 Contour surfaces for the interactions between nitro group C-X group (X-any 
halogen); a) C-F group, b) C-Cl group and c) C-Br group; red zones are most favorable 
interaction zones 
 6.4.3 Interaction mode predictions using FTIR and experimental structures  
Interaction modes predicted by the IR analysis (Table 6.2) were manifested in the 
experimental structures obtained for the 4N-I, 3N-I and 3,5DN-I. Thus, FTIR analysis for the 
compounds containing nitro⋯iodo synthon can be successfully utilized in predicting the 
interaction modes between the nitro group and the iodine atom,38 even when no other structural 
analysis methods is available. Unfortunately, a successful set of steps is not yet accessible for other 
nitro⋯halogen interactions (nitro⋯Br or nitro⋯Cl).  
When comparing the three isomers of the 1,4 family (Figure 6.9, Figure 6.10 and Figure 
6.11) it is clear that they all interact via symmetric bifurcated interactions (mode I) leading to 1D-
tape architectures, Figure 6.28. When comparing the three compounds with iodine, 4N-I, 3N-I and 
3,5DN-I, the structural complexity that a nitro group can show when interacting with a polar 
halogenated compound is clear. 4N-I shows a polar bifurcated type interaction (mode I, Figure 
6.28); 3N-I shows an asymmetric bifurcated type interaction (mode II, Figure 6.28); and 3,5DN-I 
shows an interaction rather in between the mode II and mode III, Figure 6.28. All in all the 
nitro⋯halogen interaction is present as the structure directing interaction in all six compounds; 
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thus activated halogen bonds can be introduced as convenient and predictable interacting groups 
for nitro functional group to be utilized in co-crystallizations with nitro containing energetic 
compounds.  
 
Figure 6.28 Interaction types of a nitro group with a polar group; mode I: symmetric bifurcated 
type, mode II: asymmetric bifurcated type and mode III: single interaction with oxygen 
 6.4.4 Electrostatic potentials and success rates in co-crystal formation 
It is evident that the iodoethynylnitrobenzenes display more positive electrostatic potential 
values than other well-known XB donors; cf. pentafluoroiodobenzene is about 20 kJ/mol below 
the value displayed by 3N-I (the least positive of the three new XB donors) and about 40 kJ/mol 
below that of 3,5DN-I which has the highest positive electrostatic potential in this group. The 
combination of nitro groups and an sp-hybridized carbon atoms does afford the desired double 
activation with a commensurate increase in positive potential. Even this boost in positive 
electrostatic potential on bromo- or chloro- analogues is enough that all bromo- compounds have 
MEPS values higher than iodoethynylbenzene while 3,5DN-Cl has a positive electrostatic 
potential value of 150 kJ/mol, which is only 6 kJ/mol less than that of iodoethynylbenzene.  
The IR analysis showed that in all 45 experiments with an iodoethynylnitrobenzene, the 
outcome was a co-crystal, Table 6.3 and Figure 6.29, which emphasizes that double activated XB 
donors represent powerful new tools for robust supramolecular solid-state synthesis. 
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Figure 6.29 Success rates of co-crystallization experiments; green-positive results and red 
negative results 
The inherently lower polarizability of bromine and chlorine, respectively, manifested itself 
in drastically lower success rates. Only nine of fifteen bromoethynylnitrobenzenes resulted in a 
co-crystal whereas none of the fifteen attempts with a chloroethynylnitrobenzene produced a co-
crystal (Figure 6.29 and Table 6.3). These numbers emphasize the connection between practical 
co-crystal synthesis capability and calculated electrostatic potential values. 
 Even though perfluorinated bromine-based XB donors are known,45 a CSD search for 
bromoethynylbenzene showed that there are no crystallographically characterized co-crystals 
reported in the literature where a bromoethynyl moiety drives the co-crystal synthesis.  However, 
by adding an extra activating functionality it is clear that a bromoethynyl group can now drive the 
formation of co-crystals with suitable XB acceptors by the increment of positive electrostatic 
potential on the bromine atom.    
However, the double activation was not sufficient to make a chlorine atom electrophilic 
enough to make it a synthetic vector for co-crystal synthesis. Even though theoretical46 and 
spectroscopic47 data show that chlorine atoms can, in principle, form halogen bonds, it does not 
necessarily mean that such XB donors are strong enough to drive the formation of heteromeric co-
crystal in practice. 
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 6.4.5 Grinding experiments and characterization by IR spectroscopy 
A close look at the IR spectra for the ten compounds with crystallographic data showed 
there is a significant red shift of the band associated with the triple bond of the XB donor when 
compared to the spectrum of the compound itself. Usually, the formation of a CC-I⋯acceptor 
halogen bond weakens the triple bond which is accompanied by a redshift of the triple bond 
stretch.48 However, in some of the grinding experiments a blue shift of the triple bond mode was 
observed, a possibility which has been noted in some theoretical studies.49 Different explanations 
for this kind of blue shifting phenomena are proposed. One such suggestion is that the negative 
permanent dipole moment derivative of donor molecule is responsible for the blue shifting.50 All 
in all there is no clear evidence to exactly explain the reason behind the blue shifting halogen 
bonds. 
As for the nitro stretches, in all ten co-crystals the nitro asymmetric and symmetric 
stretches show a blue shift. In all these structures, the nitro group is participating in some kind of 
weak interaction leading to the blue shift of nitro stretching frequencies. Furthermore, for seven 
out of ten structures IR analysis predicted weak interaction present in the crystal structure, Table 
6.4. Thus, the application of IR spectroscopy in determining what type of a weak interaction that 
a nitro group is involved in, is applicable when designing supramolecules and co-crystals with 
nitro containing compounds. This simple and effective method can provide much details about the 
weak interactions of a nitro group whenever structure details from single crystal X-ray diffraction 
are not available.  
 6.4.6 The effectiveness of the new halogen bond donors  
The remarkable success rate in co-crystal synthesis displayed by these 
iodoethynylnitrobenzenes leads to questions about the halogen-bond strengths that these donors 
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can generate and we addressed this in an indirect manner by examining halogen-bond distances in 
co-crystals of other well-known XB donors with the same acceptor molecules that were employed 
herein. Obviously a non-covalent bond distance in the solid state does not give a direct measure of 
‘bond strength’ but a systematic comparison of closely related data may offer an important 
indication of the relative strengths of different interactions. Thus, van der Waals radii reductions 
(Figure 6.30) can be used as an indirect method to obtain some evidence of bond strengths. The 
observed reduction in combined van der Waals radii for halogen bonds in reported structures51 of 
co-crystals with acceptors that were used in this study are summarized in Figure 6.31. 
Figure 6.30  Schematic representation of the occurrence of van der Waals radii reduction when a 
halogen bond is formed between an iodine atom (purple) and a nitrogen atom (blue) 
A total of 22 relevant crystal structures distributed over six different acceptors were 
identified and, remarkably, the I⋯acceptor distance involving an iodoethynylnitrobenzene XB 
donor was the shortest for each of the six donors. Apart from the results provided in Figure 6.31, 
the C-I⋯O bond in the co-crystal 3,5DN-I:A34 with a distance of 2.673(3) Å represents one of 
the shortest C-I⋯O bonds in the reported structures. It is shorter than the previously reported short 
C-I⋯O halogen bonds with A30,52 A3553 and electron rich carbonyl compounds.54 A much shorter 
C-I⋯O halogen bond is reported with t-BuOK but the shortness of the interaction is presumably 
due to high ionic character of the oxygen atom.55 The increased reductions in combined van der 
Waals radii and short C-I⋯acceptor bond lengths do suggest that this new group of XB donors 
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represents a very important addition to the reliable and robust synthetic tools56 that are essential to 
practical supramolecular synthesis. 
Figure 6.31 Van der Waals radii reduction comparison; for each acceptor category structures 
obtained in this study are highlighted in red 
 6.5 Conclusions  
Nine novel halogen-bond donors based on the double activation phenomena were 
synthesized and the structure analysis of the novel compounds revealed the possibility of utilizing 
the nitro⋯ethynyl-activated halogen synthon in structure directing interactions in complex systems 
and the ability to act as effective halogen-bond donors, Figure 6.32. The initial IR screening results 
for the systematic co-crystallizations (75 experiments) showed the success rate to be 100% for 
iodoethynylnitrobenzene compounds and 60% for the bromethynylnitrobenzenes while none of 
the chloroethynyllnitrobenzenes formed co-crystals. The results can be readily rationalized against 
calculated molecular electrostatic surface potentials which serves to emphasize the importance of 
the electrostatic contributions to halogen bonds in practical supramolecular synthesis.  These 
iodoethynylnitrobenzenes may be the most effective and powerful halogen-bond donors to be 
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explored to date which, coupled with their ease of synthesis, is likely to make them valuable 
additions to the crystal engineering tool box. 
Figure 6.32 Outcome of the study 
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Chapter 7 - Constructing molecular polygons using halogen bonding 
and bifurcated N-oxides1 
 7.1 Introduction 
N-oxides represent an interesting group of molecules that are highly polar due to the charge 
separation of the N-O bond.2 The oxygen atom in the N-oxide group of heteroaromatic N-oxide is 
in a state of sp2-hybridization in conjugation with a heteroaromatic ring,3 which lead to their high 
water solubility4 and lipophobicity.5 N-oxides have found applications as ligands in metal 
coordination complexes6 and they have been used as synthetic intermediates,7 biologically 
important compounds,8 drugs,9 protecting groups, auxiliary agents, photo-active compounds,10 
oxidants and in catalysis.11  
One of the significant structural characteristic of N-oxides is their ability to form bifurcated 
non-covalent bonds.12 Bifurcation can be defined as the participation of one atom in two or more 
different intermolecular interactions,13 and this is well known in many hydrogen-bonded systems 
where the N-oxide oxygen atom is interacting with two different hydrogen-bond donors 
simultaneously, Figure 7.1.14 An examination of known N-oxide crystal structures with bifurcated 
bonds shows that most of the time the bifurcated angle (donor⋯O⋯donor) is close to 120°.  
 
 
 
 
 
 
 
 
Figure 7.1 Bifurcated interactions with pyrazine-bis-N-oxide15 
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Heteroaromatic N-oxides have shown to interact effectively as electron donors towards 
perfluorocarbon iodides.16 Despite the many similarities between hydrogen bonding and halogen 
bonding, there are no reports on the deliberate use of bifurcated halogen bonds in combination 
with N-oxides to assemble supramolecular architectures with predetermined topologies and 
stoichiometries. Hypothetically, such an assembly should be possible as the halogen bond is 
mainly electrostatic in nature, and involves an electropositive -hole on a halogen atom and an 
electron-pair donor.17  
Many elegant approaches for the synthesis of discrete polygons in the solid state have been 
presented using coordinate-covalent bonds as the primary synthetic tool;18 this is mainly due to the 
reason that the geometries around the metals are fixed, and thus selecting the proper metals with 
proper coordination geometry leads to the desired outcome. In comparison, relatively few efforts 
using purely organic building blocks are known to assemble such deliberate architectures.19 There 
are reports where halogen bonds have been used with nitroxides20 and ions as halogen bond 
linkers21 for polygon designing to some extent, Figure 7.2, but halogen bonds have not been used 
in the deliberate construction of well-defined polygons in the solid state, where all interactions are 
rationalized in a synthetic strategy. 
Figure 7.2 Halogen-bond based polygons a) with radicals20 b) with ions21 
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Thus, this study was conducted in an attempt to make supramolecular polygons (rhombuses 
and hexagons) utilizing the bifurcated nature of N-oxides and the halogen bonding, Figure 7.3.  
Figure 7.3 Design strategy for molecular rhombus and hexagon 
Ten N-oxides were employed as potential halogen-bond acceptors (six mono-N-oxides and 
four bis-N-oxides), Figure 7.4.  
 
 
 
 
 
 
 
 
 
Figure 7.4 Library of N-oxides under study 
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The halogen-bond donors were selected such that the relative orientation of their donor 
sites would offer the appropriate geometric complementarity to the most commonly observed 
angle in bifurcated N-oxides in order to enable to assembly of the desired polygons.   
In order to build a rhomb, a donor molecule with an approximate angle of 60° between the 
two donor sites to complement the inherent X⋯O⋯X bond angle of 120° in a bifurcated N-oxide 
acceptor site was needed as this would complete the overall 360° requirement, Figure 7.5. In order 
to make a hexagon, the donor moieties needed to be positioned at a 120° angle with respect to each 
other resulting in a total sum of 720° for the desired synthetic target, Figure 7.5. 
 
Figure 7.5 Halogen-bond donors and selection rationale 
Furthermore, it was assumed that a switch from a monotopic acceptor molecule to a bis-N-
oxide, should change the outcome from discrete architectures to chains of polygons, Figure 7.6.   
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Figure 7.6 Design of discrete and chains of polygons 
The study is undertaken in response to two hypotheses, 
1. Complementarity of geometry and angles between the two compounds leads to the 
successful polygon formation  
2. Iodo-compounds are better halogen-bond donors than their bromo-analogues 
 7.2 Experimental  
 7.2.1 General 
A33-A35 were prepared using a previously reported method.22 The method was modified 
in order to obtain both mono- (A33-A35) and bis- (A28-A30) products at once. A36-A39 and 
halogen-bond donors were purchased from commercial sources and used without further 
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purification. 1H NMR spectra were recorded on a Varian Unity plus 400 MHz spectrometer in 
CDCl3 or DMSO-d6. Infrared spectra were recorded with a Nicolet 380 FT-IR with a digital 
resolution of 0.9 cm-1 and data processed using Omnic23 software. Melting points were determined 
using Fischer-Johns Mel-Temp melting point apparatus and are uncorrected.    
 7.2.2 Synthesis of N-oxides  
 7.2.2.1 Synthesis of pyrazine-N-oxide (A33) and pyrazine-bis-N-oxide (A28) 
 
 
 
 
A solution of 30% hydrogen peroxide (2.8 g, 0.084 mol) in 20 mL of acetic acid was added 
dropwise using a drop funnel over a period of 2.5 hours to a solution of pyrazine (1.0 g, 0.013 mol) 
in 15 mL of acetic acid at 70-80 °C. Refluxing was continued for about 24 hours until the TLC 
confirmed the presence of two products. Acetic acid was removed on a rotary evaporator, and then 
10 mL of water was added followed by evaporation. The residue was dissolved in 50 mL of hot 
chloroform and dried with a mixture of sodium sulfate and sodium carbonate and the solvent was 
removed on a rotary evaporator. The residue was chromatographed on silica with variant ratio 
mixtures of chloroform:methanol as the eluant. A33 and A28 were isolated as off white solids.  
A33 - Yield: 0.48 g (77%); m.p. 110-113 °C (reported 113-115 °C)24; 1H NMR (400 MHz, CDCl3): 
8.47 (d, 2H), 8.09 (d, 2H); A28 - Yield: 0.37 g (50%), m.p. > 300 °C (reported > 300 °C)25; 1H 
NMR (400 MHz, DMSO-d6): 8.27 (s, 4H).   
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 7.2.2.2 Synthesis of tetramethylpyrazine-N-oxide (A34) and tetramethylpyrazine-bis-N-oxide 
(A29) 
 
 
 
A solution of 30% hydrogen peroxide (2.8 g, 0.084 mol) in 20 mL of acetic acid was added 
dropwise using a drop funnel over a period of 2.5 hours to a solution of tetramethylpyrazine (1.8 
g, 0.013 mol) in 15 mL of acetic acid at 70-80 °C. Refluxing was continued for about 24 hours 
until the TLC confirmed the presence of two products. Acetic acid was removed using a rotary 
evaporator, 10 mL of water was added followed by evaporation. The residue was dissolved in 50 
mL of hot chloroform and dried with a mixture of sodium sulfate and sodium carbonate and the 
solvent removed on a rotary evaporator. The residue was chromatographed on silica with variant 
ratio mixtures of chloroform-methanol as the eluant.  A34 was isolated as an off white solid and 
A29 was isolated as a pure white solid. A34 - Yield: 0.65 g, 66%), m.p. 97-99 °C (reported 98-100 
°C)22; 1H NMR (400 MHz, CDCl3): 2.51 (d, 6H), 2.46 (d, 6H); A29 - Yield: 0.58 g (53%), m.p. 
220-222 °C; 1H NMR (400 MHz, CDCl3): 2.56 (s, 12H).  
 7.2.2.3 Synthesis of 4,4’-bipyridine-N-oxide (A35) and 4,4’-bipyridine-bis-N-oxide (A30) 
 
 
 
 
 
 
 
 
A mixture of 4,4ʹ-bipyridine (2.0 g, 13 mmol), 30% hydrogen peroxide (2.7 g, 78 mmol) 
and glacial acetic acid (25 mL) was stirred in a round bottom flask for 24 hours at 70 °C. Reaction 
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was monitored with TLC and after completion, reaction mixture was cooled to room temperature 
and the solvent was removed via a rotary evaporator and diluted with 20 mL water. The solution 
was basified with excess sodium carbonate (2.0 g) and extracted with chloroform (3 x 50 mL). The 
organic layers were combined and then concentrated under reduced pressure using a rotary 
evaporator. Mixture was further purified via column chromatography with variant mixtures of 
ethyl acetate-methanol. A35 and A30 were isolated as off white solids. A35 - Yield: 0.78g (70%); 
m.p. 170-172 °C (reported 170-171 °C)22; 1H NMR (400 MHz, DMSO-d6): 8.69 (d, 2H), 8.34 (d, 
2H), 7.93 (d, 2H), 7.81 (d, 2H); A30 - Yield: 0.43 g (34%); m.p. 297-299 °C; 1H NMR (400 MHz, 
CDCl3): 8.74 (d, 4H), 7.53 (d, 4H). 
 7.2.3 Grinding experiments and IR spectroscopy 
 
The synthetic procedure follows well-established solvent-assisted grinding protocols for 
co-crystallization reactions.26 All ten N-oxides were subjected to grinding experiments with four 
donors. For grinding, 1:1 stoichiometric amounts of acceptors and halogen-bond donors were 
mixed together and ground using a drop of methanol for several minutes. Each resulting solid was 
analysed using IR spectroscopy in order to establish if the reaction resulted in a co-crystallization 
or simply a physical mixture of the two reactants (a re-crystallization). A total of 40 grinding 
experiments were carried out and the desired outcomes were, 
1. Discrete tetrameric rhombi in reactions between 1,2-disubstituted donors and mono-N-
oxide acceptors 
2. Chains of rhombi when 1,2-disubstituted donors and bis-N-oxides were employed 
3. Chains of hexagons when the 1,3- halogenated donors were allowed to react with bis-
N-oxides 
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All in all, fifteen of the 40 experiments provided unambiguous IR spectroscopic evidence 
for co-crystal formation. 
 7.2.4 Synthesis of co-crystals  
Once a co-crystalline phase had been obtained, we attempted to grow crystals for single-
crystal diffraction. The solid ground mixtures were dissolved in 2 mL of methanol and kept in a 
slightly open vial for the single crystal formation. Once the crystals are formed they were analyzed 
using IR spectroscopy. Structures were obtained for five co-crystals: A36:D9, A37:D7, A29:D7, 
A38:D7 and A29:D9. Table 7.1 summarizes the experimental details. Appendix B.6 contains the 
relevant X-ray experimental data.  
Table 7.1 Experimental details of the five co-crystals obtained 
 
 7.3 Results  
 7.3.1 Grinding experiments and characterization by IR spectroscopy 
Fifteen of the 40 experiments provided unambiguous IR spectroscopic evidence for co-
crystal formation, resulting in a supramolecular yield of 37.5% (15/40). None of the bromo-
substituted donors produced a co-crystal, resulting in an effective success rate of 75% (15/20) for 
the iodo-based donors, Table 7.2. Detailed IR analysis is provided in Appendix C.3. 
Code 
Mixed 
Mole 
ratio 
Amounts used Solvent and method 
Crystal 
stoichiometry 
Melting 
point °C 
Crystal 
color & 
habit 
A36:D9 1:1 
A36 -10 mg, 0.10 mmol 
D9 - 54 mg, 0.10 mmol 
Methanol, 
Slow evaporation 
1:1 210-212 
Colorless 
plate 
A37:D7 1:1 
A37 - 10 mg, 0.09 mmol 
D7 - 37 mg, 0.09 mmol 
Methanol, 
Slow evaporation 
1:1 165-167 
Colorless 
prism 
A29:D7 1:1 
A29 - 10 mg, 0.059 mmol 
D7 - 24 mg, 0.059 mmol 
Methanol, 
Slow evaporation 
1:1 118-120 
Colorless 
prism 
A38:D7 1:1 
A38 - 10 mg, 0.092 mmol 
D7 - 37 mg, 0.092 mmol 
Methanol, 
Slow evaporation 
1:2 120-123 
Colorless 
cube 
A29:D9 1:1 
A29 - 10 mg, 0.059 mmol 
D9 - 30 mg, 0.059 mmol 
Methanol, 
Slow evaporation 
1:1 153-155 
Colorless 
prism 
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Table 7.2 Grinding IR analysis 
 
 7.3.2 Crystal structures 
The structure determination of A36:D9 established that the N-oxide was bifurcated (with 
an I⋯O⋯I angle of 117°) but instead of the desired discrete hexagon, an infinite polymer appeared, 
Figure 7.7. The formation of a polymer is always a possibility and on this occasion the synthetic 
target did not materialize.    
 
 
 
 
 
 
 
Figure 7.7 Bifurcated halogen bonds in A36:D9 
The crystal structure of A37:D7 also shows bifurcation at the N-oxide moiety, this time 
with a smaller I⋯O⋯I angle (93°). Whether this small angle is preventing the formation of a 
 
Donors 
% Success 
D7 D9 D16 D17 
A
cc
ep
to
rs
 
A33     2/4 50 
A34     2/4 50 
A35     2/4 50 
A36     1/4 25 
A37     1/4 24 
A38     2/4 50 
A28     0/4 0 
A29     2/4 50 
A30     2/4 50 
A39     1/4 25 
% Success 
6/10 9/10 0/10 0/10 
 
60 90 0 0 
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rhomb, or is the result of other interactions is impossible to determine but, either way, a halogen-
bonded chain is formed instead of the desired discrete polygon, Figure 7.8.  
 
 
 
 
 
 
 
 
 
 
Figure 7.8 Bifurcated halogen-bonded chain in A37:D7 
The crystal structure of A29:D7 contains two crystallographically unique N-oxides, one 
with bifurcated halogen bonds with four D7 molecules and the other with a single halogen bond 
formed with two D7 molecules, Figure 7.9.  
 
 
 
 
 
 
 
Figure 7.9 Columnar stacking in the crystal structure of A29:D7 
In this structure, the N-oxide entities with single halogen bonds interact with a nearby 
hydrogen atom forming a bifurcated hydrogen- and halogen-bond combination with an angle of 
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88°. N-oxide entities with bifurcated halogen bonds have an I⋯O⋯I angle of 153° resulting in a 
chain of polygons, but not with the intended topology and relative orientation of building blocks, 
Figure 7.10.  Neighboring halogen-bond donors are stacked into columns with a distance of 3.4 Å, 
and hence are stabilized by π-π interactions,27 Figure 7.10. 
 
 
 
 
 
 
Figure 7.10 A chain of polygons in the crystal structure of A29:D7 
The first successful supramolecular synthesis in this study was realized in the crystal 
structure of A38:D7. Bifurcation at the N-oxide (I⋯O⋯I, 105°) is present, and this time, the result 
is a discrete tetrameric rhombic architecture, Figure 7.11. 
 
 
 
 
 
 
Figure 7.11 Geometric complementarity leading to a discrete tetrameric rhomb in the crystal 
structure of A38:D7 
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The second successful synthesis was achieved with the crystal structure A29:D9. This time, 
the bifurcated I⋯O⋯I angle is close to 120°, and the complementary geometry furnished by the 
1,3-substituted donor molecule affords the intended chain of hexagonal polygons, Figure 7.12.  
Each hexagon offers a small interior ‘window’ approximately 0.72 x 0.92 nm.  
Figure 7.12 Complementarity of angle and geometry leading to fused hexagons and Space filling 
model of a hexagon in A29:D9 
 7.4 Discussion  
 7.4.1 Relative effectiveness of bromo- and iodo- substituted halogen-bond donors 
Iodo-based donors showed a success rate of 75% (15/20) while none of the bromo-
substituted donors produced a co-crystal. These results underscore that large difference in effective 
halogen-bond strength between iodo- and bromo-based halogen-bond donors for crystal 
engineering purposes. From an electrostatic point of view the positive potential on an iodine atom 
is much greater than on a bromine atom. Thus, iodine preferentially form halogen bonds with 
electronegative oxygen atoms.  
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 7.4.2 Bifurcated halogen bonds 
All five co-crystal structures contained the desired bifurcated halogen bond to the N-oxide 
oxygen atom, despite the fact that there have been only a small number of reports describing 
bifurcated halogen bonds,28 most of which are theoretical studies.29  A survey of structures in the 
CSD produces over 800 hits containing at least one I⋯O halogen bond, but less than 5% of those 
contain bifurcated bonds, and none of them include N-oxides as the acceptors even though there 
are about 30 structures in the CSD involving an N-oxide as a halogen-bond acceptor. 
 7.4.3 Polymers vs discrete architectures 
It was clear that obtaining a polymer in this type of co-crystallization setting is more 
feasible than obtaining a discrete polygonal architecture. The weak, noncovalent interactions of 
the monomer units along a polymer chain tend to add up cooperatively, amplifying supramolecular 
effects. Thus, polymers are naturally predisposed to self-organize. In these structures, both 
polymers and discrete architectures contain very similar intermolecular interactions. Thus, the 
enthalpy contribution towards the formation of the final architecture is similar and thermodynamic 
contribution towards either a polymer or a discrete architecture is similar. But kinetically, 
formation of polymers are favored due to higher collision rates of monomers which can be more 
easily attached to the ends of polymers than making individual discrete architectures. Furthermore, 
at supersaturation stage different architectures are formed as nuclei. Compared to discrete 
architectures chains are favorable as they become dominant nuclei due to higher collision rates; 
thus all the other architectures are unable to compete for critical nuclei size and undergo Oswald 
ripening.30 Oswald ripening is a phenomenon which describes the change of an inhomogeneous 
structure over time. In simple terms, in a system like this many small nuclei (discrete architectures) 
form initially, but slowly disappear except for a few that grow larger (polymer architectures), at 
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the expense of the small nuclei. The smaller nuclei act as "nutrients" for the bigger nuclei, Figure 
7.13.  
 
 
 
 
Figure 7.13 Oswald Ripening leading to domination of polymeric nuclei (blue: nuclei of 
polymer architectures, pink: nuclei of discrete architectures)  
In the cases where a successful polygonal architectures were formed preorganization play 
the major role.31 Because of the preorganization of the few molecules that initially interact with 
each other, next colliding molecules have to interact in such a way that it is easier to form a discrete 
architecture than a polymer, Figure 7.14. These nuclei with discrete architectures then act as seeds 
to grow crystals.32  
Figure 7.14 Preorganization leading to discrete architectures 
 7.5 Conclusions 
By using the geometric complementarity of two appropriate molecular building blocks it 
is possible to build polygons of specific dimensions using the strength and directionality of I⋯O 
halogen bonds, Figure 7.15. A key component of the synthetic strategy utilizes the propensity of 
the N-oxide moiety to form bifurcated intermolecular interactions with donor⋯O⋯donor angles 
close to 120°. Furthermore, this study underscore the importance of electrostatics in halogen bond 
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formation where iodo-based halogen-bond donors contain much higher electrostatic potential 
compared to bromo- analogies and thus more effective in forming halogen bonds.  
 
 
 
 
 
 
 
 
Figure 7.15 Supramolecular outcome of the study 
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Chapter 8 - Stabilizing volatile liquid chemicals using halogen-bond 
based co-crystallization1 
 8.1 Introduction 
Chemicals that exist as liquids at ambient conditions tend to be less stable and more 
difficult to handle than solid chemicals, and the relatively weak intermolecular interactions in 
liquids2 are often associated with properties such as high vapor pressure, low boiling points and 
flammability.3 As a result, liquids often present considerable environmental, health and cost-
related challenges when it comes to the handling, transportation and storage of these materials.4 
Consequently, there is an ongoing need for simple and scalable methods for stabilizing a wide 
spectrum of liquid chemicals. 
Iodoperfluoroalkanes represent an important class of compounds that are employed as 
refrigerants, foam blowing agents, propellants, heat transfer agents, and in electronic applications.5 
These compounds are also of considerable fundamental interest as halogen-bond donors,6 reactive 
intermediates,7 reactants8 and as ligands9 in chemical synthesis. Most of the compounds in this 
family are liquids at room temperature accompanied by high vapor pressures.10 Furthermore, 
iodoperfluoroalkanes are recognized as persistent organic pollutants (POPs) and also bio-
accumulate thereby carrying potential environmental and health-related hazards.11 The general 
method for stabilizing this class of compounds is refrigeration, which is both expensive and 
complicated from the point of view of handling and transporting. Thus, a different protocol for 
stabilizing iodoperfluoroalkanes without damaging their chemical integrity is desirable. 
Co-crystallization technologies are currently being applied in the fields of 
pharmaceuticals,12 agrochemicals,13 and energetic materials14 for enhancing or altering the 
physico-chemical properties while keeping the molecular structure and composition of the 
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individual components constant. Co-crystallizations have also been applied to chiral resolution,15 
separation and purification,16 and in crystallization of non-solid compounds to aid in robust and 
efficient manufacturing processes,17 but have not been widely applied for providing long-term 
stability of liquid chemicals to simplify storage and handling. This study describes a simple 
protocol (Figure 8.1) using halogen-bond based synthons for converting liquid 
iodoperfluoroalkanes into more stable crystalline materials without loss of chemical integrity of 
the high-value compound.  
Figure 8.1 Approach for converting unstable liquids to stable solids 
Three iodoperfluoroalkanes were selected, Figure 8.2. 1,2-Diiodoperfluoroethane (D1) and 
1,4-diiodoperfluorobutane (D2) are highly volatile liquids at room temperature while 1,6-
diiodoperfluorohexane (D3) has a melting temperature of 25 °C thus even a slight increment above 
room temperature leads to the liquification of this compound, which can make transport and 
storage particularly challenging.  
 
 
 
Figure 8.2 Iodoperfluoroalkanes employed in this study 
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Since iodoperfluoroalkanes are well-known halogen-bond donors, selected acceptors were 
limited to effective halogen bond acceptors with relatively high thermal stability, Figure 8.3. All 
these compounds contain an aromatic backbone decorated with either nitrogen- or oxygen atoms 
as suitable electron-pair donors, thus facilitating the formation of strong, structure directing 
halogen-bond interactions.18 
 
 
 
 
 
 
 
 
Figure 8.3 Co-formers used in the current study 
The study is undertaken in response to three hypotheses, 
1. Co-crystallization of an unstable liquid chemical with a stable solid chemical can 
successfully convert the liquid in to a stable crystalline material. 
2. The conversion give rise to the gained stability and extended shelf life of the liquid 
chemical under different conditions. 
3. Co-crystallization technology is a simple protocol, thus the method can be easily scaled 
up while utilizing the concepts of green chemistry.  
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 8.2 Experimental  
 8.2.1 General  
All the acceptors were prepared using previously reported methods and described in 
Chapters 2, 5 and 7.19 Donors D1-D3 were purchased from commercial sources and used without 
any purification. The determinations of melting points were carried out on Fisher-Johns melting 
point apparatus and are uncorrected. NMR spectra were recorded on a Varian Unity plus 400 MHz 
spectrometer in CDCl3. Infrared spectroscopy was carried out on a Nicolet 380 FT-IR with a digital 
resolution of 0.9 cm-1 and data processed using Omnic20 software. Powder diffraction patterns 
were recorded on a Bruker AXS D8 advance X-ray diffractometer. 
 8.2.2 Grinding experiments and IR spectroscopy 
The three donors and six acceptors were combined using a standard solvent assisted 
grinding protocol. For grinding, 1:1 (iodoperfluoroalkane: A33, A29, A19 and A17) or 2:1 
(iodoperfluoroalkane: A1 and A2) stoichiometric amounts were mixed together and was ground 
using a drop of methanol for several minutes. The outcomes of the eighteen attempted reactions 
were analyzed using IR spectroscopy in order to determine if a co-crystal had indeed formed, or if 
the two reactants simply reappeared as two separate homomeric liquid and a solid.  
 8.2.3 Synthesis of co-crystals 
All the grinding experiments were subsequently converted to solvent based experiments to 
grow crystals suitable for single crystal X-ray diffraction by dissolving the ground mixtures in 
methanol followed by slow evaporation of the solvent. Once the crystals are formed they were 
analyzed using IR spectroscopy. Subsequently suitable crystals were analyzed using single crystal 
X-ray diffraction. Thirteen of the eighteen experiments yielded crystals suitable for single crystal 
X-ray diffraction. A29:D1, A33:D2, A29:D2, and A29:D3 are presented here, whereas details of 
192 
the other nine crystal structures have been reported in Chapters 3 and 5 (A17:D1, A1:D1, A17:D2, 
A19:D2, A1:D2, A2:D2, A19:D3, A1:D3 and A2:D3). Table 8.1 summarizes the experimental 
details for A29:D1, A33:D2, A29:D2, and A29:D3. Appendix B.7 contains the relevant X-ray 
experimental data. 
Table 8.1 Experimental details of the four new co-crystals obtained 
 
 8.2.4 Thermal stability experiments 
The melting/decomposition temperatures for all thirteen co-crystals were determined in 
order to investigate the thermal stability of the co-crystals. Furthermore, melting points of all the 
co-formers were recorded in order to compare the melting points for obtained co-crystals with the 
starting reactants. 
 8.2.5 Stability studies of co-crystals for an extended time period 
Once the initial IR analysis and melting point analysis for the obtained co-crystals were 
done, three co-crystals, representing one for each iodoperflouoroalkane A17:D1, A1:D2 and 
A29:D3 were selected to study their stability for extended period of time. For this, selected co-
crystals were kept open to the environment and the IR spectra and melting points for these crystals 
were recorded at different time intervals for up to six months.  
Code 
Mixed 
Mole 
ratio 
Amounts used Solvent and method 
Crystal 
stoichiometry 
Melting 
point 
°C 
Crystal 
color & 
habit 
A29:D1 1:1 
A29 -10 mg, 0.059 mmol  
D1 - 21 mg, 0.059 mmol  
Methanol, 
Slow evaporation 
1:1 120-122 
Colorless 
plate 
A33:D2 1:1 
A33 - 10 mg, 0.10 mmol 
D2 - 49 mg, 0.10 mmol 
Methanol, 
Slow evaporation 
1:1 85-89 
Yellow 
prism 
A29:D2 1:1 
A29 - 10 mg, 0.059 mmol 
D2 - 27 mg, 0.059 mmol 
Methanol, 
Slow evaporation 
1:1 165-157 
Colorless 
plate 
A29:D3 1:1 
A29 - 10 mg, 0.059 mmol 
D3 - 33 mg, 0.059 mmol  
Methanol, 
Slow evaporation 
1:1 119-122 
Colorless 
prism 
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 8.2.6 Synthesis of co-crystals in bulk quantities 
To study the stability of these co-crystals further, a bulk quantity of co-crystals were 
required. Thus different crystallization attempts were made in order to obtain the selected co-
crystals (A17:D1, A1:D2 and A29:D3) in gram quantities. The first attempt was to use solvent 
assisted grinding, but the method failed as the solid co-former in each case was left in the final 
mixture. The second attempt was made using a crash cooling method. For this, stoichiometric 
amounts of co-formers were dissolved in a minimum amount of methanol and the solution was 
refluxed for one hour. After that, the solution was crash cooled in an ice bath. This method also 
failed as the solid co-former crashed from the solution instead of the co-crystal. Third choice was 
to use solvent evaporation, but it was not suitable for preparation of bulk quantities as this method 
is time consuming and needs to use large amounts of organic solvents. Finally a seed crystallization 
method was selected, where the seeds obtained from small scale slow evaporation experiments 
were used in a large scale saturated solution of co-formers in methanol to obtain the respective co-
crystal in bulk quantities. In this case, seeds are acting as nucleates or templates for crystal growth 
leading to the formation of pure co-crystals and in high yields.  
 8.2.7 Stability studies of co-crystals under different conditions 
Powder X-ray diffraction (PXRD) was selected as the method of choice to study the 
stability of co-crystals. First, the homogeneity of the solids obtained by seed crystallization was 
established using PXRD. After confirming the structural homogeneity, the three solids were 
divided into three portions (0.20 g each) and left them exposed to ambient conditions, 43% 
humidity and 83% humidity, respectively. The X-ray powder patterns for the nine samples were 
recorded in three weeks, six weeks and twelve weeks of time intervals and compared with the 
powder pattern obtained for solid co-formers.  
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 8.2.8 Separation of individual components from co-crystals 
For the separation studies, co-crystal A29:D3 was selected. Initially the two co-formers 
were used in a solubility study in different solvents in order to find the suitable solvent system for 
the separation. Solubility studies showed that D3 to be highly soluble in hexane, while not to be 
soluble in water. On the other hand, A29 was highly soluble in water but not soluble in hexane. 
Thus, hexane water mixture was used for the solvent extraction experiments. 0.20 g of co-crystal 
A29:D3 was taken into hexane (20 mL) and extracted with water (10 mL x 4). Water was removed 
under vacuum to obtain pure A29 from the aqueous layer. The organic layer was kept inside the 
fridge for hexane to evaporate and pure D3 was obtained. The purity and the successful separation 
of co-formers were clarified using NMR spectroscopy. 
 8.3 Results 
 8.3.1 Grinding experiments and characterization by IR spectroscopy 
The IR analysis for initial grinding experiments showed that each single reaction (18/18) 
did produce a co-crystal, Table 8.2. 
Table 8.2 IR analysis for grinding experiments 
Mixture 
IR bands (cm-1) 
Shifts Δcm-1 Result Halogen-bond 
donors 
Grounded Mixture 
A33:D1 
1153 
1099 
1168 
1075 
+15 
-24 
Co-crystal 
A29:D1 
1153 
1099 
1184 
1117 
+31 
+18 
Co-crystal 
A17:D1 
1153 
1099 
1181 
1108 
+28 
+9 
Co-crystal 
A19:D1 
1153 
1099 
1140 
1082 
-13 
-17 
Co-crystal 
A1:D1 
1153 
1099 
1118 
1083 
-35 
-16 
Co-crystal 
A2:D1 
1153 
1099 
1131 
1083 
-22 
-16 
Co-crystal 
A33:D2 
1192 
1133 
1184 
1117 
-8 
-16 
Co-crystal 
A29:D2 
1192 
1133 
1182 
1103 
-10 
-30 
Co-crystal 
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 8.3.2 Crystal structures  
In all thirteen cases, where a crystal structure was possible, the co-crystal formation is 
achieved via near-linear C-I⋯N/O halogen bonds. Structure details of A17:D1, A1:D1, A17:D2, 
A19:D2, A1:D2, A2:D2, A19:D3, A1:D3 and A2:D3 are provided in Chapter 3 and 5. The 
primary supramolecular assemblies in A29:D1 and A29:D2 are 1-D chains comprising alternating 
halogen-bond donor and acceptor molecules, Figure 8.4.  
Figure 8.4 Primary halogen bonds in the crystal structures of a) A29:D1 and b) A29:D2 
A17:D2 
1192 
1133 
1189 
1130 
-3 
-3 
Co-crystal 
A19:D2 
1192 
1133 
1166 
1117 
-26 
-16 
Co-crystal 
A1:D2 
1192 
1133 
1157 
1099 
-35 
-34 
Co-crystal 
A2:D2 
1192 
1133 
1162 
1137 
-30 
+4 
Co-crystal 
A33:D3 
1199 
1141 
1211 
1168 
+12 
+27 
Co-crystal 
A29:D3 
1199 
1141 
1202 
1137 
+3 
-4 
Co-crystal 
A17:D3 
1199 
1141 
1196 
1137 
-3 
-4 
Co-crystal 
A19:D3 
1199 
1141 
1209 
1137 
+10 
-4 
Co-crystal 
A1:D3 
1199 
1141 
1211 
1134 
+12 
-7 
Co-crystal 
A2:D3 
1199 
1141 
1213 
1138 
+14 
-3 
Co-crystal 
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This is also the case for A33:D2 despite the fact that there are two different acceptor sites 
on pyrazine-mono-N-oxide, Figure 8.5. 
 
 
 
Figure 8.5 Primary halogen bonds in A33:D2 
The crystal structure of A29:D3 is more complicated as there are two crystallographically 
distinct acceptors, one of which engages in bifurcated halogen bonds whereas the other participates 
in conventional single-point halogen bonds, Figure 8.6.  
 
 
 
 
 
 
 
 
 
 
 
Figure 8.6 : Primary halogen bonds in A29:D3 
 8.3.3 Thermal stability of co-crystals 
The melting/decomposition temperatures for all thirteen co-crystals are provided in Table 
8.3. The melting point comparison results are shown in Figure 8.7, Figure 8.8 and Figure 8.9.  
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Table 8.3 Melting point analysis for the co-crystals obtained 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.7 Melting point analysis for the co-crystals of D1 
 
 
Co-crystal 
Melting point of the 
iodoperfluoroalkane (°C) 
Melting point of the acceptor 
(°C) 
Melting point/decomposition 
point of the co-crystal (°C) 
A29:D1 -21 220-222 120-122 
A17:D1 -21 197-201 95-98 
A1:D1 -21 157-160 57-60 
A33:D2 -9 110-113 85-89 
A29:D2 -9 220-222 165-167 
A17:D2 -9 197-201 132-135 
A19:D2 -9 196-198 150-154 
A1:D2 -9 157-160 118-120 
A2:D2 -9 112-115 75-78 
A29:D3 25 220-222 119-122 
A19:D3 25 196-198 125-127 
A1:D3 25 157-160 94-97 
A2:D3 25 112-115 95-97 
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Figure 8.8 Melting point analysis for the co-crystals of D2 
 
 
 
 
 
 
 
 
 
Figure 8.9 Melting point analysis for the co-crystals of D3 
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 8.3.4 Stability studies of co-crystals for an extended time period 
Crystalline samples of A17:D1, A1:D2 and A29:D3 were kept open to the environment 
for up to six months and regularly examined using IR spectroscopy and thermal analysis. No 
change in the vibrational spectroscopic features or thermal stability were observed for the duration 
of the trial. In contrast, the pure iodoperfluoroalkanes completely evaporated in a matter of minutes 
to hours when left exposed to ambient conditions. Table 8.4 summarizes the melting point data, 
while Figure 8.10 and Figure 8.11 show the IR results obtained for co-crystal A17:D1. IR results 
for A1:D2 and A29:D3 are provided in Appendix C.4.  
Table 8.4 Melting point analysis of the selected co-crystals up to six months 
 
Figure 8.10 Comparison of IR peaks of D1 (orange) and A17 (red) with the co-crystal A17:D1 
(blue) 
 
 
Melting point of A17:D1 
(°C) 
Melting point of A1:D2 
(°C) 
Melting point of A29:D3 
(°C) 
Initial 95-98 118-121 119-122 
2 weeks 90-93 115-118 119-122 
4 weeks 95-99 114-116 115-118 
2 months 96-101 117-120 117-121 
6 months 97-100 115-119 120-122 
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Figure 8.11 IR analysis of co-crystal A17:D1 for the stability (initial: blue, after 2 weeks: pink, 
after 4 weeks: red, after 2 months: green, after 6 months: purple) 
 8.3.5 Stability studies of co-crystals under different conditions 
PXRD patterns obtained for A29:D3 are shown in Figure 8.12, Figure 8.13 and Figure 
8.14, along with the powder pattern comparison with the co-former (A29). Powder patterns for 
A17:D1 and A1:D2 are provided in Appendix C.4. 
 
201 
Figure 8.12 Powder pattern data for A29:D3 kept under ambient conditions 
 
Figure 8.13 Powder pattern data for A29:D3 kept under 43% humidity 
Figure 8.14 Powder pattern data for A29:D3 kept under 83% humidity 
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 8.3.6 Separation of individual components from co-crystals 
19F and 13C NMR spectra of the separated organic layer of A29:D3 are shown in Figure 
8.15 and Figure 8.16, while 1H and 13C NMR spectra of the aqueous layer is shown in Figure 8.17 
and Figure 8.18. 
Figure 8.15 19F NMR spectrum of the separated organic layer  
 
Figure 8.16 13C NMR spectrum of the separated organic layer (only D3 present, no A29) 
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Figure 8.17 1H NMR spectrum of the separated aqueous layer 
Figure 8.18 13C NMR spectrum of the separated aqueous layer (only A29 present, no D3) 
 8.4 Discussion 
 8.4.1 Stabilization via trapping the liquid chemicals 
In all thirteen structures obtained in this study, there is a substantial halogen bond between 
the targeted iodoperfluoroalkane and the co-former resulting in a new crystalline solid which 
A29-D3 Aqueous Layer 1H.esp
8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
N
or
m
al
iz
ed
 In
te
ns
ity
TMSCHLOROFORM-d
2.
54
A29-D3 Aqueous Layer 13C.esp
150 140 130 120 110 100 90 80 70 60 50 40 30 20 10
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
or
m
al
iz
ed
 In
te
ns
ity
CHLOROFORM-d
14
.6
6
14
2.
52
204 
effectively ‘traps’ the volatile alkane within a more stable crystalline material without tampering 
with the molecular structure of the alkane itself. This trapped state of the liquid chemicals leads to 
their stability, as the liquid chemical is interacting with the solid co-formers via non-covalent 
interactions. On the other hand these non-covalent interactions make it easy to separate the liquid 
chemical from the solid lattice as the separation only needs to break this weak non-covalent 
interactions between the co-formers, not the strong covalent interactions. Thus this method provide 
a simple and convenient way to stabilize volatile liquid chemicals used in a wide range of 
applications including liquid pharmaceuticals.  
 8.4.2 Thermal stabilization of co-crystals 
A couple of general observations could be made regarding the melting points of the co-
crystals as compared to those of the co-formers. First of all, in every case, the melting point of the 
co-crystal was located between that of the two co-formers and the melting point of each co-crystal 
was substantially higher than that of the melting point of the corresponding iodoperfluoroalkanes, 
Figure 8.7 to Figure 8.9. Second the increase in the melting point of these co-crystals were at least 
32 °C higher than the room temperature and could be elevated up to 140 °C. Third, the melting 
points of the co-crystals displayed a near-linear relation with the melting point of the respective 
co-former. This held true for co-crystals obtained with all three iodoperfluoroalkanes, and Figure 
8.19 displays the relationship for the co-crystals with D2. Factors contributing to the melting point 
of a crystalline solid include the molecular arrangement within the crystal lattice, molecular 
symmetry, intermolecular interactions, and conformational degrees of freedom for a molecule, but 
not limited to these. Thus it is clearly difficult to draw strict comparisons from molecular structure 
to crystalline lattice energy to melting point. The situation becomes more complex in 
multicomponent systems such as co-crystals, because each component has its own characteristic 
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properties and those can influence the environment.21 But a major impact for the melting point of 
a material arise from the intermolecular interactions of that material. Intermolecular interactions 
are stronger in a solid than a liquid. Thus the properties coming from the solid co-former are 
dominant in the ultimate co-crystal formed, leading to a linear relationship with the solid co-
former’s physical properties such as melting point. This trend is particularly important to note as 
it demonstrates that the resulting properties of a series of co-crystals are not random and that they 
are, or can be, directly linked to the molecular structure and physical properties of the 
corresponding co-former. Consequently, it is possible to ‘dial-in’ the physical property of a 
molecular solid through a careful selection of co-former in a systematic manner. 
Figure 8.19 Relationship between the melting points of co-crystals of D2 and respective co-
formers 
 8.4.3 Stability of the co-crystals for extended periods and under high humid conditions 
PXRD analysis provided insights into the stability of these co-crystals under different 
conditions for prolong periods, Figure 8.12 to Figure 8.14. Overall, the accumulated powder 
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diffraction data did not indicate that either of the three co-crystals decomposed into their individual 
components over time, even at elevated humidity levels. By carefully comparing the powder 
patterns, it could observe a broadening of peaks for some extent at 83% humidity level, attributing 
to some loss of crystallinity. But no new diffraction peaks were observed over time indicating that 
the perfluorinated alkane, despite its inherent volatility, was kept intact within the solid protective 
crystalline case afforded by the co-crystal.   
 8.4.4 Separation of individual components from co-crystals 
Finally, it was establish that the desired alkane could be readily re-generated from the co-
crystal by taking full advantage of the difference in solubility of the two species in the binary co-
crystal. The NMR data obtained for the separated layers of A29:D3 indicated that the aqueous 
layer to contain the N-oxide (A29) only while the organic layer to contain only the 
iodoperfluoroalkane (D3) Figure 8.15 to Figure 8.18. 
 8.4.5 Green chemistry aspect  
This whole process of stabilizing volatile chemicals using co-crystal technology can be 
recognized as an essentially green methodology. Initial grinding experiments used only few drops 
of methanol and slow evaporation experiments used a minimum amount of methanol (< 2.0 ml). 
Furthermore, one of the solvents used in the solvent extraction is water, which is the greenest 
solvent. On the other hand none of these processes utilized any sort of energy sources such as heat.  
Furthermore, the amount of waste produced in the process is minimum. Also it was confirmed that 
the synthesis of co-crystals can be easily scaled up with the use of minimum amount of methanol.  
 8.5 Conclusions  
Co-crystallization can be identified as a simple, effective, and convenient method for 
stabilizing volatile liquid chemicals where the chemical is effectively trapped inside a crystalline 
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lattice via non-covalent interactions. The co-crystals can be engineered to be quite stable towards 
environmental stress over extended periods of time, and both the co-former and the targeted high-
value components can be separated using simple extraction methods. The co-crystals can be 
prepared using inexpensive and inherently ‘green’ processes that are also easily scalable. Thus, 
co-crystallizations can provide a convenient way of stabilizing liquid chemicals in general, 
offering a new technology for reducing both detrimental environmental impacts and for lowering 
costs in storage, handling and transportation, Figure 8.20. 
Figure 8.20 Outcome of the study  
 8.6 References 
1. Aakeröy, C.B.; Wijethunga, T.K.; Benton, J.; Desper, J. Chem. Commun. 2015, 51, 2425-2428. 
2. Goodstein, D.L. States of matter, Courier Dover Publications, 1985. 
3. Patnaik, P. A Comprehensive Guide to the Hazardous Properties of Chemical Substances, John Wiley & Sons, 
2007. 
4. Arslan, O.; Er, I.D. J. Hazard. Mater. 2008, 154, 901-913. 
5. Nimitz, J.S.; Tapscott, R.E.; Skaggs, S.R. US Pat. US5135054A, 1992; Leck, T.J.; Bricker, S.C.; Sievert, A.C. 
US Pat. US7641809B2, 2010; Nimitz, J.S.; Lankford, L.H. US Pat. US5444102A, 1995; Deev, L.E.; 
Nazarenko, T.I.; Pashkevich, K.I.; Ponomarev, V.G. Russ. Chem. Rev. 1992, 61, 40-54. 
6. Amati, M.; Lelj, F.; Liantonio, R.; Metrangolo, P.; Luzzati, S.; Pilati, T.; Resnati, G. J. Fluorine Chem. 2004, 
125, 629-640; Chu, Q.; Wang, Z.; Huang, Q.; Yan, C.; Zhu, S. New J. Chem. 2003, 27, 1522-1527; Fan, H.; 
Eliason, J.K.; Moliva, C.D.; Olson, J.L.; Flancher, S.M.; Gealy, M.W.; Ulness, D.J. J. Phys. Chem. A 2009, 
113, 14052-14059; Johnson, M. T.; Džolić, Z.; Cetina, M.; Wendt, O. F.; Öhrström, L.; Rissanen, K. Cryst. 
Growth Des. 2012, 12, 362-368; Shen, Q.J.; Jin, W.J. Phys. Chem. Chem. Phys. 2011, 13, 13721-13729; 
Metrangolo, P.; Pilati, T.; Resnati, G.; Stevenazzia, A. Chem. Commun. 2004, 1492-1493; Corradi, E.; 
Meille, S. V.; Messina, M. T.; Metrangolo, P.; Resnati, G. Tetrahedron Lett. 1999, 40, 7519-7523; 
Lunghi, A.; Cardillo, P.; Messina, T.; Metrangolo, P.; Panzeri, W.; Resnati, G. J. Fluorine Chem. 1998, 91, 
                                                 
208 
                                                                                                                                                             
191-194; Gao, H. Y.; Shen, Q. J.; Zhao, X. R.; Yan, X.Q.; Pang, X.; Jin, W.J. J. Mater. Chem. 2012, 22, 
5336-5343; Widdifield, C. M.; Cavallo, G.; Facey, G. A.; Pilati, T.; Lin, J.; Metrangolo, P.; Resnati, G.; 
Bryce, D. L. Chem. Eur. J. 2013, 19, 11949-19962; Burton, D. D.; Fontana, F.; Metrangolo, P.; Pilati, T.; 
Resnati, G. Tetrahedron Lett. 2003, 44, 645-648; Liantonio, R.; Metrangolo, P.; Meyer, F.; Pilati, T.; Navarrini, 
W.; Resnati, G. Chem. Commun. 2006, 1819-1821; Amico, V.; Meille, S. V.; Corradi, E.; Messina, M. T.; Resnati, 
G. J. Am. Chem. Soc. 1998, 120, 8261-8262; Saccone, M.; Cavallo, G.; Metrangolo, P.; Pace, A.; Pibiri, I.; Pilati, 
T.; Resnati, G.; Terraneo, G. CrystEngComm 2013, 15, 3102-3105; Crihfield, A.; Hartwell, J.; Phelps, D.; Walsh, 
R.B; Harris, J.L.; Payne, J.F.; Pennington, W.T.; Hanks, T.W. Cryst. Growth Des 2003, 3, 313-320; Liantonio, R.; 
Metrangolo, P.; Pilati, T.; Resnati, G. Cryst. Growth Des 2003, 3, 355-362; Metrangolo, P; Meyer, F.; Pilati, T.; 
Proserpio, D. M.; Resnati, G. Chem. Eur. J. 2007, 13, 5765-5772; Dey, A.; Metrangolo, P.; Pilati, T.; Resnati, G.; 
Terraneo, G.; Wlassics, I. J. Fluorine Chem. 2009, 130, 816-823; Fox, D.; Metrangolo, P.; Pasini, D.; Pilati, T.; 
Resnati, G.; Terraneo, G. CrystEngComm 2008, 10, 1132-1136. 
7. Zhdankin, V.V.; Stang, P.J. Chem. Rev. 2008, 108, 5299-5358; Furin, G.G. Russ. Chem. Rev. 2000, 69, 491-
522. 
8. Shi, M.; Huang, J.W. J. Fluorine Chem. 2005, 126, 809-817; David, G.; Boyer, C.; Tonnar, J.; Ameduri, B.; 
Lacroix-Desmazes, P.; Boutevin, B. Chem. Rev. 2006, 106, 3936-3962; Tsuchii, K.; Ueta, Y.; Kamada, N.; 
Einaga, Y.; Nomoto, A.; Ogawa, A. Tetrahedron Lett. 2005, 46, 7275-7278. 
9. Gladysz, J. A.; Curran, D. P.; Horváth, I. T. Handbook of Fluorous Chemistry, Wiley-VCH, 2004; Gattuso, 
G.; Liantonio, R.; Metrangolo, P.; Meyer, F.; Pappalardo, A.; Parisi, M.F.; Pilati, T.; Pisagatti, I.; Resnati, G. 
Supramole. Chem. 2006, 18, 235-243.  
10. Aakeröy, C.B.; Welideniya, D.; Desper, J.; Moore, C. CrystEngComm 2014, 16, 10203-10209. 
11. Ruan, T.; Wang, Y.; Wang, T.; Zhang, Q.; Ding, L.; Liu, J.; Wang, C.; Qu, G.; Jiang, G. Environ. Sci. 
Technol. 2010, 44, 5755-5761; Yan, X.Q.; Shen, Q.J.; Zhao, X.R,; Gao, H.Y.; Pang, X.; Jin, W.J. Anal. Chim. 
Acta 2012, 753, 48-56; Muir, D.C.G.; Howard, P.H. Environ. Sci. Technol. 2006, 40, 7157-7166; Goss, K.U.; 
Bronner, G.; Harner, T.; Hertel, M.; Schmidt, T. C. Environ. Sci. Technol. 2006, 40, 3572-7577. 
12. Vishweshwar, P.; McMahon, J.A.; Bis, J. A.; Zaworotko, M.J. J. Pharm. Sci. 2006, 95, 499-516; 
Aakeröy, C.B.; Forbes, S.; Desper, J. CrystEngComm 2014, 16, 5870-5877; Blagden, N.; Coles, S. J.; Berry, 
D. J. CrystEngComm 2014, 16, 5753-5761. 
13. George, N.; Forrest, J.O.; Burton, R.C.; Aakeröy, C.B., US Pat. US2013/0203792A1, 2013. 
14. Millar, D.I.A.; Casely, H. E. M.; Allan, D.R.; Cumming, A.S.; Lennie, A.R.; Mackay, A.J.; Oswald, I.D.H.; 
Tang, C.C.; Pulham;  C.R. CrystEngComm 2012, 14, 3742-3749; Wang, Y.; Yang, Z.; Li, H.; Zhou, X.; 
Zhang, Q.; Wang, J.; Liu, Y. Propellants Explos. Pyrotech. 2014, 39, 590-596; Landenberger, K.B.; Matzger, 
A.J. Cryst. Growth Des. 2012, 12, 3603-3609; Bolton, O.; Simke, L.R.; Pagoria, P.F.; Matzger, A.J. Cryst. 
Growth. Des. 2012, 12, 4311-4314. 
15. Springuel, G.; Leyssens, T. Cryst. Growth Des. 2012, 12, 3374-3378. 
16. Urbanus, J.; Roelands, C.P.M.; Verdoes, D.; Jansens, P.J.; ter Horst, J.H. Cryst. Growth Des. 2010, 10,1171-
1179; Metrangolo, P.; Carcenac, Y.; Lahtinen, M.; Pilati, T.; Rissanen, K.; Vij, A.; Resnati, G. Science 2009, 323, 
1461-1464. 
17. Golovanov, D.G.; Lyssenko, K.A.; Antipin, M.Y.; Vygodskii, Y.S.; Lozinskaya, E.I.; Shaplov, A.S. Cryst. 
Growth Des. 2005, 5, 337-340. 
18. Aakeröy, C.B.; Wijethunga, T.K.; Desper, J. CrystEngComm 2014, 16, 28-31; Aakeröy, C.B.; Wijethunga, 
T.K.; Desper, J. J. Mol. Struct. 2014, 1072, 20-27. 
19. Aakeröy, C.B.; Wijethunga, T.K.; Desper, J. New J. Chem. 2015, 39, 822-828; Voss, M. E.; Beer, C. M.; 
Mitchell, S. A.; Blomgren P. A.; Zhichkin, P. E. Tetrahedron 2008, 64, 645-651. 
20. Omnic 8.0 © 1992-2008, Thermo Fisher Scientific Inc. 
21. Schultheiss, N.; Newman, A. Cryst. Growth Des. 2009, 6, 2950-2967. 
209 
Chapter 9 - Crystal engineering of energetic materials: Co-crystals 
of ethylenedinitramine (EDNA) with modified performance and 
improved chemical stability1 
 9.1 Introduction 
Energetic materials contain substantial amounts of stored energy that can be released 
rapidly,2 leading to explosions. Representatives of energetic materials include explosives, 
propellants and pyrotechnics.3 Even though a large number of different energetic compounds are 
known in armaments, mining, fireworks and space explorations,4 many have drawbacks leading to 
restrictions or limitations of their use.5 Common problems include sensitivity to impact, heat, 
shock or friction6 (e.g. RDX7 and CL-208), as well as undesirable reactivity towards different 
environmental conditions (e.g. nitramine explosives9), and high toxicity.10 Furthermore, highly 
powerful energetic materials inherently display high sensitivity and/or high reactivity leading to a 
power-safety contradiction11 and, consequently, designing powerful energetic materials with 
improved safety and stability is a major challenge.12  
The design of better energetic materials typically follows one of two approaches. First, a 
completely new molecule or salt can be prepared.13 But in order to discover a material with the 
required properties such as high power, low sensitivity and low reactivity expressed in an 
integrated manner,14 while optimizing all these properties within a finite time scale, is 
challenging.15 An alternative approach is to use co-crystal technology16 wherein a known energetic 
material is combined with either an energetic or a non-energetic compound17 via non-covalent 
interactions within a crystalline framework.18 Co-crystallizations can provide means for altering a 
range of properties such as density, mechanical and thermal stability, and solubility, which can all 
facilitate the pursuit of safer energetic materials.19 Furthermore, co-crystallizations can be utilized 
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in stabilizing volatile20 energetics, thereby lowering the risk of exposure through inhalation of 
toxic energetic materials.21 This provides an avenue to handle many nitro-containing energetics 
that are toxic. Thus, a co-crystal of an energetic material22 can, in certain circumstances, be more 
useful because of superior chemical stability and shelf-life even though it may have slightly lower 
energetic performance.   
A number of literature reports show evidence of successful co-crystallizations that lead to 
reduced sensitivity of the energetic materials.23 Furthermore, numerous reports provide insights 
into reducing the thermal sensitivity of energetics.24 But to date, there are no reports that employ 
co-crystallization approach with the intention of reducing the chemical reactivity to stabilize, 
highly reactive energetic compounds, Figure 9.1.  
Figure 9.1 Current situation in the field of energetic co-crystallization 
Ethylenedinitramine, (EDNA), (Figure 9.2) also known as Haleite,25 is known as the first 
entirely American high explosive.26 EDNA combines the properties of a high explosive like TNT 
and an initiating agent like mercury fulminate, possessing a high brisance, comparatively low 
impact sensitivity and high heat sensitivity. This compound is applied as a secondary explosive, 
booster explosive and in the preparation of cast explosives such as Ednatol.27 
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Figure 9.2 Chemical structure of EDNA 
An important reason behind the restrictions in the use of EDNA is its relatively high 
chemical reactivity, a common drawback associated with many nitramine-based explosives.28  
Overly acidic compounds are often prone to chemical instability and hygroscopicity,29 which can 
create problems with transport, processing, and storage, leading to a high risk of handling them. 
For example, tetranitropyrole is unstable at ambient temperatures30 and dinitrotriazole is 
deliquescent,31 and both contain an acidic N-H moiety. The highly acidic picric acid, another well-
known explosive, is corrosive and reacts readily with metals to form shock-sensitive salts.  EDNA 
is also highly acidic32 (pKa1 – 5.31 and pKa2 – 6.64).33 The reason is upon deprotonation, the 
negative charge that forms can be easily delocalized with the assistance of electron withdrawing 
nitro groups. Thus EDNA is corrosive and can react with metals and metal salts34 to produce new 
materials with unpredictable properties. For example, Cu(II)EDNA is easily synthesized and has 
low impact sensitivity35 whereas Pb(II)EDNA displays superior properties/performance compared 
to EDNA itself.36  
Thus, our study was undertaken to utilize a co-crystallization approach to block the acidic 
protons and to reduce the reactivity and to alter the physical properties and stability of EDNA 
while retaining some valuable characteristics associated with the energetic material.  A close look 
at the crystal structure of EDNA37 (Figure 9.3) reveals that these acidic protons are interacting 
with nitro oxygen atoms which are poor hydrogen-bond acceptors. Thus, it should be possible to 
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make co-crystals of EDNA by introducing strong hydrogen bond acceptors to the system, by 
disrupting this weak hydrogen bond.  
 
 
 
 
 
 
 
 
Figure 9.3 Part of the crystal structure of EDNA with hydrogen bonds between nitro oxygen 
atoms and acidic amine protons37 
With this in mind, fifteen hydrogen-bond acceptors were selected that potentially would 
compete successfully with the nitro groups for the attention of the acidic protons, Figure 9.4, 
including N-based acceptors (A21-A27, A31 and A32), O-based acceptors (A28-A30) and mixed 
N-and O-based acceptors (A33-A35). These 15 acceptors can be further categorized as symmetric 
ditopic (A21-A30), monotopic (A31 and A32) and dissymmetric ditopic (A33-A35).  The reason 
for selecting primarily ditopic acceptors (all but A31 and A32) was first of all, some degree of 
structural consistency was expected by a combination of a ditopic donor and a ditopic acceptor 
which is likely to produce infinite supramolecular chains. Second, the N-oxides are likely to form 
the same hydrogen-bonded motifs as the parent N-heterocycles but with a better oxygen balance 
which would be beneficial from a performance perspective. 
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Figure 9.4 Hydrogen-bond acceptors used in this study 
The study is undertaken in response to four hypotheses, 
1. EDNA is a suitable target for co-crystal synthesis. 
2. The acidic protons of EDNA can be engaged and can be protected via hydrogen 
bonding to suitable co-formers. 
3. Explosive properties and thermal properties of EDNA can be modulated in a useful 
manner by making co-crystals of EDNA. 
4. The chemical stability of EDNA can be enhanced by reducing the reactivity of EDNA 
through co-crystallizations.   
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 9.2 Experimental 
 9.2.1 General  
All the precursors, solvents and acceptors A21-A26 and A31 were purchased from 
commercial sources and used without further purification. EDNA was synthesized following a 
reported procedure.38 A28-A30 and A33-A35 were synthesized following previously reported 
procedures.39 A2740 and A3241 were also synthesized following reported procedures. 1H NMR 
spectra were recorded on a Varian Unity plus 400 MHz spectrometer. Infrared spectra were 
recorded with a Nicolet 380 FT-IR. Differential scanning calorimetry (DSC) measurements were 
carried out on a TA Instruments Q20, using Tzero aluminum pans under nitrogen purge (50.0 
mL/min) at a heating rate of 5 °C/min over a range of 30 - 300 °C. 
Standard protocols for handling energetic materials were followed at all times.42 All the 
synthesis and handling of EDNA were done inside a fume hood and used nonmetallic spatulas 
when measuring EDNA. Kevlar gloves, lab coat and goggles were worn all the time. Mechanical 
actions involving scratching or scraping were avoided and EDNA was synthesized only in small 
amounts (~ 200 mg). 
 9.2.2 Synthesis of EDNA  
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A round bottom flask was equipped with a stir bar and 2.0 mL of 90% nitric acid (fuming 
nitric acid) under nitrogen atmosphere and cooled down to 0 °C. To this, 0.5 g of ethylene urea (2-
imidazolidone) was added portion wise while keeping the temperature below 20 °C. The reaction 
mixture was stirred under these conditions for one hour and subsequently allowed to warm to room 
temperature. The reaction mixture was then quenched with iced water and the precipitate that 
formed was collected by filtration. 
The precipitate was added to about 20 mL of boiling water in small portions and the 
temperature of water was maintained until no more gas evolution was seen. Then the aqueous 
solution was cooled in an ice bath and the precipitated desired product was collected by filtration 
as a white crystalline powder. Yield: 0.48 g (55%); m.p. 178-180 °C (reported 174-178 °C)43; 1H 
NMR (400 MHz, DMSO-d6):12.12 (s br, 2H), 3.59 (s, 4H). 
 9.2.3 Theoretical calculations 
Geometry optimizations of EDNA at various fixed torsion angles were done with DFT at 
B3LYP/6-31G* level of theory using Spartan’08.44  
 9.2.4 Synthesis and characterization of co-crystals  
EDNA was combined with the 15 acceptors in stoichiometric ratios and dissolved in a 
minimum amount of methanol and kept in vials for slow evaporation in order to obtain co-crystals 
suitable for single crystal X-ray diffraction. Once the crystals were obtained they were analyzed 
using IR spectroscopy and DSC to identify potential co-crystals. From the initial screening with 
IR and DSC eight out of 15 experiments produced co-crystals. Out of the eight co-crystals 
obtained, six yielded crystals suitable for single-crystal diffraction: EDNA:A23, EDNA:A24, 
EDNA:A25, EDNA:A27, EDNA:A28 and EDNA:A32. Thermal properties of all eight co-
crystals were obtained using DSC data and detonation properties were calculated for the six 
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compounds for which experimental densities were available from crystallographic data. For the 
co-crystals EDNA:A23, EDNA:A24, EDNA:A25 and EDNA:A28 room temperature unit cells 
and room temperature densities were determined. Table 9.1 summarizes the experimental details 
for the six co-crystals obtained. Appendix B.8 contains the relevant X-ray experimental data and 
Appendix C.5 contains the DSC traces.  
Table 9.1 Experimental details for the co-crystals obtained 
 
 9.2.5 Impact sensitivity testing 
Impact sensitivities of EDNA, EDNA:A23 and EDNA:A28 were measured by drop 
impact testing. The tests were done using an apparatus designed to accommodate small amounts 
of material45 and was calibrated against tetranitromethane (H50 - 38 cm). Approximately 0.20 mg 
of each sample were sealed into aluminum DSC pans. A freefalling 5 lb weight was used to strike 
the samples from different heights measured in centimeters which subsequently allowed us to 
identify H50, the height at which the material exhibited a 50% chance of detonation using Bruceton 
Analysis.46 This is a nonstandard testing apparatus and the results obtained are useful for relative 
comparisons only. 
Code 
Mixed 
Mole 
ratio 
Amounts used Solvent and method 
Crystal 
stoichiometry 
Crystal 
color & 
habit 
EDNA:A23 1:1 
EDNA -10 mg, 0.067 mmol 
A23 - 10 mg, 0.067 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
prism 
EDNA:A24 1:1 
EDNA  - 10 mg, 0.067 mmol 
A24 - 12 mg, 0.067 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
plate 
EDNA:A25 1:1 
EDNA  - 10 mg, 0.067 mmol 
A25 - 12 mg, 0.067 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
prism 
EDNA:A27 1:1 
EDNA  - 10 mg, 0.067 mmol 
A27 - 12 mg, 0.067 mmol 
Methanol, 
Slow evaporation 
1:1 
Orange 
plate 
EDNA:A28 1:1 
EDNA  - 10 mg, 0.067 mmol 
A28 – 7.5 mg, 0.067 mmol 
Methanol, 
Slow evaporation 
1:1 
Colorless 
plate 
EDNA:A32 1:2 
EDNA  - 10 mg, 0.067 mmol 
A32 - 24 mg, 0.13 mmol 
Methanol, 
Slow evaporation 
1:2 
Orange  
prism 
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 9.3 Results  
 9.3.1 IR analysis 
Initial co-crystal screening was carried out by combining EDNA and the acceptors in 
stoichiometric ratios and the products obtained were analyzed with IR spectroscopy. The solvent 
of choice was methanol as both EDNA and the acceptors showed comparable solubility in 
alcohols. Eight of fifteen attempts yielded co-crystals as indicated by IR data provided in Table 
9.2. The analysis was done by comparing the IR spectrum of the crystals obtained from solution 
with the starting reactants.  
Table 9.2 IR analysis on crystals 
 
 9.3.2 Crystal structures  
Although vibrational spectroscopy provides information about whether a co-crystal has 
formed or not, it does not reveal to what extent the amine protons on EDNA are participating in 
hydrogen bonding. To address this issue, crystallographic data are needed and six of the eight new 
co-crystals were characterized using single-crystal X-ray diffraction. Crystallographic data and 
Co-crystal 
IR stretches (cm-1) 
Co-crystal or not 
EDNA Co-crystal 
EDNA:A21 1589, 1446 Only EDNA No 
EDNA:A22 1589, 1446 Only EDNA No 
EDNA:A23 1589, 1446 1592, 1440 Yes 
EDNA:A24 1589, 1446 1602, 1447 Yes 
EDNA:A25 1589, 1446 1599, 1456 Yes 
EDNA:A26 1589, 1446 1601, 1442 Yes 
EDNA:A27 1589, 1446 1585, 1444 Yes 
EDNA:A28 1589, 1446 1584, 1440 Yes 
EDNA:A29 1589, 1446 Only A9 No 
EDNA:A30 1589, 1446 Only EDNA No 
EDNA:A31 1589, 1446 1985, 1443 Yes 
EDNA:A32 1589, 1446 1587, 1426 Yes 
EDNA:A33 1589, 1446 Only EDNA No 
EDNA:A34 1589, 1446 Only EDNA No 
EDNA:A35 1589, 1446 Only EDNA No 
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halogen bond geometries for the six co-crystals (EDNA:A23, EDNA:A24, EDNA:A25, 
EDNA:A27, EDNA:A28 and EDNA:A32) are reported in the Appendix B.8.  
The crystal structure of EDNA:A23 (Figure 9.5) reveals a 1:1 stoichiometry where the two 
components are connected via primary N-H⋯N(py) hydrogen bonds. As intended, the pyridine-
based acceptor sites have provided a successful replacement for the N-H⋯O(nitro) hydrogen 
bonds present in the crystal structure of EDNA itself, Figure 9.3. Somewhat surprisingly though, 
the molecular geometry of EDNA molecules in the EDNA:A23 lattice is very different when 
compared to their molecular conformations in the crystal structure of EDNA by itself, Figure 9.3.   
 
 
 
 
 
 
 
Figure 9.5 Primary interactions in the EDNA:A23 co-crystal 
The crystal structure of EDNA:A24 reveals the expected N-H⋯N(py) hydrogen bonds and 
the two components are again present in a 1:1 ratio, Figure 9.6. In this structure the EDNA 
molecules adopt a 180° torsion angle of the N-C-C-N ‘backbone’ similarly as in EDNA crystal 
structure itself, Figure 9.3.  
 
 
 
 
 
 
Figure 9.6 Primary hydrogen bonds in the EDNA:A24 co-crystal 
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The crystal structure of EDNA:A25 (Figure 9.7) shares the main structural features with 
those found in the structure of EDNA:A24 with a 1:1 stoichiometry, structure directing N-
H⋯N(py) hydrogen bonds resulting in infinite chains, and a 180° torsion angle of the N-C-C-N 
backbone of EDNA. 
Figure 9.7 Part of the infinite hydrogen-bonded chain in the EDNA:A25 co-crystal 
Although 4,4'-azopyridine, the co-former in EDNA:A27, does contain two additional 
nitrogen atoms that, in theory, could engage with the acidic protons of EDNA, the two pyridine 
sites are substantially better acceptors,47 (Figure 9.8). Consequently, N-H⋯N(py) driven 
hydrogen-bonded chains dominate the crystal structure, similarly to what was found in both 
EDNA:A24 and EDNA:A25. The stoichiometry again is 1:1 which is dictated by the fact that 
EDNA has two strong donors which are matched by the two main N(py) acceptor sites on A27.   
Figure 9.8 Primary hydrogen bonds in the EDNA:A27 co-crystal 
The crystal structure of EDNA:A28 (Figure 9.9) shows a 1:1 stoichiometry, and infinite 
hydrogen bonds generated by N-H⋯O-N(py)  chain formation between the oxygen atoms of N-
oxide and the acidic N-H protons of EDNA. This structure illustrates that EDNA is capable of 
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forming co-crystals not only with N-based acceptors but also with O-based acceptors via the acidic 
protons. 
 
 
 
 
 
Figure 9.9 Primary interactions in the EDNA:A28 co-crystal 
The final crystal structure obtained in this series was with a monotopic hydrogen-bond 
acceptor, A32, and consequently the stoichiometry in this case is 1:2 (EDNA:A32), Figure 9.10. 
The chains that resulted when ditopic acceptors were combined with EDNA is now replaced with 
a discrete trimeric motif.   
 
 
 
 
Figure 9.10 Main hydrogen-bonds in the EDNA:A32 co-crystal 
 9.3.3 Torsion angle calculation for EDNA:A23 
As mentioned earlier the molecular geometry of EDNA molecules in the EDNA:A23 
lattice is very different when compared to their molecular conformations in the crystal structure of 
EDNA by itself as well as the other co-crystals in this series. The N-C-C-N torsion angle for 
EDNA in EDNA:A23 is 28°, while it is 180° for pure EDNA. In order to find the energy difference 
between the two orientations, a molecular structure optimization was performed.  A plot of energy 
vs torsion angle, (Figure 9.11) shows that the energy difference between the two conformations is 
about 24 kJ/mol, favoring the molecular structure observed in the EDNA crystal structure. It is 
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reasonable to assume that the relatively small energy differences can readily be compensated for 
by the new N-H⋯N(py) hydrogen bonds that are observed in the structure of EDNA:A23.  
 
 
 
 
 
 
 
 
 
Figure 9.11 Relative energies of different orientations of EDNA. (N-C-C-N torsion angle was 
changed from 0° to 360° with an increment of 30°); Red point : N-C-C-N angle is 180° (pure 
EDNA) and yellow point : N-C-C-N angle is 28° (EDNA:A23) 
 9.3.4 Thermal analysis 
The thermal analysis of the eight co-crystals (including the two co-crystals without single 
crystal data) was mainly focused on four aspects: melting temperature, decomposition temperature, 
enthalpy of melting and enthalpy of decomposition, and the results were compared with that of 
EDNA. As an example, Figure 9.12 shows the DSC trace for EDNA:A27. The results are 
summarized in Table 9.3. Pure EDNA has a melting point of 180 °C and decomposes at 186 °C 
accompanied by a 1971 ± 18 J/g release of energy (for comparison the corresponding energy 
release for HMX is 1987 J/g 48 ). 
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Figure 9.12 DSC trace for EDNA:A27 co-crystal 
Table 9.3 Thermal properties of co-crystals 
 
 9.3.5 Performance analysis 
The detonation properties of the six co-crystals were calculated using experimental 
densities obtained from the single-crystal structure determinations. Detonation velocities and 
pressures were calculated using nitrogen equivalents of different detonation products,49 and 
oxygen balances were calculated using well-established methods.50 Table 9.4 summarizes the 
Compound/C
o-crystal 
Co-former 
melting point 
(0C) 
Co-crystal 
Melting 
point (0C) 
Melting 
enthalpy (J/g) 
Decomposition 
point (0C) 
Energy released at 
decomposition 
(J/g) 
EDNA - 180 215 ± 5 186 1971 ± 18 
EDNA:A23 112-114 146 146 ± 11 189 1055 ± 11 
EDNA:A24 110-112 129 133 ± 14 191 985 ± 3 
EDNA:A25 148-152 - - 198 955 ± 23 
EDNA:A26 53-56 118 119 ± 5 194 769 ± 31 
EDNA:A27 106-110 154 160 ± 28 165 1242 ± 15 
EDNA:A28 285-289 156 150 ± 7 172 1447 ± 14 
EDNA:A31 69-73 94 198 ± 2 203 1214 ± 37 
EDNA:A32 96-99 133 121 ± 4 168 982 ± 18 
Melting enthalpies and decomposition enthalpies are reported as an average from two trials for each compound with the calculated standard 
deviation 
Melting point  
Decomposition enthalpy 
Decomposition point  
Melting enthalpy 
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detonation properties for the six co-crystals. The oxygen balance of an explosive is the mass of 
oxygen either in excess or in deficit of that required for the complete oxidation of the carbon and 
hydrogen atoms present in the explosive.51A negative balance means that there is an insufficient 
amount of oxygen for complete combustion. EDNA has an oxygen balance of -32% and the co-
crystals of EDNA presented here have a more negative oxygen balance with EDNA:A28 at -67% 
being the least unfavorable (for comparison TNT has an oxygen balance of -74%).  
The impact sensitivities of EDNA, EDNA:A23, and EDNA:A28 were examined using 
conventional drop-weight measurements and calculated using Bruceton Analysis. The H50 values 
are 99 ± 1 cm, 140 ± 1 cm, and 138 ± 1 cm, respectively, where a higher value indicates reduced 
sensitivity. 
Table 9.4 Detonation properties of co-crystals 
 
 9.4 Discussion 
 9.4.1 Structural consistency and diversity 
In all six crystal structures the targeted acidic N-H protons did form hydrogen bonds with 
the acceptors resulting in successful co-crystallization. In five of the six structures, EDNA:A23 
being the exception, the EDNA molecule adopted the most favorable molecular geometry with 
Compound/Co-
crystal 
Density (g/cm3) 
Detonation 
velocity* (km/s) 
Detonation 
pressure* (GPa) 
Oxygen 
balance* 
EDNA 1.65 (RT) 7.890 26.72 -32 
EDNA:A23 
1.489 (120K) 
1.452 (RT) 
6.178 15.24 -141 
EDNA:A24 
1.407 (120K) 
1.355 (RT) 
5.967 13.70 -158 
EDNA:A25 
1.460 (120K) 
1.434 (RT) 
6.030 14.32 -154 
EDNA:A27 1.529 (120K) 6.504 17.21 -129 
EDNA:A28 
1.68 (120K) 
1.64(RT) 
7.256 22.73 -67 
EDNA:A32 1.432 (120K) 5.948 13.75 -173 
*Calculated properties 
All the velocity and pressure calculations for the co-crystals are done using low temperature densities while for EDNA the calculations are 
done using room temperature density 
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180° torsion angle of the N-C-C-N backbone. Another supramolecular synthetic target in this study 
was to achieve some structural consistency through the use of ditopic hydrogen-bond acceptors. 
In four of the five crystal structures of EDNA with ditopic acceptors (A23, A24, A25, A28) the 
result was an infinite hydrogen-bonded chain of alternating EDNA:co-former components, and 
the zig-zag shaped chain found in the crystal structure of EDNA:A23 was due to the unusual 
conformation of the backbone of the EDNA molecules  in that particular solid.    
 9.4.2 Alteration of thermal properties  
The melting points for six of the eight co-crystals of EDNA fall between those of the two 
pure components of each co-crystal, Figure 9.13.  EDNA:A28 has a lower melting point than both 
initial compounds while EDNA:A25, has a decomposition temperature approximately twenty 
degrees higher than the melting point of EDNA, and about ten degrees above its decomposition 
temperature. As mentioned previously, a drawback with EDNA is a relatively high sensitivity to 
heat, which means that the co-crystal EDNA:A25 offers an improvement in this respect.  
The relationship between molecular structure and melting point of the corresponding solid 
is governed by numerous intermolecular interactions and it is largely unpredictable. However, a 
systematic co-crystallization approach, can provide some trends and correlations between 
molecular structure and properties even in heteromeric solids as long as the primary structural 
features are somewhat consistent from one compound to the next. Despite the lack of strong 
correlation between the two variables, the general trend indicates that the co-former has an 
influence on the co-crystals of EDNA.  
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Figure 9.13 Co-crystal and co-former melting points 
Among the eight co-crystals EDNA:A28 gives the highest enthalpy change upon 
decomposition (as determined by DSC) which is likely related to the influence of the co-former, 
A28, which has a more favorable oxygen balance than any of the co-formers used in this study.52  
The DSC analysis also shows that there is a relatively large temperature difference between the 
melting and decomposition temperature in EDNA:A26 and EDNA:A31 compared to the same 
parameter in pure EDNA. This means that the window of stability beyond the melting point can 
be substantially improved upon co-crystallization. It is particularly interesting to note that the 
molten phase of EDNA:A31 shows a stability beyond that of the decomposition temperature of 
EDNA itself which indicates that some critical intermolecular interactions remain intact in the 
liquid phase. 
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 9.4.3 Alteration of detonation properties  
Density is a major contributor to the explosive properties of an energetic material.53 
Therefore, an analysis was done to examine whether there is any correlation between the density 
of the pure co-former and the density of the corresponding EDNA co-crystal, Figure 9.14 and 
Figure 9.15. The analysis is done only for the co-crystals where the room temperature densities 
are reported for the co-formers.  
 EDNA:A28 has a comparable density (1.64 g/cm3) to EDNA (1.65 g/cm3).  As observed 
with the melting points of the EDNA co-crystals, there is an increase of density of the co-crystal 
as the density of the co-former goes up (EDNA:A25 is a slight anomaly) and the big improvement 
is seen in the co-crystal with an N-oxide based co-former, A8.   
Figure 9.14 Co-crystal and co-former densities 
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Figure 9.15 Correlation between co-crystal and co-former densities  
In this systematic approach, structural consistency was a desired outcome as then it could 
also expect a positive correlation between packing coefficient and density (no heavy atoms beyond 
nitrogen and oxygen were present in any of the co-formers). To verify this hypothesis the two 
parameters were plotted against each other, Figure 9.16. 
 
Figure 9.16 A plot of packing coefficient vs. density in six EDNA co-crystals 
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As shown, the packing coefficient provides an excellent indication of density of the 
resulting lattice. 
 9.4.4 N-oxides as better co-formers  
The use of N-oxide as co-formers serves two purposes when it comes to designing and 
synthesizing energetic co-crystals. The oxygen balance is obviously benefitting by moving from a 
parent N-heterocycle to the corresponding N-oxide, but the density can also improve.54  In order 
to examine how general this second point is, a CSD analysis was conducted to compare densities 
of ten N-heterocyclic compounds and their corresponding mono-, and/or bis- N-oxides,55Figure 
9.17. 
Figure 9.17 Densities of N-heterocyclic compounds and their corresponding mono- or bis- N-
oxides 
Although the data set is not very large, the general trend is clear and unambiguous. In each 
case, the N-oxide display a higher density (as determined by single-crystal X-ray diffraction) than 
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the parent N-heterocycle and the increases range from a few percent to almost 50% in the case of 
pyrazine vs. pyrazine bis-N-oxide. Furthermore this change of density is increasing in the order or 
parent heterocycle to mono-N-oxide to bis-N-oxide. The types of compounds in this series also 
span a large range and include molecules decorated with a variety of functional groups. Against 
this background, it is not surprising that the EDNA co-crystal with a density that comparable to 
that of EDNA itself involves pyrazine bis-N-oxide as the co-former. Furthermore, it may be 
particularly worthwhile to examine N-oxides as co-formers in future strategies towards enhancing 
the density of heteromeric energetic materials. 
 9.4.5 Alteration of impact sensitivity 
EDNA is considered to be an energetic compound with relatively low sensitivity to impact 
and friction and this is a property that helps to determine if a material is suitable as a primary or 
secondary explosive as well as what kind of precautions are needed for storage and handling. Any 
incorporation of EDNA within a new crystalline material is likely to alter the impact sensitivity, 
as well as any property governed by the nature of the solid state. Thus, the impact sensitivity of 
two co-crystals in this series with particularly favorable thermal stability, EDNA:A23, and 
energetic properties, EDNA:A28 were determined and compared with the impact sensitivity of 
EDNA. The two co-crystals were significantly less impact sensitive than EDNA itself. The co-
formers in the lattice can essentially be viewed as acting as buffers or barriers between the 
inherently unstable energetic molecules which consequently improves the sensitivity.   
 9.4.6 Alteration of reactivity and stability 
The acidity of pure EDNA makes it corrosive and prone to react with metals which can 
restrict processability and shelf-life. Furthermore, the sensitivity of the products formed can create 
a completely new set of unpredictable and undesirable challenges. One reason for co-crystallizing 
230 
EDNA with molecules capable of binding to the acidic protons was to introduce a “supramolecular 
protecting group” that might reduce the chemical reactivity of EDNA thereby making it more 
stable. In order to test the validity of this approach, a simple qualitative test was carried out with 
EDNA and EDNA:A28. Small amount of the selected samples were sprinkled in a slurried form 
(with a few drops of methanol) directly onto strips of copper metal, Figure 9.18. 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.18 A slurry of EDNA (top left) and EDNA:A28 (top right), respectively, in contact 
with copper metal. Notable corrosion of the metal was observed after 20 hrs in the case of pure 
EDNA (bottom left) but no visible change to the copper metal took place with EDNA:A28 under 
the same conditions (bottom right) 
The corrosive nature of EDNA is clearly manifested even after a relatively short amount 
of time (20 hrs) at ambient temperature, whereas the EDNA:A28 solid form did not display any 
noticeable reaction with the copper metal.   
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 9.5 Conclusions 
 A systematic co-crystallization study of EDNA has demonstrated that the acidic protons 
in the energetic material can be successfully targeted with suitable hydrogen-bond acceptors. Six 
of the eight co-crystals synthesized were characterized using single crystal diffraction and the 
outcome was predictable supramolecular motifs based upon N-H⋯N and N-H⋯O structure-
directing hydrogen bonds. The co-formers also act as “supramolecular protecting groups” resulting 
in a reduced chemical instability/corrosiveness which is otherwise challenging when it comes to 
the storage and handling of EDNA, Figure 9.19. Thermal properties, impact sensitivity, and 
detonation velocities and pressure could also be modified and altered with a degree of 
predictability. Because of the structural consistency throughout the series of co-formers, some 
correlations between molecular structure/property of the pure co-former and the physical 
properties performance of the resulting energetic co-crystal was observed. This clearly suggests 
that systematic co-crystallizations allow to fine-tune properties that are important for storage, 
handling, and processing, with minimal negative impact on the eventual energetic behavior of the 
targeted substance. 
 
Figure 9.19 Supramolecular protecting group approach to stabilize EDNA 
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Chapter 10 - Summary and future work 
 10.1 Summary  
Physical properties of bulk solids are typically governed by molecular structure and 
molecular conformation, and by the intermolecular arrangement, interactions and packing of 
individual building blocks with respect to each other in a crystal lattice. Thus, in order to 
manipulate the properties of bulk materials, either alterations of molecular structure and 
conformations or refinements in packing arrangements are required. A co-crystal can be 
recognized as a supramolecular entity which enables the modification of physical properties of a 
material without tampering with the molecular structure and inherent chemical properties. Thus, a 
co-crystal leads to macroscopic property alterations by changing the spatial relationships between 
molecules in the crystal. In order to design co-crystals with pre-organized connectivities, a 
thorough understanding of the various intermolecular interactions that govern the solid-state 
architectures is essential. Hence, the first part of this dissertation is focused on understanding the 
behavior of the most well-known non-covalent interactions utilized in co-crystal synthesis, 
hydrogen bonds and halogen bonds. The second half of the dissertation is focused on applying 
hydrogen- and halogen-bond based co-crystallizations to fine-tune properties of functional 
materials.  
In order to examine the hierarchical nature of hydrogen- and halogen-bond interactions, a 
library of biimidazole based ditopic acceptors were synthesized. Calculated molecular electrostatic 
potential values were utilized in predicting the possible interaction hierarchy and the structural 
results confirmed that both hydrogen and halogen bond interactions follow a best-donor/best-
acceptor interaction hierarchy based on MEPS, Figure 10.1.1  
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Figure 10.1 Hierarchical outcome of hydrogen-bond and halogen-bond interactions; A1: best 
acceptor, A2: 2nd best acceptor1 
By extending the library of ditopic acceptors, it was realized that even though that halogen 
bonds follow an interaction hierarchy, when the MEPS difference between the two acceptor sites 
falls below 35 kJ/mol unites, the selection vanishes, Figure 10.2.  
Figure 10.2 MEPS based selectivity outcome of halogen bonding; A1: best acceptor, A2: 2nd 
best acceptor 
Next the competitive nature of hydrogen- and halogen-bond interactions were investigated 
utilizing a library of heteroaryl-2-imidazole molecules. The results suggested that both interaction 
types are equally competitive in such a competitive scenario, which is not surprising as both 
interactions have comparable strengths, Figure 10.3.2  
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Figure 10.3 Structural outcome of the competitive study between hydrogen bond and halogen 
bond; A1: best acceptor, A2: 2nd best acceptor2 
Even though there is an abundance of hydrogen-bond donors, there is a scant number of 
halogen-bond donor families available. Thus, a double activation method was employed in 
designing a new family of halogen-bond donors which were proven to be more effective than 
currently known analogues, Figure 10.4. The series of molecules were activated with a 
combination of electron-withdrawing capabilities of −NO2 moieties with the polarizing effects  
of an sp-carbon.3 Thus, the same group of molecules was exploited in an investigation of 
interaction preferences of nitro groups and the results revealed the possibility of using the 
nitro⋯haloethynyl interactions in co-crystallizations of energetic materials.  
 
 
 
 
 
 
Figure 10.4 Design of effective halogen-bond donors with double activation3  
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As one of the applications of co-crystallization, a series of N-oxides were utilized in a 
rational design strategy of molecular polygons. Bifurcated halogen bonds constructed from N-
oxides and complementary halogen-bond donors provided the basis for the deliberate assembly of 
molecular polygons in the solid state and furnished the desired architectures, Figure 10.5.4  
The knowledge of hydrogen- and halogen-bond based co-crystallizations were applied in 
stabilizing volatile liquid chemicals and a reactive energetic compound. Through the use of 
halogen-bond driven co-crystal synthesis, liquid iodoperfluoroalkanes were transformed into 
crystalline materials with low-vapor pressure, considerable thermal stability, and moisture 
resistance, Figure 10.5.5 Ethylenedinitramine (EDNA), a well-known explosive, suffers from high 
chemical reactivity due to the presence of acidic protons and was combined with potential 
acceptors via hydrogen bonding. The co-crystallization approach was successful not only in 
altering the physical properties of EDNA, while retaining the energetic properties, but also led to 
the gained stability by eliminating the chemical reactivity, Figure 10.5.6  
Figure 10.5 Applications of co-crystal technology4,5,6  
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 10.2 Future work 
The work outlined in this dissertation provides the basis for understanding not only the 
behavior of basic intermolecular interactions in solid state but also for fine-tuning properties of 
functional materials via co-crystallizations. However, there is still much to be done and below are 
a few examples.  
 10.2.1 Designing halogen-bond based ternary co-crystals 
The synthesis of ternary co-crystals, in which three neutral solid compounds are included 
in a single crystal structure, is very challenging.7 To attain this target, control over intermolecular 
interactions and precise selection of supramolecular synthons are required.8 Even though there are 
examples based on hydrogen bonds9 and a combination of hydrogen and halogen bonds10 in 
designing ternary systems, such a system based only on halogen bonds has not been reported. 
However, it should be possible to obtain a halogen-bond based ternary system by combining an 
asymmetric ditopic acceptor and two single point halogen-bond donors with different MEPS 
values on the halogen atom in 1:1:1 stoichiometry, Figure 10.6.  
 
 
 
 
 
Figure 10.6 Design strategy for a halogen-bond based ternary co-crystal 
 10.2.2 Design of new hydrogen-bond donors via double activation 
Chapter 6 describes the usage of double activation to design an effective group of halogen-
bond donors. Also, it is reported that an ethynyl attached hydrogen atom can participate in weak 
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hydrogen bond formation, due to the positive potential obtained via polarization effect.11 Thus, it 
should be possible to utilize a double activation method to obtain effective hydrogen-bond donors 
by combining the electron withdrawing capability of −NO2 moieties and the polarizing effect of 
an sp-carbon (Figure 10.7), which can be an addition to the toolbox of supramolecular chemistry.  
 
 
 
 
 
Figure 10.7 Two possible outcomes of co-crystallizations with ethynylnitrobenzenes a) a Csp-
H⋯N hydrogen bond and b) a Csp-H⋯O hydrogen bond 
 10.2.3 Halogen-bond based molecular rectangles 
Chapter 7 describes the use of halogen-bond based co-crystallization to obtain rationally 
designed molecular rhombuses and molecular hexagons. A similar design strategy could lead to 
other supramolecular polygons such as rectangles, Figure 10.8. In order to design rectangles a 
halogen-bond donor with an approximately 90º angle was designed and utilized in co-
crystallizations to obtain molecular rectangles, Figure 10.9. The future plan is to expand this study 
to obtain more rationally designed molecular polygons.  
 
 
 
 
Figure 10.8 Design strategy of a molecular rectangle 
 
Donor  
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Figure 10.9 A molecular rectangle between 1,2-bispyridylethylene and 1,8-
bis(iodoethynyl)anthracene assembled via halogen bonding 
 10.2.4 Hydrogen bonded co-crystallizations for improving chemical stability of 
dinitroimidazole based energetic materials 
Chapter 9 shows the success in utilizing co-crystallization to alter the properties of an 
energetic compound. Likewise, dinitroimidazole based energetic compounds are well-known for 
their attractive impact insensitivity.12 But these compounds are highly acidic, thus chemical 
reactivity is a major drawback that hampers the utilization of these compounds. A hydrogen-bond 
based co-crystallization approach could reduce the reactivity and enhance the stability, while 
retaining the energetic potentials. Initially, two dinitroimidazole compounds, 2,4-dinitroimidazole 
(2,4-DNI) and 4,5-dinitroimidazole (4,5-DNI) were selected and co-crystallized with 
aminopyridine compounds, Figure 10.10. Future plans for this study include obtaining more co-
crystals of dinitroimidazoles and to study the property modifications as well as reactivity 
alterations. 
 
Figure 10.10 A salt formed between 4,5-DNI and 2-aminopyridine 
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Appendix A - NMR Data 
 A.1 Chapter 2 
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TW - 1,1'-bis(pyridin-2-ylmethyl)-2,2'-biimidazole.esp
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A1-Adi - 1-1 mixed stoichiometry.esp
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A1-Seb - 1-1 mixed stoichiometry.esp
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A1-Adi - 1-4 mixed stoichiometry.esp
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A1-Seb - 1-4 mixed stoichiometry.esp
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A3-Adi - 1-4 mixed stoichiometry.esp
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A3-Seb - 1-4 mixed stoichiometry.esp
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1-(pyridin-4-ylmethyl)-benzimidazole .esp
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H NMR of 1-(pyridin-4-ylmethyl)-benzimidazole 
(A5) 
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4-((imidazol-1-yl)methyl)pyridine.esp
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H NMR of 4-((imidazol-1-yl)methyl)pyridine 
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4-((2-phenyl-imidazol-1-yl)methyl)pyridine .esp
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H NMR of 4-((2-phenyl-imidazol-1-yl)methyl)pyridine (A9) 
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H NMR of 5,6-dimethyl-1-(pyridin-3-ylmethyl)-benzoimidazole (A10) 
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3-((2-phenylimidazol-1-yl)methyl)pyridine .esp
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H NMR of 3-((2-phenylimidazol-1-yl)methyl)pyridine (A11) 
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9 8 7 6 5 4 3 2 1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
2.341.021.061.101.101.081.030.99
DMSO-d6
2
.5
0
5
.2
6
6
.9
3
7
.2
4
7
.3
8
7
.6
5
7
.6
5
7
.8
2
8
.5
1
8
.5
18
.5
2
8
.5
6
1
H NMR of 3-((imidazol-1-yl)methyl)pyridine 
(A12) 
256 
 
 
 
 
 
 
 
 
 
 
 
 A.3 Chapter 5 
 
 
 
 
 
 
 
 
 
 
N,N-dimethylpyridin-3-amine.esp
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3-(imidazol-2-yl)pyridine.esp
14 13 12 11 10 9 8 7 6 5 4 3 2 1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.980.971.100.971.000.74
DMSO-d6
Water
1
2
.7
1
9
.1
3
8
.5
3 8
.2
6
8
.2
4
7
.4
7
7
.4
6
7
.2
0
2-(imidazol-2-yl)pyridine.esp
13 12 11 10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
0.830.930.960.940.931.000.78
H2O
DMSO-d6
1
2
.6
9
8
.5
2
8
.5
1
7
.9
5
7
.8
0
7
.7
8
7
.2
9
7
.2
8
7
.2
6
7
.1
5
7
.0
0
258 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2-(imidazol-2-yl)pyrazine.esp
11 10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
0.981.020.930.971.001.27
CHLOROFORM-d
TMS
1
0
.3
4
9
.4
4 9
.4
4
8
.5
4
8
.5
3
8
.4
9 8
.4
9
8
.4
8 7
.3
1
7
.2
3
0
.0
1
0
.0
0
2-(imidazol-2-yl)pyrimidine.esp
14 13 12 11 10 9 8 7 6 5 4 3 2 1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.531.421.002.420.87
1
2
.9
0
8
.8
3 8
.8
2
8
.8
1
8
.2
8
7
.4
0
7
.4
0
7
.3
9
7
.1
8
259 
 A.4 Chapter 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
trimethyl((4-nitrophenyl)ethynyl)silane.esp
9 8 7 6 5 4 3 2 1 0 -1
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
8.952.042.00
TMS
CHLOROFORM-d
0
.2
8
0
.2
9
1
.5
97
.5
9
7
.6
1
8
.1
7
8
.1
9
1
H NMR spectrum of trimethyl((4-nitrophenyl)ethynyl)silane 
1-(iodoethynyl)-4-nitrobenzene .esp
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1.982.00
TMS
CHLOROFORM-d
1
.5
5
7
.5
7
7
.5
9
8
.1
8
8
.2
0
1
H NMR spectrum of 1-(iodoethynyl)-4-nitrobenzene (4N-I) 
260 
1-(iodoethynyl)-4-nitrobenzene (4N-I).esp
180 160 140 120 100 80 60 40 20
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1
5
.5
2
9
3
.2
9
1
2
4
.4
6
1
3
0
.9
1
1
3
4
.0
8
1
7
3
.2
4
13
C NMR spectrum of 1-(iodoethynyl)-4-nitrobenzene (4N-I) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-(bromoethynyl)-4-nitrobenzene.esp
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
2.002.00
TMS
CHLOROFORM-d
7
.6
07
.6
2
8
.1
9
8
.2
1
1
H NMR spectrum of 1-(bromoethynyl)-4-nitrobenzene (4N-Br) 
261 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-(chloroethynyl)-4-nitrobenzene .esp
8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
2.062.00
TMS
CHLOROFORM-d
0
.2
8
1
.5
7
7
.5
9
7
.6
1
8
.1
9
8
.2
1
1
H NMR spectrum of 1-(chloroethynyl)-4-nitrobenzene (4N-Cl) 
1-(bromoethynyl)-3-nitrobenzene (3N-Br).esp
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
5
3
.5
8
7
7
.7
2
1
2
3
.3
7
1
2
4
.3
8
1
2
6
.8
2
1
2
9
.3
8
1
3
7
.6
1
1
4
7
.9
6
13
C NMR spectrum of 1-(bromoethynyl)-4-nitrobenzene  
(4N-Br) 
262 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-(chloroethynyl)-3,5-dinitrobenzene (3,5DN-Cl).esp
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
6
5
.4
5
7
5
.0
7
1
1
8
.4
6
1
2
5
.8
4
1
3
1
.7
7
1
4
8
.1
0
13
C NMR spectrum of 1-(chloroethynyl)-4-nitrobenzene  
(4N-Cl) 
trimethyl((3-nitrophenyl)ethynyl)silane.esp
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
9.131.121.111.030.99
TMS
CHLOROFORM-d
0
.2
7
7
.4
7
7
.4
9
7
.7
4
7
.7
6
8
.1
5
8
.3
0
8
.3
1
8
.3
1
1
H NMR spectrum of trimethyl((3-nitrophenyl)ethynyl)silane 
263 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-(iodoethynyl)-3-nitrobenzene .esp
9 8 7 6 5 4 3 2 1 0 -1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1.111.091.111.00
TMS
CHLOROFORM-d
7
.5
0
7
.5
2
7
.7
3
7
.7
5
8
.1
8
8
.2
9
1
H NMR spectrum of 1-(iodoethynyl)-3-nitrobenzene (3N-I) 
1-(iodoethynyl)-3-nitrobenzene (3N-I).esp
160 140 120 100 80 60 40 20
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1
1
.1
4
9
1
.6
1
1
2
3
.4
5
1
2
7
.1
8
1
2
9
.2
9
1
3
7
.9
2
1
5
5
.2
6
13
 C NMR spectrum of 1-(iodoethynyl)-3-nitrobenzene (3N-I) 
264 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-(bromoethynyl)-3-nitrobenzene .esp
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1.091.061.010.97
TMSCHLOROFORM-d
1
.2
6
1
.5
7
7
.5
0
7
.5
2
7
.7
5
7
.7
7
8
.2
0
8
.2
0
8
.3
1
8
.3
2
1
H NMR spectrum of 1-(bromoethynyl)-3-nitrobenzene (3N-Br) 
1-(bromoethynyl)-3-nitrobenzene (3N-Br).esp
152 144 136 128 120 112 104 96 88 80 72 64 56 48
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
5
3
.5
8
7
7
.7
2
1
2
3
.3
7
1
2
4
.3
8
1
2
6
.8
2
1
2
9
.3
8
1
3
7
.6
1
1
4
7
.9
6
13
 C NMR spectrum of 1-(bromoethynyl)-3-nitrobenzene  
(3N-Br) 
265 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-(chloroethynyl)-3-nitrobenzene .esp
9 8 7 6 5 4 3 2 1 0 -1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1.261.111.191.00
TMS
CHLOROFORM-d
1
.6
0
7
.5
0
7
.5
2
7
.7
4
7
.7
6
8
.1
9
8
.2
1
8
.2
9
8
.3
0
8
.3
0
1
H NMR spectrum of 1-(chloroethynyl)-3-nitrobenzene (3N-Cl) 
1-(chloroethynyl)-3-nitrobenzene (3N-Cl).esp
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
3
0
.8
9
6
7
.1
1
7
1
.2
2
1
2
3
.3
1
1
2
3
.8
5
1
2
6
.7
9
1
2
9
.4
1
1
3
7
.6
1
1
4
9
.4
4
13
C NMR spectrum of 1-(chloroethynyl)-3-nitrobenzene  
(3N-Cl) 
266 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
((3,5-dinitrophenyl)ethynyl)trimethylsilane.esp
9 8 7 6 5 4 3 2 1 0 -1
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
9.082.000.99
0
.3
0
0
.3
1
1
.5
5
8
.5
8
8
.5
8
8
.9
6
1
H NMR spectrum of ((3,5-dinitrophenyl)ethynyl)trimethylsilane 
1-(iodoethynyl)-3,5-dinitrobenzene .esp
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
2.001.00
0
.0
0
1
.5
8
8
.5
7
8
.9
8
1
H NMR spectrum of 1-(iodoethynyl)-3,5-dinitrobenzene (3,5DN-I) 
267 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-(iodoethynyl)-3,5-dinitrobenzene (3,5DN-I).esp
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1
6
.5
9
8
9
.7
8
1
1
8
.5
0
1
2
6
.8
5
1
3
2
.1
0
1
4
8
.3
0
13
C NMR spectrum of 1-(iodoethynyl)-3,5-dinitrobenzene (3,5DN-I) 
1-(bromoethynyl)-3,5-dinitrobenzene .esp
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1.971.00
CHLOROFORM-d
TMS
8
.5
9
8
.6
0
9
.0
0
9
.0
0
9
.0
1
1
H NMR spectrum of 1-(bromoethynyl)-3,5-dinitrobenzene (3,5DN-Br) 
268 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-(bromoethynyl)-3,5-dinitrobenzene (3,5DN-Br).esp
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
5
7
.9
7
7
6
.0
1
1
1
8
.4
5
1
2
6
.2
7
1
3
1
.7
5
1
4
8
.3
4
13
C NMR spectrum of 1-(bromoethynyl)-3,5-dinitrobenzene  
(3,5DN-Br) 
1-(chloroethynyl)-3,5-dinitrobenzene .esp
9 8 7 6 5 4 3 2 1 0 -1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
2.071.00
TMS
CHLOROFORM-d
0
.0
1
0
.0
1
8
.6
0
8
.6
0
9
.0
1
9
.0
1
1
H NMR spectrum of 1-(chloroethynyl)-3,5-dinitrobenzene (3,5DN-Cl) 
269 
 
 
 
 
 
 
 
 
 
 
 
 A.5 Chapter 7 
 
 
 
 
 
 
 
 
 
 
 
1-(chloroethynyl)-3,5-dinitrobenzene (3,5DN-Cl).esp
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
6
5
.4
5
7
5
.0
7
1
1
8
.4
6
1
2
5
.8
4
1
3
1
.7
7
1
4
8
.1
0
13
C NMR spectrum of 1-(chloroethynyl)-3,5-dinitrobenzene 
(3,5DN-Cl) 
pyrazine-N-oxide .esp
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.032.00
CHLOROFORM-d
TMS
8
.4
7
8
.4
6
8
.1
0
8
.0
9
-0
.0
1
270 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pyrazine-bis-N-oxide .esp
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.00
TMS
DMSO-d6
8
.2
7
tetramethylpyrazine-N-oxide .esp
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
6.016.04
CHLOROFORM-d TMS
2
.5
1
2
.4
6
271 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
tetramethylpyrazine-bis-N-oxide .esp
10 9 8 7 6 5 4 3 2 1 0 -1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
12.00
CHLOROFORM-d
TMS
2
.5
6
4,4’bipyridne-N-oxide .esp
12 11 10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.362.242.002.04
DMSO-d6
8
.6
9
8
.6
7 8
.3
2
7
.9
3 7
.8
1
7
.8
0
272 
 
 
 
 
 
 
 
 
 
 
 
 A.6 Chapter 9 
 
 
 
 
 
 
 
 
4,4’bipyridne -bis-N-oxide .esp
11 10 9 8 7 6 5 4 3 2 1 0 -1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.134.00
TMS
8
.7
5
8
.7
4
7
.5
6
7
.5
4
EDNA.esp
13 12 11 10 9 8 7 6 5 4 3 2 1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.001.88
DMSO-d6
Water
1
2
.1
2
3
.5
9
273 
Appendix B - Single crystal X-ray crystallography data
 B.1 Chapter 2  
Experimental details 
Datasets were collected on a Bruker Kappa APEX II system using CuKα radiation 
(A1:Dod, A1:Suc, A3:Seb, A3:Sub, A3:Dod, A1:Seb, A4:Mal) or a on a Bruker APEX II system 
using MoKα radiation (A3:Adi, A1:Sub, A1:Adi, A1:Glu, A1:Mal, A3:Pim). Data were 
collected using APEX2 software.1 Initial cell constants were found by small widely separated 
“matrix” runs. Data collection strategies were determined using COSMO.2 Scan speed and scan 
widths were chosen based on scattering power and peak rocking curves. All datasets were collected 
at -153 °C using an Oxford Croystream low-temperature device. 
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,3 using this 
improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT from 
the final merged dataset. Lorenz and polarization corrections were applied. Multi-scan absorption 
corrections were performed with SADABS.4 
Data were reduced with SHELXTL.5 The structures were solved in all cases by direct 
methods without incident. Except as noted, hydrogen atoms were located in idealized positions 
and were treated with a riding model. All non-hydrogen atoms were assigned anisotropic thermal 
parameters. Refinements continued to convergence, using the recommended weighting schemes. 
In A1:Dod, A1:Suc, A3:Adi, A1:Sub, A1:Adi, A3:Seb, A3:Sub and A3:Dod; both the 
amine and the diacid sit on crystallographic inversion centers. Coordinates of the unique 
carboxylic acid proton were allowed to refine. Crystal structure of A1:Seb was a nonmerohedral 
twin and the data were processed with TWINABS.6 In this structure both the amine and the diacid 
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sit on crystallographic inversion centers. Coordinates of the unique carboxylic acid proton were 
allowed to refine. In A4:Mal both the amine and the diacid sit on general positions. Coordinates 
of the carboxylic acid protons were allowed to refine. In A1:Glu, the amine sits on crystallographic 
inversion centers; the diacid sits on a general position, giving 1 : 2 amine : diacid stoichiometry. 
Coordinates of the carboxylic acid protons were allowed to refine. In A1:Mal both the amine and 
the diacid sit on general positions. Two orientations for one pyridine moiety (N41-C46) and one 
acid moiety (C53 / O53 / O54), representing different orientations of the –COOH group, were 
located in the difference map. Relative populations were allowed to refine. Thermal parameters 
were pairwise constrained using EADP commands. Geometry of the pyridine rings were restrained 
using the SAME command. All hydrogen atoms were included in calculated positions and were 
allowed to ride. In A3:Pim the amine sits on crystallographic inversion centers; the diacid sits on 
a general position, giving 1 : 2 amine : diacid stoichiometry. Coordinates of the carboxylic acid 
protons were allowed to refine. 
Crystallographic data  
Code A1:Suc A1:Adi A1:Sub A1:Seb A1:Dod A1:Mal A1:Glu 
Formula 
moiety 
(C18H16N6) 
(C4H6O4) 
(C18H16N6) 
(C6H10O4) 
(C18H16N6) 
(C8H14O4) 
(C18H16N6) 
(C10H18O4) 
(C18H16N6) 
(C12H22O4) 
(C18H16N6) 
(C3H4O4) 
(C18H16N6) 
(C5H8O4)2 
Empirical 
formula 
C22H22N6O4 C24H26N6O4 C26H30N6O4 C28H34N6O4 C30H38N6O4 C21H20N6O4 C28H32N6O8 
Molecular 
weight 
434.46 462.51 490.56 518.61 546.66 420.43 580.60 
Color, Habit 
colorless 
prism 
bronze plate orange plate orange plate bronze prism 
colourless 
needle 
bronze prism 
Crystal system Triclinic Triclinic Triclinic Triclinic Triclinic Monoclinic Triclinic 
Space group, Z P-1, 1 P-1, 1 P-1, 1 P-1, 1 P-1, 1 P2(1)/c, 4 P-1, 1 
a, Å 4.8468(8) 5.5146(11) 5.6196(11) 5.6320(7) 5.6047(8) 14.797(3) 7.6142(11) 
b, Å 9.2594(16) 6.8100(14) 6.7825(13) 6.8450(8) 6.8589(10) 4.5097(7) 8.6608(13) 
c, Å 12.245(2) 15.254(3) 16.078(3) 17.748(2) 18.879(3) 29.886(5) 11.0348(16) 
α, ° 69.536(7) 79.288(6) 87.236(4) 93.630(7) 97.644(5) 90.00 102.357(5) 
β, ° 89.567(7) 85.259(6) 82.669(4) 98.988(7) 91.164(5) 104.056(8) 105.996(5) 
γ, ° 85.993(7) 75.952(5) 75.451(4) 104.670(7) 104.659(5) 90.00 93.866(5) 
Volume, Å3 513.50(15) 545.60(19) 588.22(19) 649.97(13) 694.80(18) 1934.6(6) 677.09(17) 
Density, g/cm3 1.405 1.408 1.385 1.325 1.307 1.444 1.424 
Temperature, 
°K 
120(2) 120(2) 120(2) 120(2) 120(2) 120(2) 120(2) 
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Crystal size, 
min x mid x 
max 
0.236 x 0.239 
x 0.543 
0.10 x 0.32 x 
0.38 
0.12 x 0.30 x 
0.36 
0.10 x 0.26 x 
0.34 
0.22 x 0.28 x 
0.32 
0.08 x 0.10 x 
0.36 
0.18 x 0.36 x 
0.44 
X-ray 
wavelength, Å 
1.54178 0.71073 0.71073 1.54178 1.54178 0.71073 0.71073 
μ, mm-1 0.827 0.099 0.096 0.737 0.716 0.104 0.106 
Absorption 
corr 
multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / 
max 
0.645 / 0.753 
0.9634 / 
0.9902 
0.9662 / 
0.9886 
0.7876 / 
0.9299 
0.8032 / 
0.8584 
0.9636 / 
0.9918 
0.9547 / 
0.9811 
θmin, ° 3.85 3.13 3.10 2.54 2.36 1.42 1.98 
θmax, ° 67.98 32.02 32.75 68.93 68.24 30.08 32.68 
Reflections        
collected 6345 7187 10698 4606 9252 20190 17551 
independent 1799 3167 3929 4606 2438 5562 4555 
observed 1660 2613 3433 3942 2269 2992 4015 
Threshold 
expression 
>2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) 
R1 (observed) 0.0507 0.0467 0.0458 0.0550 0.0523 0.0652 0.0422 
wR2 (all) 0.1400 0.1358 0.1329 0.1976 0.1716 0.1937 0.1231 
Goodness of fit 
(all) 
1.084 1.099 1.014 1.544 1.472 0.997 0.973 
Δρ max / min 0.355 / -0.431 0.414 / -0.223 0.459 / -0.308 0.322 / -0.451 0.311 / -0.242 0.271 / -0.418 0.430 / -0.279 
2θ limit 67.50 27.50 30.00 68.93 67.50 30.00 30.00 
Completeness 
to 2θ limit 
0.969 0.973 0.971 0.974 0.968 0.981 0.994 
 
Code A3:Adi A3:Seb A3:Sub A3:Dod A3:Pim A4:Mal 
Formula 
moiety 
(C18H16N6) 
(C6H10O4) 
(C18H16N6) 
(C10H18O4) 
(C18H16N6) 
(C8H14O4) 
(C18H16N6) 
(C12H22O4) 
(C18H16N6) 
(C7H12O4)2 
(C20H18N4) 
(C3H4O4) 
Empirical 
formula 
C24H26N6O4 C28H34N6O4 C26H30N6O4 C30H38N6O4 C32H40N6O8 C23H22N4O4 
Molecular 
weight 
462.51 518.61 490.56 546.66 636.70 418.45 
Color, Habit colourless plate colourless prism colourless prism colourless prism colourless plate yellow prism 
Crystal system Triclinic Triclinic Triclinic Triclinic Triclinic Monoclinic 
Space group, Z P-1, 1 P-1, 1 P-1, 1 P-1, 1 P-1, 1 P2(1)/n, 4 
a, Å 5.0121(5) 5.2731(8) 5.1024(10) 5.2955(8) 4.9161(10) 11.4449(17) 
b, Å 7.8964(8) 7.8464(11) 8.0128(15) 7.8185(13) 8.0077(16) 8.9002(15) 
c, Å 15.1589(16) 17.163(3) 16.497(3) 18.424(3) 20.828(4) 21.338(3) 
α, ° 78.403(4) 81.964(6) 99.940(9) 85.042(10) 87.266(11) 90.00 
β, ° 88.333(4) 88.938(6) 93.967(10) 83.543(10) 88.665(10) 94.855(10) 
γ, ° 72.636(3) 72.499(6) 108.231(8) 71.912(10) 72.608(9) 90.00 
Volume, Å3 560.62(10) 670.38(17) 625.5(2) 719.4(2) 781.5(3) 2165.7(6) 
Density, g/cm3 1.370 1.285 1.302 1.262 1.353 1.283 
Temperature, 
°K 
120(2) 120(2) 120(2) 120(2) 120(2) 120(2) 
Crystal size, 
min x mid x 
max 
0.10 x 0.26 x 
0.36 
0.14 x 0.26 x 
0.32 
0.20 x 0.28 x 
0.32 
0.16 x 0.24 x 
0.28 
0.08 x 0.18 x 
0.38 
0.14 x 0.18 x 0.24 
X-ray 
wavelength, Å 
0.71073 1.54178 1.54178 1.54178 0.71073 1.54178 
μ, mm-1 0.096 0.715 0.737 0.692 0.099 0.737 
Absorption 
corr 
multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / 
max 
0.9662 / 0.9904 0.8035 / 0.9065 0.7983 / 0.8666 0.8299 / 0.8974 0.9635 / 0.9922 0.8430 / 0.9039 
θmin, ° 1.37 5.21 2.74 2.42 0.98 4.16 
θmax, ° 32.01 67.90 66.73 68.34 31.05 67.60 
Reflections       
collected 12569 11734 9109 11812 21382 10824 
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Hydrogen bond geometries  
 
 B.2 Chapter 3 
Experimental details 
Datasets were collected on a Bruker Kappa APEX II system with Cu radiation at 120 K 
(A1:D2 and A2:D7), a Kappa APEX II system with Mo radiation at 90 K (A2:D37), or SMART 
APEX II system with Mo radiation at 120 K (remaining structures), using APEX2 software.1 An 
Oxford Croystream 700 low-temperature device was used to control temperature. MoKα radiation 
was used. Initial cell constants were found by small widely separated “matrix” runs.  Data 
collection strategies were determined using COSMO.2 Scan speeds and scan widths were chosen 
based on scattering power and peak rocking curves. 
independent 3713 2326 2111 2493 4657 3641 
observed 3150 2145 1891 2079 2306 2941 
Threshold 
expression 
>2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) 
R1 (observed) 0.0434 0.0327 0.0496 0.0446 0.0996 0.0417 
wR2 (all) 0.1317 0.0850 0.1580 0.1335 0.2647 0.1494 
Goodness of fit 
(all) 
1.116 1.060 1.176 1.100 1.286 1.102 
Δρ max / min 0.325 / -0.289 0.167 / -0.185 0.225 / -0.274 0.226 / -0.329 0.455 / -0.418 0.352 / -0.367 
2θ limit 30.00 67.50 66.73 67.50 30.00 66.00 
Completeness 
to 2θ limit 
0.994 0.957 0.952 0.954 0.979 0.952 
Co-crystal D–H⋯A D–H (Å) H⋯A (Å) D⋯A (Å) D–H⋯N (°) 
A1:Suc O(31)-H(31)⋯N(21) 0.92(3) 1.74(3) 2.6484(19) 168(2) 
A1:Adi O(31)-H(31)⋯N(21) 0.91(2) 1.77(2) 2.6765(14) 176.3(16) 
A1:Sub O(31)-H(31)⋯N(21) 0.961(18) 1.700(18) 2.6604(12) 177.3(15) 
A1:Seb O(31)-H(31)⋯N(21) 1.05(2) 1.63(2) 2.6857(18) 178.1(17) 
A1:Dod O(31)-H(31)⋯N(21) 0.89(2) 1.80(2) 2.6890(15) 176.6(19) 
A1:Mal 
O(51)-H(51)⋯N(31) 
O(53A)-H(53A)⋯N(41A)#1 
O(53B)-H(53B)⋯N(41B)#1 
0.84 
0.84 
0.84 
1.73 
1.75 
1.74 
2.551(2) 
2.586(4) 
2.576(16) 
166.5 
169.9 
178.3 
A1:Glu 
O(31)-H(31)⋯N(21) 
O(35)-H(35)⋯O(36)#2 
0.958(15) 
0.851(17) 
1.695(15) 
1.802(17) 
2.6475(10) 
2.6520(11) 
172.9(14) 
177.3(16) 
A3:Adi O(31)-H(31)⋯N(21) 0.920(17) 1.798(17) 2.7046(12) 167.7(15) 
A3:Sub O(31)-H(31)⋯N(21) 0.96(3) 1.78(3) 2.722(2) 167(2) 
A3:Seb O(31)-H(31)⋯N(21) 0.906(17) 1.847(17) 2.7294(13) 163.9(14) 
A3:Dod O(31)-H(31)⋯N(21) 0.89(3) 1.86(3) 2.727(2) 163(2) 
A3:Pim 
O(31)-H(31)⋯N(21) 
O(37)-H(37)⋯O(38)#2 
0.82(4) 
0.83(5) 
1.92(4) 
1.85(5) 
2.677(3) 
2.668(3) 
155(4) 
169(4) 
A4:Mal 
O(51)-H(51)⋯N(13) 
O(53)-H(53)⋯N(33)#1 
0.91(3) 
0.97(3) 
1.80(3) 
1.75(3) 
2.702(2) 
2.714(2) 
172(2) 
177(2) 
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Unit cell constants and orientation matrices were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integrations were performed with SAINT,3 using 
these improved unit cells as a starting point. Precise unit cell constants were calculated in SAINT 
from the final merged datasets. Lorenz and polarization corrections were applied. Absorption 
corrections was applied using SADABS.4 
Datasets were reduced with SHELXTL.5 The structures were solved by direct methods 
without incident. Coordinates for all carboxylic acid and phenol hydrogen atoms were allowed to 
refine. All other hydrogens were assigned to idealized positions and were allowed to ride. Isotropic 
thermal parameters for the hydrogen atoms were constrained to be 1.5x (methyl) / 1.2x (all other) 
that of the connected atom. 
Crystallographic data  
 A1:D1 A1:D2 A1:D3 A1:D4 A2:D2 A2:D3 
Formula moiety 
(C18H16N6)(C2F4I
2) 
(C18H16N6)(C4F8I
2) 
(C18H16N6)(C8F16
I2)2 
(C18H16N6)(C4F8I
2) 
(C18H16N6)(C6F12
I2)2 
C18H16N6,C6F12I2 
Empirical 
formula 
C20H16F4I2N6 C22H16F8I2N6 C34H16F32I4N6 C22H16F8I2N6 C30H16F24I4N6 C24H16F12I2N6 
Molecular weight 670.19 770.21 1624.13 770.21 1424.09 870.23 
Color,  Habit Colourless prism Colourless plate Colourless plate Colourless plate Bronze prism Colorless block 
Crystal system Triclinic Triclinic Triclinic Triclinic Triclinic Triclinic 
Space group,  Z P-1, 1 P-1, 2 P-1, 1 P-1, 1 P-1, 1 P-1, 2 
a, Å 5.7868(3) 4.9080(5) 5.4392(4) 5.6725(9) 5.5456(8) 5.8360(4) 
b, Å 7.7496(4) 9.1160(8) 12.5586(10) 7.8185(12) 12.3595(17) 13.0345(9) 
c, Å 13.2037(8) 29.031(3) 17.0838(13) 14.983(2) 14.772(2) 18.9742(13) 
α, ° 97.3990(16) 81.699(5) 105.585(3) 89.405(7) 100.144(4) 77.126(3) 
β, ° 95.6153(15) 88.168(6) 93.762(2) 85.612(6) 94.600(4) 88.717(3) 
γ, ° 104.7924(16) 77.390(6) 90.837(2) 74.823(6) 92.321(4) 79.610(3) 
Volume, Å3 562.43(5) 1254.3(2) 1121.01(15) 639.44(17) 991.9(2) 1383.76(16) 
X-ray wavelength 0.71073 1.54178 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 2.849 20.476 2.951 2.542 3.289 2.382 
Temperature, °K 120 120 120 120 120 90 
Crystal size, 
mm x mm x mm 
0.16 x 0.28 x 
0.32 
0.26 x 0.22 x 
0.06 
0.24 x 0.18 x 
0.06 
0.26 x 0.16 x 
0.08 
0.42 x 0.34 x 
0.18 
0.10 x 0.08 x 
0.05 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.4625 / 0.6585 0.076 / 0.373 0.538 / 0.843 0.558 / 0.823 0.339 / 0.589 0.797 / 0.890 
θ min / max, ° 2.75/32.64 5.04 / 68.59 1.68 / 31.50 2.70 / 32.56 1.68 / 33.72 3.02 / 27.50 
Reflections       
collected 11124 15481 20969 12918 31031 14199 
independent 3718 4324 6899 3936 7589 5807 
observed 3480 3846 5661 3534 6978 4256 
Threshold 
expression 
>2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) 
R1 (observed) 0.0245 0.0530 0.0412 0.0312 0.0289 0.0384 
wR2 (all) 0.0599 0.1363 0.1019 0.0846 0.0790 0.0760 
S 1.063 1.130 1.010 1.043 1.018 1.026 
Δρ max / min 1.088 / -0.565 1.674 / -1.421 2.493 / -1.168 1.369 / -1.402 1.834 / -1.271 0.891 / -0.943 
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2θ limit 30.00 67.50 30.00 27.50 30.00 25.00 
Completeness to 
2θ limit 
0.992 0.954 0.962 0.979 0.996 0.978 
 
Code A3:D9 A3:D10 A2:D7 A2:D9 A2:D10 
Formula moiety (C18 H16 N6)(C6F3I3) (C18H16N6)(C12F8I2)2 (C18H16N6)(C6F4I2)2 (C18H16N6)(C6F3I3)2 (C18H16N6)(C12F8I2)2 
Empirical formula C24H16F3I3N6 C42H16F16I4N6 C30H16F8I4N6 C30H16F6I6N6 C42H16F16I4N6 
Molecular weight 826.13 1416.21 1120.09 1335.89 1416.21 
Color,  Habit colourless prism colourless plate colourless plate colourless prism colourless plate 
Crystal system Monoclinic Triclinic Triclinic Triclinic Triclinic 
Space group,  Z C2/c, 4 P-1, 1 P-1, 1 P-1, 2 P-1, 1 
crystal size, 
mm x mm x mm 
0.34 x 0.16 x 0.08 0.26 x 0.24x 0.12 0.22 x 0.14 x 0.04 0.32 x 0.18 x 0.08 0.36 x 0.28 x 0.12 
a, Å 4.4155(2) 8.4474(5) 8.1124(6) 9.0099(6) 8.1127(10) 
b, Å 17.6583(9) 8.6272(5) 8.9038(6) 14.1693(9) 8.4048(10) 
c, Å 32.0389(16) 14.2758(8) 12.4514(9) 15.3092(10) 15.8930(19) 
α, ° 90.00 88.512(2) 108.524(3) 103.421(2) 84.449(3) 
β, ° 90.4570(10) 88.180(2) 102.920(3) 103.049(2) 79.163(3) 
γ, ° 90.00 89.813(2) 95.389(3) 102.874(2) 83.723(3) 
Volume, Å3 2498.0(2) 1039.50(10) 817.85(10) 1772.1(2) 1054.7(2) 
X-ray wavelength 0.71073 0.71073 1.54178 0.71073 0.71073 
μ, mm-1 3.803 3.112 30.633 5.323 3.068 
trans min / max 0.358 / 0.751 0.498 / 0.706 0.158 / 0.468 0.281 / 0.675 0.405 / 0.710 
Reflections      
collected 13344 23597 10389 41275 14229 
independent 4435 6107 2824 12220 7012 
observed 4224 5718 2574 11263 6298 
Threshold 
expression 
>2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) 
R1 (observed) 0.0334 0.0192 0.0434 0.0253 0.0245 
wR2 (all) 0.0834 0.0543 0.1218 0.0513 0.0626 
S 1.074 0.981 1.022 1.124 1.053 
 
Code A2:D8 A1:D7 A1:D8 A1:D10 A4:D9 
Formula moiety (C18H16N6)(C6F4I2) (C18H16N6)(C6F4I2)2 (C18H16N6)(C6F4I2) (C18H16N6)(C12F8I2)2 (C20H18N4)(C6F3I3) 
Empirical formula C24H16F4I2N6 C30H16F8I4N6 C24H16F4I2N6 C42H16F16I4N6 C26H18F3I3N4 
Molecular weight 718.23 1120.09 718.23 1416.21 824.14 
Color,  Habit colourless plate colourless prism colourless plate colourless prism colourless plate 
Crystal system Triclinic Monoclinic Triclinic Triclinic Triclinic 
Space group,  Z P-1, 1 P21/c, 2 P-1, 1 P-1, 1 P-1, 4 
crystal size, 
mm x mm x mm 
0.34 x 0.28 x 0.06 0.36 x 0.20 x 0.14 0.34 x 0.28 x 0.14 0.40 x 0.26 x 0.22 0.32 x 0.24 x 0.08 
a, Å 5.8829(3) 13.069(4) 5.1265(5) 5.2777(4) 11.3637(12) 
b, Å 9.7141(5) 4.4363(12) 9.8466(10) 14.2810(11) 13.0207(15) 
c, Å 10.8695(6) 28.718(8) 12.5775(13) 14.3038(11) 19.240(2) 
α, ° 91.555(2) 90.00 76.972(3) 84.605(3) 99.718(3) 
β, ° 100.9460(10) 101.630(8) 86.963(2) 82.149(2) 91.134(3) 
γ, ° 107.2690(10) 90.00 75.742(2) 83.415(2) 109.709(3) 
Volume, Å3 580.05(5) 1630.9(8) 599.50(10) 1057.57(14) 2632.5(5) 
X-ray wavelength 0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 2.770 3.900 2.681 3.059 3.606 
trans min / max 0.453 / 0.851 0.334 / 0.611 0.463 / 0.705 0.374 / 0.553 0.392 / 0.761 
Reflections      
collected 13635 23399 11962 27574 33527 
independent 3870 5568 4046 8021 33527 
observed 3735 4978 3831 7600 28115 
Threshold 
expression 
>2σ (I) >2σ (I) >2σ (I) >2σ (I) >2σ (I) 
R1 (observed) 0.0180 0.0231 0.0190 0.0206 0.0665 
wR2 (all) 0.0501 0.0569 0.0525 0.0566 0.1900 
S 0.934 1.026 0.984 0.981 1.049 
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Halogen bond geometries  
 
 B.3 Chapter 4 
Experimental details 
Datasets were collected on a Bruker APEX II system with MoKα radiation using APEX2 
software.1 Initial cell constants were found by small widely separated “matrix” runs. Data 
collection strategies were determined using COSMO.2 Scan speed and scan widths were chosen 
based on scattering power and peak rocking curves. All datasets were collected at -153 °C using 
an Oxford Croystream low-temperature device. 
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,3 using this 
improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT from 
the final merged dataset. Lorenz and polarization corrections were applied. Unless otherwise 
noted, multi-scan absorption corrections were performed with SADABS.4 
Co-crystal C-I⋯N N⋯I (Å) N⋯I-C (0) 
A1:D1 C(31)-I(1)⋯N(21) 2.8175(18) 175.63(7) 
A1:D2 C(31)-I(1)⋯N(11) 2.786(2) 178.49(10) 
A1:D3 C(31)-I(1)⋯N(11) 2.8029(18) 172.54(8) 
A1:D4 C(31)-I(1)⋯N(21) 2.789(3) 173.13(12) 
A1:D7 
C(31)-I(1)⋯N(21) 
C(32)-I(2)⋯I(1) 
2.7777(18) 
3.8424(7) 
177.06(6) 
173.59(5) 
A1:D8 C(31)-I(1)⋯N(11) 2.7913(14) 175.98(5) 
A1:D10 C(31)-I(1)⋯N(21) 2.7747(13) 173.45(5) 
A2:D2 C(31)-I(1)⋯N(211) 2.812(7) 174.5(3) 
A2:D3 
C(1)-I(1)⋯N(1) 
C(21)-N(6)⋯I(2) 
2.802(4) 
3.150(4) 
176.54(15) 
144.0(3) 
A2:D7 
C(31)-I(1)⋯N(21) 
C(32)-I(2)⋯N(21) 
2.848(5) 
3.255(5) 
174.39(19) 
165.16(18) 
A2:D8 C(31)-I(1)⋯N(21) 2.8598(13) 175.13(5) 
A2:D9 
C(312)-I(42)⋯N(212) 
C(311)-I(11)⋯N(211) 
C(332)-I(52)⋯N(132) 
2.757(2) 
2.830(2) 
3.123(2) 
176.06(8) 
176.70(8) 
164.81(7) 
A2:D10 
C(31)-I(1)⋯N(21) 
C(41)-I(2)⋯N(13) 
2.824(2) 
3.1345(19) 
175.93(7) 
166.07(7) 
A3:D9 C(33)-I(2)⋯N(21) 2.887(3) 178.09(10) 
A3:D10 
C(31)-I(1)⋯N(21) 
C(41)-I(2)⋯N(13)#2 
2.8813(16) 
3.3015(17) 
175.87(6) 
164.27(6) 
A4:D9 
C(511)-I(11)⋯N(131) 
C(512)-I(42)⋯N(132) 
2.897(4) 
3.028(4) 
174.13(16) 
171.17(19) 
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Data were reduced with SHELXTL.5 The structures were solved in all cases by direct 
methods without incident. Unless otherwise noted, hydrogen atoms were located in idealized 
positions and were treated with a riding model. All non-hydrogen atoms were assigned anisotropic 
thermal parameters. Refinements continued to convergence, using the recommended weighting 
schemes. 
A5:D7 - Stoichiometry is 2: 3 amine : diiodo compound. One of the diiodo compounds 
straddled a crystallographic inversion center. 
A5:D9 - The asymmetric unit contains a 1 : 1 ratio of amine : diiodo compound. 
A6:D2 - Stoichiometry is 2: 3 amine : diiodo compound. One of the diiodo compounds 
was disordered, and the other diiodo compound straddled a crystallographic inversion center and 
was assigned 50% occupancy. Pairwise thermal constraints and distance constraints were applied 
to both dioodo compounds. A free variable was used to control the ratio of species for the first 
iodo compound. 
A6:D7 - Stoichiometry is 2: 3 amine : diiodo compound. One of the diiodo compounds 
straddled a crystallographic inversion center 
A7:D310 - Dataset was collected on an Oxford Diffraction Xcalibur four-circle kappa 
geometry single-crystal diffractometer with Sapphire 3 CCD detector, using a graphite 
monochromated MoK ( = 0.71073 Å) radiation, and applying the CrysAlisPro Software system8 
at 296 K. The crystal–detector distance was 45 mm.  
Data reduction, including Lorentz and polarization corrections as well as absorption 
correction, was done by CrysAlis RED program.8  The structure was solved by Direct methods 
implemented in the SHELXS-2013 program.9 The coordinates and the anisotropic displacement 
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parameters for all non-hydrogen atoms were refined by full-matrix least-squares methods based 
on F2 using the SHELXL-2013 program.9  
All hydrogen atoms were placed in geometrically idealized positions and constrained to 
ride on their carbon atom at distances of 0.93 or 0.97 Å for aromatic or methylene hydrogen atoms, 
respectively, and with Uiso(H) = 1.2Ueq(C) (for aromatic H) and Uiso(H) = 1.5Ueq(C) (for methylene 
group). 
A7:D8 - The asymmetric unit contains a 1 : 1 ratio of amine : diiodo compound. 
A7:D10 - The asymmetric unit contains one amine / diiodo compound pair. 
A8:D8 - The asymmetric unit contains 2 amines and 2 diiodo compounds. The SHELXL 
“RESI” command was use to assign similar names to these molecules. 
A8:D9 - The asymmetric unit contains a 1 : 2 ratio of amine : triiodo compound. 
A9:D8 - Stoichiometry is 2 : 1 amine : diiodo compound. The diiiodo compound sits on a 
crystallographic inversion center. 
A9:D9 - The asymmetric unit contains one amine / triiodo compound pair. 
A10:D4 - Stoichiometry is 2: 3 amine : diiodo compound. One of the diiodo compounds 
straddled a crystallographic inversion center and was disordered,. Pairwise thermal constraints and 
distance constraints were applied to both dioodo compounds. A free variable was used to control 
the ratio of species for the first iodo compound. Carbon and fluorine atoms for the first diiodo 
compound and carbon atoms for the second diiodo compound were given isotropic thermal 
parameters. 
A10:D7 - The asymmetric unit contains a 1 : 1 ratio of amine : diiodo compound. 
A10:D8 - Stoichiometry is 1: 1 amine : diiodo compound. The asymmetric unit contains 
two half-diiodo compounds. Each diiodo compound sits on a crystallographic inversion center. 
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A10:D9 - The asymmetric unit contains a 1 : 2 ratio of amine : triiodo compound. 
A11:D9 - The asymmetric unit contains a 1 : 1 ratio of amine : triiodo compound. It also 
contains a solvent methanol, whose occupancy was set to 0.25 during refinement. The solvent 
carbon and oxygen atoms were refined with isotropic thermal parameters. 
A11:D10 - The asymmetric unit contains a 1 : 2 ratio of amine : diiodo compound. It also 
contains a molecule of acetone. 
A12:D2 - The asymmetric unit contains one amine / diiodo compound pair. 
A12:D8 - The asymmetric unit contains one amine / diiodo compound pair. 
A13:D1 - The asymmetric unit contains six amines and four diiodo compounds. It also 
contains two molecules of hydroiodic acid. Proton transfer to two amines was observed, and 
coordinates for these two protons were allowed to refine. 
A13:D2 - The crystal was a nonmerohedral twin and data intensities were processed with 
TWINABS.6 Stoichiometry is 2: 1 amine : diiodo compound. The asymmetric unit contains two 
amines and two half-diiodo compounds. Each diiodo compound sits on a crystallographic 
inversion center. 
A13:D3 - The crystal was a nonmerohedral twin and data intensities were processed with 
TWINABS.6 The asymmetric unit contains a 1 : 1 ratio of amine : diiodo compound. 
A13:D7 - The asymmetric unit contains a 1 : 1 ratio of amine : diiodo compound. 
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Crystallographic data  
 
Code A7:D10 A8:D8 A8:D9 A9:D8 A9:D9 A10:D4 
Formula moiety 
(C9H9N3) 
(C12F8I2) 
(C13H11N3) 
(C6F4I2) 
(C13H11N3) 
(C6F3I3)2 
(C15H13N3)2 
(C6F4I2) 
(C15H13N3) 
(C6F3I3) 
(C15H15N3)2 
(C8F16I2)3 
Empirical 
formula 
C21H9F8I2N3 C19H11F4I2N3 C25H11F6I6N3 C36H26F4I2N6 C21H13F3I3N3 C54H30F48I6N6 
Molecular weight 709.11 611.11 1228.77 872.43 745.04 2436.24 
Color, Habit yellow plate colourless prism colourless rod colourless plate colourless block colourless rod 
Crystal system Monoclinic Monoclinic Monoclinic Monoclinic Triclinic Triclinic 
Space group, Z P2(1)/c, 2 P2(1)/c, 8 P2(1)/n, 4 P2(1)/c, 2 P-1, 2 P-1, 1 
a, Å 8.0816(9) 16.3849(19) 14.0476(14) 5.4499(4) 9.0175(7) 6.2290(4) 
b, Å 23.780(3) 20.688(3) 9.0900(9) 12.0840(9) 10.1261(8) 15.6889(11) 
c, Å 11.2100(13) 11.4260(14) 24.060(3) 24.4295(17) 13.2460(11) 18.5576(13) 
α, ° 90 90.00 90.00 90.00 76.552(3) 79.581(3) 
β, ° 92.000(4) 93.752(3) 96.564(4) 94.263(2) 77.654(3) 89.789(2) 
γ, ° 90 90.00 90.00 90.00 69.369(2) 82.712(2) 
Volume, Å3 2153.0(4) 3864.7(9) 3052.1(6) 1604.4(2) 1089.30(15) 1768.9(2) 
Code A5:D8 A5:D10 A6:D2 A6:D8 A7:D3 A7:D8 
Formula moiety 
(C13H11N3)2 
(C6F4I2)3 
(C13H11N3)(C12F8
I2) 
(C15H15N3)2 
(C4F8I2)3 
(C15H15N3)2 
(C6F4I2)3 
(C9H9N3) 
(C6F12I2) 
(C9H9N3) 
(C6F4I2) 
Empirical 
formula 
C44H22F12I6N6 C25H11F8I2N3 C42H30F24I6N6 C48H30F12I6N6 C12H9F12I2N3 C15H9F4I2N3 
Molecular 
weight 
1624.08 759.17 1836.12 1680.18 713.05 561.05 
Color, Habit colourless needle colourless plate colourless plate colourless needle colourless block colourless prism 
Crystal system Monoclinic Triclinic Triclinic Monoclinic Monoclinic Monoclinic 
Space group, Z P2(1)/c, 2 P-1, 2 P-1, 1 C2/c, 4 P 21/n, 4 P2(1)/c, 4 
a, Å 20.534(2) 8.7174(7) 6.1821(9) 45.703(4) 11.293(1) 8.2550(12) 
b, Å 4.7796(5) 11.0124(10) 14.174(2) 4.8060(5) 9.8282(11) 19.307(3) 
c, Å 24.675(3) 13.5138(12) 15.913(2) 23.908(2) 20.583(3) 10.4263(15) 
α, ° 90.00 76.218(2) 76.382(4) 90.00 90.00 90.00 
β, ° 102.521(4) 75.941(2) 89.240(3) 105.369(9) 105.137(14) 92.213(4) 
γ, ° 90.00 79.323(2) 86.597(4) 90.00 90.00 90.00 
Volume, Å3 2364.1(4) 1211.00(18) 1352.8(3) 5063.5(9) 2205.3(5) 1660.5(4) 
Density, g/cm3 2.281 2.082 2.254 2.204 2.148 2.244 
Temperature, 
°K 
120(2) 120(2) 120(2) 120(2) 296(2) 120(2) 
Crystal size, 
min x mid x 
max 
0.06 x 0.08 x 
0.44 
0.10 x 0.28 x 
0.34 
0.12 x 0.38 x 
0.44 
0.06 x 0.10 x 
0.44 
0.24 x 0.37 x 
0.46 
0.26 x 0.34 x 
0.38 
X-ray 
wavelength, Å 
0.71073 0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 4.030 2.680 3.566 3.767 2.959 3.831 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / 
max 
0.2701 / 0.7940 0.4627 / 0.7754 0.3030 / 0.6743 0.2880 / 0.8055 0.297 / 0.486 0.3238 / 0.4358 
θmin, ° 1.69 1.92 1.73 1.76 4.27 2.11 
θmax, ° 32.13 31.95 32.06 32.53 29.25 32.51 
Reflections       
collected 24646 24172 41225 27573 10140 30444 
independent 7497 7352 8742 8623 4957 5567 
observed 5880 6502 8041 7071 3165 5312 
Threshold 
expression 
>2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0296 0.0209 0.0414 0.0296 0.0470 0.0199 
wR2 (all) 0.0711 0.0485 0.1014 0.0605 0.1194 0.0432 
Goodness of fit 
(all) 
1.028 1.041 1.030 1.038 1.008 1.112 
Δρ max / min 1.102 / -0.878 0.591 / -0.562 1.544 / -1.601 1.630 / -1.332 0.803 / -0.727 0.518 / -0.625 
2θ limit 30.00 30.00 30.00 32.50 25.24 31.00 
Completeness to 
2θ limit 
0.977 0.980 0.997 0.940 0.970 0.988 
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Density, g/cm3 2.188 2.101 2.674 1.806 2.272 2.287 
Temperature, °K 120(2) 120(2) 120(2) 120(2) 120(2) 120(2) 
Crystal size, 
min x mid x max 
0.100 x 0.320 x 
0.360 
0.12 x 0.26 x 
0.44 
0.06 x 0.08 x 
0.32 
0.06 x 0.20 x 
0.42 
0.14 x 0.18 x 
0.22 
0.08 x 0.12 x 
0.38 
X-ray 
wavelength, Å 
0.71073 0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 3.006 3.302 6.165 2.021 4.343 2.805 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.526 / 0.753 0.3244 / 0.6927 0.2430 / 0.7086 0.4840 / 0.8883 0.4484 / 0.5815 0.4154 / 0.8068 
θmin, ° 1.713 1.59 1.60 1.67 1.60 1.57 
θmax, ° 32.706 32.06 32.62 32.03 33.27 32.62 
Reflections       
collected 35429 36736 40571 23137 31815 32693 
independent 7547 12505 10577 5133 7252 11844 
observed 6839 10148 8100 4583 6349 9710 
Threshold 
expression 
I > 2σ(I) >2σ(I) >2σ(I) I >2σ(I) I >2σ(I) >2σ(I) 
R1 (observed) 0.0289 0.0265 0.0307 0.0233 0.0271 0.0395 
wR2 (all) 0.0751 0.0596 0.0540 0.0565 0.0569 0.1062 
Goodness of fit 
(all) 
1.095 1.060 1.078 1.035 1.030 1.096 
Δρ max / min 0.982 / -1.154 1.056 / -0.554 1.365 / -1.570 0.707 / -0.439 0.894 / -0.874 2.480 / -1.803 
2θ limit 31.000 30.00 30.00 30.00 30.00 30.00 
Completeness to 
2θ limit 
0.991 0.972 0.989 0.985 0.998 0.982 
 
Code A10:D7 A10:D8 A10:D9 A11:D9 A11:D10 A12:D2 
Formula 
moiety 
(C15H15N3) 
(C6F4I2)2 
(C15H15N3) 
(C6F4I2) 
(C15H15N3) 
(C6F3I3)2 
(C15H13N3) 
(C6F3I3) 
(C1H4O)0.25 
(C15H13N3) 
(C12F8I2)2 
(C3H6O1) 
(C9H9N3) 
(C4F8I2) 
Empirical 
formula 
C27H15F8I4N3 C21H15F4I2N3 C27H15F6I6N3 C21.25H14F3I3N3O0.25 C42H19F16I4N3O C13H9F8I2N3 
Molecular 
weight 
1041.02 639.16 1256.82 753.05 1393.20 613.03 
Color, Habit bronze plate gold prism 
colourless 
prism 
colourless prism colourless priism 
colourless 
plate 
Crystal system Triclinic Triclinic Triclinic Triclinic Triclinic Monoclinic 
Space group, Z P-1, 2 P-1, 2 P-1, 2 P-1, 2 P-1, 2 P2(1)/c, 4 
a, Å 8.1680(15) 6.3653(9) 9.0728(17) 9.2576(14) 8.5570(5) 11.0738(19) 
b, Å 13.8655(18) 9.0358(13) 9.4997(17) 11.5659(17) 16.0998(11) 16.892(3) 
c, Å 14.800(3) 19.158(3) 19.925(4) 11.9691(18) 16.3207(11) 10.0913(16) 
α, ° 108.699(11) 102.267(5) 92.496(6) 108.555(5) 75.578(2) 90.00 
β, ° 102.03(2) 96.243(5) 101.102(7) 90.795(5) 80.8737(19) 109.070(5) 
γ, ° 102.751(14) 98.349(5) 108.962(6) 103.393(4) 88.850(2) 90.00 
Volume, Å3 1476.1(5) 1054.1(3) 1583.2(5) 1176.6(3) 2149.6(2) 1784.1(5) 
Density, g/cm3 2.342 2.014 2.636 2.126 2.152 2.282 
Temperature, 
°K 
120(2) 120(2) 120(2) 120(2) 120(2) 120(2) 
Crystal size, 
min x mid x 
max 
0.14 x 0.26 x 
0.34 
0.14 x 0.26 x 
0.38 
0.18 x 0.24 x 
0.30 
0.26 x 0.34 x 0.44 0.16 x 0.24 x 0.42 
0.08 x 0.22 x 
0.34 
X-ray 
wavelength, Å 
0.71073 0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 4.296 3.031 5.946 4.023 3.008 3.607 
Absorption 
corr 
multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / 
max 
0.3229 / 0.5845 0.3921 / 0.6763 0.2686 / 0.4141 0.2706 / 0.4211 0.3647 / 0.6447 
0.3735 / 
0.7613 
θmin, ° 1.52 2.20 1.05 1.80 1.30 2.41 
θmax, ° 33.18 33.16 32.12 30.58 32.58 32.52 
Reflections       
collected 25813 27813 32477 25794 77154 45544 
independent 9348 6850 10130 7142 14445 6200 
observed 8729 6229 9066 6563 12730 4946 
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Threshold 
expression 
>2σ(I) >2σ(I) >2σ(I) I >2σ(I) I >2σ(I) I >2σ(I) 
R1 (observed) 0.0307 0.0190 0.0251 0.0226 0.0225 0.0346 
wR2 (all) 0.0795 0.0459 0.0718 0.0537 0.0551 0.0684 
Goodness of fit 
(all) 
1.088 0.967 1.161 1.060 1.077 1.087 
Δρ max / min 1.945 / -1.753 0.530 / -0.445 1.191 / -1.379 0.741 / -0.936 0.678 / -1.210 1.593 / -1.000 
2θ limit 30.00 30.00 30.00 30.00 30.00 31.00 
Completeness 
to 2θ limit 
0.952 0.981 0.964 0.996 0.998 0.998 
 
 
Halogen bond geometries  
Co-crystal C−I⋯N N⋯I (Å) N⋯I-C (0) 
A5:D7 
C(31)-I(1)···N(13) 
C(41)-I(2)···N(21) 
2.782(2) 
2.762(3) 
168.27(10) 
177.29(10) 
A5:D9 
C(31)-I(1)⋯N(13) 
C(41)-I(2)⋯N(21)#1 
2.9658(16) 
2.8379(16) 
166.92(6) 
177.30(6) 
A6:D2 
C(41A)-I(1)⋯N(13) 
C(41B)-I(1)⋯N(13) 
C(44A)-I(2A)⋯N(31)#1 
C(44B)-I(2B)⋯N(31)#1 
2.838(3) 
2.838(3) 
2.769(3) 
2.868(3) 
169.5(2) 
174.6(3) 
169.0(3) 
175.6(2) 
A6:D7 
C(41)-I(1)⋯N(13) 
C(51)-I(2)⋯N(31) 
2.813(2) 
2.764(2) 
179.33(8) 
176.80(8) 
A7:D3 C(10)-I(1)⋯N(3) 2.854(6) 174.9(2) 
Code A12:D8 A13:D1 A13:D2 A13:D3 A13:D7 
Formula moiety 
(C9H9N3) 
(C6F4I2) 
(C7H10N2)3(C2F4I2)2 
(H1I1)1 
(C7H10N2)2 
(C4F8I2) 
(C7H10N2) 
(C6F12I2) 
(C7H10N2) 
(C6F4I2) 
Empirical formula C15H9F4I2N3 C25H31F8I5N6 C18H20F8I2N4 C13H10F12I2N2 C13H10F4I2N2 
Molecular weight 561.05 1202.06 698.18 676.03 524.03 
Color, Habit colourless prism colourless plate colourless plate colourless plate colourless prism 
Crystal system Triclinic Triclinic Triclinic Monoclinic Triclinic 
Space group, Z P-1, 2 P-1, 4 P-1, 2 P2(1)/c, 4 P-1, 4 
a, Å3 8.9744(13) 9.9115(14) 9.1093(8) 10.4273(8) 8.4741(5) 
b, Å3 9.0522(14) 17.748(2) 10.3042(9) 6.8308(5) 12.2584(6) 
c, Å3 11.9251(18) 21.823(3) 12.7170(11) 27.504(2) 15.3992(8) 
α, ° 101.157(4) 76.380(4) 96.877(3) 90.00 103.739(2) 
β, ° 107.766(3) 82.913(4) 90.277(3) 94.820(2) 97.874(2) 
γ, ° 107.334(3) 87.460(4) 96.466(3) 90.00 95.942(2) 
Volume, Å3 836.5(2) 3701.9(8) 1177.34(18) 1952.1(3) 1523.77(14) 
Density, g/cm3 2.228 2.157 1.969 2.300 2.284 
Temperature, °K 120(2) 120(2) 120(2) 120(2) 120(2) 
Crystal size, 
min x mid x max 
0.10 x 0.22 x 0.32 0.04 x 0.18 x 0.26 0.08 x 0.20 x 0.40 0.08 x 0.28 x 0.32 0.12 x 0.20 x 0.32 
X-ray wavelength, Å 0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 3.802 4.267 2.747 3.334 4.164 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.3758 / 0.7023 0.5795 / 0.7463 0.4062 / 0.8102 0.4150 / 0.7763 0.3492 / 0.6349 
θmin, ° 1.89 1.18 1.61 1.96 1.38 
θmax, ° 32.53 32.03 31.59 32.05 33.13 
Reflections      
collected 21465 76484 13955 9624 31993 
independent 5554 23133 13955 9624 9317 
observed 4898 18020 9585 8055 8016 
Threshold expression I >2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0240 0.0436 0.0475 0.0640 0.0291 
wR2 (all) 0.0534 0.1205 0.1396 0.1914 0.0642 
Goodness of fit (all) 1.048 1.050 1.017 1.388 1.053 
Δρ max / min 0.970 / -0.571 6.740 / -4.192 1.540 / -1.754 2.427 / -1.803 1.095 / -0.442 
2θ limit 31.00 30.00 31.00 31.50 30.00 
Completeness to 2θ 
limit 
0.972 0.977 0.987 0.963 0.947 
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C(15)-I(2)⋯N(1)i 2.866(5) 174.0(2) 
A7:D7 
C(31)-I(1)⋯N(13) 
C(34)-I(2)⋯N(21)#2 
2.8336(16) 
2.8149(15) 
170.80(6) 
174.00(6) 
A7:D9 
C(31)-I(1)···N(13) 
C(41)-I(2)···N(21)#1 
2.766(3) 
2.768(3) 
174.21(8) 
177.05(9) 
A8:D7 
C311-I11⋯N131 
C341-I21⋯N211#1 
C312-I32⋯N132 
2.8096(19) 
2.8502(19) 
2.7891(18) 
176.85(8) 
170.39(7) 
177.27(7) 
A8:D8 
C(31)-I(1)⋯N(13) 
C(41)-I(4)⋯N(21) 
2.807(2) 
2.820(2) 
175.70(11) 
177.93(10) 
A9:D7 C(41)-I(1)⋯N(13) 2.7601(9) 176.67(4) 
A9:D8 
C(41)-I(1)⋯N(13) 
C(43)-I(2)⋯N(21)#1 
2.852(2) 
2.889(2) 
169.65(7) 
172.31(8) 
A10:D4 
C(41A)-I(1)···N(13) 
C(41B)-I(1)···N(13) 
C(51)-I(2)···N(31) 
2.924(3) 
2.924(3) 
2.982(3) 
172.7(2) 
171.5(5) 
169.96(13) 
A10:D6 
C(41)-I(1)⋯N(13) 
C(51)-I(3)⋯N(31) 
2.793(2) 
3.016(2) 
177.63(9) 
170.94(9) 
A10:D7 
C(41)-I(1)⋯N(13) 
C(51)-I(2)⋯N(31) 
2.8071(14) 
2.8788(16) 
177.59(5) 
174.16(6) 
A10:D8 
C(41)-I(1)⋯N(13) 
C(51)-I(4)⋯N(31) 
2.965(3) 
2.788(3) 
165.81(10) 
176.44(13) 
A11:D8 
C(41)-I(1)⋯N(13) 
C(26)-N(21)⋯I(2)#1 
2.814(2) 
2.8063(19) 
171.73(7) 
125.91(15) 
A11:D9 
C(12)-N(13)⋯I(1) 
C(51)-I(2)⋯N(21)#1 
2.7579(14) 
2.7696(15) 
130.05(11) 
177.11(5) 
A12:D2 
C(31)-I(1)⋯N(13) 
C(34)-I(2)⋯N(21)#1 
2.757(3) 
2.815(2) 
178.49(10) 
2.815(2) 
A12:D7 
C(31)-I(1)⋯N(13) 
C(34)-I(2)⋯N(21)#1 
2.8357(17) 
2.8688(18) 
171.67(7) 
172.76(7) 
A13:D1 
C(6)-I(6)···N(11) 
C(8)-I(8)···N(21) 
2.664(4) 
2.689(4) 
176.48(15) 
172.01(16) 
A13:D2 
C211-I11⋯N111 
C212-I22⋯N112 
2.641(3) 
2.668(3) 
178.10(11) 
178.93(11) 
A13:D3 
C(21)-I(1)⋯N(11) 
C(26)-I(2)⋯N(14)#1 
2.683(4) 
3.440(5) 
176.4(2) 
164.42(18) 
A13:D6 
C(31)-I(1)···N(11) 
C(32)-I(2)···N(21) 
2.722(2) 
2.776(2) 
178.30(10) 
173.43(9) 
 
 B.4 Chapter 5 
Experimental details 
Datasets were collected on a Bruker Kappa APEX II system using CuKα radiation 
(A18:D3), or a on a Bruker APEX II system using MoKα radiation (all others except A17:D1 and 
A17:D7). Data were collected using APEX2 software. 1 Initial cell constants were found by small 
widely separated “matrix” runs. Data collection strategies were determined using COSMO.2 Scan 
speed and scan widths were chosen based on scattering power and peak rocking curves. All 
datasets were collected at -153 °C using an Oxford Croystream low-temperature device. 
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Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,3 using this 
improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT from 
the final merged dataset. Lorenz and polarization corrections were applied. Multi-scan absorption 
corrections were performed with SADABS.4 
Data were reduced with SHELXTL.5 The structures were solved in all cases by direct 
methods without incident. Except as noted, hydrogen atoms were located in idealized positions 
and were treated with a riding model. All non-hydrogen atoms were assigned anisotropic thermal 
parameters. Refinements continued to convergence, using the recommended weighting schemes. 
A17:D17 - The single crystal X-ray diffraction studies were carried out on a Bruker D8 
Smart Apex CCD diffractometer equipped with Mo K
α 
 radiation ( = 0.71073 Å) and . A 0.44 x 
0.20 x 0.14 mm colorless rod was mounted on a Cryoloop with Paratone oil.  Data were collected 
in a nitrogen gas stream at 100(2) K using  and scans.  Crystal-to-detector distance was 60 mm 
and exposure time was 10 seconds per frame using a scan width of 0.4°.  Data collection was 100% 
complete to 25.00° in .  A total of 15508 reflections were collected covering the indices, -
15<=h<=16 -11<=k<=11, -12<=l<=12. 2435 reflections were found to be symmetry independent, 
with a Rint of 0.0315.  Indexing and unit cell refinement indicated a primitive, monoclinic lattice.  
The space group was found to be P21/c.  The data were integrated using the Bruker SAINT 
software program and scaled using the SADABS software program.  Solution by direct methods 
(SHELXS) produced a complete phasing model consistent with the proposed structure. All 
nonhydrogen atoms were refined anisotropically by full-matrix least-squares (SHELXL-97).  All 
hydrogen atoms were placed using a riding model.  Their positions were constrained relative to 
their parent atom using the appropriate HFIX command in SHELXL-97. 
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A17:D77 - Colorless crystal, mounted on a Cryoloop with Paratone-N oil and data collected 
at 100 K using a Bruker APEX I CCD with Mo K alpha radiation. Data corrected for absorption 
with SADABS and structure solved by direct methods. All non-hydrogen atoms were refined 
anisotropically by full matrix least squares on F2. Hydrogen atom H1N was found from a Fourier 
difference map and was allowed to refined with a N-H distance of 0.87 (2) angstroms and isotropic 
displacement parameters set to 1.20 Ueq of the parent N atom. All other H atoms were placed in 
calculated positions with appropriate riding modes. 
A16:D8 - The halo compound sits on a crystallographic inversion center, giving an overall 
2 : 1 amine : halo compound stoichiometry. Two alternate protonation schemes for the imidazole 
moiety were observed, corresponding to oppositely directed translation-related linear hydrogen 
bonding chains in the y direction. Two PARTs were assembled to account for the two schemes, 
with EADP and EXYZ instructions pairwise included for superimposed nitrogen atoms (N11A & 
N11B and N13A & N13B). The proportion of the two sites was allowed to refine by using a free 
variable; this free variable refined to 0.20(4), representing a ~ 20:80 proportion for the two 
schemes. 
A17:D2 - The halo compound sits on a crystallographic inversion center, giving an overall 
2 : 1 amine : halo compound stoichiometry. Two alternate protonation schemes for the imidazole 
moiety were observed, corresponding to oppositely directed linear hydrogen bonding chains along 
the c glide plane. A hydrogen atom was included at both imidazole nitrogen atoms (N21 and N23) 
in idealized positions, and the occupancy of these two hydrogen atoms was allowed to refine, while 
summing to 1.0, by using a free variable; this free variable refined to 0.81(4), representing a ~ 
81:19 proportion for the two schemes. 
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A17:D8 - The halo compound sits on a crystallographic inversion center, giving an overall 
2 : 1 amine : halo compound stoichiometry. Coordinates for the amine proton H11 were allowed 
to refine. 
A17:D9 - The halo compound sits on a crystallographic twofold axis, giving an overall 2 : 
1 amine : halo compound stoichiometry. Coordinates for the amine proton H11 were allowed to 
refine. 
A17:D10 - The compound crystallizes with an overall 2 : 1 amine : halo compound 
stoichiometry. The structure was solved and refined in the noncentrosymmetric space group Pc, 
and was treated as a racemic twin, with the batch scale factor refining to 0.129(11). For each 
imidazole moiety, two alternate protonation schemes were observed, corresponding to oppositely 
directed linear hydrogen bonding chains along the c glide plane. For each imidazole moiety, 
PARTs were assembled to account for the two schemes, with EADP and EXYZ instructions 
pairwise included for superimposed nitrogen atoms (N11A & N11B; N13A & N13B; N31A & 
N31B; N33A & N33B). 
A17:D14 - The halo compound sits on a crystallographic inversion center, giving an overall 
2 : 1 amine : halo compound stoichiometry. Occupancies of the bromine and the iodine atoms were 
fixed to 0.50 to accommodate disorder on the inversion center. Two alternate protonation schemes 
for the imidazole moiety were observed, corresponding to oppositely directed linear hydrogen 
bonding chains along the c glide plane. For each imidazole moiety, the proportion of the two sites 
was allowed to refine by using free variables; this free variables refined to 0.64(6) and 0.33(6) for 
the two sites. Two PARTs were assembled to account for the two schemes, with EADP and EXYZ 
instructions pairwise included for superimposed nitrogen atoms (N11A & N11B and N13A & 
290 
N13B). The proportion of the two sites was allowed to refine by using a free variable; this free 
variable refined to 0.23(20). 
A18:D3 - The halo compound sits on a crystallographic inversion center. There are two 
different amine species present: the first sits on a general position, and the second straddles a 
crystallographic inversion center and was modeled as a complete molecule having an occupancy 
of 50%. The overall stoichiometry was therefore 2 : 1 amine : halo compound. The geometry of 
the second amine was restrained to approximate the fully ordered first amine by using the SHELXL 
SAME command, and the EADP command was used to pairwise constrain thermal parameters of 
atoms in the partially occupied amine that are located in proximity to each other. 
A18:D8 - The asymmetric unit contains two amines on general positions, one halo 
compound on a general position, and two half-halo compounds sitting adjacent to crystallographic 
inversion centers. Overall stoichiometry in the asymmetric unit is therefore 2 : 2 amine : halo 
compound. Coordinates for the amine protons H11 and H31 were allowed to refine. 
A18:D10 - The halo compound sits on a crystallographic 2-fold axis, giving an overall 2 : 
1 amine : halo compound stoichiometry. Coordinates for the amine proton H11 were allowed to 
refine. 
A19:D2 - The halo compound sits on a crystallographic inversion center, giving an overall 
2 : 1 amine : halo compound stoichiometry. The amine was disordered over two distinct sites. 
Occupancies for the two species were set to 0.50, and the SAME command was used to restrain 
geometries. Thermal parameters for certain closely positioned atoms were constrained by using 
the EADP command. Two alternate protonation schemes for both imidazole moieties were 
observed. For each imidazole molecule, N-H hydrogen atoms were added in idealized positions, 
and the population of the two hydrogen atoms was controlled with a free variable. The halo 
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compound was disordered over two closely located sites. The SAME command was used to 
restrain geometries, the EADP command was used to pairwise constrain closely located atoms, 
and the proportion of the two species was controlled with a free variable. 
A18:D8 - The halo compound sits on a crystallographic inversion center, giving an overall 
2 : 1 amine : halo compound stoichiometry. Coordinates for the amine proton H11 were allowed 
to refine. 
A18:D9 - The halo compound sits on a crystallographic 2-fold axis, giving an overall 2 : 1 
amine : halo compound stoichiometry. Two alternate protonation schemes for the imidazole 
moiety were observed, corresponding to oppositely directed linear hydrogen bonding chains along 
the ba glide plane. Two PARTs were assembled to account for the two schemes, with EADP and 
EXYZ instructions pairwise included for superimposed nitrogen atoms (N11A & N11B and N13A 
& N13B). The proportion of the two sites was allowed to refine by using a free variable; this free 
variable refined to 0.80(3), representing a ~ 80:20 proportion for the two schemes. 
A18:D101 - The compound crystallizes with an overall 2 : 1 amine : halo compound 
stoichiometry. Coordinates for the amine protons H11 and H31 were allowed to refine. 
Crystallographic data  
 
Code  A16:D8 A17:D1 A17:D2 A17:D7 A17:D8 
Formula moiety 
(C8H7N3)2 
(C6F4I2) 
(C8H7N3)2, (C2 F4 I2) 
(C8H7N3)2 
(C4F8I2) 
(C8H7N3)2, (C6F4I2) 
(C8H7N3)2 
(C6F4I2) 
Empirical formula C22H14F4I2N6 C18H14F4I2N6 C20H14F8I2N6 C22H14F4I2N6 C22H14F4I2N6 
Molecular weight 692.19 644.15 744.17 692.19 692.19 
Color, Habit colourless needle 
Colourless, 
Rod 
colourless prism 
Colourless, 
Block 
colourless plate 
Crystal system Monoclinic Monoclinic Monoclinic Monoclinic Monoclinic 
Space group, Z P2(1)/n, 2 P2(1)/c, 2 P2(1)/c, 2 Cm, 2 P2(1)/c, 2 
a, Å 12.9720(11) 12.3214(7) 14.3500(9) 10.0009(13) 4.1462(3) 
b, Å 5.0426(4) 8.9036(5) 8.7642(5) 28.964(4) 27.9646(17) 
c, Å 17.0878(15) 9.8742(6) 9.9637(6) 4.1036(6) 9.9124(6) 
α, ° 90.00 90.00 90.00 90.00 90.00 
β, ° 92.470(4) 100.4930(10) 106.551(2) 100.997(2) 100.094(2) 
γ, ° 90.00 90.00 90.00 90.00 90.00 
Volume, Å3 1116.72(16) 1065.13(11) 1201.18(12) 1166.8(3) 1131.52(13) 
Density, g/cm3 2.059 2.008 2.058 1.970 2.032 
Crystal size, min x 
mid x max 
0.06 x 0.10 x 0.42 0.44 x 0.20  x 0.14 0.16 x 0.22 x 0.30 0.30 x 0.20 x 0.10 0.06 x 0.18 x 0.26 
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μ, mm-1 2.874 3.004 2.702 2.750 2.836 
Trans min / max 0.3782 / 0.8465 0.3515/ 0.6784 0.4978 / 0.6717 0.4925/ 0.7705 0.5259 / 0.8483 
θmin, ° 1.93 1.68 1.48 2.81 1.46 
θmax, ° 32.56 27.49 33.14 26.40 32.58 
Reflections      
collected 17748 15508 21724 8684 13291 
independent 3962 2435 4223 2217 3850 
observed 3386 2327 3853 2118 3433 
Threshold 
expression 
>2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0256 0.0215 0.0284 0.0203 0.0254 
wR2 (all) 0.0622 0.0570 0.0639 0.0470 0.0607 
Goodness of fit (all) 1.058 1.037 1.110 1.023 1.022 
Δρ max / min 1.046 / -0.910 0.913/-0.609 1.394 / -0.763 0.408/ 0.452 0.734 / -0.545 
2θ limit 30.00 25.00 27.50 25.00 30.00 
Completeness to 2θ 
limit 
0.994 1.000 0.986 1.000 0.983 
 
Code  A17:D9 A17:D10 A17:D14 A18:D3 A18:D8 
Formula moiety 
(C8H7N3)2 
(C6F3I3) 
(C8H7N3)2 
(C12F8I2) 
(C8H7N3)2 
(C6BrF4I) 
(C8H7N3)3 
(C6F12I2) 
(C8H7N3)2 
(C6F4I2) 
Empirical formula C22H14F3I3N6 C28H14F8I2N6 C22H14BrF4IN6 C30H21F12I2N9 C22H14F4I2N6 
Molecular weight 800.09 840.25 645.20 989.36 692.19 
Color, Habit colourless plate colourless prism colourless rod colourless prism colourless needle 
Crystal system Orthorhombic Monoclinic Monoclinic Triclinic Monoclinic 
Space group, Z Pbcn, 4 Pc, 2 P2(1)/c, 2 P-1, 1 P2(1)/n, 2 
a, Å 32.4147(16) 4.2333(3) 4.0019(11) 5.1393(6) 12.9720(11) 
b, Å 9.9354(5) 32.768(2) 28.546(8) 11.0259(12) 5.0426(4) 
c, Å 7.4776(4) 9.9627(8) 9.972(3) 15.2795(17) 17.0878(15) 
α, ° 90.00 90.00 90.00 92.084(3) 90.00 
β, ° 90.00 93.7600(10) 98.464(8) 91.221(3) 92.470(4) 
γ, ° 90.00 90.00 90.00 100.093(3) 90.00 
Volume, Å3 2408.2(2) 1379.00(18) 1126.7(5) 851.52(17) 1116.72(16) 
Density, g/cm3 2.207 2.024 1.902 1.929 2.059 
Crystal size, min x 
mid x max 
0.06 x 0.20 x 0.28 0.12 x 0.20 x 0.28 0.06 x 0.14 x 0.26 0.08 x 0.14 x 0.22 0.06 x 0.10 x 0.42 
μ, mm-1 3.941 2.367 3.251 15.460 2.874 
Trans min / max 0.4050 / 0.7979 0.5570 / 0.7643 0.4853 / 0.8288 0.1321 / 0.3710 0.3782 / 0.8465 
θmin, ° 2.14 5.40 2.18 2.90 1.93 
θmax, ° 32.58 30.97 29.61 69.25 32.56 
Reflections      
collected 18651 15349 14624 13661 17748 
independent 3961 7025 3088 2928 3962 
observed 3361 6767 2657 2797 3386 
Threshold 
expression 
>2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0343 0.0205 0.1103 0.0368 0.0256 
wR2 (all) 0.0805 0.0480 0.2432 0.1302 0.0622 
Goodness of fit (all) 1.158 1.027 1.348 1.241 1.058 
Δρ max / min 1.906 / -0.858 0.625 / -0.414 1.180 / -1.820 0.769 / -0.997 1.046 / -0.910 
2θ limit 30.00 27.50 25.00 67.50 30.00 
Completeness to 2θ 
limit 
0.988 0.978 0.991 0.942 0.994 
 
Code A18:D10 A19:D2 A19:D8 A19:D9 A19:D10 
Formula moiety 
(C8H7N3)2 
(C12F8I2) 
(C7H6N4)2 
(C4F8I2) 
(C7H6N4)2 
(C6F4I2) 
(C7H6N4)2 
(C6F3I3) 
(C7H6N4)2 
(C12F8I2) 
Empirical formula C28H14F8I2N6 C18H12F8I2N8 C20H12F4I2N8 C20H12F3I3N8 C26H12F8I2N8 
Molecular weight 840.25 746.16 694.18 802.08 842.24 
Color, Habit colourless prism colourless prism colourless plate colourless rod yellow prism 
Crystal system Monoclinic Triclinic Monoclinic Orthorhombic Triclinic 
Space group, Z C2/c, 4 P-1, 1 P2(1)/c, 2 Pbcn, 4 P-1, 2 
a, Å 24.4359(12) 6.1488(7) 11.0717(6) 33.0655(16) 7.6527(4) 
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b, Å 7.2667(4) 6.3967(7) 10.6250(6) 9.8284(5) 12.7331(7) 
c, Å 16.3695(8) 15.8942(19) 10.1858(6) 7.3176(3) 15.4446(9) 
α, ° 90.00 81.861(4) 90.00 90.00 67.3200(10) 
β, ° 109.7130(10) 85.950(4) 108.814(2) 90.00 88.558(2) 
γ, ° 90.00 72.388(3) 90.00 90.00 81.6160(10) 
Volume, Å3 2736.4(2) 589.59(12) 1134.20(11) 2378.08(19) 1372.95(13) 
Density, g/cm3 2.040 2.101 2.033 2.240 2.037 
Crystal size, min x 
mid x max 
0.18 x 0.24 x 0.32 0.04 x 0.12 x 0.22 0.10 x 0.26 x 0.34 0.04 x 0.10 x 0.28 0.22 x 0.26 x 0.32 
μ, mm-1 2.386 2.755 2.832 3.993 2.380 
Trans min / max 0.5157 / 0.6734 0.5824 / 0.8978 0.4460 / 0.7649 0.4010 / 0.8566 0.5164 / 0.6226 
θmin, ° 2.64 1.29 1.94 2.16 1.75 
θmax, ° 33.13 32.70 32.64 32.52 33.45 
Reflections      
collected 14274 3658 10920 36207 40305 
independent 4778 3658 3791 4246 9826 
observed 4451 3313 3467 3689 9163 
Threshold 
expression 
>2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0231 0.0314 0.0219 0.0212 0.0210 
wR2 (all) 0.0570 0.1144 0.0595 0.0480 0.0516 
Goodness of fit (all) 1.029 1.135 1.077 1.046 1.041 
Δρ max / min 1.073 / -0.856 2.122 / -0.925 0.620 / -0.677 0.684 / -0.719 0.646 / -0.545 
2θ limit 30.00 27.50 30.00 32.52 30.00 
Completeness to 2θ 
limit 
0.985 0.984 0.983 0.983 0.987 
 
Halogen bond geometries  
 
 
 
 
Co-crystal C-I⋯N N⋯I (Å) N⋯I-C (°) 
A16:D8 C(31)-I(1)⋯N(21) 2.7985(17) 172.82(7) 
A17:D1 C(1)-I(1)⋯N(1) 2.851(2) 174.73(10) 
A17:D2 C(31)-I(1)⋯N(11) 2.8362(18) 169.70(8) 
A17:D7 C(1)-I(1)⋯N(3) 2.8602 (0.0031) 176.05( 0.11) 
A17:D8 C(31)-I(1)⋯N(21) 2.8085(18) 177.47(7) 
A17:D9 C(33)-I(2)⋯N(21) 2.914(3) 165.82(11) 
A17:D10 
C(51)-I(1)⋯N(21) 
C(61)-I(2)⋯N(41) 
2.846(3) 
2.813(3) 
178.60(10) 
175.53(11) 
A17:D14 C(51)-I(1)⋯N(21) 2.808(9) 178.5(3) 
A18:D3 C(51)-I(1)⋯N(13) 2.856(5) 176.0(2) 
A18:D8 
C(51)-I(1)⋯N(13) 
C(54)-I(2)⋯N(33) 
2.848(2) 
2.875(2) 
174.26(9) 
175.50(9) 
A18:D10 C(31)-I(1)⋯N(13) 2.9167(14) 173.26(5) 
A19:D2 
C(31B)-I(1)⋯N(14B) 
C(31A)-I(1)⋯N(14B) 
C(31B)-I(1)⋯N(14A) 
C(31A)-I(1)⋯N(14A) 
2.836(7) 
2.836(7) 
2.865(7) 
2.865(7) 
165.2(4) 
176.3(2) 
168.4(4) 
165.2(2) 
A19:D8 C(31)-I(1)⋯N(24) 2.8254(16) 173.90(6) 
A19:D9 C(33)-I(33)⋯N(24) 2.9383(15) 164.66(6) 
A19:D10 
C(12)-I(1)⋯N(13) 
C(32)-I(2)⋯N(33) 
2.8484(12) 
2.8625(12) 
140.10(10) 
140.81(10) 
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Hydrogen bond geometries 
Co-crystal D–H⋯A  D–H (Å) H⋯A (Å) D⋯A (Å) D–H⋯N (°) 
A16:D8 
N(11A)-H(11)⋯N(13A)#2 
N(13B)-H(13)⋯N(11B)#3 
0.88 
0.88 
2.15 
2.09 
2.882(2) 
2.882(2) 
140.6 
149.7 
A17:D1 N(3)-H(3)⋯N(2)#2 0.84(3) 2.01(3) 2.839(2) 169(3) 
A17:D2 
N(21)-H(21)⋯N(23)#2 
N(23)-H(23)⋯N(21)#3 
0.88 
0.88 
1.98 
2.08 
2.853(2) 
2.853(2) 
169.2 
146.1 
A17:D7 
N(1)-H(1N)⋯N(2)#2 
C(11)-H(11A)⋯N(2)#2 
0.879(18) 
0.95 
2.01(2) 
2.59 
2.879(4) 
3.441(5) 
171(4) 
148.8 
A17:D8 N(11)-H(11)⋯N(13)#2 0.88(3) 1.96(3) 2.834(2) 170(2) 
A17:D9 N11-H11⋯N13_$2 0.87(4) 2.00(4) 2.866(4) 173(4) 
A17:D10 
N(11A)-H(11)⋯N(13A)#1 
N(13B)-H(13)⋯N(11B)#2 
N(31A)-H(31)⋯N(33A)#3 
N(33B)-H(33)⋯N(31B)#4 
0.88 
0.88 
0.88 
0.88 
1.98 
1.97 
2.02 
2.01 
2.839(4) 
2.839(4) 
2.872(3) 
2.872(3) 
165.1 
167.0 
163.6 
167.9 
A17:D14 
N(11A)-H(11)⋯N(13A)#3 
N(13B)-H(13)⋯N(11B)#4 
0.88 
0.88 
2.01 
1.99 
2.862(11) 
2.862(11) 
162.0 
171.4 
A18:D3 
N(11)-H(11)⋯N(33) 
N(11)-H(11)⋯N(42)#2 
N(31)-H(31)⋯N(22)#2 
0.88 
0.88 
0.88 
2.20 
2.08 
2.31 
2.953(11) 
2.879(8) 
3.143(12) 
142.9 
150.0 
158.4 
A18:D8 
N(11)-H(11)⋯N(41)#3 
N(31)-H(31)⋯N(21)#4 
0.79(4) 
0.86(4) 
2.11(4) 
2.10(4) 
2.882(3) 
2.943(3) 
166(4) 
166(3) 
A18:D10 N(11)-H(11)⋯N(21)#2 0.87(3) 2.17(3) 2.9934(19) 157(2) 
A19:D2 
N(21A)-H(21A)⋯N(21A)#2 
N(23A)-H(23A)⋯N(23A)#3 
N(21B)-H(21B)⋯N(21B)#4 
N(23B)-H(23B)⋯N(23B)#5 
0.90 
0.90 
0.90 
0.90 
1.91 
2.12 
1.90 
2.14 
2.802(18) 
3.001(13) 
2.793(14) 
3.003(18) 
169.3 
164.5 
174.7 
159.9 
A19:D8 N(11)-H(11)⋯N(13)#2 0.76(3) 2.17(3) 2.900(2) 161(3) 
A19:D9 
N(11A)-H(11)⋯N(13A)#2 
N(13B)-H(13)⋯N(11B)#3 
0.88 
0.88 
1.91 
1.93 
2.7823(18) 
2.7823(18) 
170.6 
161.9 
A19:D10 
N(11)-H(11)⋯N(41)#1 
N(31)-H(31)⋯N(21)#2 
0.85(2) 
0.84(2) 
2.22(2) 
2.14(2) 
2.9877(18) 
2.9552(18) 
150(2) 
163(2) 
 
 B.5 Chapter 6 
Experimental details for haloethynylnitrobenzene compounds 
Crystals from 4N-I, 4N-Br, 3,5-DN-I and 3,5DN-Br were solved using single crystal X-
ray analysis. The samples (4N-I, 4N-Br and 3,5-DN-I) were analyzed with a Bruker APEX II 
system using MoKα radiation. Data collection was carried out using APEX2 software.1 Initial cell 
constants were found by small widely separated “matrix” runs. Data collection strategies were 
determined using COSMO.2 Scan speed and scan widths were chosen based on scattering power 
and peak rocking curves. All datasets were collected at -153 °C using an Oxford Croystream low-
temperature device. 
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Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,3 using this 
improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT from 
the final merged dataset. Lorenz and polarization corrections were applied. Multi-scan absorption 
corrections were performed with SADABS.4 
Data were reduced with SHELXTL.5 The structure was solved by direct methods without 
incident. All hydrogen atoms were located in idealized positions and were treated with a riding 
model. Unless otherwise noted, non-hydrogen atoms were assigned anisotropic thermal 
parameters. Refinements continued to convergence, using the recommended weighting schemes. 
Dataset for 3,5DN-Br10 was collected on an Oxford Diffraction Xcalibur four-circle kappa 
geometry single-crystal diffractometer with Sapphire 3 CCD detector, using a graphite 
monochromated MoK ( = 0.71073 Å) radiation, and applying the CrysAlisPro Software system8 
at 296 K. The crystal–detector distance was 45 mm.  
Data reduction, including Lorentz and polarization corrections as well as absorption 
correction, was done by CrysAlis RED program.8 The structure was solved by direct methods 
implemented in the SHELXS-2013 program.9 The coordinates and the anisotropic displacement 
parameters for all non-hydrogen atoms were refined by full-matrix least-squares methods based 
on F2 using the SHELXL-2013 program.9 All hydrogen atoms were placed in geometrically 
idealized positions and constrained to ride on their carbon atom at distance 0.93 Å and with 
Uiso(H) = 1.2Ueq(C). 
The structures for 4N-Cl and 3N-I were obtained from powder data.11 
 
 
296 
Crystallographic data for haloethynylnitrobenzene compounds 
Code 4N-I 4N-Br 3,5DN-I 3,5DN-Br 
Formula moiety C8H4INO2 C8H4BrNO2 C8H3IN2O4 C8H9BrN2O4 
Empirical formula C8H4INO2 C8H4BrNO2 C8H3IN2O4 C8H9BrN2O4 
Molecular weight 273.02 226.03 318.02 271.02 
Color, Habit bronze plate bronze rod orange plate yellow block 
Crystal system Orthorhombic Orthorhombic Monoclinic Monoclinic 
Space group, Z Pnma, 4 Pnma, 4 P2(1)/c, 4 P21/c, 4 
a, Å 7.005(3) 6.8296(5) 8.2717(13) 8.361(1) 
b, Å 9.681(4) 9.4723(8) 17.741(3) 17.158(2) 
c, Å 12.490(5) 12.1948(10) 7.1646(11) 7.349(1) 
α, ° 90.00 90.00 90.00 90 
β, ° 90.00 90.00 114.558(4) 115.971(17) 
γ, ° 90.00 90.00 90.00 90 
Volume, Å3 847.0(6) 788.91(11) 956.3(3) 947.9(2) 
Density, g/cm3 2.141 1.903 2.209 1.899 
Temperature, °K 120(2) 120(2) 120(2) 296(2) 
Crystal size, min x mid 
x max 
0.06 x 0.14 x 0.30 0.18 x 0.24 x 0.26 0.12 x 0.32 x 0.48 0.42 x 0.46 x 0.58 
X-ray wavelength, Å 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 3.735 5.161 3.343 4.331 
Absorption corr multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.4004 / 0.8069 0.3472 / 0.4568 0.2967 / 0.6898 0.114 / 0.159 
θmin, ° 2.66 2.72 2.30 4.48 
θmax, ° 31.04 33.12 32.91 27.99 
Reflections     
collected 6377 7860 14259 2747 
independent 1103 1429 3457 1888 
observed 807 1112 3118 1220 
Threshold expression >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0413 0.0278 0.0277 0.0538 
wR2 (all) 0.1300 0.0719 0.0681 0.1711 
Goodness of fit (all) 1.052 1.066 1.031 1.071 
Δρ max / min 1.700 / -0.986 0.432 / -0.553 1.195 / -0.857 0.496 / -0.479 
2θ limit 27.50 30.00 32.50 25.24 
Completeness to 2θ 
limit 
0.954 0.998 0.989 0.874 
Halogen bond geometries for Haloethynylnitrobenzene compounds 
Experimental details for co-crystals 
The samples were analyzed with a Bruker APEX II system using MoKα radiation. Data 
collection was carried out using APEX2 software.1 Initial cell constants were found by small 
widely separated “matrix” runs. Data collection strategies were determined using COSMO.2 Scan 
Compound C-I/Br⋯O O⋯I/Br (Å) O⋯I,Br-C (°) 
4N-I 
C(22A)-I(1)⋯O(14A)#1 
C(22A)-I(1)⋯O(14A)#2 
3.247(5) 
3.247(5) 
160.60(10) 
160.60(10) 
4N-Br 
C(18A)-Br(1)⋯O(14A)#1 
C(18B)-Br(2)⋯O(14B)#2 
3.1751(14) 
3.13(3) 
160.07(3) 
157(5) 
3,5DN-I C(18)-I(1)⋯O(16)#1 3.0524(19) 168.15(8) 
3,5DN-Br 
C(8)-Br(1)⋯O(1) 
C(8)-Br(1)⋯O(2) 
C(8)-Br(1)⋯O(4) 
3.502(6) 
3.410(5) 
3.064(4) 
140.0(2) 
67.9(2) 
159.2(2) 
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speed and scan widths were chosen based on scattering power and peak rocking curves. All 
datasets were collected at -153 °C using an Oxford Croystream low-temperature device. 
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,3 using this 
improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT from 
the final merged dataset. Lorenz and polarization corrections were applied. Multi-scan absorption 
corrections were performed with SADABS4 unless otherwise indicated. 
Data were reduced with SHELXTL.5 The structure was solved by direct methods without 
incident. All hydrogen atoms were located in idealized positions and were treated with a riding 
model. Unless otherwise noted, non-hydrogen atoms were assigned anisotropic thermal 
parameters. Refinements continued to convergence, using the recommended weighting schemes. 
4N-I:A23 - The crystal was a non-merohedral twin, and data were processed with 
TWINABS.6 The asymmetric unit contains a half-iodo compound (located on a mirror plane), a 
quarter-diamine compound (located on a 2/m special position) and a solvent site (straddling a 2/m 
special position). Solvent was assigned as 10% ethyl acetate and 15% water. No attempt was made 
to locate the hydrogen atoms on the water. All solvent atoms shared the same isotropic thermal 
parameter. The ethyl acetate was constrained to an idealized geometry and refined as a rigid body. 
4N-I:A24 - The asymmetric unit contains an iodo compound and a half-diamine compound 
(located on an inversion center). 
4N-I:A32 - The asymmetric unit contains a single iodo compound and a single amine 
compound. 
3N-I:A25 - The asymmetric unit contains an iodo compound and a half-diamine compound 
(located on an inversion center). 
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3N-I:A31 - The asymmetric unit contains two iodo compound / amine compound pairs. 
Each pair was assigned to a SHELXL RESIdue. 
3N-I:A33 - The asymmetric unit contains an iodo compound and an amine / amine oxide 
compound. The nitro group was disordered over two closely related positions, representing wobble 
around the C-NO2 bond. Geometries of the two species were restrained with the SAME command, 
and thermal parameters were pairwise constrained using EADP commands. 
3,5DN-I:A22 - The asymmetric unit contains an iodo compound and a half-diamine 
compound (located on an inversion center). 
3,5DN-I:A2910 - Dataset was collected on an Oxford Diffraction Xcalibur four-circle 
kappa geometry single-crystal diffractometer with Sapphire 3 CCD detector, using a graphite 
monochromated MoK ( = 0.71073 Å) radiation, and applying the CrysAlisPro Software system8 
at 296 K. The crystal–detector distance was 45 mm.  
Data reduction, including Lorentz and polarization corrections as well as absorption 
correction, was done by CrysAlis RED program.8 The structure was solved by direct methods 
implemented in the SHELXS-2013 program.9 The coordinates and the anisotropic displacement 
parameters for all non-hydrogen atoms were refined by full-matrix least-squares methods based 
on F2 using the SHELXL-2013 program.8  
All hydrogen atoms were placed in geometrically idealized positions and constrained to 
ride on their carbon atom at distances of 0.93 or 0.96 Å for aromatic or methyl hydrogen atoms, 
respectively, and with Uiso(H) = 1.2Ueq(C) (for aromatic H) and Uiso(H) = 1.5Ueq(C) (for methyl 
group). 
3,5DN-I:A34 - The asymmetric unit contains an iodo compound and a half-amine / amine 
oxide compound. The latter compound straddles a crystallographic inversion center and was 
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assigned 50% occupancy. Thermal parameters for closely located atoms were pairwise constrained 
using the EADP command. 
3N-Br:A27 - The asymmetric unit contains a bromo compound and a half-diamine 
compound (located on an inversion center). 
Crystallographic data for co-crystals 
Code 4N-I:A23 4N-I:A24 4N-I:A32 3N-I:A25 3N-I:A31 
Formula moiety 
(C8H4INO2) 
(C10H8N2)1 
(C4H8O2)0.4 
(O)0.6 
(C8H4INO2) 
(C12H12N2) 
(C8H4INO2) 
(C11H9N3) 
(C8H4INO2)2 
(C12H10N2) 
(C8H4INO2) 
(C11H9N) 
Empirical formula C27.60H19.20I2N4O5.40 C28H20I2N4O4 C19H13IN4O2 C28H18I2N4O4 C19H13IN2O2 
Molecular weight 747.07 730.28 456.23 728.26 428.21 
Color, Habit yellow plate bronze plate orange plate orange plate bronze prism 
Crystal system Monoclinic Monoclinic Triclinic Monoclinic Triclinic 
Space group, Z C2/m, 2 C2/c, 4 P -1, 2 C2/c, 4 P -1, 4 
a, Å 37.367(9) 27.050(4) 6.9150(16) 30.735(4) 10.8063(11) 
b, Å 9.281(2) 6.5379(9) 7.4716(17) 4.1717(5) 11.8386(12) 
c, Å 3.9389(10) 15.045(2) 17.015(4) 24.404(3) 14.1068(15) 
α, ° 90.00 90.00 81.600(6) 90.00 75.741(3) 
β, ° 93.504(13) 90.353(3) 86.083(5) 122.674(2) 74.494(3) 
γ, ° 90.00 90.00 88.809(5) 90.00 77.324(3) 
Volume, Å3 1363.5(5) 2660.7(6) 867.6(3) 2633.9(5) 1662.5(3) 
Density, g/cm3 1.820 1.823 1.746 1.837 1.711 
Temp, °K 120(2) 120(2) 120(2) 120(2) 120(2) 
Crystal size, min x 
mid x max 
0.06 x 0.20 x 0.34 0.18 x 0.42 x 0.44 
0.240 x 0.380 x 
0.500 
0.08 x 0.28 x 0.42 
0.220 x 0.300 x 
0.420 
X-ray wavelength, 
Å 
0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 2.353 2.406 1.867 2.430 1.939 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.5017 / 0.8717 0.4174 / 0.6713 0.518 / 0.663 0.4284 / 0.8293 0.596 / 0.675 
θmin, ° 1.09 1.51 2.425 1.57 1.529 
θmax, ° 30.70 31.75 32.067 31.62 32.384 
Reflections      
collected 10251 23927 24441 18477 77079 
independent 10251 4226 5375 4178 11385 
observed 9111 3947 4820 3862 10260 
Threshold 
expression 
>2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0663 0.0184 0.0386 0.0201 0.0240 
wR2 (all) 0.1853 0.0492 0.1262 0.0582 0.0610 
Goodness of fit (all) 1.061 0.959 1.211 1.095 1.035 
Δρ max / min 3.267 / -2.547 0.600 / -0.420 1.594 / -1.417 0.503 / -0.583 1.043 / -0.677 
2θ limit 30.00 30.00 30.000 30.00 31.500 
Completeness to 2θ 
limit 
0.957 0.989 0.972 0.996 0.982 
 
Code 3N-I:A33 3,5DN-I:A22 3,5DN-I:A29 3,5DN-I:A34 3N-Br:A27 
Formula moiety 
(C8H4INO2) 
(C4H4N2O) 
(C8H3IN2O4)2 
(C8H12N2) 
(C8H3IN2O4) 
0.5(C8H12N2O2) 
(C8H3IN2O4)2 
(C8H12N2O2) 
(C8H4INO2) 
(C10H8N4) 
Empirical formula C12H8IN3O3 C24H18I2N6O8 C12H9IN3O5 C24H18I2N6O9 C26H16Br2N6O4 
Molecular weight 369.11 772.24 402.12 788.24 636.27 
Color, Habit bronze rod bronze prism colourless block red block bronze prism 
Crystal system Triclinic Triclinic Monoclinic Monoclinic Triclinic 
Space group, Z P-1, 2 P-1, 1 C2/c, 8 C 2/c, 4 P -1, 1 
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a, Å 4.0966(5) 8.1864(10) 15.4144(6) 15.1898(10) 3.8963(5) 
b, Å 11.8038(16) 8.5567(11) 8.2857(3) 8.2587(5) 11.7174(15) 
c, Å 13.4460(18) 11.0361(14) 22.9469(7) 22.1641(14) 14.7266(18) 
α, ° 98.083(4) 70.225(3) 90.00 90 70.319(3) 
β, ° 97.777(3) 72.603(3) 95.327(3) 93.6905(17) 82.570(4) 
γ, ° 94.731(3) 68.891(3) 90.00 90 87.838(4) 
Volume, Å3 634.38(14) 664.70(14) 2918.1(2) 2774.7(3) 627.73(14) 
Density, g/cm3 1.932 1.929 1.831 1.887 1.683 
Temp, °K 120(2) 120(2) 296(2) 120(2) 120(2) 
Crystal size, min x 
mid x max 
0.08 x 0.12 x 0.38 0.28 x 0.42 x 0.44 0.26 x 0.37 x 0.43 
0.240 x 0.280 x 
0.300 
0.200 x 0.360 x 
0.480 
X-ray wavelength, 
Å 
0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 2.531 2.426 2.219 2.329 3.275 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.4463 / 0.8231 0.4149 / 0.5499 0.426 / 0.573 0.473 / 0.605 0.432 / 0.560 
θmin, ° 1.75 2.00 4.60 1.841 1.846 
θmax, ° 31.49 32.03 30.84 32.597 32.591 
Reflections      
collected 16750 14426 7862 17959 18433 
independent 4002 4337 4245 4749 4237 
observed 3747 3996 3437 4565 3954 
Threshold 
expression 
>2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0278 0.0399 0.0331 0.0292 0.0298 
wR2 (all) 0.0728 0.1139 0.0775 0.0822 0.0795 
Goodness of fit (all) 1.061 1.082 0.971 1.175 1.014 
Δρ max / min 2.040 / -1.079 2.328 / -2.282 0.446 / -0.543 0.633 / -0.959 1.303 / -0.504 
2θ limit 31.49 30.00 30.00 30.000 30.000 
Completeness to 2θ 
limit 
0.955 0.994 0.995 0.987 0.994 
 
Halogen bond geometries for co-crystals 
Co-crystal C-I/Br⋯N/O I/Br⋯O/N (Å) C-I/Br⋯N/O (°) 
4N-I:A23 C(18)-I(1)⋯N(21) 2.721(5) 179.9(3) 
4N-I:A24 C(18)-I(1)⋯N(21) 2.7372(13) 174.46(5) 
4N-I:A32 C(22)-I(1)⋯N(31) 2.714(3) 178.59(13) 
3N-I:A25 C(18)-I(1)⋯N(21) 2.7549(17) 173.80(7) 
3N-I:A31 
C(221)-I(11)⋯N(311) 
C(222)-I(22)⋯N(312) 
2.7301(13) 
2.7096(14) 
175.13(5) 
175.80(5) 
3N-I:A33 C(22)-I(1)⋯N(34) 2.792(2) 176.77(8) 
3,5DN-I:A22 C(22)-I(1)⋯N(31) 2.933(3) 179.44(11) 
3,5DN-I:A29 C(8)-I(1)⋯O(5) 2.734(2) 173.4(2) 
3,5DN-I:A34 
C(18)-I(1)⋯O(31) 
C(18)-I(1)⋯N(34)#1 
2.673(3) 
3.052(5) 
171.97(10) 
169.94(12) 
3N-Br:A27 C(22)-Br(1)⋯N(31) 2.8452(13) 177.62(5) 
 
 B.6 Chapter 7 
Experimental details 
X-ray data were collected on a Bruker SMART APEX II CCD diffractometer at 120 K 
using, a fine-focus molybdenum K tube. Data were collected using APEX21 software. Initial cell 
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constants were found by small widely separated “matrix” runs. Scan speed and scan width were 
chosen based on scattering power and peak rocking curves. Unit cell constants and orientation 
matrix were improved by least-squares refinement of reflections thresholded from the entire 
dataset. Integration was performed with SAINT,3 using this improved unit cell as a starting point. 
Precise unit cell constants were calculated in SAINT from the final merged dataset. Lorenz and 
polarization corrections were applied. Laué symmetry, space group, and unit cell contents were 
found with XPREP.  Data were reduced with SHELXTL.5 The structures were solved in all cases 
by direct methods without incident. All hydrogen atoms were assigned to idealized positions and 
were allowed to ride. Heavy atoms were refined with anisotropic thermal parameters. Absorption 
correction was carried out on all datasets. 
Crystallographic data  
Code A36:D9 A37:D7 A29:D7 A38:D7 A29:D9 
Formula moiety 
(C5H5NO) 
(C6F3I3) 
(C6H7NO) 
(C6F4I2) 
(C8H12N2O2)2 
(C6F4I2)4 
(C6H7NO) 
(C6 F4I2) 
(C8H12N2O2) 
(C6F3I3)2 
Empirical formula C11H5F3I3NO C12H7F4I2NO C40H24F16I8N4O4 C12H7F4I2NO C20H12F6I6N2O2 
Molecular weight 604.86 510.99 1943.83 510.99 1187.72 
Color,  Habit colourless plate colourless prism colourless cube colourless prism colourless prism 
Crystal size, mm3 0.44 x 0.34 x 0.18 0.42 x 0.28 x 0.16 0.26 x 0.24 x 0.22 0.34 x 0.24 x 0.20 0.32 x 0.24 x 0.14 
Crystal system Monoclinic Triclinic Monoclinic Monoclinic Triclinic 
Space group,  Z P21/n, 4 P-1, 2 P21/c, 4 P21/c, 4 P-1, 1 
a, Å 12.4824(12) 7.9400(5) 14.1359(14) 7.8713(9) 7.9660(6) 
b, Å 7.3041(7) 8.5688(6) 15.1116(15) 23.203(3) 9.2821(7) 
c, Å 15.4872(16) 11.5503(8) 24.361(3) 7.8169(9) 10.1097(8) 
α, °  89.243(2)   100.812(3) 
β, ° 97.536(3) 83.738(2) 105.927(3) 92.019(4) 106.262(2) 
γ, °  65.570(2)   95.408(3) 
Volume, Å3 1399.8(2) 710.77(8) 5004.2(9) 1426.8(3) 696.28(9) 
Density, g/cm3 2.870 2.388 2.580 2.379 2.833 
Temperature, °K 120(2) 120(2) 120(2) 120(2) 120(2) 
X-ray wavelength 0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 6.723 4.463 5.064 4.447 6.755 
θmin, ° 2.25 1.77 1.60 1.76 2.15 
θmax, ° 32.54 32.57 33.14 32.66 33.13 
Reflections      
collected 13950 11235 81993 16697 18582 
independent 4568 4521 18382 5006 4468 
observed 4343 4212 16534 4805 4255 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan 
trans min / max 0.1559 / 0.3775 0.2558 / 0.5354 0.3527 / 0.4021 0.3132 / 0.4700 0.2211 / 0.4515 
Threshold 
expression 
>2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0249 0.0288 0.0341 0.0221 0.0204 
wR2 (all) 0.0586 0.0768 0.0816 0.0505 0.0530 
S 1.210 1.089 1.025 1.186 1.133 
Δρ max / min 0.854 / -1.792 2.286 / -0.812 7.622 / -6.171 0.704 / -0.679 1.535 / -0.912 
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Halogen bond geometries 
 
 B.7 Chapter 8 
Experimental details 
Datasets were collected on a Bruker APEX II system using MoKα radiation using APEX2 
software.1 Initial cell constants were found by small widely separated “matrix” runs. Data 
collection strategies were determined using COSMO.2 Scan speed and scan widths were chosen 
based on scattering power and peak rocking curves. All datasets were collected at -153 °C using 
an Oxford Croystream low-temperature device. 
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,3 using this 
improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT from 
the final merged dataset. Lorenz and polarization corrections were applied. Multi-scan absorption 
corrections were performed with SADABS.4 Data were reduced with SHELXTL.5 The structures 
were solved in all cases by direct methods without incident. Except for A29:D3, all molecules 
were fully ordered. In A29:D3 the unit cell contains two halo compounds and two half-pyrazines. 
The contents were divided into two SHELXL RESIdues for refinement. One of the four –CF2I 
Co-crystal C-I⋯O I⋯O (Å) C-I⋯O (°) 
A36:D9 
C(21)-I(21)⋯O(11) 
C(23)-I(23)⋯O(11)#2 
2.7413(0.0019) 
2.8082(19) 
176.90(8) 
179.54(9) 
A37:D7 
C(21)-I(1)⋯O(11) 
C(22)-I(2)⋯O(11)#1 
2.833(2) 
2.848(2) 
166.68(8) 
170.30(8) 
A29:D7 
C(52)-I(2)⋯O(14)#1 
C(61)-I(3)⋯O(31) 
C(71)-I(5)⋯O(14) 
C(72)-I(6)⋯O(11)#1 
C(81)-I(7)⋯O(34) 
2.893(2) 
2.854(2) 
2.918(2) 
2.889(2) 
2.870(2) 
171.12(9) 
168.41(9) 
167.54(9) 
163.06(9) 
168.44(9) 
A38:D7 
C(21)-I(1)⋯O(11) 
C(22)-I(2)⋯O(11)#1 
2.7729(17) 
2.7739(17) 
175.73(7) 
172.03(7) 
A29:D9 
C(11)-I(11)⋯O(21) 
C(13)-I(13)⋯O(21)#1 
2.7413(19) 
2.8809(18) 
173.62(8) 
170.97(8) 
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termini was slightly disordered, in an ~ 85%:15% ratio. Thermal parameter constraints and 
distance restraints were used to refine the minor species to convergence. 
Crystallographic data  
Code A29:D1 A33:D2 A29:D2 A29:D3 
Formula moiety (C8H12N2O2)(C2F4I2) (C4H4N2O)(C4F8I2) (C8H12N2O2)(C4F8I2) (C8H12N2O2)(C6F12I2)2 
Empirical formula C10H12F4I2N2O2 C8H4F8I2N2O C12H12F8I2N2O2 C20H12F24I4N2O2 
Molecular weight 522.02 549.93 622.04 1275.92 
Color, Habit colourless plate yellow prism colourless plate colourless prism 
Crystal system Monoclinic Triclinic Monoclinic Triclinic 
Space group, Z P2(1)/c, 2 P-1, 2 P2(1)/c, 2 P-1, 2 
a, Å 8.6275(16) 5.3515(5) 9.3817(10) 12.3893(14) 
b, Å 12.005(2) 11.1482(11) 12.8620(14) 12.6332(14) 
c, Å 8.3466(15) 12.0159(12) 8.1127(9) 13.1553(14) 
α, ° 90.00 85.076(2) 90.00 67.319(4) 
β, ° 118.080(5) 80.408(3) 110.521(3) 75.273(4) 
γ, ° 90.00 84.424(2) 90.00 67.884(4) 
Volume, Å3 762.7(2) 701.72(12) 916.82(17) 1745.6(3) 
Density, g/cm3 2.273 2.603 2.253 2.427 
Temperature, °K 120(2) 120(2) 120(2) 120(2) 
Crystal size, 
min x mid x max 
0.10 x 0.22 x 0.28 0.14 x 0.28 x 0.34 0.08 x 0.26 x 0.40 0.18 x 0.24 x 0.32 
X-ray wavelength, Å 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 4.167 4.571 3.517 3.723 
Absorption corr multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.3883 / 0.6807 0.3056 / 0.5670 0.3336 / 0.7662 0.3821 / 0.5538 
θmin, ° 2.68 2.61 2.32 1.69 
θmax, ° 32.03 33.72 32.95 32.11 
Reflections     
collected 11427 18809 11185 38902 
independent 2488 5086 3188 11420 
observed 2326 4597 2911 9437 
Threshold expression >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0227 0.0258 0.0230 0.0421 
wR2 (all) 0.0527 0.0723 0.0615 0.1218 
Goodness of fit (all) 1.039 1.128 1.082 0.994 
Δρ max / min 2.752 / -1.138 0.639 / -0.969 0.776 / -1.122 1.496 / -1.733 
2θ limit 31.00 30.00 30.00 30.00 
R1 (observed) 0.0227 0.0258 0.0230 0.0421 
 
Halogen bond geometries 
 
 
Co-crystal C-I⋯N/O I⋯O/N (Å) C-I⋯N/O (0) 
A29:D1 C(31)-I(1)⋯O(11) 2.7767(16) 171.75(7) 
A33:D2 
C(21)-I(1)⋯O(11) 
C(24)-I(2)⋯N(14)#1 
2.8543(18) 
2.902(2) 
163.78(8) 
177.95(10) 
A29:D2 C(31)-I(1)⋯O(11) 2.7617(16) 174.62(7) 
A29:D3 
C311-I11⋯O111 
C361-I21⋯O112 
C312-I32⋯O112 
2.812(3) 
2.770(3) 
2.810(3) 
174.45(13) 
175.87(14) 
175.72(17) 
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Experimental details 
Datasets were collected on a Bruker APEX II system using MoKa radiation using APEX2 
software.1 Initial cell constants were found by small widely separated “matrix” runs. Data 
collection strategies were determined using COSMO.2 Scan speed and scan widths were chosen 
based on scattering power and peak rocking curves. All datasets were collected at -153 °C using 
an Oxford Croystream low-temperature device. 
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,3 using this 
improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT from 
the final merged dataset. Lorenz and polarization corrections were applied. Multi-scan absorption 
corrections were performed with SADABS.4 
Data were reduced with SHELXTL.5 The structures were solved in all cases by direct 
methods without incident. Coordinates for the nitramine hydrogen atoms were allowed to refine. 
All other hydrogen atoms were located in idealized positions and were treated with a riding model. 
All non-hydrogen atoms were assigned anisotropic thermal parameters. Refinements continued to 
convergence, using the recommended weighting schemes. 
Crystallographic data  
Code EDNA:A23 EDNA:A24 EDNA:A25 EDNA:A27 EDNA:A28 EDNA:A32 
Formula moiety 
(C2H6N4O4) 
(C10H8N2) 
(C2H6N4O4) 
(C12H12N2) 
(C2H6N4O4) 
(C12H10N2) 
(C2H6N4O4) 
(C10H8N4) 
(C2H6N4O4) 
(C4H4N2O2) 
(C2H6N4O4) 
(C11H9N3)2 
Empirical formula C12H14N6O4 C14H18N6O4 C14H16N6O4 C12H14N8O4 C6H10N6O6 C24H24N10O4 
Molecular weight 306.29 334.34 332.33 334.31 262.20 516.53 
Color, Habit colourless prism colourless plate colourless prism orange plate colourless plate orange prism 
Crystal system Monoclinic Triclinic Triclinic Triclinic Triclinic Monoclinic 
Space group, Z C2/c, 8 P-1, 2 P-1, 1 P-1, 1 P-1, 1 C2/c, 4 
a, Å 24.520(4) 6.3530(4) 5.596(3) 4.6203(8) 4.9014(6) 15.959(3) 
b, Å 8.9878(14) 9.0752(6) 5.937(4) 5.9591(11) 5.5303(6) 5.9411(11) 
c, Å 13.431(2) 14.3940(10) 12.577(7) 13.434(2) 10.5912(12) 25.382(5) 
α, ° 90.00 79.611(4) 88.615(13) 82.499(7) 75.475(4) 90.00 
β, ° 112.585(9) 77.859(3) 81.533(13) 84.010(7) 89.206(5) 95.332(9) 
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Hydrogen bond geometries  
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γ, ° 90.00 79.588(3) 66.280(11) 83.819(7) 69.384(4) 90.00 
Volume, Å3 2733.0(7) 789.17(9) 378.1(4) 363.04(11) 259.23(5) 2396.2(8) 
Density, g/cm3 1.489 1.407 1.460 1.529 1.680 1.432 
Temperature, °K 120(2) 120(2) 120(2) 120(2) 120(2) 120(2) 
Crystal size, 
min x mid x max 
0.12 x 0.20 x 
0.32 
0.10 x 0.34 x 
0.42 
0.12 x 0.30 x 
0.46 
0.12 x 0.34 x 
0.48 
0.10 x 0.38 x 
0.42 
0.12 x 0.22 x 
0.38 
X-ray wavelength, Å 0.71073 0.71073 0.71073 0.71073 0.71073 0.71073 
μ, mm-1 0.115 0.106 0.111 0.119 0.150 0.103 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.9640 / 0.9863 0.9567 / 0.9894 0.9508 / 0.9868 0.9449 / 0.9858 0.9398 / 0.9852 0.9619 / 0.9877 
θmin, ° 1.80 1.46 1.64 1.54 1.99 1.61 
θmax, ° 32.02 30.99 30.67 32.08 32.08 31.56 
Reflections       
collected 13309 14843 8238 6893 3707 12455 
independent 4228 4581 2265 2269 1654 3665 
observed 2510 2983 1800 1971 1422 2609 
       
Threshold expression >2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) 
R1 (observed) 0.0536 0.0649 0.0639 0.0399 0.0388 0.0568 
wR2 (all) 0.1545 0.1832 0.1876 0.1202 0.1110 0.1760 
Goodness of fit (all) 1.038 1.069 1.366 1.079 1.076 1.106 
Δρ max / min 0.357 / -0.326 0.298 / -0.480 0.591 / -0.304 0.407 / -0.308 0.408 / -0.295 0.435 / -0.335 
2θ limit 30.00 27.50 30.67 30.00 30.00 30.00 
Completeness to 2θ 
limit 
0.983 0.990 0.973 0.984 0.977 0.959 
Co-crystal D–H⋯A/Å D–H/Å H⋯A/Å D⋯A/Å D–H⋯N/° 
EDNA:A23 
N(12)-H(12)⋯N(21) 
N(15)-H(15)⋯N(31)#1 
0.95(18) 
1.5(18) 
1.85(19) 
1.74(18) 
2.787(19) 
2.788(19) 
169.6(15) 
176.9(15) 
EDNA:A24 
N121-H121⋯N211 
N122-H122⋯N212 
0.83(2) 
0.97(2) 
1.98(2) 
1.82(2) 
2.780(2) 
2.770(2) 
164(2) 
169.2(17) 
EDNA:A25 N(12)-H(12)⋯N(21) 0.89(2) 1.87(2) 2.747(2) 167.5(19) 
EDNA:A27 N(12)-H(12)⋯N(21) 0.92(15) 1.93(15) 2.841(12) 175.0(13) 
EDNA:A28 N(12)-H(12)⋯O(21) 0.90(18) 1.86(18) 2.720(13) 159.4(16) 
EDNA:A32 N(12)-H(12)⋯N(21) 0.92(17) 1.89(17) 2.818(17) 176.4(16) 
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10. Data collection and structure solution were done at University of Zagreb, Croatia by Dr. Marijana Dakovic.  
11. Powder data collaction and structure solution were done at Max Planck Institute for Solid State Research, Germany 
by Dr. Tomce Runcevski. 
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Appendix C - IR data, DSC data and PXRD data 
 C.1 Chapter 5 
Grinding IR data for the successful co-crystal formations 
Mixture 
IR bands (cm-1) 
Shifts Δcm-1 
Halogen-bond donors Ground mixture 
A16:D2 
1192 
1041 
1178 
1048 
-14 
+7 
A16:D6 
1488 
805 
1481 
796 
-7 
-9 
A16:D7 
1309 
772 
1305 
765 
-4 
-7 
A16:D8 
1459 
941 
1456 
937 
-3 
-4 
A16:D10 
1459 
954 
1456 
950 
-3 
-4 
A17:D1 
1100 
693 
1095 
700 
-5 
+7 
A17:D2 
1192 
634 
1184 
637 
-7 
+3 
A17:D3 
1199 
1086 
1201 
1078 
+3 
-8 
A17:D6 
1488 
805 
1485 
800 
-3 
-5 
A17:D7 
1489 
1438 
1484 
1432 
-5 
-6 
A17:D8 
1459 
759 
1456 
751 
-3 
-7 
A17:D9 
1403 
1049 
1398 
1045 
-5 
-4 
A17:D10 
1219 
954 
1216 
950 
-3 
-4 
A17:D14 
1471 
772 
1459 
769 
-11 
-3 
A17:D15 
1464 
955 
1468 
959 
-4 
+3 
A18:D3 
1199 
1141 
1191 
1153 
-7 
+11 
A18:D7 
1489 
1438 
1484 
1435 
-5 
-4 
A18:D8 
1459 
759 
1453 
751 
-6 
-7 
A18:D10 
1459 
954 
1456 
944 
-3 
-10 
A18:D14 
1471 
772 
1465 
769 
-6 
-3 
A19:D1 
1100 
693 
1096 
702 
-4 
+9 
A19:D2 
1192 
1133 
1188 
1125 
-3 
-7 
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A19:D3 
1199 
1086 
1209 
1079 
+10 
-7 
A19:D4 
1204 
834 
1216 
830 
+12 
-4 
A19:D6 
1488 
805 
1484 
798 
-4 
-7 
A19:D8 
1459 
759 
1455 
752 
-4 
-7 
A19:D9 
1563 
1049 
1560 
1044 
-3 
-5 
A19:D10 
1459 
954 
1453 
949 
-6 
-7 
A20:D7 
1110 
1438 
1104 
1442 
-6 
+4 
A20:D8 
1212 
1460 
1215 
1451 
+3 
-9 
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 C.2 Chapter 6 
Analysis for IR markers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IR markers of 1-(iodoethynyl)-4-nitrobenzene 
 (4N-I) - solid 
IR markers of 1-(iodoethynyl)-4-nitrobenzene (4N-I) – solution  
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IR markers of 1-(iodoethynyl)-3-nitrobenzene (3N-I) – solid  
IR markers of 1-(iodoethynyl)-3-nitrobenzene (3N-I) – solution  
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IR markers of 1-(iodoethynyl)-3,5-dinitrobenzene 
 (3,5DN-I) – solid  
IR markers of 1-(iodoethynyl)-3,5-dinitrobenzene (3,5DN-I) – solution   
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Experimental and IR data - iodoethynylnitrobenzenes 
Code 
Combined 
stoichiometry 
IR results (wave numbers cm-1) 
Shifts 
Δ (cm-1) 
Result 
Crystal 
formation 
from 
solution 
Halogen-bond 
donor 
Co-crystal 
4N-I:A21 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2170 
1503 
1340 
+5 
+5 
+5 
Co-crystal Y 
4N-I:A22 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2168 
1500 
1338 
+3 
+2 
+3 
Co-crystal Y 
4N-I:A23 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2151 
1511 
1338 
-14 
+13 
+3 
Co-crystal Y 
4N-I:A24 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2152 
1510 
1338 
-13 
+12 
+3 
Co-crystal Y 
4N-I:A25 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2155 
1504 
1339 
-10 
+6 
+4 
Co-crystal Powder 
4N-I:A26 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2152 
1508 
1339 
-13 
+8 
+4 
Co-crystal Y 
4N-I:A27 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2152 
1510 
1336 
-13 
+12 
+1 
Co-crystal Y 
4N-I:A28 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2169 
1499 
1338 
+4 
+1 
+3 
Co-crystal Y 
4N-I:A29 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2170 
1500 
1337 
+5 
+2 
+2 
Co-crystal Y 
4N-I:A30 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2168 
1487 
1342 
+3 
-12 
+7 
Co-crystal Y 
4N-I:A31 1:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2152 
1508 
1338 
-13 
+10 
+3 
Co-crystal Y 
4N-I:A32 1:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2156 
1501 
1337 
-9 
+3 
+2 
Co-crystal Y 
4N-I:A33 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2168 
1495 
1334 
+3 
+3 
-1 
Co-crystal Y 
4N-I:A34 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2169 
1499 
1338 
+4 
+1 
+3 
Co-crystal Y 
4N-I:A35 2:1 
2165 (triple bond) 
1498 (nitro asy.) 
1335 (nitro sym.) 
2177 
1509 
1341 
+15 
+11 
+6 
Co-crystal Powder 
3N-I:A21 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2151 
1502 
1336 
-21 
-12 
-7 
Co-crystal Y 
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3N-I:A22 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2159 
1499 
1339 
-13 
-15 
-4 
Co-crystal Y 
3N-I:A23 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2163 
1519 
1347 
-9 
+5 
+4 
Co-crystal Y 
3N-I:A24 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2159 
1522 
1348 
-13 
+8 
+5 
Co-crystal Y 
3N-I:A25 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2159 
1520 
1346 
-13 
+6 
+3 
Co-crystal Y 
3N-I:A26 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2159 
1522 
1344 
-13 
+8 
+1 
Co-crystal Y 
3N-I:A27 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2168 
1519 
1346 
-4 
+5 
+3 
Co-crystal Y 
3N-I:A28 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2175 
1519 
1347 
+3 
+5 
+4 
Co-crystal Powder 
3N-I:A29 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2168 
1516 
1346 
-4 
+2 
+3 
Co-crystal Y 
3N-I:A30 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2156 
1515 
1346 
-16 
+1 
+3 
Co-crystal Y 
3N-I:A31 1:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2159 
1519 
1345 
-13 
+5 
+2 
Co-crystal Y 
3N-I:A32 1:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2177 
1515 
1346 
+5 
+1 
+3 
Co-crystal Y 
3N-I:A33 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2176 
1522 
1352 
+4 
+8 
+9 
Co-crystal Y 
3N-I:A34 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2151 
1520 
1348 
-21 
+6 
+5 
Co-crystal Y 
3N-I:A35 2:1 
2172 (triple bond) 
1514 (nitro asy.) 
1343 (nitro sym.) 
2169 
1518 
1350 
+3 
+4 
+7 
Co-crystal Y 
3,5DN-I:A21 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2159 
1533 
1339 
-8 
+8 
+3 
Co-crystal Powder 
3,5DN-I:A22 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2156 
1529 
1338 
-11 
+4 
+2 
Co-crystal Y 
3,5DN-I:A23 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2154 
1532 
1346 
-13 
+7 
+10 
Co-crystal Y 
3,5DN-I:A24 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2157 
1532 
1339 
-10 
+7 
+3 
Co-crystal Y 
3,5DN-I:A25 2:1 2167 (triple bond) 2158 -9 Co-crystal Y 
314 
 
 
1525 (nitro asy.) 
1336 (nitro sym.) 
1528 
1339 
+3 
+3 
3,5DN-I:A26 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2151 
1532 
1341 
-16 
+7 
+5 
Co-crystal Y 
3,5DN-I:A27 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2150 
1531 
1343 
-17 
+6 
+7 
Co-crystal Y 
3,5DN-I:A28 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2160 
1533 
1340 
-7 
+8 
+4 
Co-crystal Y 
3,5DN-I:A29 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2160 
1531 
1342 
-7 
+6 
+6 
Co-crystal Y 
3,5DN-I:A30 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2160 
1533 
1340 
-7 
+8 
+4 
Co-crystal Y 
3,5DN-I:A31 1:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2177 
1530 
1340 
+10 
+5 
+4 
Co-crystal Y 
3,5DN-I:A32 1:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2163 
1526 
1341 
-4 
+1 
+5 
Co-crystal Y 
3,5DN-I:A33 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2171 
1531 
1341 
+4 
+6 
+5 
Co-crystal Y 
3,5DN-I:A34 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2170 
1531 
1342 
+3 
+6 
+6 
Co-crystal Y 
3,5DN-I:A35 2:1 
2167 (triple bond) 
1525 (nitro asy.) 
1336 (nitro sym.) 
2150 
1530 
1341 
-17 
+5 
+5 
Co-crystal Powder 
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Experimental and IR data - bromoethynylnitrobenzenes 
 
 
Code 
Combined 
stoichiometry 
IR results (wave numbers cm-1) 
Shifts 
Δ (cm-1) 
Result 
Crystal 
formation 
from 
solution 
Halogen-bond 
donor 
Co-crystal 
4N-Br:A23 2:1 
2190 (triple bond) 
1502 (nitro asy.) 
1341 (nitro sym.) 
2194 
1505 
1340 
+4 
+3 
-1 
Co-crystal 
Flimsy 
crystals 
4N-Br:A24 2:1 
2190 (triple bond) 
1502 (nitro asy.) 
1341 (nitro sym.) 
2194 
1503 
1340 
+4 
-2 
-1 
Co-crystal Powder 
4N-Br:A27 2:1 
2190 (triple bond) 
1502 (nitro asy.) 
1341 (nitro sym.) 
2188 
1502 
1341 
-2 
0 
0 
Not a co-
crystal 
NA 
4N-Br:A31 1:1 
2190 (triple bond) 
1502 (nitro asy.) 
1341 (nitro sym.) 
2193 
1503 
1343 
+3 
+1 
+2 
Co-crystal 
Flimsy 
crystals 
4N-Br:A33 2:1 
2190 (triple bond) 
1502 (nitro asy.) 
1341 (nitro sym.) 
2190 
1503 
1340 
0 
+1 
-1 
Not a co-
crystal 
Flimsy 
crystals 
3N-Br:A23 2:1 
2198 (triple bond) 
1518 (nitro asy.) 
1344 (nitro sym.) 
2193 
1523 
1346 
-5 
+5 
+2 
Co-crystal Powder 
3N-Br:A24 2:1 
2198 (triple bond) 
1518 (nitro asy.) 
1344 (nitro sym.) 
2199 
1519 
1344 
+1 
+1 
0 
Not a co-
crystal 
NA 
3N-Br:A27 2:1 
2198 (triple bond) 
1518 (nitro asy.) 
1344 (nitro sym.) 
2190 
1521 
1343 
-8 
+3 
-1 
Co-crystal 
Flimsy 
crystals 
3N-Br:A31 1:1 
2198 (triple bond) 
1518 (nitro asy.) 
1344 (nitro sym.) 
2201 
1521 
1347 
+3 
+3 
+3 
Co-crystal Powder 
3N-Br:A33 2:1 
2198 (triple bond) 
1518 (nitro asy.) 
1344 (nitro sym.) 
2194 
1523 
1344 
-4 
+5 
0 
Co-crystal Gel 
3,5DN-Br:A23 2:1 
2193 (triple bond) 
1532 (nitro asy.) 
1339 (nitro sym.) 
2196 
1531 
1342 
+3 
-1 
+3 
Co-crystal Powder 
3,5DN-Br:A24 2:1 
2193 (triple bond) 
1532 (nitro asy.) 
1339 (nitro sym.) 
2193 
1533 
1340 
0 
+1 
+1 
Not a co-
crystal 
NA 
3,5DN-Br:A27 2:1 
2193 (triple bond) 
1532 (nitro asy.) 
1339 (nitro sym.) 
2197 
1534 
1341 
+4 
+2 
+2 
Co-crystal 
Flimsy 
crystals 
3,5DN-Br:A31 1:1 
2193 (triple bond) 
1532 (nitro asy.) 
1339 (nitro sym.) 
2193 
1532 
1341 
0 
0 
+2 
Not a co-
crystal 
NA 
3,5DN-Br:A33 2:1 
2193 (triple bond) 
1532 (nitro asy.) 
1339 (nitro sym.) 
2193 
1532 
1339 
0 
0 
0 
Not a co-
crystal 
NA 
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Experimental and IR data - chloroethynylnitrobenzenes 
 
 
Code 
Combined 
stoichiometry 
IR results (wave numbers cm-1) 
Shifts 
Δ (cm-1) 
Co-
crystal 
or not 
Crystal 
formation 
from 
solution 
Halogen-bond 
donor 
Co-crystal 
4N-Cl:A23 2:1 
2208 (triple bond) 
1505 (nitro asy.) 
1343 (nitro sym.) 
2210 
1507 
1341 
+2 
+2 
-2 
Not a co-
crystal 
NA 
4N-Cl :A24 2:1 
2208 (triple bond) 
1505 (nitro asy.) 
1343 (nitro sym.) 
2209 
1503 
1341 
+1 
-2 
-2 
Not a co-
crystal 
NA 
4N-Cl :A27 2:1 
2208 (triple bond) 
1505 (nitro asy.) 
1343 (nitro sym.) 
2210 
1505 
1342 
+2 
0 
-1 
Not a co-
crystal 
NA 
4N-Cl :A31 1:1 
2208 (triple bond) 
1505 (nitro asy.) 
1343 (nitro sym.) 
2209 
1507 
1343 
+1 
+2 
0 
Not a co-
crystal 
NA 
4N-Cl:A33 2:1 
2208 (triple bond) 
1505 (nitro asy.) 
1343 (nitro sym.) 
2210 
1503 
1343 
+2 
-2 
0 
Not a co-
crystal 
NA 
3N-Cl:A23 2:1 
2221 (triple bond) 
1524 (nitro asy.) 
1337 (nitro sym.) 
2221 
1526 
1339 
0 
+2 
+1 
Not a co-
crystal 
NA 
3N-Cl:A24 2:1 
2221 (triple bond) 
1524 (nitro asy.) 
1337 (nitro sym.) 
2222 
1523 
1338 
+1 
-1 
+1 
Not a co-
crystal 
NA 
3N-Cl:A27 2:1 
2221 (triple bond) 
1524 (nitro asy.) 
1337 (nitro sym.) 
2219 
1522 
1338 
-2 
-2 
+1 
Not a co-
crystal 
NA 
3N-Cl:A31 1:1 
2221 (triple bond) 
1524 (nitro asy.) 
1337 (nitro sym.) 
2221 
1523 
1338 
0 
-1 
+1 
Not a co-
crystal 
NA 
3N-Cl:A33 2:1 
2221 (triple bond) 
1524 (nitro asy.) 
1337 (nitro sym.) 
2222 
1525 
1338 
+1 
+1 
+1 
Not a co-
crystal 
NA 
3,5DN-Cl:A23 2:1 
2213 (triple bond) 
1536 (nitro asy.) 
1340 (nitro sym.) 
2215 
1534 
1338 
+2 
-2 
-2 
Not a co-
crystal 
NA 
3,5DN-Cl:A24 2:1 
2213 (triple bond) 
1536 (nitro asy.) 
1340 (nitro sym.) 
2214 
1535 
1340 
+1 
-1 
0 
Not a co-
crystal 
NA 
3,5DN-Cl:A27 2:1 
2213 (triple bond) 
1536 (nitro asy.) 
1340 (nitro sym.) 
2215 
1535 
1340 
+2 
-1 
0 
Not a co-
crystal 
NA 
3,5DN-Cl:A31 1:1 
2213 (triple bond) 
1536 (nitro asy.) 
1340 (nitro sym.) 
2211 
1534 
1340 
-2 
-2 
0 
Not a co-
crystal 
NA 
3,5DN-Cl:A33 2:1 
2213 (triple bond) 
1536 (nitro asy.) 
1340 (nitro sym.) 
2214 
1537 
1339 
+1 
+1 
-1 
Not a co-
crystal 
NA 
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 C.3 Chapter 7 
Grinding IR analysis 
Mixture 
IR bands (cm-1) 
Shifts Δcm-1 Result Halogen-bond 
donors 
Ground Mixture 
A33:D7 
1489 
1438 
813 
1486 
1430 
811 
-3 
-8 
-2 
Co-crystal 
A33:D16 
1498 
1459 
801 
1500 
1461 
802 
+2 
+2 
+1 
No co-crystal 
A33:D9 
1563 
1403 
1049 
1560 
1400 
1045 
-3 
-3 
-4 
Co-crystal 
A33:D17 
1484 
1446 
893 
No D4 present - No co-crystal 
A34:D7 
1489 
1438 
813 
1487 
1434 
810 
-2 
-4 
-3 
Co-crystal 
A34:D16 
1498 
1459 
801 
1498 
1458 
801 
0 
-1 
0 
No co-crystal 
A34:D9 
1563 
1403 
1049 
1561 
1400 
1045 
-2 
-3 
-4 
Co-crystal 
A34:D17 
1484 
1446 
893 
1484 
1447 
893 
0 
+1 
0 
No co-crystal 
A35:D7 
1489 
1438 
813 
1480 
1428 
809 
-9 
-10 
-4 
Co-crystal 
A35:D16 
1498 
1459 
801 
No D2 present - No co-crystal 
A35:D9 
1563 
1403 
1049 
1561 
1394 
1038 
-2 
-9 
-11 
Co-crystal 
A35:D17 
1484 
1446 
893 
1484 
1448 
895 
0 
-2 
-2 
No co-crystal 
A36:D7 
1489 
1438 
813 
No D7 present - No co-crystal 
A36:D16 
1498 
1459 
801 
No D16 present - No co-crystal 
A36:D9 
1563 
1403 
1049 
1560 
1397 
1043 
-3 
-6 
-6 
Co-crystal 
A36:D17 1484 No D17 present - No co-crystal 
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1446 
893 
A37:D7 
1489 
1438 
813 
1488 
1436 
812 
-1 
-2 
-1 
No co-crystal 
A37:D16 
1498 
1459 
801 
1498 
1457 
800 
0 
-2 
-1 
No co-crystal 
A37:D9 
1563 
1403 
1049 
1560 
1397 
1036 
-3 
-6 
-13 
Co-crystal 
A37:D17 
1484 
1446 
893 
No D17 present - No co-crystal 
A38:D7 
1489 
1438 
813 
1481 
1429 
811 
-8 
-9 
-2 
Co-crystal 
A38:D16 
1498 
1459 
801 
No D16 present - No co-crystal 
A38:D9 
1563 
1403 
1049 
1560 
1399 
1044 
-3 
-4 
-5 
Co-crystal 
A38:D17 
1484 
1446 
893 
1482 
1445 
891 
-2 
-1 
-2 
No co-crystal 
A28:D7 
1489 
1438 
813 
No D7 present 
 
- 
No co-crystal 
A28:D16 
1498 
1459 
801 
1500 
1458 
799 
+2 
-1 
+2 
No co-crystal 
A28:D9 
1563 
1403 
1049 
1561 
1401 
1048 
-2 
-2 
-1 
No co-crystal 
A28:D17 
1484 
1446 
893 
1482 
1445 
895 
-2 
-1 
+2 
No co-crystal 
A29:D7 
1489 
1438 
813 
1484 
1434 
811 
-5 
-4 
-2 
Co-crystal 
A29:D16 
1498 
1459 
801 
No D16 present - No co-crystal 
A29:D9 
1563 
1403 
1049 
1561 
1400 
1046 
-2 
-3 
-3 
Co-crystal 
A29:D17 
1484 
1446 
893 
No D17 present - No co-crystal 
A30:D7 
1489 
1438 
813 
1480 
1429 
803 
-9 
-9 
-10 
Co-crystal 
A30:D16 
1498 
1459 
No D16 present - No co-crystal 
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801 
A30:D9 
1563 
1403 
1049 
1561 
1394 
1038 
-2 
-7 
-9 
Co-crystal 
A30:D17 
1484 
1446 
893 
1483 
1445 
893 
-1 
-1 
0 
No co-crystal 
A39:D7 
1489 
1438 
813 
No D7 present - No co-crystal 
A39:D16 
1498 
1459 
801 
No D16 present - No co-crystal 
A39:D9 
1563 
1403 
1049 
1560 
1399 
1048 
-3 
-4 
-1 
Co-crystal 
A39:D17 
1484 
1446 
893 
1484 
1445 
891 
0 
-1 
-2 
No co-crystal 
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 C.4 Chapter 8 
IR data 
 
Comparison of IR peaks of D1 and A17 with the co-crystal D1:A17 
 
 
 
 
 
 
IR analysis of co-crystal D1:A17 for the stability 
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Comparison of IR peaks of D2 and A1 with the co-crystal D2:A1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IR analysis of co-crystal D2:A1 for the stability 
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Comparison of IR peaks of D3 and A29 with the co-crystal D3:A29 
 
 
 
 
 
 
 
 
 
 
 
 
IR analysis of co-crystal D3:A29 for the stability 
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PXRD Data 
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 C.5 Chapter 9 
DSC data  
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